Last updated: 2024-05-17
Checks: 7 0
Knit directory: ATAC_learning/
This reproducible R Markdown analysis was created with workflowr (version 1.7.1). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
Great! Since the R Markdown file has been committed to the Git repository, you know the exact version of the code that produced these results.
Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it’s best to always run the code in an empty environment.
The command set.seed(20231016) was run prior to running
the code in the R Markdown file. Setting a seed ensures that any results
that rely on randomness, e.g. subsampling or permutations, are
reproducible.
Great job! Recording the operating system, R version, and package versions is critical for reproducibility.
Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.
Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version 9fb4f9a. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish or
wflow_git_commit). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .RData
Ignored: .Rhistory
Ignored: .Rproj.user/
Ignored: data/All_merged_peaks.tsv
Ignored: data/CAD_gwas_dataframe.RDS
Ignored: data/Collapsed_expressed_NG_peak_table.csv
Ignored: data/DEG_toplist_sep_n45.RDS
Ignored: data/FRiP_first_run.txt
Ignored: data/Frip_1_reads.csv
Ignored: data/Frip_2_reads.csv
Ignored: data/Frip_3_reads.csv
Ignored: data/Frip_4_reads.csv
Ignored: data/Frip_5_reads.csv
Ignored: data/Frip_6_reads.csv
Ignored: data/GO_KEGG_analysis/
Ignored: data/Ind1_75DA24h_dedup_peaks.csv
Ignored: data/Ind1_TSS_peaks.RDS
Ignored: data/Ind1_firstfragment_files.txt
Ignored: data/Ind1_fragment_files.txt
Ignored: data/Ind1_peaks_list.RDS
Ignored: data/Ind1_summary.txt
Ignored: data/Ind2_TSS_peaks.RDS
Ignored: data/Ind2_fragment_files.txt
Ignored: data/Ind2_peaks_list.RDS
Ignored: data/Ind2_summary.txt
Ignored: data/Ind3_TSS_peaks.RDS
Ignored: data/Ind3_fragment_files.txt
Ignored: data/Ind3_peaks_list.RDS
Ignored: data/Ind3_summary.txt
Ignored: data/Ind4_79B24h_dedup_peaks.csv
Ignored: data/Ind4_TSS_peaks.RDS
Ignored: data/Ind4_V24h_fraglength.txt
Ignored: data/Ind4_fragment_files.txt
Ignored: data/Ind4_fragment_filesN.txt
Ignored: data/Ind4_peaks_list.RDS
Ignored: data/Ind4_summary.txt
Ignored: data/Ind5_TSS_peaks.RDS
Ignored: data/Ind5_fragment_files.txt
Ignored: data/Ind5_fragment_filesN.txt
Ignored: data/Ind5_peaks_list.RDS
Ignored: data/Ind5_summary.txt
Ignored: data/Ind6_TSS_peaks.RDS
Ignored: data/Ind6_fragment_files.txt
Ignored: data/Ind6_peaks_list.RDS
Ignored: data/Ind6_summary.txt
Ignored: data/Knowles_4.RDS
Ignored: data/Knowles_5.RDS
Ignored: data/Knowles_6.RDS
Ignored: data/MI_gwas.RDS
Ignored: data/SNP_supp_schneider.RDS
Ignored: data/all_TSSE_scores.RDS
Ignored: data/aln_run1_results.txt
Ignored: data/anno_ind1_DA24h.RDS
Ignored: data/anno_ind4_V24h.RDS
Ignored: data/background_n45_he_peaks.RDS
Ignored: data/cardiac_muscle_FRIP.csv
Ignored: data/cardiomyocyte_FRIP.csv
Ignored: data/cormotif_full_4_run.RDS
Ignored: data/cormotif_full_4_run_he.RDS
Ignored: data/cormotif_full_6_run.RDS
Ignored: data/cormotif_full_6_run_he.RDS
Ignored: data/cormotif_probability_45_list.csv
Ignored: data/cormotif_probability_45_list_he.csv
Ignored: data/cormotif_probability_all_6_list.csv
Ignored: data/cormotif_probability_all_6_list_he.csv
Ignored: data/embryo_heart_FRIP.csv
Ignored: data/enhancer_list_ENCFF126UHK.bed
Ignored: data/enhancerdata/
Ignored: data/filt_Peaks_efit2.RDS
Ignored: data/filt_Peaks_efit2_bl.RDS
Ignored: data/filt_Peaks_efit2_n45.RDS
Ignored: data/first_Peaksummarycounts.csv
Ignored: data/first_run_frag_counts.txt
Ignored: data/full_bedfiles/
Ignored: data/gene_ref.csv
Ignored: data/gwas_1_dataframe.RDS
Ignored: data/gwas_2_dataframe.RDS
Ignored: data/gwas_3_dataframe.RDS
Ignored: data/gwas_4_dataframe.RDS
Ignored: data/gwas_5_dataframe.RDS
Ignored: data/high_conf_peak_counts.csv
Ignored: data/high_conf_peak_counts.txt
Ignored: data/high_conf_peaks_bl_counts.txt
Ignored: data/high_conf_peaks_counts.txt
Ignored: data/hits_files/
Ignored: data/ind1_DA24hpeaks.RDS
Ignored: data/ind1_TSSE.RDS
Ignored: data/ind2_TSSE.RDS
Ignored: data/ind3_TSSE.RDS
Ignored: data/ind4_TSSE.RDS
Ignored: data/ind4_V24hpeaks.RDS
Ignored: data/ind5_TSSE.RDS
Ignored: data/ind6_TSSE.RDS
Ignored: data/initial_complete_stats_run1.txt
Ignored: data/left_ventricle_FRIP.csv
Ignored: data/mergedPeads.gff
Ignored: data/mergedPeaks.gff
Ignored: data/motif_list_full
Ignored: data/motif_list_n45
Ignored: data/motif_list_n45.RDS
Ignored: data/multiqc_fastqc_run1.txt
Ignored: data/multiqc_fastqc_run2.txt
Ignored: data/multiqc_genestat_run1.txt
Ignored: data/multiqc_genestat_run2.txt
Ignored: data/my_hc_filt_counts.RDS
Ignored: data/my_hc_filt_counts_n45.RDS
Ignored: data/n45_bedfiles/
Ignored: data/n45_files
Ignored: data/other_papers/
Ignored: data/peakAnnoList_1.RDS
Ignored: data/peakAnnoList_2.RDS
Ignored: data/peakAnnoList_24_full.RDS
Ignored: data/peakAnnoList_24_n45.RDS
Ignored: data/peakAnnoList_3.RDS
Ignored: data/peakAnnoList_3_full.RDS
Ignored: data/peakAnnoList_3_n45.RDS
Ignored: data/peakAnnoList_4.RDS
Ignored: data/peakAnnoList_5.RDS
Ignored: data/peakAnnoList_6.RDS
Ignored: data/peakAnnoList_full_motif.RDS
Ignored: data/peakAnnoList_n45_motif.RDS
Ignored: data/siglist_full.RDS
Ignored: data/siglist_n45.RDS
Ignored: data/testnames.txt
Ignored: data/toplist_6.RDS
Ignored: data/toplist_full.RDS
Ignored: data/toplist_full_DAR_6.RDS
Ignored: data/toplist_n45.RDS
Ignored: data/trimmed_seq_length.csv
Ignored: data/unclassified_full_set_peaks.RDS
Ignored: data/unclassified_n45_set_peaks.RDS
Ignored: data/xstreme/
Ignored: trimmed_Ind1_75DA24h_S7.nodup.splited.bam/
Untracked files:
Untracked: EAR_2_plot.pdf
Untracked: ESR_1_plot.pdf
Untracked: Firstcorr plotATAC.pdf
Untracked: IND1_2_3_6_corrplot.pdf
Untracked: LR_3_plot.pdf
Untracked: NR_1_plot.pdf
Untracked: analysis/Enhancer_files.Rmd
Untracked: analysis/my_hc_filt_counts.csv
Untracked: code/IGV_snapshot_code.R
Untracked: code/LongDARlist.R
Untracked: code/TSSE.R
Untracked: code/corMotifcustom.R
Untracked: code/just_for_Fun.R
Untracked: code/toplist_assembly.R
Untracked: lcpm_filtered_corplot.pdf
Untracked: log2cpmfragcount.pdf
Untracked: output/cormotif_probability_45_list.csv
Untracked: output/cormotif_probability_all_6_list.csv
Untracked: splited/
Untracked: trimmed_Ind1_75DA24h_S7.nodup.fragment.size.distribution.pdf
Untracked: trimmed_Ind1_75DA3h_S1.nodup.fragment.size.distribution.pdf
Unstaged changes:
Modified: analysis/CorMotif_data_n45.Rmd
Modified: analysis/Jaspar_motif.Rmd
Modified: analysis/Peak_analysis.Rmd
Modified: analysis/Smaller_set_DAR.Rmd
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown (analysis/GO_KEGG_analysis.Rmd) and
HTML (docs/GO_KEGG_analysis.html) files. If you’ve
configured a remote Git repository (see ?wflow_git_remote),
click on the hyperlinks in the table below to view the files as they
were in that past version.
| File | Version | Author | Date | Message |
|---|---|---|---|---|
| Rmd | 9fb4f9a | reneeisnowhere | 2024-05-17 | adding in updates from Neargenes and enhncers |
| html | 2d991d7 | reneeisnowhere | 2024-05-03 | Build site. |
| Rmd | f57f2ee | reneeisnowhere | 2024-05-03 | first update |
library(tidyverse)
# library(ggsignif)
# library(cowplot)
# library(ggpubr)
# library(sjmisc)
library(kableExtra)
library(broom)
# library(biomaRt)
library(RColorBrewer)
library(gprofiler2)
# library(qvalue)
library(ChIPseeker)
library("TxDb.Hsapiens.UCSC.hg38.knownGene")
library("org.Hs.eg.db")
# library(ATACseqQC)
library(rtracklayer)
library(edgeR)
library(ggfortify)
library(limma)
library(readr)
library(BiocGenerics)
library(gridExtra)
library(VennDiagram)
library(scales)
# library(ggVennDiagram)
# library(Cormotif)
library(BiocParallel)
library(ggpubr)
# library(devtools)
# # install_github('davetang/bedr')
# library(bedr)
library(biomaRt)peakAnnoList_n45_motif <- readRDS("data/peakAnnoList_n45_motif.RDS")
# list2env(peakAnnoList_n45_motif, envir = .GlobalEnv)
EAR_df <- as.data.frame(peakAnnoList_n45_motif$EAR_n45_gr)
EAR_df_gr <- GRanges(EAR_df)
ESR_df <- as.data.frame(peakAnnoList_n45_motif$ESR_n45_gr)
ESR_df_gr <- GRanges(ESR_df)
LR_df <- as.data.frame(peakAnnoList_n45_motif$LR_n45_gr)
LR_df_gr <- GRanges(LR_df)
NR_df <- as.data.frame(peakAnnoList_n45_motif$NR_n45_gr)
NR_df_gr <- GRanges(NR_df)
exp_neargene_table <- read_delim("data/n45_bedfiles/exp_neargene_table.tsv",
delim = "\t", escape_double = FALSE,
trim_ws = TRUE)
# col_ng_peak <- exp_neargene_table %>%
# group_by(chr, start, end, peakid) %>%
# summarise(NCBI_gene = paste(unique(ENTREZID),collapse=","),
# ensembl_ID= paste(unique(ensembl_id),collapse = ","),
# SYMBOL= paste(unique(SYMBOL),collapse = ",") ,
# dist_to_NG =min(dist_to_NG))
#
EAR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% EAR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
ESR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% ESR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
LR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% LR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
NR_NG_list <- exp_neargene_table %>%
dplyr::filter(peakid %in% NR_df$id) %>%
dplyr::select(ENTREZID) %>%
distinct()
background_df <- exp_neargene_table %>%
dplyr::select(ENTREZID) %>%
distinct()
EAR_resgenes <- readRDS("data/GO_KEGG_analysis/EAR_resgenes.RDS")
ESR_resgenes <- readRDS("data/GO_KEGG_analysis/ESR_resgenes.RDS")
LR_resgenes <- readRDS("data/GO_KEGG_analysis/LR_resgenes.RDS")
NR_resgenes <- readRDS("data/GO_KEGG_analysis/NR_resgenes.RDS")
EAR_enh_peaks_20k <- readRDS("data/enhancerdata/EAR_enh_peaks_20k.RDS")
ESR_enh_peaks_20k <- readRDS("data/enhancerdata/ESR_enh_peaks_20k.RDS")
LR_enh_peaks_20k <- readRDS("data/enhancerdata/LR_enh_peaks_20k.RDS")
NR_enh_peaks_20k <- readRDS("data/enhancerdata/NR_enh_peaks_20k.RDS")
EAR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/EAR_resgenes_20k.RDS")
EAR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/EAR_resgenes_20k_enh.RDS")
ESR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/ESR_resgenes_20k.RDS")
ESR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/ESR_resgenes_20k_enh.RDS")
LR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/LR_resgenes_20k.RDS")
LR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/LR_resgenes_20k_enh.RDS")
NR_resgenes_20k <- readRDS("data/GO_KEGG_analysis/NR_resgenes_20k.RDS")
NR_resgenes_20k_enh <- readRDS("data/GO_KEGG_analysis/NR_resgenes_20k_enh.RDS")# EAR_resgenes <- gost(query = EAR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes,"data/GO_KEGG_analysis/EAR_resgenes.RDS")
EARnom <- gostplot(EAR_resgenes, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable <- EAR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 898 | 1844 | 4.11e-28 |
| GO:BP | GO:0032502 | developmental process | 1806 | 4179 | 6.83e-26 |
| GO:BP | GO:0048856 | anatomical structure development | 1683 | 3867 | 2.86e-25 |
| GO:BP | GO:0007275 | multicellular organism development | 1413 | 3170 | 3.48e-25 |
| GO:BP | GO:0032501 | multicellular organismal process | 1918 | 4504 | 2.88e-24 |
| GO:BP | GO:0048869 | cellular developmental process | 1262 | 2804 | 8.92e-24 |
| GO:BP | GO:0030154 | cell differentiation | 1261 | 2803 | 1.02e-23 |
| GO:BP | GO:0050793 | regulation of developmental process | 809 | 1697 | 7.18e-22 |
| GO:BP | GO:0048731 | system development | 1211 | 2719 | 1.94e-20 |
| GO:BP | GO:0016477 | cell migration | 515 | 1011 | 3.91e-20 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 890 | 1924 | 1.81e-19 |
| GO:BP | GO:0007154 | cell communication | 1686 | 3983 | 1.59e-18 |
| GO:BP | GO:0023052 | signaling | 1660 | 3918 | 2.46e-18 |
| GO:BP | GO:0048699 | generation of neurons | 535 | 1076 | 3.58e-18 |
| GO:BP | GO:0040012 | regulation of locomotion | 380 | 720 | 1.16e-17 |
| GO:BP | GO:0030334 | regulation of cell migration | 357 | 668 | 1.16e-17 |
| GO:BP | GO:2000145 | regulation of cell motility | 371 | 700 | 1.19e-17 |
| GO:BP | GO:0048870 | cell motility | 549 | 1120 | 4.10e-17 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 357 | 673 | 4.96e-17 |
| GO:BP | GO:0007165 | signal transduction | 1534 | 3611 | 5.22e-17 |
| GO:BP | GO:0022008 | neurogenesis | 602 | 1251 | 8.71e-17 |
| GO:BP | GO:0040011 | locomotion | 413 | 805 | 1.25e-16 |
| GO:BP | GO:0072359 | circulatory system development | 438 | 864 | 1.52e-16 |
| GO:BP | GO:0030182 | neuron differentiation | 500 | 1014 | 4.14e-16 |
| GO:BP | GO:0048513 | animal organ development | 901 | 2004 | 1.36e-15 |
| GO:BP | GO:0050789 | regulation of biological process | 2957 | 7516 | 2.09e-15 |
| GO:BP | GO:0009888 | tissue development | 634 | 1348 | 4.41e-15 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 469 | 951 | 4.83e-15 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 452 | 913 | 8.19e-15 |
| GO:BP | GO:0050794 | regulation of cellular process | 2823 | 7153 | 8.19e-15 |
| GO:BP | GO:0065007 | biological regulation | 3028 | 7734 | 1.41e-14 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 517 | 1073 | 2.39e-14 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1900 | 4640 | 4.73e-14 |
| GO:BP | GO:0048468 | cell development | 845 | 1886 | 4.95e-14 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1571 | 3764 | 4.95e-14 |
| GO:BP | GO:0007155 | cell adhesion | 460 | 941 | 5.94e-14 |
| GO:BP | GO:0007399 | nervous system development | 800 | 1775 | 6.41e-14 |
| GO:BP | GO:0009790 | embryo development | 409 | 821 | 6.86e-14 |
| GO:BP | GO:0050896 | response to stimulus | 2170 | 5379 | 1.18e-13 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1486 | 3550 | 1.59e-13 |
| GO:BP | GO:0035239 | tube morphogenesis | 328 | 638 | 3.14e-13 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1766 | 4301 | 3.91e-13 |
| GO:BP | GO:0035295 | tube development | 391 | 787 | 5.10e-13 |
| GO:BP | GO:0034330 | cell junction organization | 286 | 545 | 7.88e-13 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 411 | 837 | 9.46e-13 |
| GO:BP | GO:0007423 | sensory organ development | 215 | 387 | 1.12e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1631 | 3954 | 1.57e-12 |
| GO:BP | GO:0010646 | regulation of cell communication | 1054 | 2444 | 1.80e-12 |
| GO:BP | GO:0048666 | neuron development | 408 | 838 | 5.95e-12 |
| GO:BP | GO:0003008 | system process | 532 | 1139 | 7.86e-12 |
| GO:BP | GO:0023051 | regulation of signaling | 1047 | 2438 | 8.93e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 302 | 591 | 9.93e-12 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 309 | 609 | 1.58e-11 |
| GO:BP | GO:0031175 | neuron projection development | 366 | 743 | 1.67e-11 |
| GO:BP | GO:0035556 | intracellular signal transduction | 854 | 1951 | 2.38e-11 |
| GO:BP | GO:0009966 | regulation of signal transduction | 938 | 2166 | 2.52e-11 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 226 | 422 | 3.57e-11 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 599 | 1314 | 4.36e-11 |
| GO:BP | GO:0000902 | cell morphogenesis | 351 | 713 | 5.76e-11 |
| GO:BP | GO:0001501 | skeletal system development | 191 | 347 | 9.68e-11 |
| GO:BP | GO:0001944 | vasculature development | 280 | 552 | 2.24e-10 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 310 | 622 | 2.24e-10 |
| GO:BP | GO:0030900 | forebrain development | 155 | 272 | 3.85e-10 |
| GO:BP | GO:0001568 | blood vessel development | 267 | 525 | 5.12e-10 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 262 | 516 | 1.02e-09 |
| GO:BP | GO:0065008 | regulation of biological quality | 820 | 1893 | 1.15e-09 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 257 | 505 | 1.15e-09 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 784 | 1801 | 1.15e-09 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 191 | 355 | 1.34e-09 |
| GO:BP | GO:0060429 | epithelium development | 377 | 792 | 2.17e-09 |
| GO:BP | GO:0007507 | heart development | 253 | 499 | 2.66e-09 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 231 | 450 | 4.42e-09 |
| GO:BP | GO:0007267 | cell-cell signaling | 494 | 1082 | 4.64e-09 |
| GO:BP | GO:0007417 | central nervous system development | 334 | 694 | 6.43e-09 |
| GO:BP | GO:0048589 | developmental growth | 252 | 501 | 7.88e-09 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 802 | 1862 | 7.88e-09 |
| GO:BP | GO:0048729 | tissue morphogenesis | 231 | 453 | 9.50e-09 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 475 | 1040 | 1.03e-08 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 242 | 479 | 1.06e-08 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 254 | 508 | 1.35e-08 |
| GO:BP | GO:0001503 | ossification | 164 | 302 | 1.35e-08 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1130 | 2717 | 1.35e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 472 | 1035 | 1.47e-08 |
| GO:BP | GO:0034329 | cell junction assembly | 173 | 323 | 1.74e-08 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 247 | 494 | 2.33e-08 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 494 | 1093 | 2.57e-08 |
| GO:BP | GO:0030030 | cell projection organization | 529 | 1182 | 3.41e-08 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 248 | 498 | 3.42e-08 |
| GO:BP | GO:0014706 | striated muscle tissue development | 122 | 213 | 3.92e-08 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 228 | 452 | 4.03e-08 |
| GO:BP | GO:0060322 | head development | 265 | 539 | 4.21e-08 |
| GO:BP | GO:0070848 | response to growth factor | 268 | 547 | 5.16e-08 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 116 | 201 | 5.44e-08 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 220 | 435 | 5.88e-08 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 541 | 1218 | 7.89e-08 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 338 | 717 | 8.14e-08 |
| GO:BP | GO:0023056 | positive regulation of signaling | 542 | 1221 | 8.33e-08 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 513 | 1150 | 1.06e-07 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 258 | 528 | 1.43e-07 |
| GO:BP | GO:0007420 | brain development | 245 | 498 | 1.69e-07 |
| GO:BP | GO:0061061 | muscle structure development | 261 | 536 | 1.72e-07 |
| GO:BP | GO:0043583 | ear development | 91 | 151 | 1.85e-07 |
| GO:BP | GO:0048880 | sensory system development | 144 | 266 | 1.96e-07 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 282 | 588 | 2.55e-07 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 101 | 173 | 2.72e-07 |
| GO:BP | GO:0001525 | angiogenesis | 194 | 381 | 2.81e-07 |
| GO:BP | GO:0001654 | eye development | 142 | 263 | 3.07e-07 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 118 | 210 | 3.07e-07 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 121 | 217 | 3.59e-07 |
| GO:BP | GO:0150063 | visual system development | 142 | 264 | 4.21e-07 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 88 | 4.53e-07 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 177 | 344 | 4.89e-07 |
| GO:BP | GO:0060284 | regulation of cell development | 273 | 570 | 5.02e-07 |
| GO:BP | GO:0051216 | cartilage development | 87 | 145 | 5.09e-07 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 527 | 1197 | 5.36e-07 |
| GO:BP | GO:0010631 | epithelial cell migration | 132 | 243 | 6.17e-07 |
| GO:BP | GO:0090132 | epithelium migration | 132 | 243 | 6.17e-07 |
| GO:BP | GO:0098609 | cell-cell adhesion | 270 | 564 | 6.20e-07 |
| GO:BP | GO:0040007 | growth | 325 | 697 | 6.25e-07 |
| GO:BP | GO:0001764 | neuron migration | 79 | 129 | 6.61e-07 |
| GO:BP | GO:0060537 | muscle tissue development | 174 | 339 | 7.73e-07 |
| GO:BP | GO:0050808 | synapse organization | 173 | 337 | 8.34e-07 |
| GO:BP | GO:0003013 | circulatory system process | 211 | 426 | 9.64e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 568 | 1306 | 1.06e-06 |
| GO:BP | GO:0042221 | response to chemical | 955 | 2304 | 1.08e-06 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 131 | 243 | 1.22e-06 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 186 | 369 | 1.35e-06 |
| GO:BP | GO:0007409 | axonogenesis | 172 | 337 | 1.51e-06 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 560 | 1289 | 1.56e-06 |
| GO:BP | GO:0048839 | inner ear development | 80 | 133 | 1.56e-06 |
| GO:BP | GO:0061564 | axon development | 187 | 372 | 1.56e-06 |
| GO:BP | GO:0060021 | roof of mouth development | 48 | 69 | 1.71e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 326 | 706 | 1.89e-06 |
| GO:BP | GO:0090130 | tissue migration | 132 | 247 | 2.04e-06 |
| GO:BP | GO:0016358 | dendrite development | 103 | 183 | 2.18e-06 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 105 | 188 | 2.76e-06 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 201 | 408 | 3.29e-06 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 204 | 416 | 4.07e-06 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 195 | 395 | 4.26e-06 |
| GO:BP | GO:0030029 | actin filament-based process | 297 | 640 | 4.36e-06 |
| GO:BP | GO:0044057 | regulation of system process | 190 | 384 | 5.04e-06 |
| GO:BP | GO:0048568 | embryonic organ development | 155 | 303 | 5.70e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 472 | 1077 | 6.07e-06 |
| GO:BP | GO:0048732 | gland development | 157 | 308 | 6.25e-06 |
| GO:BP | GO:0003007 | heart morphogenesis | 117 | 218 | 8.62e-06 |
| GO:BP | GO:0061448 | connective tissue development | 111 | 205 | 9.75e-06 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 85 | 148 | 9.75e-06 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 219 | 456 | 1.01e-05 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 177 | 358 | 1.44e-05 |
| GO:BP | GO:0007389 | pattern specification process | 146 | 286 | 1.52e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 206 | 427 | 1.53e-05 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 732 | 1751 | 1.58e-05 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 177 | 359 | 1.79e-05 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 190 | 390 | 1.90e-05 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 45 | 67 | 2.05e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 985 | 2415 | 2.05e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 121 | 230 | 2.05e-05 |
| GO:BP | GO:0007411 | axon guidance | 95 | 172 | 2.13e-05 |
| GO:BP | GO:0097485 | neuron projection guidance | 95 | 172 | 2.13e-05 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 635 | 1504 | 2.24e-05 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 103 | 190 | 2.32e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 897 | 2186 | 2.42e-05 |
| GO:BP | GO:0010033 | response to organic substance | 724 | 1736 | 2.71e-05 |
| GO:BP | GO:0021537 | telencephalon development | 105 | 195 | 2.73e-05 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 134 | 261 | 2.87e-05 |
| GO:BP | GO:0050807 | regulation of synapse organization | 95 | 173 | 2.92e-05 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 71 | 121 | 2.99e-05 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 122 | 234 | 3.23e-05 |
| GO:BP | GO:0016043 | cellular component organization | 1874 | 4802 | 3.24e-05 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 96 | 176 | 3.77e-05 |
| GO:BP | GO:0001649 | osteoblast differentiation | 95 | 174 | 4.04e-05 |
| GO:BP | GO:0009987 | cellular process | 3975 | 10686 | 4.12e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 160 | 323 | 4.12e-05 |
| GO:BP | GO:0050877 | nervous system process | 275 | 600 | 4.21e-05 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 132 | 258 | 4.23e-05 |
| GO:BP | GO:0048588 | developmental cell growth | 97 | 179 | 4.75e-05 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 149 | 298 | 4.85e-05 |
| GO:BP | GO:0008015 | blood circulation | 174 | 357 | 5.05e-05 |
| GO:BP | GO:0050890 | cognition | 112 | 213 | 5.11e-05 |
| GO:BP | GO:0000165 | MAPK cascade | 235 | 504 | 5.53e-05 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 150 | 301 | 5.61e-05 |
| GO:BP | GO:0035265 | organ growth | 73 | 127 | 5.74e-05 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1939 | 4988 | 5.76e-05 |
| GO:BP | GO:0099536 | synaptic signaling | 226 | 483 | 6.35e-05 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 16 | 17 | 6.38e-05 |
| GO:BP | GO:0006468 | protein phosphorylation | 417 | 958 | 7.02e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1057 | 2622 | 7.62e-05 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 74 | 130 | 7.84e-05 |
| GO:BP | GO:0045444 | fat cell differentiation | 96 | 179 | 9.34e-05 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 446 | 1034 | 9.54e-05 |
| GO:BP | GO:0048592 | eye morphogenesis | 63 | 107 | 9.78e-05 |
| GO:BP | GO:0051960 | regulation of nervous system development | 165 | 339 | 9.94e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 124 | 243 | 9.94e-05 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 373 | 850 | 1.00e-04 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 219 | 469 | 1.06e-04 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 105 | 200 | 1.12e-04 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 252 | 550 | 1.14e-04 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 382 | 874 | 1.18e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 548 | 1297 | 1.20e-04 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 240 | 521 | 1.20e-04 |
| GO:BP | GO:0072001 | renal system development | 124 | 244 | 1.25e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 119 | 233 | 1.44e-04 |
| GO:BP | GO:0023057 | negative regulation of signaling | 445 | 1036 | 1.58e-04 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 74 | 132 | 1.58e-04 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 201 | 428 | 1.66e-04 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 217 | 467 | 1.71e-04 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 157 | 323 | 1.82e-04 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 334 | 757 | 1.87e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 151 | 309 | 1.89e-04 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 29 | 40 | 1.92e-04 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 75 | 135 | 2.07e-04 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 147 | 300 | 2.07e-04 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 141 | 286 | 2.13e-04 |
| GO:BP | GO:0003002 | regionalization | 129 | 258 | 2.19e-04 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 61 | 105 | 2.32e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 87 | 162 | 2.32e-04 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 156 | 322 | 2.36e-04 |
| GO:BP | GO:0045165 | cell fate commitment | 82 | 151 | 2.42e-04 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 105 | 203 | 2.45e-04 |
| GO:BP | GO:0007369 | gastrulation | 77 | 140 | 2.47e-04 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 70 | 125 | 2.83e-04 |
| GO:BP | GO:0043009 | chordate embryonic development | 232 | 507 | 2.89e-04 |
| GO:BP | GO:0051049 | regulation of transport | 467 | 1098 | 2.89e-04 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 128 | 257 | 2.92e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 63 | 110 | 2.96e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 63 | 110 | 2.96e-04 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 142 | 290 | 2.96e-04 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 63 | 110 | 2.96e-04 |
| GO:BP | GO:0042592 | homeostatic process | 482 | 1137 | 3.01e-04 |
| GO:BP | GO:0022612 | gland morphogenesis | 55 | 93 | 3.04e-04 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 124 | 248 | 3.09e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 141 | 288 | 3.14e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 315 | 714 | 3.22e-04 |
| GO:BP | GO:0007610 | behavior | 196 | 420 | 3.22e-04 |
| GO:BP | GO:0002063 | chondrocyte development | 19 | 23 | 3.51e-04 |
| GO:BP | GO:0008150 | biological_process | 4156 | 11244 | 3.65e-04 |
| GO:BP | GO:0016049 | cell growth | 180 | 382 | 3.65e-04 |
| GO:BP | GO:0065009 | regulation of molecular function | 544 | 1299 | 3.81e-04 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 95 | 182 | 3.84e-04 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 49 | 81 | 3.87e-04 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 255 | 566 | 3.90e-04 |
| GO:BP | GO:0007611 | learning or memory | 98 | 189 | 3.97e-04 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 48 | 79 | 3.98e-04 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 57 | 98 | 4.00e-04 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 213 | 463 | 4.07e-04 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 213 | 463 | 4.07e-04 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 63 | 111 | 4.09e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 278 | 624 | 4.34e-04 |
| GO:BP | GO:0003281 | ventricular septum development | 43 | 69 | 4.57e-04 |
| GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 34 | 51 | 4.71e-04 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 938 | 2333 | 4.73e-04 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 60 | 105 | 4.89e-04 |
| GO:BP | GO:0099173 | postsynapse organization | 79 | 147 | 5.18e-04 |
| GO:BP | GO:0060173 | limb development | 74 | 136 | 5.42e-04 |
| GO:BP | GO:0048736 | appendage development | 74 | 136 | 5.42e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 69 | 125 | 5.53e-04 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 57 | 99 | 5.80e-04 |
| GO:BP | GO:0001822 | kidney development | 118 | 237 | 5.92e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 99 | 193 | 6.04e-04 |
| GO:BP | GO:2001222 | regulation of neuron migration | 27 | 38 | 6.25e-04 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 120 | 242 | 6.32e-04 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 91 | 175 | 6.56e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 60 | 106 | 7.00e-04 |
| GO:BP | GO:0060348 | bone development | 78 | 146 | 7.47e-04 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 40 | 64 | 7.85e-04 |
| GO:BP | GO:0003279 | cardiac septum development | 58 | 102 | 7.85e-04 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 40 | 64 | 7.85e-04 |
| GO:BP | GO:0021543 | pallium development | 73 | 135 | 7.85e-04 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 51 | 87 | 7.88e-04 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 51 | 87 | 7.88e-04 |
| GO:BP | GO:0006811 | monoatomic ion transport | 314 | 719 | 7.89e-04 |
| GO:BP | GO:0016310 | phosphorylation | 481 | 1145 | 8.12e-04 |
| GO:BP | GO:0048645 | animal organ formation | 34 | 52 | 8.12e-04 |
| GO:BP | GO:0003205 | cardiac chamber development | 80 | 151 | 8.43e-04 |
| GO:BP | GO:0032879 | regulation of localization | 594 | 1439 | 9.38e-04 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 413 | 972 | 9.46e-04 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 24 | 33 | 9.46e-04 |
| GO:BP | GO:0042476 | odontogenesis | 47 | 79 | 9.46e-04 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 82 | 156 | 9.60e-04 |
| GO:BP | GO:0031399 | regulation of protein modification process | 389 | 911 | 9.67e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 173 | 371 | 9.70e-04 |
| GO:BP | GO:0030198 | extracellular matrix organization | 111 | 223 | 9.80e-04 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 122 | 249 | 1.01e-03 |
| GO:BP | GO:0007416 | synapse assembly | 73 | 136 | 1.03e-03 |
| GO:BP | GO:0008038 | neuron recognition | 25 | 35 | 1.03e-03 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 127 | 261 | 1.04e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 176 | 379 | 1.08e-03 |
| GO:BP | GO:1990138 | neuron projection extension | 72 | 134 | 1.10e-03 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 26 | 37 | 1.11e-03 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 126 | 259 | 1.12e-03 |
| GO:BP | GO:0048663 | neuron fate commitment | 20 | 26 | 1.15e-03 |
| GO:BP | GO:0060485 | mesenchyme development | 120 | 245 | 1.16e-03 |
| GO:BP | GO:0045778 | positive regulation of ossification | 27 | 39 | 1.18e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 260 | 587 | 1.18e-03 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 50 | 86 | 1.18e-03 |
| GO:BP | GO:0043062 | extracellular structure organization | 111 | 224 | 1.19e-03 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 111 | 224 | 1.19e-03 |
| GO:BP | GO:0022029 | telencephalon cell migration | 28 | 41 | 1.22e-03 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 388 | 911 | 1.22e-03 |
| GO:BP | GO:0007612 | learning | 61 | 110 | 1.23e-03 |
| GO:BP | GO:0021885 | forebrain cell migration | 29 | 43 | 1.26e-03 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 55 | 97 | 1.27e-03 |
| GO:BP | GO:1903522 | regulation of blood circulation | 98 | 194 | 1.27e-03 |
| GO:BP | GO:0045666 | positive regulation of neuron differentiation | 36 | 57 | 1.29e-03 |
| GO:BP | GO:0044319 | wound healing, spreading of cells | 21 | 28 | 1.32e-03 |
| GO:BP | GO:0090505 | epiboly involved in wound healing | 21 | 28 | 1.32e-03 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 267 | 606 | 1.40e-03 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 135 | 282 | 1.49e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 45 | 76 | 1.49e-03 |
| GO:BP | GO:0001823 | mesonephros development | 44 | 74 | 1.57e-03 |
| GO:BP | GO:0001508 | action potential | 57 | 102 | 1.58e-03 |
| GO:BP | GO:0045995 | regulation of embryonic development | 43 | 72 | 1.63e-03 |
| GO:BP | GO:0001657 | ureteric bud development | 43 | 72 | 1.63e-03 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 23 | 32 | 1.67e-03 |
| GO:BP | GO:0072073 | kidney epithelium development | 61 | 111 | 1.67e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 50 | 87 | 1.67e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 511 | 1231 | 1.67e-03 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 209 | 463 | 1.67e-03 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 209 | 463 | 1.67e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 512 | 1234 | 1.72e-03 |
| GO:BP | GO:0030879 | mammary gland development | 55 | 98 | 1.76e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 49 | 85 | 1.76e-03 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 24 | 34 | 1.81e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 76 | 145 | 1.84e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 39 | 64 | 1.87e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 79 | 152 | 1.92e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 79 | 152 | 1.92e-03 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 25 | 36 | 1.92e-03 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 104 | 210 | 1.94e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 104 | 210 | 1.94e-03 |
| GO:BP | GO:0040008 | regulation of growth | 208 | 462 | 2.02e-03 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 97 | 194 | 2.12e-03 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 31 | 48 | 2.21e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 557 | 1354 | 2.22e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 841 | 2100 | 2.23e-03 |
| GO:BP | GO:0072164 | mesonephric tubule development | 43 | 73 | 2.39e-03 |
| GO:BP | GO:0048706 | embryonic skeletal system development | 43 | 73 | 2.39e-03 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 43 | 73 | 2.39e-03 |
| GO:BP | GO:0009611 | response to wounding | 175 | 382 | 2.44e-03 |
| GO:BP | GO:0060419 | heart growth | 42 | 71 | 2.51e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 88 | 174 | 2.64e-03 |
| GO:BP | GO:0035270 | endocrine system development | 48 | 84 | 2.68e-03 |
| GO:BP | GO:0030001 | metal ion transport | 232 | 524 | 2.76e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 58 | 106 | 2.76e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 141 | 300 | 2.76e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 53 | 95 | 2.76e-03 |
| GO:BP | GO:0048675 | axon extension | 53 | 95 | 2.76e-03 |
| GO:BP | GO:0090504 | epiboly | 21 | 29 | 2.77e-03 |
| GO:BP | GO:0003231 | cardiac ventricle development | 62 | 115 | 2.81e-03 |
| GO:BP | GO:0003170 | heart valve development | 39 | 65 | 2.83e-03 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 13 | 15 | 2.91e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 52 | 93 | 2.92e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 264 | 605 | 3.00e-03 |
| GO:BP | GO:0007517 | muscle organ development | 127 | 267 | 3.09e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 741 | 1841 | 3.11e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 45 | 78 | 3.12e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 334 | 783 | 3.20e-03 |
| GO:BP | GO:0033993 | response to lipid | 251 | 573 | 3.25e-03 |
| GO:BP | GO:0051179 | localization | 1448 | 3731 | 3.27e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 44 | 76 | 3.28e-03 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 34 | 55 | 3.34e-03 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 78 | 152 | 3.34e-03 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 34 | 55 | 3.34e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 493 | 1193 | 3.36e-03 |
| GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 17 | 22 | 3.42e-03 |
| GO:BP | GO:0042471 | ear morphogenesis | 43 | 74 | 3.43e-03 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 96 | 194 | 3.44e-03 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 230 | 521 | 3.45e-03 |
| GO:BP | GO:0006812 | monoatomic cation transport | 267 | 614 | 3.47e-03 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 54 | 98 | 3.48e-03 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 27 | 41 | 3.56e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 42 | 72 | 3.56e-03 |
| GO:BP | GO:1990089 | response to nerve growth factor | 27 | 41 | 3.56e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 27 | 41 | 3.56e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 721 | 1791 | 3.65e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 775 | 1934 | 3.77e-03 |
| GO:BP | GO:0032409 | regulation of transporter activity | 76 | 148 | 3.81e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 131 | 278 | 3.83e-03 |
| GO:BP | GO:0003015 | heart process | 100 | 204 | 3.83e-03 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 57 | 105 | 3.83e-03 |
| GO:BP | GO:0001704 | formation of primary germ layer | 52 | 94 | 3.93e-03 |
| GO:BP | GO:0003272 | endocardial cushion formation | 18 | 24 | 3.95e-03 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 85 | 169 | 3.95e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 646 | 1595 | 3.95e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 745 | 1856 | 4.05e-03 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 68 | 130 | 4.06e-03 |
| GO:BP | GO:0035115 | embryonic forelimb morphogenesis | 14 | 17 | 4.09e-03 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 55 | 101 | 4.39e-03 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 453 | 1093 | 4.47e-03 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 59 | 110 | 4.47e-03 |
| GO:BP | GO:0010092 | specification of animal organ identity | 19 | 26 | 4.47e-03 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 103 | 212 | 4.57e-03 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 273 | 633 | 5.34e-03 |
| GO:BP | GO:0060323 | head morphogenesis | 21 | 30 | 5.36e-03 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 21 | 30 | 5.36e-03 |
| GO:BP | GO:0150146 | cell junction disassembly | 15 | 19 | 5.39e-03 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 15 | 19 | 5.39e-03 |
| GO:BP | GO:0035137 | hindlimb morphogenesis | 15 | 19 | 5.39e-03 |
| GO:BP | GO:0035136 | forelimb morphogenesis | 15 | 19 | 5.39e-03 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 186 | 415 | 5.43e-03 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 64 | 122 | 5.45e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 31 | 50 | 5.59e-03 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 218 | 495 | 5.59e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 40 | 69 | 5.73e-03 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 46 | 82 | 5.73e-03 |
| GO:BP | GO:0003197 | endocardial cushion development | 29 | 46 | 5.84e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 28 | 44 | 5.93e-03 |
| GO:BP | GO:0019827 | stem cell population maintenance | 73 | 143 | 5.95e-03 |
| GO:BP | GO:0010596 | negative regulation of endothelial cell migration | 25 | 38 | 5.95e-03 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 25 | 38 | 5.95e-03 |
| GO:BP | GO:0007632 | visual behavior | 26 | 40 | 5.95e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 39 | 67 | 5.95e-03 |
| GO:BP | GO:0031290 | retinal ganglion cell axon guidance | 12 | 14 | 5.95e-03 |
| GO:BP | GO:2000725 | regulation of cardiac muscle cell differentiation | 12 | 14 | 5.95e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 66 | 127 | 6.02e-03 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 54 | 100 | 6.25e-03 |
| GO:BP | GO:0030282 | bone mineralization | 44 | 78 | 6.42e-03 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 16 | 21 | 6.43e-03 |
| GO:BP | GO:0007492 | endoderm development | 37 | 63 | 6.61e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 132 | 284 | 6.86e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 48 | 87 | 6.89e-03 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 48 | 87 | 6.89e-03 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 71 | 139 | 6.89e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 241 | 555 | 7.16e-03 |
| GO:BP | GO:0060840 | artery development | 47 | 85 | 7.38e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 47 | 85 | 7.38e-03 |
| GO:BP | GO:0031128 | developmental induction | 17 | 23 | 7.40e-03 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 211 | 480 | 7.52e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 96 | 198 | 7.53e-03 |
| GO:BP | GO:0008016 | regulation of heart contraction | 82 | 165 | 7.56e-03 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 135 | 292 | 7.61e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 41 | 72 | 7.62e-03 |
| GO:BP | GO:0048863 | stem cell differentiation | 93 | 191 | 7.66e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 777 | 1951 | 7.69e-03 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 90 | 184 | 7.80e-03 |
| GO:BP | GO:1905208 | negative regulation of cardiocyte differentiation | 10 | 11 | 7.80e-03 |
| GO:BP | GO:0038180 | nerve growth factor signaling pathway | 10 | 11 | 7.80e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 103 | 215 | 7.92e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 72 | 142 | 7.98e-03 |
| GO:BP | GO:1903689 | regulation of wound healing, spreading of epidermal cells | 8 | 8 | 7.98e-03 |
| GO:BP | GO:0060993 | kidney morphogenesis | 39 | 68 | 8.53e-03 |
| GO:BP | GO:0060047 | heart contraction | 94 | 194 | 8.66e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 80 | 161 | 8.69e-03 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 49 | 90 | 8.69e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 19 | 27 | 8.72e-03 |
| GO:BP | GO:0060325 | face morphogenesis | 19 | 27 | 8.72e-03 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 30 | 49 | 8.73e-03 |
| GO:BP | GO:0042063 | gliogenesis | 114 | 242 | 8.74e-03 |
| GO:BP | GO:0030278 | regulation of ossification | 44 | 79 | 8.76e-03 |
| GO:BP | GO:0007010 | cytoskeleton organization | 470 | 1146 | 8.83e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 38 | 66 | 8.90e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 67 | 131 | 9.03e-03 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 82 | 166 | 9.17e-03 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 48 | 88 | 9.17e-03 |
| GO:BP | GO:0048565 | digestive tract development | 48 | 88 | 9.17e-03 |
| GO:BP | GO:0098727 | maintenance of cell number | 73 | 145 | 9.21e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 338 | 805 | 9.24e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 27 | 43 | 9.39e-03 |
| GO:BP | GO:0006915 | apoptotic process | 558 | 1377 | 9.44e-03 |
| GO:BP | GO:0010171 | body morphogenesis | 26 | 41 | 9.55e-03 |
| GO:BP | GO:0021536 | diencephalon development | 25 | 39 | 9.68e-03 |
| GO:BP | GO:0048511 | rhythmic process | 105 | 221 | 9.69e-03 |
| GO:BP | GO:0008542 | visual learning | 23 | 35 | 9.69e-03 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 69 | 136 | 9.76e-03 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 51 | 95 | 9.95e-03 |
| GO:BP | GO:0051234 | establishment of localization | 1257 | 3240 | 1.01e-02 |
| GO:BP | GO:0008219 | cell death | 575 | 1423 | 1.03e-02 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 35 | 60 | 1.03e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 35 | 60 | 1.03e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 104 | 219 | 1.03e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 41 | 73 | 1.04e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 58 | 111 | 1.04e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 68 | 134 | 1.04e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 91 | 188 | 1.04e-02 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 337 | 804 | 1.05e-02 |
| GO:BP | GO:0021987 | cerebral cortex development | 50 | 93 | 1.05e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 88 | 181 | 1.06e-02 |
| GO:BP | GO:0051147 | regulation of muscle cell differentiation | 61 | 118 | 1.07e-02 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 172 | 386 | 1.10e-02 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 176 | 396 | 1.10e-02 |
| GO:BP | GO:0061572 | actin filament bundle organization | 67 | 132 | 1.12e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 15 | 20 | 1.18e-02 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 128 | 278 | 1.18e-02 |
| GO:BP | GO:0022030 | telencephalon glial cell migration | 15 | 20 | 1.18e-02 |
| GO:BP | GO:0099560 | synaptic membrane adhesion | 15 | 20 | 1.18e-02 |
| GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 15 | 20 | 1.18e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 32 | 54 | 1.18e-02 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 32 | 54 | 1.18e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 121 | 261 | 1.18e-02 |
| GO:BP | GO:0007398 | ectoderm development | 11 | 13 | 1.19e-02 |
| GO:BP | GO:0031032 | actomyosin structure organization | 89 | 184 | 1.19e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 69 | 137 | 1.20e-02 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 52 | 98 | 1.20e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 69 | 137 | 1.20e-02 |
| GO:BP | GO:0007015 | actin filament organization | 160 | 357 | 1.20e-02 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 31 | 52 | 1.22e-02 |
| GO:BP | GO:0003012 | muscle system process | 147 | 325 | 1.22e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 284 | 670 | 1.23e-02 |
| GO:BP | GO:0061035 | regulation of cartilage development | 30 | 50 | 1.28e-02 |
| GO:BP | GO:0051148 | negative regulation of muscle cell differentiation | 30 | 50 | 1.28e-02 |
| GO:BP | GO:0055123 | digestive system development | 51 | 96 | 1.28e-02 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 68 | 135 | 1.28e-02 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 93 | 194 | 1.29e-02 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 654 | 1635 | 1.29e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 85 | 175 | 1.29e-02 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 16 | 22 | 1.29e-02 |
| GO:BP | GO:0012501 | programmed cell death | 572 | 1419 | 1.30e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 61 | 119 | 1.34e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 46 | 85 | 1.35e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 36 | 63 | 1.35e-02 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 46 | 85 | 1.35e-02 |
| GO:BP | GO:0021761 | limbic system development | 46 | 85 | 1.35e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 36 | 63 | 1.35e-02 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 28 | 46 | 1.36e-02 |
| GO:BP | GO:0003407 | neural retina development | 28 | 46 | 1.36e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 57 | 110 | 1.38e-02 |
| GO:BP | GO:0030516 | regulation of axon extension | 41 | 74 | 1.38e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 41 | 74 | 1.38e-02 |
| GO:BP | GO:0017145 | stem cell division | 17 | 24 | 1.38e-02 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 27 | 44 | 1.40e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 35 | 61 | 1.42e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 78 | 159 | 1.43e-02 |
| GO:BP | GO:0042391 | regulation of membrane potential | 129 | 282 | 1.44e-02 |
| GO:BP | GO:0007623 | circadian rhythm | 75 | 152 | 1.44e-02 |
| GO:BP | GO:0086009 | membrane repolarization | 26 | 42 | 1.44e-02 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 189 | 431 | 1.44e-02 |
| GO:BP | GO:0045058 | T cell selection | 18 | 26 | 1.45e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 649 | 1624 | 1.45e-02 |
| GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 19 | 28 | 1.51e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 77 | 157 | 1.53e-02 |
| GO:BP | GO:0001759 | organ induction | 12 | 15 | 1.53e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 23 | 36 | 1.53e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 12 | 15 | 1.53e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 20 | 30 | 1.53e-02 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 22 | 34 | 1.54e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 288 | 683 | 1.55e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 65 | 129 | 1.55e-02 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 82 | 169 | 1.57e-02 |
| GO:BP | GO:0046834 | lipid phosphorylation | 9 | 10 | 1.59e-02 |
| GO:BP | GO:0060572 | morphogenesis of an epithelial bud | 9 | 10 | 1.59e-02 |
| GO:BP | GO:0061458 | reproductive system development | 97 | 205 | 1.61e-02 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 58 | 113 | 1.62e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 380 | 921 | 1.64e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 47 | 88 | 1.64e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 111 | 239 | 1.64e-02 |
| GO:BP | GO:0007254 | JNK cascade | 64 | 127 | 1.67e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 172 | 390 | 1.73e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 42 | 77 | 1.74e-02 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 31 | 53 | 1.74e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 37 | 66 | 1.75e-02 |
| GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 37 | 66 | 1.75e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 145 | 323 | 1.77e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 433 | 1060 | 1.79e-02 |
| GO:BP | GO:0042060 | wound healing | 132 | 291 | 1.79e-02 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 634 | 1588 | 1.79e-02 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 56 | 109 | 1.88e-02 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 92 | 194 | 1.92e-02 |
| GO:BP | GO:0051641 | cellular localization | 1022 | 2623 | 1.95e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 271 | 642 | 1.96e-02 |
| GO:BP | GO:0003158 | endothelium development | 52 | 100 | 1.96e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 48 | 91 | 2.01e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 48 | 91 | 2.01e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 28 | 47 | 2.02e-02 |
| GO:BP | GO:0030048 | actin filament-based movement | 55 | 107 | 2.02e-02 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 167 | 379 | 2.08e-02 |
| GO:BP | GO:0002360 | T cell lineage commitment | 14 | 19 | 2.09e-02 |
| GO:BP | GO:0021772 | olfactory bulb development | 14 | 19 | 2.09e-02 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 27 | 45 | 2.09e-02 |
| GO:BP | GO:0060512 | prostate gland morphogenesis | 14 | 19 | 2.09e-02 |
| GO:BP | GO:2000647 | negative regulation of stem cell proliferation | 14 | 19 | 2.09e-02 |
| GO:BP | GO:0048566 | embryonic digestive tract development | 14 | 19 | 2.09e-02 |
| GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 14 | 19 | 2.09e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 39 | 71 | 2.10e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 421 | 1031 | 2.10e-02 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 88 | 185 | 2.11e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 95 | 202 | 2.18e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 33 | 58 | 2.22e-02 |
| GO:BP | GO:0072028 | nephron morphogenesis | 33 | 58 | 2.22e-02 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 467 | 1152 | 2.22e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 50 | 96 | 2.24e-02 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 25 | 41 | 2.26e-02 |
| GO:BP | GO:0086011 | membrane repolarization during action potential | 15 | 21 | 2.27e-02 |
| GO:BP | GO:0021983 | pituitary gland development | 15 | 21 | 2.27e-02 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 46 | 87 | 2.29e-02 |
| GO:BP | GO:0050773 | regulation of dendrite development | 42 | 78 | 2.30e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 71 | 145 | 2.31e-02 |
| GO:BP | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 10 | 12 | 2.31e-02 |
| GO:BP | GO:0045176 | apical protein localization | 10 | 12 | 2.31e-02 |
| GO:BP | GO:0002088 | lens development in camera-type eye | 32 | 56 | 2.31e-02 |
| GO:BP | GO:0045670 | regulation of osteoclast differentiation | 24 | 39 | 2.31e-02 |
| GO:BP | GO:0032486 | Rap protein signal transduction | 10 | 12 | 2.31e-02 |
| GO:BP | GO:0014009 | glial cell proliferation | 24 | 39 | 2.31e-02 |
| GO:BP | GO:0048708 | astrocyte differentiation | 32 | 56 | 2.31e-02 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 24 | 39 | 2.31e-02 |
| GO:BP | GO:0051491 | positive regulation of filopodium assembly | 16 | 23 | 2.38e-02 |
| GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 16 | 23 | 2.38e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 604 | 1514 | 2.42e-02 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 41 | 76 | 2.43e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 45 | 85 | 2.43e-02 |
| GO:BP | GO:0001775 | cell activation | 264 | 627 | 2.51e-02 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 20 | 31 | 2.53e-02 |
| GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 20 | 31 | 2.53e-02 |
| GO:BP | GO:0060563 | neuroepithelial cell differentiation | 19 | 29 | 2.53e-02 |
| GO:BP | GO:0006810 | transport | 1154 | 2984 | 2.53e-02 |
| GO:BP | GO:0051050 | positive regulation of transport | 242 | 571 | 2.57e-02 |
| GO:BP | GO:0061180 | mammary gland epithelium development | 30 | 52 | 2.59e-02 |
| GO:BP | GO:0001708 | cell fate specification | 30 | 52 | 2.59e-02 |
| GO:BP | GO:0045927 | positive regulation of growth | 87 | 184 | 2.67e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 54 | 106 | 2.70e-02 |
| GO:BP | GO:0002011 | morphogenesis of an epithelial sheet | 29 | 50 | 2.74e-02 |
| GO:BP | GO:0042490 | mechanoreceptor differentiation | 29 | 50 | 2.74e-02 |
| GO:BP | GO:0030199 | collagen fibril organization | 29 | 50 | 2.74e-02 |
| GO:BP | GO:0006936 | muscle contraction | 116 | 255 | 2.85e-02 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 34 | 61 | 2.87e-02 |
| GO:BP | GO:0008306 | associative learning | 34 | 61 | 2.87e-02 |
| GO:BP | GO:0001656 | metanephros development | 34 | 61 | 2.87e-02 |
| GO:BP | GO:0060113 | inner ear receptor cell differentiation | 28 | 48 | 2.90e-02 |
| GO:BP | GO:0071772 | response to BMP | 59 | 118 | 2.94e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 59 | 118 | 2.94e-02 |
| GO:BP | GO:0048485 | sympathetic nervous system development | 11 | 14 | 2.94e-02 |
| GO:BP | GO:0010842 | retina layer formation | 11 | 14 | 2.94e-02 |
| GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 11 | 14 | 2.94e-02 |
| GO:BP | GO:0008347 | glial cell migration | 27 | 46 | 3.05e-02 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 27 | 46 | 3.05e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 49 | 95 | 3.05e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 99 | 214 | 3.11e-02 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 55 | 109 | 3.16e-02 |
| GO:BP | GO:0098657 | import into cell | 261 | 622 | 3.19e-02 |
| GO:BP | GO:0060324 | face development | 26 | 44 | 3.20e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 26 | 44 | 3.20e-02 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 41 | 77 | 3.22e-02 |
| GO:BP | GO:0007600 | sensory perception | 114 | 251 | 3.23e-02 |
| GO:BP | GO:0021954 | central nervous system neuron development | 32 | 57 | 3.24e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 25 | 42 | 3.36e-02 |
| GO:BP | GO:0060601 | lateral sprouting from an epithelium | 8 | 9 | 3.36e-02 |
| GO:BP | GO:1901329 | regulation of odontoblast differentiation | 8 | 9 | 3.36e-02 |
| GO:BP | GO:0045986 | negative regulation of smooth muscle contraction | 8 | 9 | 3.36e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 71 | 147 | 3.37e-02 |
| GO:BP | GO:0006935 | chemotaxis | 111 | 244 | 3.39e-02 |
| GO:BP | GO:0007498 | mesoderm development | 44 | 84 | 3.39e-02 |
| GO:BP | GO:0042330 | taxis | 111 | 244 | 3.39e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 31 | 55 | 3.44e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 23 | 38 | 3.68e-02 |
| GO:BP | GO:0061001 | regulation of dendritic spine morphogenesis | 22 | 36 | 3.84e-02 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 22 | 36 | 3.84e-02 |
| GO:BP | GO:0048704 | embryonic skeletal system morphogenesis | 29 | 51 | 3.94e-02 |
| GO:BP | GO:0001707 | mesoderm formation | 29 | 51 | 3.94e-02 |
| GO:BP | GO:0051591 | response to cAMP | 34 | 62 | 3.95e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 152 | 347 | 3.96e-02 |
| GO:BP | GO:0030509 | BMP signaling pathway | 55 | 110 | 3.96e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 100 | 218 | 3.96e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 325 | 790 | 4.01e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 86 | 184 | 4.02e-02 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 14 | 20 | 4.04e-02 |
| GO:BP | GO:0021516 | dorsal spinal cord development | 6 | 6 | 4.04e-02 |
| GO:BP | GO:0048617 | embryonic foregut morphogenesis | 6 | 6 | 4.04e-02 |
| GO:BP | GO:1901289 | succinyl-CoA catabolic process | 6 | 6 | 4.04e-02 |
| GO:BP | GO:0072178 | nephric duct morphogenesis | 6 | 6 | 4.04e-02 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 6 | 6 | 4.04e-02 |
| GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 6 | 6 | 4.04e-02 |
| GO:BP | GO:0050982 | detection of mechanical stimulus | 20 | 32 | 4.05e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 71 | 148 | 4.05e-02 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 28 | 49 | 4.13e-02 |
| GO:BP | GO:0060914 | heart formation | 19 | 30 | 4.15e-02 |
| GO:BP | GO:0033688 | regulation of osteoblast proliferation | 15 | 22 | 4.16e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 33 | 60 | 4.16e-02 |
| GO:BP | GO:0021675 | nerve development | 33 | 60 | 4.16e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 57 | 115 | 4.17e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 57 | 115 | 4.17e-02 |
| GO:BP | GO:0072006 | nephron development | 57 | 115 | 4.17e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 41 | 78 | 4.17e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 17 | 26 | 4.18e-02 |
| GO:BP | GO:0071392 | cellular response to estradiol stimulus | 16 | 24 | 4.18e-02 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 16 | 24 | 4.18e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 17 | 26 | 4.18e-02 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 16 | 24 | 4.18e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 17 | 26 | 4.18e-02 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 17 | 26 | 4.18e-02 |
| GO:BP | GO:0035282 | segmentation | 37 | 69 | 4.18e-02 |
| GO:BP | GO:0033687 | osteoblast proliferation | 17 | 26 | 4.18e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 85 | 182 | 4.19e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 44 | 85 | 4.30e-02 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 364 | 893 | 4.37e-02 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 32 | 58 | 4.38e-02 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 32 | 58 | 4.38e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 59 | 120 | 4.38e-02 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 56 | 113 | 4.43e-02 |
| GO:BP | GO:0055001 | muscle cell development | 77 | 163 | 4.43e-02 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 26 | 45 | 4.56e-02 |
| GO:BP | GO:0035331 | negative regulation of hippo signaling | 9 | 11 | 4.61e-02 |
| GO:BP | GO:0021895 | cerebral cortex neuron differentiation | 9 | 11 | 4.61e-02 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 43 | 83 | 4.62e-02 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 31 | 56 | 4.67e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 31 | 56 | 4.67e-02 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 31 | 56 | 4.67e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 354 | 868 | 4.70e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 97 | 212 | 4.70e-02 |
| GO:BP | GO:0061326 | renal tubule development | 39 | 74 | 4.75e-02 |
| GO:BP | GO:0048864 | stem cell development | 39 | 74 | 4.75e-02 |
| GO:BP | GO:0030316 | osteoclast differentiation | 35 | 65 | 4.78e-02 |
| GO:BP | GO:0051496 | positive regulation of stress fiber assembly | 25 | 43 | 4.78e-02 |
| GO:BP | GO:0009880 | embryonic pattern specification | 25 | 43 | 4.78e-02 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 68 | 142 | 4.93e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 60 | 123 | 4.97e-02 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 30 | 54 | 4.97e-02 |
EARnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 97 | 169 | 6.03e-06 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 90 | 162 | 7.47e-05 |
| KEGG | KEGG:04360 | Axon guidance | 84 | 155 | 4.62e-04 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 42 | 66 | 5.12e-04 |
| KEGG | KEGG:04520 | Adherens junction | 49 | 83 | 1.45e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 71 | 133 | 2.44e-03 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 75 | 147 | 6.33e-03 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 111 | 231 | 6.33e-03 |
| KEGG | KEGG:04726 | Serotonergic synapse | 35 | 58 | 6.33e-03 |
| KEGG | KEGG:05200 | Pathways in cancer | 177 | 391 | 6.33e-03 |
| KEGG | KEGG:05222 | Small cell lung cancer | 46 | 82 | 6.46e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 118 | 250 | 7.19e-03 |
| KEGG | KEGG:04014 | Ras signaling pathway | 81 | 164 | 9.91e-03 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 63 | 122 | 9.91e-03 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 38 | 67 | 1.24e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 48 | 90 | 1.47e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 82 | 169 | 1.47e-02 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 79 | 162 | 1.47e-02 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 38 | 69 | 2.10e-02 |
| KEGG | KEGG:04730 | Long-term depression | 24 | 39 | 2.10e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 64 | 129 | 2.22e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 37 | 68 | 2.80e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 41 | 78 | 3.73e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 53 | 106 | 3.91e-02 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 31 | 56 | 3.97e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 53 | 107 | 4.66e-02 |
# ESR_resgenes <- gost(query = ESR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes,"data/GO_KEGG_analysis/ESR_resgenes.RDS")
ESRnom <- gostplot(ESR_resgenes, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable <- ESR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 2719 | 4504 | 6.19e-51 |
| GO:BP | GO:0048856 | anatomical structure development | 2368 | 3867 | 1.05e-48 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1237 | 1844 | 1.90e-47 |
| GO:BP | GO:0032502 | developmental process | 2521 | 4179 | 2.35e-45 |
| GO:BP | GO:0007275 | multicellular organism development | 1971 | 3170 | 2.02e-44 |
| GO:BP | GO:0007154 | cell communication | 2411 | 3983 | 2.68e-44 |
| GO:BP | GO:0023052 | signaling | 2374 | 3918 | 7.47e-44 |
| GO:BP | GO:0048731 | system development | 1713 | 2719 | 3.79e-42 |
| GO:BP | GO:0007165 | signal transduction | 2187 | 3611 | 9.13e-39 |
| GO:BP | GO:0030154 | cell differentiation | 1746 | 2803 | 1.06e-38 |
| GO:BP | GO:0048869 | cellular developmental process | 1746 | 2804 | 1.33e-38 |
| GO:BP | GO:0050896 | response to stimulus | 3104 | 5379 | 5.22e-35 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2717 | 4640 | 6.46e-35 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1237 | 1924 | 5.46e-34 |
| GO:BP | GO:0009888 | tissue development | 904 | 1348 | 2.90e-33 |
| GO:BP | GO:0048513 | animal organ development | 1279 | 2004 | 3.55e-33 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 597 | 837 | 4.28e-32 |
| GO:BP | GO:0007399 | nervous system development | 1136 | 1775 | 1.60e-29 |
| GO:BP | GO:0007155 | cell adhesion | 651 | 941 | 7.22e-29 |
| GO:BP | GO:0010646 | regulation of cell communication | 1503 | 2444 | 4.76e-28 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1142 | 1801 | 2.61e-27 |
| GO:BP | GO:0023051 | regulation of signaling | 1496 | 2438 | 3.01e-27 |
| GO:BP | GO:0035295 | tube development | 553 | 787 | 7.25e-27 |
| GO:BP | GO:0072359 | circulatory system development | 599 | 864 | 8.41e-27 |
| GO:BP | GO:0016477 | cell migration | 686 | 1011 | 9.57e-27 |
| GO:BP | GO:0048468 | cell development | 1184 | 1886 | 5.73e-26 |
| GO:BP | GO:0050793 | regulation of developmental process | 1076 | 1697 | 1.61e-25 |
| GO:BP | GO:0048870 | cell motility | 745 | 1120 | 2.94e-25 |
| GO:BP | GO:0035239 | tube morphogenesis | 458 | 638 | 3.31e-25 |
| GO:BP | GO:0022008 | neurogenesis | 819 | 1251 | 9.61e-25 |
| GO:BP | GO:0003008 | system process | 752 | 1139 | 4.38e-24 |
| GO:BP | GO:0048729 | tissue morphogenesis | 340 | 453 | 6.87e-24 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 475 | 673 | 1.46e-23 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 692 | 1040 | 2.24e-23 |
| GO:BP | GO:0048699 | generation of neurons | 711 | 1076 | 8.28e-23 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 637 | 951 | 1.83e-22 |
| GO:BP | GO:0030182 | neuron differentiation | 671 | 1014 | 1.21e-21 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 842 | 1314 | 2.89e-21 |
| GO:BP | GO:0007267 | cell-cell signaling | 709 | 1082 | 2.91e-21 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1316 | 2166 | 6.52e-21 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 493 | 717 | 1.33e-20 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 607 | 913 | 3.88e-20 |
| GO:BP | GO:0030334 | regulation of cell migration | 461 | 668 | 1.15e-19 |
| GO:BP | GO:0001944 | vasculature development | 391 | 552 | 1.24e-19 |
| GO:BP | GO:0050789 | regulation of biological process | 4101 | 7516 | 3.07e-19 |
| GO:BP | GO:0040011 | locomotion | 540 | 805 | 5.25e-19 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1605 | 2717 | 7.46e-19 |
| GO:BP | GO:2000145 | regulation of cell motility | 477 | 700 | 1.07e-18 |
| GO:BP | GO:0001568 | blood vessel development | 372 | 525 | 1.07e-18 |
| GO:BP | GO:0044057 | regulation of system process | 285 | 384 | 1.07e-18 |
| GO:BP | GO:0065007 | biological regulation | 4205 | 7734 | 1.75e-18 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 422 | 609 | 1.86e-18 |
| GO:BP | GO:0040012 | regulation of locomotion | 488 | 720 | 1.89e-18 |
| GO:BP | GO:0060429 | epithelium development | 530 | 792 | 2.43e-18 |
| GO:BP | GO:0034330 | cell junction organization | 383 | 545 | 2.60e-18 |
| GO:BP | GO:0098609 | cell-cell adhesion | 394 | 564 | 3.80e-18 |
| GO:BP | GO:0050794 | regulation of cellular process | 3906 | 7153 | 1.53e-17 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 323 | 450 | 1.64e-17 |
| GO:BP | GO:0030029 | actin filament-based process | 437 | 640 | 2.59e-17 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 272 | 369 | 3.69e-17 |
| GO:BP | GO:0000902 | cell morphogenesis | 478 | 713 | 1.18e-16 |
| GO:BP | GO:0009790 | embryo development | 541 | 821 | 1.22e-16 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 664 | 1035 | 1.36e-16 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1175 | 1951 | 1.58e-16 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 685 | 1073 | 1.95e-16 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 405 | 591 | 2.08e-16 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 403 | 588 | 2.42e-16 |
| GO:BP | GO:0003013 | circulatory system process | 305 | 426 | 2.87e-16 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2429 | 4301 | 3.13e-16 |
| GO:BP | GO:0060485 | mesenchyme development | 191 | 245 | 3.48e-16 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2146 | 3764 | 3.74e-16 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2246 | 3954 | 3.89e-16 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 302 | 422 | 4.42e-16 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 354 | 508 | 5.26e-16 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2030 | 3550 | 9.49e-16 |
| GO:BP | GO:0070848 | response to growth factor | 376 | 547 | 1.55e-15 |
| GO:BP | GO:0007507 | heart development | 347 | 499 | 1.86e-15 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1120 | 1862 | 1.96e-15 |
| GO:BP | GO:0008015 | blood circulation | 260 | 357 | 2.56e-15 |
| GO:BP | GO:0065008 | regulation of biological quality | 1136 | 1893 | 2.94e-15 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 749 | 1197 | 4.69e-15 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 722 | 1150 | 6.09e-15 |
| GO:BP | GO:0048666 | neuron development | 544 | 838 | 7.15e-15 |
| GO:BP | GO:0061061 | muscle structure development | 367 | 536 | 9.31e-15 |
| GO:BP | GO:0030030 | cell projection organization | 739 | 1182 | 1.01e-14 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 362 | 528 | 1.09e-14 |
| GO:BP | GO:0031175 | neuron projection development | 488 | 743 | 1.35e-14 |
| GO:BP | GO:0014706 | striated muscle tissue development | 167 | 213 | 1.47e-14 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 158 | 200 | 2.74e-14 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 158 | 201 | 6.30e-14 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 382 | 566 | 6.89e-14 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 676 | 1077 | 6.96e-14 |
| GO:BP | GO:0001525 | angiogenesis | 271 | 381 | 7.21e-14 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 338 | 494 | 1.76e-13 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 315 | 456 | 2.20e-13 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 340 | 498 | 2.30e-13 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 322 | 469 | 3.95e-13 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 460 | 706 | 7.81e-13 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 194 | 261 | 9.34e-13 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 749 | 1218 | 1.35e-12 |
| GO:BP | GO:0023057 | negative regulation of signaling | 647 | 1036 | 1.35e-12 |
| GO:BP | GO:0007423 | sensory organ development | 271 | 387 | 1.52e-12 |
| GO:BP | GO:0023056 | positive regulation of signaling | 750 | 1221 | 1.80e-12 |
| GO:BP | GO:0007010 | cytoskeleton organization | 708 | 1146 | 1.89e-12 |
| GO:BP | GO:0051049 | regulation of transport | 681 | 1098 | 1.98e-12 |
| GO:BP | GO:0008283 | cell population proliferation | 797 | 1306 | 1.99e-12 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 645 | 1034 | 2.00e-12 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 325 | 479 | 3.29e-12 |
| GO:BP | GO:0003012 | muscle system process | 232 | 325 | 4.33e-12 |
| GO:BP | GO:0060537 | muscle tissue development | 240 | 339 | 6.98e-12 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 243 | 344 | 7.18e-12 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 407 | 622 | 1.06e-11 |
| GO:BP | GO:0042221 | response to chemical | 1336 | 2304 | 1.47e-11 |
| GO:BP | GO:0006468 | protein phosphorylation | 598 | 958 | 1.59e-11 |
| GO:BP | GO:0034329 | cell junction assembly | 229 | 323 | 1.99e-11 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 296 | 435 | 2.60e-11 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 337 | 505 | 3.26e-11 |
| GO:BP | GO:0098657 | import into cell | 405 | 622 | 3.52e-11 |
| GO:BP | GO:0007417 | central nervous system development | 446 | 694 | 4.58e-11 |
| GO:BP | GO:0048589 | developmental growth | 334 | 501 | 4.96e-11 |
| GO:BP | GO:0072001 | renal system development | 179 | 244 | 6.49e-11 |
| GO:BP | GO:0010720 | positive regulation of cell development | 219 | 309 | 6.74e-11 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 342 | 516 | 8.22e-11 |
| GO:BP | GO:0048568 | embryonic organ development | 215 | 303 | 8.93e-11 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 725 | 1193 | 1.10e-10 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 777 | 1289 | 1.75e-10 |
| GO:BP | GO:0051960 | regulation of nervous system development | 236 | 339 | 1.76e-10 |
| GO:BP | GO:0060322 | head development | 354 | 539 | 1.98e-10 |
| GO:BP | GO:0072073 | kidney epithelium development | 92 | 111 | 2.23e-10 |
| GO:BP | GO:0030001 | metal ion transport | 345 | 524 | 2.32e-10 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 600 | 972 | 2.48e-10 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 667 | 1093 | 3.12e-10 |
| GO:BP | GO:0001501 | skeletal system development | 240 | 347 | 3.22e-10 |
| GO:BP | GO:0003007 | heart morphogenesis | 161 | 218 | 3.42e-10 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 91 | 110 | 3.49e-10 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 478 | 757 | 3.61e-10 |
| GO:BP | GO:0045165 | cell fate commitment | 118 | 151 | 4.59e-10 |
| GO:BP | GO:0003205 | cardiac chamber development | 118 | 151 | 4.59e-10 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 132 | 173 | 5.78e-10 |
| GO:BP | GO:0007420 | brain development | 328 | 498 | 7.15e-10 |
| GO:BP | GO:0001822 | kidney development | 172 | 237 | 7.36e-10 |
| GO:BP | GO:0032879 | regulation of localization | 855 | 1439 | 9.26e-10 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 209 | 298 | 9.79e-10 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 261 | 386 | 1.63e-09 |
| GO:BP | GO:0001823 | mesonephros development | 65 | 74 | 1.79e-09 |
| GO:BP | GO:0006936 | muscle contraction | 182 | 255 | 1.94e-09 |
| GO:BP | GO:1903522 | regulation of blood circulation | 144 | 194 | 2.29e-09 |
| GO:BP | GO:0003231 | cardiac ventricle development | 93 | 115 | 2.36e-09 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 242 | 355 | 2.45e-09 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 299 | 452 | 2.74e-09 |
| GO:BP | GO:0072164 | mesonephric tubule development | 64 | 73 | 2.95e-09 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 64 | 73 | 2.95e-09 |
| GO:BP | GO:0060284 | regulation of cell development | 367 | 570 | 3.33e-09 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 177 | 248 | 3.47e-09 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 265 | 395 | 3.86e-09 |
| GO:BP | GO:0016310 | phosphorylation | 689 | 1145 | 4.94e-09 |
| GO:BP | GO:0001657 | ureteric bud development | 63 | 72 | 4.94e-09 |
| GO:BP | GO:0016043 | cellular component organization | 2629 | 4802 | 5.18e-09 |
| GO:BP | GO:0051179 | localization | 2071 | 3731 | 5.58e-09 |
| GO:BP | GO:0030900 | forebrain development | 191 | 272 | 5.75e-09 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 272 | 408 | 5.80e-09 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 261 | 390 | 7.69e-09 |
| GO:BP | GO:0090257 | regulation of muscle system process | 132 | 177 | 8.05e-09 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 208 | 301 | 8.37e-09 |
| GO:BP | GO:0140352 | export from cell | 379 | 594 | 8.42e-09 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 140 | 190 | 9.34e-09 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 59 | 67 | 1.06e-08 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 59 | 67 | 1.06e-08 |
| GO:BP | GO:0007409 | axonogenesis | 229 | 337 | 1.18e-08 |
| GO:BP | GO:0061448 | connective tissue development | 149 | 205 | 1.27e-08 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 196 | 282 | 1.27e-08 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 106 | 137 | 1.32e-08 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 485 | 783 | 1.39e-08 |
| GO:BP | GO:0060047 | heart contraction | 142 | 194 | 1.46e-08 |
| GO:BP | GO:0051216 | cartilage development | 111 | 145 | 1.55e-08 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 275 | 416 | 1.62e-08 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 282 | 428 | 1.62e-08 |
| GO:BP | GO:0048880 | sensory system development | 186 | 266 | 1.62e-08 |
| GO:BP | GO:0042692 | muscle cell differentiation | 220 | 323 | 1.82e-08 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 220 | 323 | 1.82e-08 |
| GO:BP | GO:0061564 | axon development | 249 | 372 | 1.82e-08 |
| GO:BP | GO:0001654 | eye development | 184 | 263 | 1.84e-08 |
| GO:BP | GO:0006810 | transport | 1673 | 2984 | 1.89e-08 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 90 | 113 | 1.89e-08 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1015 | 1751 | 2.12e-08 |
| GO:BP | GO:0050808 | synapse organization | 228 | 337 | 2.23e-08 |
| GO:BP | GO:0035265 | organ growth | 99 | 127 | 2.28e-08 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 304 | 467 | 2.31e-08 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 219 | 322 | 2.36e-08 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 335 | 521 | 2.49e-08 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1480 | 2622 | 2.65e-08 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 73 | 88 | 2.66e-08 |
| GO:BP | GO:0150063 | visual system development | 184 | 264 | 2.85e-08 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 165 | 233 | 3.35e-08 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 301 | 463 | 3.37e-08 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 301 | 463 | 3.37e-08 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 121 | 162 | 3.39e-08 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 141 | 194 | 3.39e-08 |
| GO:BP | GO:0065009 | regulation of molecular function | 768 | 1299 | 3.42e-08 |
| GO:BP | GO:0048863 | stem cell differentiation | 139 | 191 | 3.84e-08 |
| GO:BP | GO:0003015 | heart process | 147 | 204 | 3.96e-08 |
| GO:BP | GO:0060419 | heart growth | 61 | 71 | 4.05e-08 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 240 | 359 | 4.09e-08 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 117 | 156 | 4.09e-08 |
| GO:BP | GO:0040007 | growth | 434 | 697 | 4.15e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 879 | 1504 | 4.15e-08 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 199 | 290 | 4.29e-08 |
| GO:BP | GO:0097485 | neuron projection guidance | 127 | 172 | 4.29e-08 |
| GO:BP | GO:0007411 | axon guidance | 127 | 172 | 4.29e-08 |
| GO:BP | GO:0003279 | cardiac septum development | 82 | 102 | 4.35e-08 |
| GO:BP | GO:0099536 | synaptic signaling | 312 | 483 | 4.35e-08 |
| GO:BP | GO:0090130 | tissue migration | 173 | 247 | 4.71e-08 |
| GO:BP | GO:0043062 | extracellular structure organization | 159 | 224 | 4.73e-08 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 159 | 224 | 4.73e-08 |
| GO:BP | GO:0001775 | cell activation | 394 | 627 | 4.92e-08 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 239 | 358 | 5.11e-08 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 168 | 239 | 5.22e-08 |
| GO:BP | GO:0046903 | secretion | 391 | 622 | 5.28e-08 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 300 | 463 | 5.48e-08 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 300 | 463 | 5.48e-08 |
| GO:BP | GO:0071310 | cellular response to organic substance | 765 | 1297 | 6.20e-08 |
| GO:BP | GO:0045216 | cell-cell junction organization | 114 | 152 | 6.21e-08 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 381 | 605 | 6.21e-08 |
| GO:BP | GO:0030198 | extracellular matrix organization | 158 | 223 | 6.36e-08 |
| GO:BP | GO:0043009 | chordate embryonic development | 325 | 507 | 6.45e-08 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 426 | 685 | 6.91e-08 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 170 | 243 | 7.05e-08 |
| GO:BP | GO:0090132 | epithelium migration | 170 | 243 | 7.05e-08 |
| GO:BP | GO:0010631 | epithelial cell migration | 170 | 243 | 7.05e-08 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 197 | 288 | 7.18e-08 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 179 | 258 | 7.25e-08 |
| GO:BP | GO:0008016 | regulation of heart contraction | 122 | 165 | 7.25e-08 |
| GO:BP | GO:0006897 | endocytosis | 316 | 492 | 7.78e-08 |
| GO:BP | GO:0072006 | nephron development | 90 | 115 | 8.05e-08 |
| GO:BP | GO:0010033 | response to organic substance | 1002 | 1736 | 8.14e-08 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 349 | 550 | 8.55e-08 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 396 | 633 | 9.09e-08 |
| GO:BP | GO:0006816 | calcium ion transport | 181 | 262 | 9.74e-08 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 164 | 234 | 1.07e-07 |
| GO:BP | GO:0006811 | monoatomic ion transport | 444 | 719 | 1.11e-07 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1364 | 2415 | 1.12e-07 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 54 | 62 | 1.14e-07 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 190 | 278 | 1.48e-07 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 94 | 122 | 1.48e-07 |
| GO:BP | GO:0043010 | camera-type eye development | 161 | 230 | 1.68e-07 |
| GO:BP | GO:0050877 | nervous system process | 376 | 600 | 1.71e-07 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 150 | 212 | 1.77e-07 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 516 | 850 | 1.79e-07 |
| GO:BP | GO:0006915 | apoptotic process | 805 | 1377 | 1.93e-07 |
| GO:BP | GO:0060348 | bone development | 109 | 146 | 2.00e-07 |
| GO:BP | GO:0035148 | tube formation | 95 | 124 | 2.01e-07 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 135 | 188 | 2.28e-07 |
| GO:BP | GO:0061035 | regulation of cartilage development | 45 | 50 | 2.39e-07 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 285 | 442 | 2.61e-07 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 202 | 300 | 3.06e-07 |
| GO:BP | GO:0032940 | secretion by cell | 347 | 551 | 3.08e-07 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 276 | 427 | 3.18e-07 |
| GO:BP | GO:1901698 | response to nitrogen compound | 451 | 736 | 3.30e-07 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 148 | 210 | 3.30e-07 |
| GO:BP | GO:0051234 | establishment of localization | 1795 | 3240 | 3.40e-07 |
| GO:BP | GO:0008219 | cell death | 828 | 1423 | 3.56e-07 |
| GO:BP | GO:0031399 | regulation of protein modification process | 548 | 911 | 3.60e-07 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 367 | 587 | 3.67e-07 |
| GO:BP | GO:0033002 | muscle cell proliferation | 112 | 152 | 4.19e-07 |
| GO:BP | GO:0012501 | programmed cell death | 825 | 1419 | 4.62e-07 |
| GO:BP | GO:0023061 | signal release | 210 | 315 | 5.25e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 647 | 1093 | 5.44e-07 |
| GO:BP | GO:0009605 | response to external stimulus | 900 | 1559 | 5.67e-07 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 101 | 135 | 5.72e-07 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 90 | 118 | 7.05e-07 |
| GO:BP | GO:0071772 | response to BMP | 90 | 118 | 7.05e-07 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 147 | 210 | 7.29e-07 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1313 | 2333 | 7.32e-07 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 107 | 145 | 7.56e-07 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 95 | 126 | 7.75e-07 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 328 | 521 | 7.90e-07 |
| GO:BP | GO:0061326 | renal tubule development | 61 | 74 | 8.38e-07 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 191 | 284 | 8.38e-07 |
| GO:BP | GO:0051046 | regulation of secretion | 256 | 396 | 1.02e-06 |
| GO:BP | GO:0072175 | epithelial tube formation | 89 | 117 | 1.03e-06 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 54 | 64 | 1.10e-06 |
| GO:BP | GO:0001503 | ossification | 201 | 302 | 1.24e-06 |
| GO:BP | GO:1901342 | regulation of vasculature development | 139 | 198 | 1.29e-06 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 97 | 130 | 1.33e-06 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 68 | 85 | 1.35e-06 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 151 | 218 | 1.36e-06 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 131 | 185 | 1.38e-06 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 39 | 43 | 1.41e-06 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 146 | 210 | 1.55e-06 |
| GO:BP | GO:0007610 | behavior | 269 | 420 | 1.57e-06 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 129 | 182 | 1.58e-06 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 51 | 60 | 1.58e-06 |
| GO:BP | GO:0009611 | response to wounding | 247 | 382 | 1.68e-06 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 98 | 132 | 1.68e-06 |
| GO:BP | GO:0007369 | gastrulation | 103 | 140 | 1.69e-06 |
| GO:BP | GO:0007389 | pattern specification process | 191 | 286 | 1.78e-06 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 150 | 217 | 1.79e-06 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 130 | 184 | 1.86e-06 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 480 | 796 | 1.86e-06 |
| GO:BP | GO:0055085 | transmembrane transport | 549 | 921 | 1.86e-06 |
| GO:BP | GO:0030048 | actin filament-based movement | 82 | 107 | 1.90e-06 |
| GO:BP | GO:0006935 | chemotaxis | 166 | 244 | 1.95e-06 |
| GO:BP | GO:0042330 | taxis | 166 | 244 | 1.95e-06 |
| GO:BP | GO:0003281 | ventricular septum development | 57 | 69 | 1.95e-06 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 61 | 75 | 2.05e-06 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 63 | 78 | 2.05e-06 |
| GO:BP | GO:0045321 | leukocyte activation | 331 | 530 | 2.06e-06 |
| GO:BP | GO:0046777 | protein autophosphorylation | 104 | 142 | 2.07e-06 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 340 | 546 | 2.08e-06 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1069 | 1883 | 2.08e-06 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 48 | 56 | 2.17e-06 |
| GO:BP | GO:0007015 | actin filament organization | 232 | 357 | 2.19e-06 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 251 | 390 | 2.24e-06 |
| GO:BP | GO:0006812 | monoatomic cation transport | 378 | 614 | 2.31e-06 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 50 | 59 | 2.45e-06 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 74 | 95 | 2.46e-06 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 484 | 805 | 2.62e-06 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 265 | 415 | 2.69e-06 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 302 | 480 | 2.78e-06 |
| GO:BP | GO:0007517 | muscle organ development | 179 | 267 | 2.87e-06 |
| GO:BP | GO:0048839 | inner ear development | 98 | 133 | 2.92e-06 |
| GO:BP | GO:0060993 | kidney morphogenesis | 56 | 68 | 2.99e-06 |
| GO:BP | GO:0048645 | animal organ formation | 45 | 52 | 2.99e-06 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 542 | 911 | 3.04e-06 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 145 | 210 | 3.05e-06 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 483 | 804 | 3.05e-06 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 62 | 77 | 3.06e-06 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 433 | 714 | 3.17e-06 |
| GO:BP | GO:0051050 | positive regulation of transport | 353 | 571 | 3.29e-06 |
| GO:BP | GO:0043583 | ear development | 109 | 151 | 3.37e-06 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 47 | 55 | 3.45e-06 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 310 | 495 | 3.46e-06 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1078 | 1904 | 3.53e-06 |
| GO:BP | GO:0001704 | formation of primary germ layer | 73 | 94 | 3.59e-06 |
| GO:BP | GO:0042592 | homeostatic process | 665 | 1137 | 3.62e-06 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 175 | 261 | 3.77e-06 |
| GO:BP | GO:0072028 | nephron morphogenesis | 49 | 58 | 3.81e-06 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 49 | 58 | 3.81e-06 |
| GO:BP | GO:0048844 | artery morphogenesis | 49 | 58 | 3.81e-06 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 135 | 194 | 3.94e-06 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 69 | 88 | 3.99e-06 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 110 | 153 | 4.04e-06 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 51 | 61 | 4.12e-06 |
| GO:BP | GO:0061337 | cardiac conduction | 67 | 85 | 4.17e-06 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 53 | 64 | 4.37e-06 |
| GO:BP | GO:0072080 | nephron tubule development | 57 | 70 | 4.61e-06 |
| GO:BP | GO:0042391 | regulation of membrane potential | 187 | 282 | 4.61e-06 |
| GO:BP | GO:0030509 | BMP signaling pathway | 83 | 110 | 4.62e-06 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2690 | 4988 | 5.01e-06 |
| GO:BP | GO:0022612 | gland morphogenesis | 72 | 93 | 5.24e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 300 | 479 | 5.24e-06 |
| GO:BP | GO:0042060 | wound healing | 192 | 291 | 5.39e-06 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 101 | 139 | 5.46e-06 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 70 | 90 | 5.56e-06 |
| GO:BP | GO:0000165 | MAPK cascade | 314 | 504 | 5.56e-06 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 123 | 175 | 5.72e-06 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 68 | 87 | 5.90e-06 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 163 | 242 | 6.11e-06 |
| GO:BP | GO:0072009 | nephron epithelium development | 66 | 84 | 6.22e-06 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 371 | 606 | 6.31e-06 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 36 | 40 | 6.35e-06 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 27 | 28 | 6.52e-06 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 391 | 642 | 6.52e-06 |
| GO:BP | GO:0009987 | cellular process | 5561 | 10686 | 6.84e-06 |
| GO:BP | GO:0021915 | neural tube development | 97 | 133 | 6.88e-06 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 60 | 75 | 6.88e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 105 | 146 | 7.11e-06 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 80 | 106 | 7.20e-06 |
| GO:BP | GO:0031214 | biomineral tissue development | 80 | 106 | 7.20e-06 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 116 | 164 | 7.20e-06 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 272 | 431 | 7.29e-06 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 252 | 396 | 7.41e-06 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 67 | 86 | 8.72e-06 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 123 | 176 | 9.02e-06 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 47 | 56 | 9.52e-06 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 86 | 116 | 9.88e-06 |
| GO:BP | GO:0050807 | regulation of synapse organization | 121 | 173 | 1.04e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 237 | 371 | 1.07e-05 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 130 | 188 | 1.07e-05 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 196 | 300 | 1.09e-05 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 234 | 366 | 1.14e-05 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 172 | 259 | 1.15e-05 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 483 | 811 | 1.16e-05 |
| GO:BP | GO:0035108 | limb morphogenesis | 82 | 110 | 1.22e-05 |
| GO:BP | GO:0035107 | appendage morphogenesis | 82 | 110 | 1.22e-05 |
| GO:BP | GO:0060420 | regulation of heart growth | 42 | 49 | 1.23e-05 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 108 | 152 | 1.24e-05 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 22 | 22 | 1.24e-05 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 22 | 22 | 1.24e-05 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 108 | 152 | 1.24e-05 |
| GO:BP | GO:0060840 | artery development | 66 | 85 | 1.28e-05 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 412 | 683 | 1.28e-05 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 114 | 162 | 1.32e-05 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 29 | 31 | 1.32e-05 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 64 | 82 | 1.35e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1222 | 2186 | 1.35e-05 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 135 | 197 | 1.39e-05 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 46 | 55 | 1.49e-05 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 60 | 76 | 1.50e-05 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 223 | 348 | 1.58e-05 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 118 | 169 | 1.58e-05 |
| GO:BP | GO:0048588 | developmental cell growth | 124 | 179 | 1.61e-05 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 146 | 216 | 1.71e-05 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 81 | 109 | 1.72e-05 |
| GO:BP | GO:0007498 | mesoderm development | 65 | 84 | 1.90e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 105 | 148 | 1.92e-05 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 89 | 122 | 1.92e-05 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 79 | 106 | 1.92e-05 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 25 | 26 | 2.07e-05 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 92 | 127 | 2.10e-05 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 31 | 34 | 2.12e-05 |
| GO:BP | GO:0003161 | cardiac conduction system development | 31 | 34 | 2.12e-05 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 165 | 249 | 2.25e-05 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 240 | 379 | 2.29e-05 |
| GO:BP | GO:1905314 | semi-lunar valve development | 36 | 41 | 2.29e-05 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 45 | 54 | 2.33e-05 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 45 | 54 | 2.33e-05 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 45 | 54 | 2.33e-05 |
| GO:BP | GO:0010817 | regulation of hormone levels | 205 | 318 | 2.33e-05 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 73 | 97 | 2.61e-05 |
| GO:BP | GO:0048732 | gland development | 199 | 308 | 2.64e-05 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 137 | 202 | 2.70e-05 |
| GO:BP | GO:0046879 | hormone secretion | 137 | 202 | 2.70e-05 |
| GO:BP | GO:0048771 | tissue remodeling | 83 | 113 | 2.73e-05 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 83 | 113 | 2.73e-05 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 38 | 44 | 2.74e-05 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 99 | 139 | 2.85e-05 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 186 | 286 | 3.07e-05 |
| GO:BP | GO:0048041 | focal adhesion assembly | 60 | 77 | 3.18e-05 |
| GO:BP | GO:0050865 | regulation of cell activation | 221 | 347 | 3.25e-05 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 117 | 169 | 3.29e-05 |
| GO:BP | GO:0001649 | osteoblast differentiation | 120 | 174 | 3.29e-05 |
| GO:BP | GO:0015833 | peptide transport | 123 | 179 | 3.29e-05 |
| GO:BP | GO:0031644 | regulation of nervous system process | 58 | 74 | 3.33e-05 |
| GO:BP | GO:0048864 | stem cell development | 58 | 74 | 3.33e-05 |
| GO:BP | GO:0042471 | ear morphogenesis | 58 | 74 | 3.33e-05 |
| GO:BP | GO:0046649 | lymphocyte activation | 276 | 444 | 3.36e-05 |
| GO:BP | GO:0048592 | eye morphogenesis | 79 | 107 | 3.41e-05 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 24 | 25 | 3.65e-05 |
| GO:BP | GO:0003170 | heart valve development | 52 | 65 | 3.77e-05 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 115 | 166 | 3.77e-05 |
| GO:BP | GO:0035296 | regulation of tube diameter | 75 | 101 | 4.29e-05 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 125 | 183 | 4.29e-05 |
| GO:BP | GO:0035150 | regulation of tube size | 75 | 101 | 4.29e-05 |
| GO:BP | GO:0097746 | blood vessel diameter maintenance | 75 | 101 | 4.29e-05 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 96 | 135 | 4.45e-05 |
| GO:BP | GO:0006813 | potassium ion transport | 96 | 135 | 4.45e-05 |
| GO:BP | GO:0003002 | regionalization | 169 | 258 | 4.65e-05 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 91 | 127 | 4.83e-05 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 152 | 229 | 4.83e-05 |
| GO:BP | GO:0009914 | hormone transport | 139 | 207 | 5.02e-05 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 39 | 46 | 5.02e-05 |
| GO:BP | GO:0048878 | chemical homeostasis | 401 | 670 | 5.04e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 160 | 243 | 5.41e-05 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 143 | 214 | 5.43e-05 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 238 | 379 | 5.89e-05 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 49 | 61 | 5.89e-05 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1040 | 1856 | 6.19e-05 |
| GO:BP | GO:0030097 | hemopoiesis | 375 | 624 | 6.22e-05 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 60 | 78 | 6.44e-05 |
| GO:BP | GO:0031032 | actomyosin structure organization | 125 | 184 | 6.44e-05 |
| GO:BP | GO:0003272 | endocardial cushion formation | 23 | 24 | 6.53e-05 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 173 | 266 | 6.68e-05 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 442 | 746 | 6.76e-05 |
| GO:BP | GO:0048736 | appendage development | 96 | 136 | 7.25e-05 |
| GO:BP | GO:0060173 | limb development | 96 | 136 | 7.25e-05 |
| GO:BP | GO:0014812 | muscle cell migration | 56 | 72 | 7.43e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1031 | 1841 | 7.75e-05 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 19 | 19 | 7.75e-05 |
| GO:BP | GO:0014032 | neural crest cell development | 54 | 69 | 7.88e-05 |
| GO:BP | GO:0006939 | smooth muscle contraction | 54 | 69 | 7.88e-05 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 38 | 45 | 8.03e-05 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 83 | 115 | 8.09e-05 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 83 | 115 | 8.09e-05 |
| GO:BP | GO:0042110 | T cell activation | 195 | 305 | 8.59e-05 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 40 | 48 | 8.60e-05 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 73 | 99 | 8.60e-05 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 86 | 120 | 8.61e-05 |
| GO:BP | GO:0055001 | muscle cell development | 112 | 163 | 8.88e-05 |
| GO:BP | GO:0001707 | mesoderm formation | 42 | 51 | 8.89e-05 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 48 | 60 | 8.89e-05 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 42 | 51 | 8.89e-05 |
| GO:BP | GO:0045666 | positive regulation of neuron differentiation | 46 | 57 | 9.01e-05 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 612 | 1060 | 9.15e-05 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 119 | 175 | 9.88e-05 |
| GO:BP | GO:0006949 | syncytium formation | 33 | 38 | 1.00e-04 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 101 | 145 | 1.01e-04 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 521 | 893 | 1.02e-04 |
| GO:BP | GO:0008544 | epidermis development | 139 | 209 | 1.04e-04 |
| GO:BP | GO:0008150 | biological_process | 5821 | 11244 | 1.13e-04 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 22 | 23 | 1.15e-04 |
| GO:BP | GO:0002063 | chondrocyte development | 22 | 23 | 1.15e-04 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 130 | 194 | 1.16e-04 |
| GO:BP | GO:0060541 | respiratory system development | 111 | 162 | 1.17e-04 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 85 | 119 | 1.18e-04 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 72 | 98 | 1.21e-04 |
| GO:BP | GO:0030010 | establishment of cell polarity | 88 | 124 | 1.24e-04 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 37 | 44 | 1.27e-04 |
| GO:BP | GO:0060976 | coronary vasculature development | 37 | 44 | 1.27e-04 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 595 | 1031 | 1.31e-04 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 94 | 134 | 1.31e-04 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 112 | 164 | 1.33e-04 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 47 | 59 | 1.34e-04 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 135 | 203 | 1.39e-04 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 43 | 53 | 1.39e-04 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 179 | 279 | 1.47e-04 |
| GO:BP | GO:0003158 | endothelium development | 73 | 100 | 1.50e-04 |
| GO:BP | GO:0002790 | peptide secretion | 113 | 166 | 1.52e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 95 | 136 | 1.54e-04 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 101 | 146 | 1.57e-04 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1001 | 1791 | 1.61e-04 |
| GO:BP | GO:0003176 | aortic valve development | 32 | 37 | 1.63e-04 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 76 | 105 | 1.63e-04 |
| GO:BP | GO:0050708 | regulation of protein secretion | 120 | 178 | 1.64e-04 |
| GO:BP | GO:0021537 | telencephalon development | 130 | 195 | 1.66e-04 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 87 | 123 | 1.67e-04 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 27 | 30 | 1.72e-04 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 102 | 148 | 1.81e-04 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 198 | 313 | 1.85e-04 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 88 | 125 | 2.00e-04 |
| GO:BP | GO:0048663 | neuron fate commitment | 24 | 26 | 2.04e-04 |
| GO:BP | GO:0010092 | specification of animal organ identity | 24 | 26 | 2.04e-04 |
| GO:BP | GO:0003177 | pulmonary valve development | 21 | 22 | 2.04e-04 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 94 | 135 | 2.07e-04 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 44 | 55 | 2.09e-04 |
| GO:BP | GO:0003197 | endocardial cushion development | 38 | 46 | 2.09e-04 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 44 | 55 | 2.09e-04 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 40 | 49 | 2.13e-04 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 129 | 194 | 2.14e-04 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 165 | 256 | 2.18e-04 |
| GO:BP | GO:2000648 | positive regulation of stem cell proliferation | 29 | 33 | 2.21e-04 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 29 | 33 | 2.21e-04 |
| GO:BP | GO:0061572 | actin filament bundle organization | 92 | 132 | 2.37e-04 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 104 | 152 | 2.37e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 170 | 265 | 2.39e-04 |
| GO:BP | GO:0048565 | digestive tract development | 65 | 88 | 2.39e-04 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 81 | 114 | 2.51e-04 |
| GO:BP | GO:0036211 | protein modification process | 1263 | 2291 | 2.54e-04 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 73 | 101 | 2.55e-04 |
| GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 17 | 17 | 2.58e-04 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 84 | 119 | 2.60e-04 |
| GO:BP | GO:0140253 | cell-cell fusion | 31 | 36 | 2.61e-04 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 31 | 36 | 2.61e-04 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 31 | 36 | 2.61e-04 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 31 | 36 | 2.61e-04 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 63 | 85 | 2.66e-04 |
| GO:BP | GO:0007492 | endoderm development | 49 | 63 | 2.68e-04 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 76 | 106 | 2.70e-04 |
| GO:BP | GO:1990138 | neuron projection extension | 93 | 134 | 2.72e-04 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 47 | 60 | 2.85e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 47 | 60 | 2.85e-04 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 71 | 98 | 2.87e-04 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 33 | 39 | 2.90e-04 |
| GO:BP | GO:0071774 | response to fibroblast growth factor | 61 | 82 | 2.96e-04 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 66 | 90 | 2.96e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 143 | 219 | 2.97e-04 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 177 | 278 | 2.97e-04 |
| GO:BP | GO:0006954 | inflammatory response | 260 | 425 | 3.08e-04 |
| GO:BP | GO:0032835 | glomerulus development | 43 | 54 | 3.11e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 43 | 54 | 3.11e-04 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 91 | 131 | 3.11e-04 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 77 | 108 | 3.23e-04 |
| GO:BP | GO:0042476 | odontogenesis | 59 | 79 | 3.27e-04 |
| GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 59 | 79 | 3.27e-04 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 64 | 87 | 3.30e-04 |
| GO:BP | GO:0014020 | primary neural tube formation | 64 | 87 | 3.30e-04 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 64 | 87 | 3.30e-04 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 64 | 87 | 3.30e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 167 | 261 | 3.35e-04 |
| GO:BP | GO:0050863 | regulation of T cell activation | 134 | 204 | 3.45e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 263 | 431 | 3.51e-04 |
| GO:BP | GO:0002064 | epithelial cell development | 101 | 148 | 3.51e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 95 | 138 | 3.58e-04 |
| GO:BP | GO:0001841 | neural tube formation | 67 | 92 | 3.63e-04 |
| GO:BP | GO:0010721 | negative regulation of cell development | 121 | 182 | 3.74e-04 |
| GO:BP | GO:0060349 | bone morphogenesis | 55 | 73 | 4.03e-04 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 65 | 89 | 4.13e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 60 | 81 | 4.16e-04 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 122 | 184 | 4.16e-04 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 30 | 35 | 4.16e-04 |
| GO:BP | GO:0030072 | peptide hormone secretion | 109 | 162 | 4.32e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 140 | 215 | 4.32e-04 |
| GO:BP | GO:0045444 | fat cell differentiation | 119 | 179 | 4.33e-04 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 53 | 70 | 4.40e-04 |
| GO:BP | GO:0016049 | cell growth | 235 | 382 | 4.40e-04 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 53 | 70 | 4.40e-04 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 53 | 70 | 4.40e-04 |
| GO:BP | GO:0043616 | keratinocyte proliferation | 32 | 38 | 4.56e-04 |
| GO:BP | GO:0099173 | postsynapse organization | 100 | 147 | 4.61e-04 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 97 | 142 | 4.69e-04 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 25 | 28 | 4.70e-04 |
| GO:BP | GO:0098739 | import across plasma membrane | 85 | 122 | 4.70e-04 |
| GO:BP | GO:0030073 | insulin secretion | 94 | 137 | 4.72e-04 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 34 | 41 | 4.78e-04 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 34 | 41 | 4.78e-04 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 40 | 50 | 4.78e-04 |
| GO:BP | GO:0034332 | adherens junction organization | 36 | 44 | 4.89e-04 |
| GO:BP | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 66 | 91 | 5.02e-04 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 66 | 91 | 5.02e-04 |
| GO:BP | GO:0009306 | protein secretion | 161 | 252 | 5.06e-04 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 161 | 252 | 5.06e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 49 | 64 | 5.24e-04 |
| GO:BP | GO:0016358 | dendrite development | 121 | 183 | 5.26e-04 |
| GO:BP | GO:0030324 | lung development | 98 | 144 | 5.28e-04 |
| GO:BP | GO:0055123 | digestive system development | 69 | 96 | 5.36e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 47 | 61 | 5.69e-04 |
| GO:BP | GO:0042063 | gliogenesis | 155 | 242 | 5.80e-04 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 122 | 185 | 5.82e-04 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 159 | 249 | 5.83e-04 |
| GO:BP | GO:0042886 | amide transport | 133 | 204 | 6.02e-04 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 378 | 642 | 6.10e-04 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 654 | 1152 | 6.14e-04 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 81 | 116 | 6.18e-04 |
| GO:BP | GO:0007416 | synapse assembly | 93 | 136 | 6.18e-04 |
| GO:BP | GO:0051051 | negative regulation of transport | 180 | 286 | 6.18e-04 |
| GO:BP | GO:0051235 | maintenance of location | 160 | 251 | 6.25e-04 |
| GO:BP | GO:0032526 | response to retinoic acid | 57 | 77 | 6.51e-04 |
| GO:BP | GO:0001666 | response to hypoxia | 149 | 232 | 6.58e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 120 | 182 | 6.71e-04 |
| GO:BP | GO:0030323 | respiratory tube development | 100 | 148 | 6.76e-04 |
| GO:BP | GO:0001708 | cell fate specification | 41 | 52 | 6.91e-04 |
| GO:BP | GO:0001570 | vasculogenesis | 50 | 66 | 6.93e-04 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 79 | 113 | 7.12e-04 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 91 | 133 | 7.15e-04 |
| GO:BP | GO:0030100 | regulation of endocytosis | 128 | 196 | 7.32e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 35 | 43 | 7.54e-04 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 155 | 243 | 7.73e-04 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 247 | 406 | 7.73e-04 |
| GO:BP | GO:0007215 | glutamate receptor signaling pathway | 24 | 27 | 7.79e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 262 | 433 | 7.82e-04 |
| GO:BP | GO:0043542 | endothelial cell migration | 115 | 174 | 8.14e-04 |
| GO:BP | GO:0006836 | neurotransmitter transport | 92 | 135 | 8.15e-04 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 58 | 79 | 8.16e-04 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 148 | 231 | 8.16e-04 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 172 | 273 | 8.17e-04 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 89 | 130 | 8.22e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 86 | 125 | 8.28e-04 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 66 | 92 | 8.36e-04 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 66 | 92 | 8.36e-04 |
| GO:BP | GO:0001759 | organ induction | 15 | 15 | 8.36e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 126 | 193 | 8.37e-04 |
| GO:BP | GO:0010001 | glial cell differentiation | 119 | 181 | 8.45e-04 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 119 | 181 | 8.45e-04 |
| GO:BP | GO:0060606 | tube closure | 61 | 84 | 8.84e-04 |
| GO:BP | GO:0035270 | endocrine system development | 61 | 84 | 8.84e-04 |
| GO:BP | GO:0010876 | lipid localization | 186 | 298 | 8.84e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 195 | 314 | 8.99e-04 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 329 | 555 | 9.01e-04 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 56 | 76 | 9.06e-04 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 56 | 76 | 9.06e-04 |
| GO:BP | GO:0060914 | heart formation | 26 | 30 | 9.27e-04 |
| GO:BP | GO:0002791 | regulation of peptide secretion | 90 | 132 | 9.27e-04 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 42 | 54 | 9.55e-04 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 49 | 65 | 9.86e-04 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 49 | 65 | 9.86e-04 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 128 | 197 | 9.95e-04 |
| GO:BP | GO:0051047 | positive regulation of secretion | 132 | 204 | 1.02e-03 |
| GO:BP | GO:0030031 | cell projection assembly | 269 | 447 | 1.03e-03 |
| GO:BP | GO:1901652 | response to peptide | 225 | 368 | 1.03e-03 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 28 | 33 | 1.04e-03 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 18 | 19 | 1.06e-03 |
| GO:BP | GO:0001764 | neuron migration | 88 | 129 | 1.07e-03 |
| GO:BP | GO:0001755 | neural crest cell migration | 38 | 48 | 1.07e-03 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 38 | 48 | 1.07e-03 |
| GO:BP | GO:0140115 | export across plasma membrane | 38 | 48 | 1.07e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 76 | 109 | 1.08e-03 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 47 | 62 | 1.08e-03 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 101 | 151 | 1.08e-03 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 79 | 114 | 1.08e-03 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 30 | 36 | 1.10e-03 |
| GO:BP | GO:0002376 | immune system process | 789 | 1410 | 1.12e-03 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 52 | 70 | 1.13e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 52 | 70 | 1.13e-03 |
| GO:BP | GO:0040008 | regulation of growth | 277 | 462 | 1.13e-03 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 228 | 374 | 1.17e-03 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 68 | 96 | 1.18e-03 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 243 | 401 | 1.19e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 263 | 437 | 1.19e-03 |
| GO:BP | GO:0051641 | cellular localization | 1428 | 2623 | 1.19e-03 |
| GO:BP | GO:0007611 | learning or memory | 123 | 189 | 1.20e-03 |
| GO:BP | GO:0001843 | neural tube closure | 60 | 83 | 1.20e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 60 | 83 | 1.20e-03 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 77 | 111 | 1.24e-03 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 363 | 619 | 1.24e-03 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 50 | 67 | 1.25e-03 |
| GO:BP | GO:0051588 | regulation of neurotransmitter transport | 50 | 67 | 1.25e-03 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 50 | 67 | 1.25e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 55 | 75 | 1.25e-03 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 131 | 203 | 1.25e-03 |
| GO:BP | GO:0045927 | positive regulation of growth | 120 | 184 | 1.26e-03 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 43 | 56 | 1.27e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 53 | 72 | 1.42e-03 |
| GO:BP | GO:0014902 | myotube differentiation | 61 | 85 | 1.47e-03 |
| GO:BP | GO:1902414 | protein localization to cell junction | 61 | 85 | 1.47e-03 |
| GO:BP | GO:0060563 | neuroepithelial cell differentiation | 25 | 29 | 1.48e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 25 | 29 | 1.48e-03 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 39 | 50 | 1.49e-03 |
| GO:BP | GO:0023019 | signal transduction involved in regulation of gene expression | 14 | 14 | 1.50e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 229 | 377 | 1.51e-03 |
| GO:BP | GO:0090276 | regulation of peptide hormone secretion | 88 | 130 | 1.57e-03 |
| GO:BP | GO:0046888 | negative regulation of hormone secretion | 37 | 47 | 1.58e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 216 | 354 | 1.61e-03 |
| GO:BP | GO:1905207 | regulation of cardiocyte differentiation | 20 | 22 | 1.61e-03 |
| GO:BP | GO:0048333 | mesodermal cell differentiation | 20 | 22 | 1.61e-03 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 20 | 22 | 1.61e-03 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 27 | 32 | 1.63e-03 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 27 | 32 | 1.63e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 35 | 44 | 1.66e-03 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 127 | 197 | 1.67e-03 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 44 | 58 | 1.70e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 33 | 41 | 1.71e-03 |
| GO:BP | GO:0006814 | sodium ion transport | 92 | 137 | 1.71e-03 |
| GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 31 | 38 | 1.72e-03 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 31 | 38 | 1.72e-03 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 120 | 185 | 1.72e-03 |
| GO:BP | GO:0007613 | memory | 62 | 87 | 1.74e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 54 | 74 | 1.74e-03 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 49 | 66 | 1.76e-03 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 106 | 161 | 1.78e-03 |
| GO:BP | GO:0001816 | cytokine production | 264 | 441 | 1.82e-03 |
| GO:BP | GO:0031099 | regeneration | 96 | 144 | 1.83e-03 |
| GO:BP | GO:0050890 | cognition | 136 | 213 | 1.83e-03 |
| GO:BP | GO:0007009 | plasma membrane organization | 74 | 107 | 1.89e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 161 | 257 | 1.91e-03 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 52 | 71 | 1.97e-03 |
| GO:BP | GO:0090087 | regulation of peptide transport | 90 | 134 | 1.97e-03 |
| GO:BP | GO:0072089 | stem cell proliferation | 60 | 84 | 1.99e-03 |
| GO:BP | GO:0043500 | muscle adaptation | 63 | 89 | 2.08e-03 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 63 | 89 | 2.08e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 884 | 1595 | 2.08e-03 |
| GO:BP | GO:0006470 | protein dephosphorylation | 115 | 177 | 2.11e-03 |
| GO:BP | GO:0006869 | lipid transport | 163 | 261 | 2.16e-03 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 75 | 109 | 2.18e-03 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 38 | 49 | 2.18e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 38 | 49 | 2.18e-03 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 58 | 81 | 2.28e-03 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 58 | 81 | 2.28e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 36 | 46 | 2.34e-03 |
| GO:BP | GO:0097120 | receptor localization to synapse | 36 | 46 | 2.34e-03 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 24 | 28 | 2.38e-03 |
| GO:BP | GO:0001817 | regulation of cytokine production | 261 | 437 | 2.39e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 82 | 121 | 2.41e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 53 | 73 | 2.43e-03 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 67 | 96 | 2.49e-03 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 76 | 111 | 2.49e-03 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 48 | 65 | 2.50e-03 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 26 | 31 | 2.56e-03 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 26 | 31 | 2.56e-03 |
| GO:BP | GO:0050900 | leukocyte migration | 125 | 195 | 2.57e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 110 | 169 | 2.57e-03 |
| GO:BP | GO:0050795 | regulation of behavior | 32 | 40 | 2.58e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 56 | 78 | 2.58e-03 |
| GO:BP | GO:0071868 | cellular response to monoamine stimulus | 28 | 34 | 2.64e-03 |
| GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 28 | 34 | 2.64e-03 |
| GO:BP | GO:0061037 | negative regulation of cartilage development | 19 | 21 | 2.68e-03 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 19 | 21 | 2.68e-03 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 62 | 88 | 2.81e-03 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 77 | 113 | 2.83e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 65 | 93 | 2.86e-03 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 68 | 98 | 2.89e-03 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 71 | 103 | 2.89e-03 |
| GO:BP | GO:0033993 | response to lipid | 335 | 573 | 2.91e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 689 | 1231 | 2.92e-03 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 39 | 51 | 2.93e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 169 | 273 | 3.01e-03 |
| GO:BP | GO:0009725 | response to hormone | 355 | 610 | 3.06e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 57 | 80 | 3.10e-03 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 49 | 67 | 3.10e-03 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 16 | 17 | 3.13e-03 |
| GO:BP | GO:0034505 | tooth mineralization | 16 | 17 | 3.13e-03 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 16 | 17 | 3.13e-03 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 60 | 85 | 3.21e-03 |
| GO:BP | GO:0071396 | cellular response to lipid | 233 | 388 | 3.24e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 166 | 268 | 3.24e-03 |
| GO:BP | GO:0001890 | placenta development | 75 | 110 | 3.25e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 690 | 1234 | 3.30e-03 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 21 | 24 | 3.33e-03 |
| GO:BP | GO:0003401 | axis elongation | 21 | 24 | 3.33e-03 |
| GO:BP | GO:1905332 | positive regulation of morphogenesis of an epithelium | 21 | 24 | 3.33e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 1257 | 2309 | 3.34e-03 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 33 | 42 | 3.70e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 497 | 874 | 3.70e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 73 | 107 | 3.78e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 61 | 87 | 3.79e-03 |
| GO:BP | GO:0001508 | action potential | 70 | 102 | 3.81e-03 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 50 | 69 | 3.81e-03 |
| GO:BP | GO:0099643 | signal release from synapse | 70 | 102 | 3.81e-03 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 70 | 102 | 3.81e-03 |
| GO:BP | GO:0060021 | roof of mouth development | 50 | 69 | 3.81e-03 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 64 | 92 | 3.81e-03 |
| GO:BP | GO:0021536 | diencephalon development | 31 | 39 | 3.87e-03 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 334 | 573 | 3.88e-03 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 45 | 61 | 3.92e-03 |
| GO:BP | GO:0001656 | metanephros development | 45 | 61 | 3.92e-03 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 123 | 193 | 3.92e-03 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 29 | 36 | 3.99e-03 |
| GO:BP | GO:0071869 | response to catecholamine | 29 | 36 | 3.99e-03 |
| GO:BP | GO:0071867 | response to monoamine | 29 | 36 | 3.99e-03 |
| GO:BP | GO:0097306 | cellular response to alcohol | 53 | 74 | 4.02e-03 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 27 | 33 | 4.05e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 38 | 50 | 4.22e-03 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 38 | 50 | 4.22e-03 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 38 | 50 | 4.22e-03 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 74 | 109 | 4.24e-03 |
| GO:BP | GO:0051250 | negative regulation of lymphocyte activation | 59 | 84 | 4.31e-03 |
| GO:BP | GO:0051048 | negative regulation of secretion | 71 | 104 | 4.32e-03 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 43 | 58 | 4.39e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 43 | 58 | 4.39e-03 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 286 | 486 | 4.44e-03 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 18 | 20 | 4.46e-03 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 81 | 121 | 4.50e-03 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 36 | 47 | 4.63e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 46 | 63 | 4.88e-03 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 46 | 63 | 4.88e-03 |
| GO:BP | GO:0036302 | atrioventricular canal development | 12 | 12 | 4.89e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 12 | 12 | 4.89e-03 |
| GO:BP | GO:0099505 | regulation of presynaptic membrane potential | 12 | 12 | 4.89e-03 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 313 | 536 | 4.89e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 72 | 106 | 4.89e-03 |
| GO:BP | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 12 | 12 | 4.89e-03 |
| GO:BP | GO:0007405 | neuroblast proliferation | 41 | 55 | 4.89e-03 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 12 | 12 | 4.89e-03 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 41 | 55 | 4.89e-03 |
| GO:BP | GO:0038066 | p38MAPK cascade | 34 | 44 | 4.99e-03 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 34 | 44 | 4.99e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 34 | 44 | 4.99e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 34 | 44 | 4.99e-03 |
| GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 49 | 68 | 5.20e-03 |
| GO:BP | GO:0030162 | regulation of proteolysis | 247 | 416 | 5.29e-03 |
| GO:BP | GO:0032331 | negative regulation of chondrocyte differentiation | 15 | 16 | 5.36e-03 |
| GO:BP | GO:0001709 | cell fate determination | 20 | 23 | 5.36e-03 |
| GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 20 | 23 | 5.36e-03 |
| GO:BP | GO:0050919 | negative chemotaxis | 32 | 41 | 5.36e-03 |
| GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 15 | 16 | 5.36e-03 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 32 | 41 | 5.36e-03 |
| GO:BP | GO:0031128 | developmental induction | 20 | 23 | 5.36e-03 |
| GO:BP | GO:0014888 | striated muscle adaptation | 32 | 41 | 5.36e-03 |
| GO:BP | GO:0060037 | pharyngeal system development | 20 | 23 | 5.36e-03 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 39 | 52 | 5.42e-03 |
| GO:BP | GO:0021675 | nerve development | 44 | 60 | 5.42e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 751 | 1354 | 5.54e-03 |
| GO:BP | GO:0030282 | bone mineralization | 55 | 78 | 5.62e-03 |
| GO:BP | GO:0051480 | regulation of cytosolic calcium ion concentration | 30 | 38 | 5.72e-03 |
| GO:BP | GO:0042752 | regulation of circadian rhythm | 61 | 88 | 5.78e-03 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 178 | 292 | 5.78e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 47 | 65 | 5.89e-03 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 22 | 26 | 5.90e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 22 | 26 | 5.90e-03 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 98 | 151 | 5.93e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 28 | 35 | 5.97e-03 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 28 | 35 | 5.97e-03 |
| GO:BP | GO:0090278 | negative regulation of peptide hormone secretion | 26 | 32 | 6.11e-03 |
| GO:BP | GO:0010656 | negative regulation of muscle cell apoptotic process | 26 | 32 | 6.11e-03 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 24 | 29 | 6.11e-03 |
| GO:BP | GO:0010837 | regulation of keratinocyte proliferation | 26 | 32 | 6.11e-03 |
| GO:BP | GO:0021954 | central nervous system neuron development | 42 | 57 | 6.11e-03 |
| GO:BP | GO:0071604 | transforming growth factor beta production | 26 | 32 | 6.11e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 71 | 105 | 6.30e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 231 | 388 | 6.31e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 200 | 332 | 6.36e-03 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 68 | 100 | 6.44e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 65 | 95 | 6.55e-03 |
| GO:BP | GO:0016311 | dephosphorylation | 144 | 232 | 6.55e-03 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 65 | 95 | 6.55e-03 |
| GO:BP | GO:0050866 | negative regulation of cell activation | 78 | 117 | 6.59e-03 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 35 | 46 | 6.59e-03 |
| GO:BP | GO:0006950 | response to stress | 1373 | 2540 | 6.68e-03 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 48 | 67 | 7.09e-03 |
| GO:BP | GO:0001892 | embryonic placenta development | 48 | 67 | 7.09e-03 |
| GO:BP | GO:0030217 | T cell differentiation | 116 | 183 | 7.20e-03 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 33 | 43 | 7.26e-03 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 79 | 119 | 7.35e-03 |
| GO:BP | GO:0062009 | secondary palate development | 17 | 19 | 7.35e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 51 | 72 | 7.37e-03 |
| GO:BP | GO:0045995 | regulation of embryonic development | 51 | 72 | 7.37e-03 |
| GO:BP | GO:0002695 | negative regulation of leukocyte activation | 66 | 97 | 7.45e-03 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 101 | 157 | 7.54e-03 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 43 | 59 | 7.54e-03 |
| GO:BP | GO:0046849 | bone remodeling | 43 | 59 | 7.54e-03 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 57 | 82 | 7.63e-03 |
| GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 38 | 51 | 7.67e-03 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 175 | 288 | 7.70e-03 |
| GO:BP | GO:0060326 | cell chemotaxis | 98 | 152 | 8.05e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 375 | 654 | 8.47e-03 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 67 | 99 | 8.47e-03 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 77 | 116 | 8.52e-03 |
| GO:BP | GO:0044843 | cell cycle G1/S phase transition | 127 | 203 | 8.58e-03 |
| GO:BP | GO:0021700 | developmental maturation | 127 | 203 | 8.58e-03 |
| GO:BP | GO:0071300 | cellular response to retinoic acid | 36 | 48 | 8.60e-03 |
| GO:BP | GO:0002021 | response to dietary excess | 19 | 22 | 8.64e-03 |
| GO:BP | GO:0097150 | neuronal stem cell population maintenance | 19 | 22 | 8.64e-03 |
| GO:BP | GO:0031623 | receptor internalization | 61 | 89 | 8.77e-03 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 88 | 135 | 8.85e-03 |
| GO:BP | GO:0070661 | leukocyte proliferation | 111 | 175 | 8.86e-03 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 27 | 34 | 8.99e-03 |
| GO:BP | GO:0003230 | cardiac atrium development | 27 | 34 | 8.99e-03 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 14 | 15 | 9.15e-03 |
| GO:BP | GO:0014047 | glutamate secretion | 14 | 15 | 9.15e-03 |
| GO:BP | GO:0071636 | positive regulation of transforming growth factor beta production | 14 | 15 | 9.15e-03 |
| GO:BP | GO:0055012 | ventricular cardiac muscle cell differentiation | 14 | 15 | 9.15e-03 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 44 | 61 | 9.19e-03 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 44 | 61 | 9.19e-03 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 25 | 31 | 9.28e-03 |
| GO:BP | GO:1900744 | regulation of p38MAPK cascade | 25 | 31 | 9.28e-03 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 85 | 130 | 9.28e-03 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 25 | 31 | 9.28e-03 |
| GO:BP | GO:1903351 | cellular response to dopamine | 25 | 31 | 9.28e-03 |
| GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 25 | 31 | 9.28e-03 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 78 | 118 | 9.29e-03 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 78 | 118 | 9.29e-03 |
| GO:BP | GO:0048483 | autonomic nervous system development | 23 | 28 | 9.40e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 23 | 28 | 9.40e-03 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 175 | 289 | 9.41e-03 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 47 | 66 | 9.59e-03 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 75 | 113 | 9.72e-03 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 196 | 327 | 9.73e-03 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 50 | 71 | 9.88e-03 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 50 | 71 | 9.88e-03 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 157 | 257 | 9.96e-03 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 59 | 86 | 1.00e-02 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 53 | 76 | 1.00e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 126 | 202 | 1.03e-02 |
| GO:BP | GO:0045123 | cellular extravasation | 32 | 42 | 1.04e-02 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 214 | 360 | 1.05e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 150 | 245 | 1.12e-02 |
| GO:BP | GO:0042098 | T cell proliferation | 73 | 110 | 1.13e-02 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 73 | 110 | 1.13e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 48 | 68 | 1.14e-02 |
| GO:BP | GO:0055002 | striated muscle cell development | 48 | 68 | 1.14e-02 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 211 | 355 | 1.14e-02 |
| GO:BP | GO:0050922 | negative regulation of chemotaxis | 30 | 39 | 1.15e-02 |
| GO:BP | GO:0003014 | renal system process | 51 | 73 | 1.16e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 57 | 83 | 1.16e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 57 | 83 | 1.16e-02 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 84 | 129 | 1.17e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 70 | 105 | 1.17e-02 |
| GO:BP | GO:0042310 | vasoconstriction | 40 | 55 | 1.18e-02 |
| GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 16 | 18 | 1.20e-02 |
| GO:BP | GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 16 | 18 | 1.20e-02 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 16 | 18 | 1.20e-02 |
| GO:BP | GO:0055093 | response to hyperoxia | 16 | 18 | 1.20e-02 |
| GO:BP | GO:0045649 | regulation of macrophage differentiation | 16 | 18 | 1.20e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 16 | 18 | 1.20e-02 |
| GO:BP | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway | 16 | 18 | 1.20e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 28 | 36 | 1.24e-02 |
| GO:BP | GO:0060443 | mammary gland morphogenesis | 28 | 36 | 1.24e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 100 | 157 | 1.24e-02 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 242 | 412 | 1.25e-02 |
| GO:BP | GO:0048675 | axon extension | 64 | 95 | 1.25e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 153 | 251 | 1.28e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 153 | 251 | 1.28e-02 |
| GO:BP | GO:0008366 | axon ensheathment | 78 | 119 | 1.30e-02 |
| GO:BP | GO:0007272 | ensheathment of neurons | 78 | 119 | 1.30e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 58 | 85 | 1.31e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 58 | 85 | 1.31e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 101 | 159 | 1.32e-02 |
| GO:BP | GO:0022414 | reproductive process | 491 | 874 | 1.36e-02 |
| GO:BP | GO:0021983 | pituitary gland development | 18 | 21 | 1.37e-02 |
| GO:BP | GO:0060384 | innervation | 18 | 21 | 1.37e-02 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1051 | 1934 | 1.37e-02 |
| GO:BP | GO:0061458 | reproductive system development | 127 | 205 | 1.38e-02 |
| GO:BP | GO:0043412 | macromolecule modification | 1341 | 2489 | 1.39e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0046676 | negative regulation of insulin secretion | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0048512 | circadian behavior | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0007616 | long-term memory | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 24 | 30 | 1.39e-02 |
| GO:BP | GO:0050817 | coagulation | 94 | 147 | 1.40e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 94 | 147 | 1.40e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 79 | 121 | 1.41e-02 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 41 | 57 | 1.42e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 41 | 57 | 1.42e-02 |
| GO:BP | GO:0051899 | membrane depolarization | 41 | 57 | 1.42e-02 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 20 | 24 | 1.42e-02 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 20 | 24 | 1.42e-02 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 22 | 27 | 1.42e-02 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 22 | 27 | 1.42e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 20 | 24 | 1.42e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 20 | 24 | 1.42e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 22 | 27 | 1.42e-02 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 20 | 24 | 1.42e-02 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 224 | 380 | 1.42e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 115 | 184 | 1.44e-02 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 59 | 87 | 1.46e-02 |
| GO:BP | GO:0030168 | platelet activation | 59 | 87 | 1.46e-02 |
| GO:BP | GO:0030902 | hindbrain development | 69 | 104 | 1.47e-02 |
| GO:BP | GO:0045582 | positive regulation of T cell differentiation | 50 | 72 | 1.52e-02 |
| GO:BP | GO:0021533 | cell differentiation in hindbrain | 13 | 14 | 1.53e-02 |
| GO:BP | GO:0043217 | myelin maintenance | 13 | 14 | 1.53e-02 |
| GO:BP | GO:0010002 | cardioblast differentiation | 13 | 14 | 1.53e-02 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 1137 | 2100 | 1.54e-02 |
| GO:BP | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0072497 | mesenchymal stem cell differentiation | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0045906 | negative regulation of vasoconstriction | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0022410 | circadian sleep/wake cycle process | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0099149 | regulation of postsynaptic neurotransmitter receptor internalization | 10 | 10 | 1.54e-02 |
| GO:BP | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0030431 | sleep | 10 | 10 | 1.54e-02 |
| GO:BP | GO:0043549 | regulation of kinase activity | 211 | 357 | 1.59e-02 |
| GO:BP | GO:1903531 | negative regulation of secretion by cell | 63 | 94 | 1.59e-02 |
| GO:BP | GO:0007596 | blood coagulation | 92 | 144 | 1.59e-02 |
| GO:BP | GO:0050918 | positive chemotaxis | 29 | 38 | 1.62e-02 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 29 | 38 | 1.62e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 70 | 106 | 1.62e-02 |
| GO:BP | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 29 | 38 | 1.62e-02 |
| GO:BP | GO:0045103 | intermediate filament-based process | 29 | 38 | 1.62e-02 |
| GO:BP | GO:0001706 | endoderm formation | 34 | 46 | 1.67e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 532 | 953 | 1.68e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 54 | 79 | 1.72e-02 |
| GO:BP | GO:0010038 | response to metal ion | 151 | 249 | 1.76e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 156 | 258 | 1.76e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 64 | 96 | 1.77e-02 |
| GO:BP | GO:0008038 | neuron recognition | 27 | 35 | 1.78e-02 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 137 | 224 | 1.78e-02 |
| GO:BP | GO:0042593 | glucose homeostasis | 106 | 169 | 1.80e-02 |
| GO:BP | GO:0051223 | regulation of protein transport | 193 | 325 | 1.81e-02 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 37 | 51 | 1.82e-02 |
| GO:BP | GO:0007599 | hemostasis | 94 | 148 | 1.84e-02 |
| GO:BP | GO:0009880 | embryonic pattern specification | 32 | 43 | 1.89e-02 |
| GO:BP | GO:0042129 | regulation of T cell proliferation | 58 | 86 | 1.91e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 323 | 564 | 1.91e-02 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0051590 | positive regulation of neurotransmitter transport | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0007622 | rhythmic behavior | 25 | 32 | 1.92e-02 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 15 | 17 | 1.92e-02 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 15 | 17 | 1.92e-02 |
| GO:BP | GO:1903350 | response to dopamine | 25 | 32 | 1.92e-02 |
| GO:BP | GO:0060711 | labyrinthine layer development | 25 | 32 | 1.92e-02 |
| GO:BP | GO:0007612 | learning | 72 | 110 | 1.95e-02 |
| GO:BP | GO:0030879 | mammary gland development | 65 | 98 | 1.95e-02 |
| GO:BP | GO:0001701 | in utero embryonic development | 196 | 331 | 1.98e-02 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 130 | 212 | 1.98e-02 |
| GO:BP | GO:0030239 | myofibril assembly | 46 | 66 | 2.00e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 49 | 71 | 2.00e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 46 | 66 | 2.00e-02 |
| GO:BP | GO:0042552 | myelination | 76 | 117 | 2.01e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 23 | 29 | 2.04e-02 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 145 | 239 | 2.04e-02 |
| GO:BP | GO:0097106 | postsynaptic density organization | 23 | 29 | 2.04e-02 |
| GO:BP | GO:0042491 | inner ear auditory receptor cell differentiation | 23 | 29 | 2.04e-02 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 23 | 29 | 2.04e-02 |
| GO:BP | GO:0031102 | neuron projection regeneration | 35 | 48 | 2.05e-02 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 35 | 48 | 2.05e-02 |
| GO:BP | GO:0048286 | lung alveolus development | 30 | 40 | 2.09e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 88 | 138 | 2.09e-02 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 17 | 20 | 2.11e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 17 | 20 | 2.11e-02 |
| GO:BP | GO:0048710 | regulation of astrocyte differentiation | 17 | 20 | 2.11e-02 |
| GO:BP | GO:0048730 | epidermis morphogenesis | 17 | 20 | 2.11e-02 |
| GO:BP | GO:0043588 | skin development | 109 | 175 | 2.12e-02 |
| GO:BP | GO:0048806 | genitalia development | 21 | 26 | 2.13e-02 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 21 | 26 | 2.13e-02 |
| GO:BP | GO:0007212 | dopamine receptor signaling pathway | 21 | 26 | 2.13e-02 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 21 | 26 | 2.13e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 19 | 23 | 2.15e-02 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 38 | 53 | 2.15e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 19 | 23 | 2.15e-02 |
| GO:BP | GO:0072012 | glomerulus vasculature development | 19 | 23 | 2.15e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 19 | 23 | 2.15e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 38 | 53 | 2.15e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 56 | 83 | 2.15e-02 |
| GO:BP | GO:0045761 | regulation of adenylate cyclase activity | 19 | 23 | 2.15e-02 |
| GO:BP | GO:0019216 | regulation of lipid metabolic process | 132 | 216 | 2.15e-02 |
| GO:BP | GO:0010469 | regulation of signaling receptor activity | 41 | 58 | 2.24e-02 |
| GO:BP | GO:0048706 | embryonic skeletal system development | 50 | 73 | 2.26e-02 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 50 | 73 | 2.26e-02 |
| GO:BP | GO:0097581 | lamellipodium organization | 50 | 73 | 2.26e-02 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 106 | 170 | 2.27e-02 |
| GO:BP | GO:0097061 | dendritic spine organization | 44 | 63 | 2.27e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 28 | 37 | 2.29e-02 |
| GO:BP | GO:0045104 | intermediate filament cytoskeleton organization | 28 | 37 | 2.29e-02 |
| GO:BP | GO:0045747 | positive regulation of Notch signaling pathway | 28 | 37 | 2.29e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 28 | 37 | 2.29e-02 |
| GO:BP | GO:0001818 | negative regulation of cytokine production | 102 | 163 | 2.30e-02 |
| GO:BP | GO:0010761 | fibroblast migration | 36 | 50 | 2.48e-02 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 36 | 50 | 2.48e-02 |
| GO:BP | GO:0042490 | mechanoreceptor differentiation | 36 | 50 | 2.48e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 140 | 231 | 2.48e-02 |
| GO:BP | GO:1901655 | cellular response to ketone | 54 | 80 | 2.50e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 171 | 287 | 2.51e-02 |
| GO:BP | GO:0008104 | protein localization | 1081 | 2000 | 2.51e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 397 | 704 | 2.51e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 26 | 34 | 2.52e-02 |
| GO:BP | GO:0071895 | odontoblast differentiation | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 26 | 34 | 2.52e-02 |
| GO:BP | GO:0048665 | neuron fate specification | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 26 | 34 | 2.52e-02 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 12 | 13 | 2.52e-02 |
| GO:BP | GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0060841 | venous blood vessel development | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0000003 | reproduction | 492 | 882 | 2.52e-02 |
| GO:BP | GO:0030033 | microvillus assembly | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0035315 | hair cell differentiation | 26 | 34 | 2.52e-02 |
| GO:BP | GO:0009954 | proximal/distal pattern formation | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0001956 | positive regulation of neurotransmitter secretion | 12 | 13 | 2.52e-02 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 68 | 104 | 2.54e-02 |
| GO:BP | GO:0070509 | calcium ion import | 39 | 55 | 2.54e-02 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 39 | 55 | 2.54e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 31 | 42 | 2.58e-02 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 31 | 42 | 2.58e-02 |
| GO:BP | GO:0051966 | regulation of synaptic transmission, glutamatergic | 31 | 42 | 2.58e-02 |
| GO:BP | GO:0001938 | positive regulation of endothelial cell proliferation | 48 | 70 | 2.58e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 42 | 60 | 2.59e-02 |
| GO:BP | GO:0035418 | protein localization to synapse | 42 | 60 | 2.59e-02 |
| GO:BP | GO:0030316 | osteoclast differentiation | 45 | 65 | 2.59e-02 |
| GO:BP | GO:0001942 | hair follicle development | 45 | 65 | 2.59e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1055 | 1951 | 2.60e-02 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 58 | 87 | 2.65e-02 |
| GO:BP | GO:0051147 | regulation of muscle cell differentiation | 76 | 118 | 2.65e-02 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 65 | 99 | 2.67e-02 |
| GO:BP | GO:0046629 | gamma-delta T cell activation | 9 | 9 | 2.68e-02 |
| GO:BP | GO:2000288 | positive regulation of myoblast proliferation | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0002024 | diet induced thermogenesis | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0010838 | positive regulation of keratinocyte proliferation | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0099509 | regulation of presynaptic cytosolic calcium ion concentration | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0032060 | bleb assembly | 9 | 9 | 2.68e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 540 | 973 | 2.68e-02 |
| GO:BP | GO:2000739 | regulation of mesenchymal stem cell differentiation | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0048845 | venous blood vessel morphogenesis | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0001768 | establishment of T cell polarity | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0051643 | endoplasmic reticulum localization | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 9 | 9 | 2.68e-02 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 24 | 31 | 2.72e-02 |
| GO:BP | GO:0060688 | regulation of morphogenesis of a branching structure | 24 | 31 | 2.72e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 24 | 31 | 2.72e-02 |
| GO:BP | GO:0070664 | negative regulation of leukocyte proliferation | 34 | 47 | 2.74e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 34 | 47 | 2.74e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 34 | 47 | 2.74e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 34 | 47 | 2.74e-02 |
| GO:BP | GO:0007584 | response to nutrient | 73 | 113 | 2.79e-02 |
| GO:BP | GO:0061024 | membrane organization | 354 | 625 | 2.81e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 106 | 171 | 2.82e-02 |
| GO:BP | GO:0045619 | regulation of lymphocyte differentiation | 81 | 127 | 2.85e-02 |
| GO:BP | GO:0042311 | vasodilation | 29 | 39 | 2.86e-02 |
| GO:BP | GO:0051965 | positive regulation of synapse assembly | 29 | 39 | 2.86e-02 |
| GO:BP | GO:0035904 | aorta development | 37 | 52 | 2.87e-02 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 37 | 52 | 2.87e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1085 | 2010 | 2.87e-02 |
| GO:BP | GO:0003171 | atrioventricular valve development | 22 | 28 | 2.92e-02 |
| GO:BP | GO:0022405 | hair cycle process | 46 | 67 | 2.92e-02 |
| GO:BP | GO:0022404 | molting cycle process | 46 | 67 | 2.92e-02 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 22 | 28 | 2.92e-02 |
| GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 22 | 28 | 2.92e-02 |
| GO:BP | GO:0044331 | cell-cell adhesion mediated by cadherin | 22 | 28 | 2.92e-02 |
| GO:BP | GO:0031503 | protein-containing complex localization | 98 | 157 | 2.93e-02 |
| GO:BP | GO:0086014 | atrial cardiac muscle cell action potential | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0086026 | atrial cardiac muscle cell to AV node cell signaling | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0003128 | heart field specification | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0086066 | atrial cardiac muscle cell to AV node cell communication | 14 | 16 | 2.99e-02 |
| GO:BP | GO:1900274 | regulation of phospholipase C activity | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0045762 | positive regulation of adenylate cyclase activity | 14 | 16 | 2.99e-02 |
| GO:BP | GO:0019827 | stem cell population maintenance | 90 | 143 | 3.00e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 535 | 965 | 3.01e-02 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 20 | 25 | 3.09e-02 |
| GO:BP | GO:0061437 | renal system vasculature development | 20 | 25 | 3.09e-02 |
| GO:BP | GO:0007435 | salivary gland morphogenesis | 20 | 25 | 3.09e-02 |
| GO:BP | GO:0061440 | kidney vasculature development | 20 | 25 | 3.09e-02 |
| GO:BP | GO:0098703 | calcium ion import across plasma membrane | 20 | 25 | 3.09e-02 |
| GO:BP | GO:0007623 | circadian rhythm | 95 | 152 | 3.15e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 60 | 91 | 3.17e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 60 | 91 | 3.17e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 27 | 36 | 3.17e-02 |
| GO:BP | GO:0035306 | positive regulation of dephosphorylation | 27 | 36 | 3.17e-02 |
| GO:BP | GO:0060512 | prostate gland morphogenesis | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0098810 | neurotransmitter reuptake | 16 | 19 | 3.17e-02 |
| GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0099590 | neurotransmitter receptor internalization | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 16 | 19 | 3.17e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0042092 | type 2 immune response | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0003338 | metanephros morphogenesis | 16 | 19 | 3.17e-02 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 71 | 110 | 3.17e-02 |
| GO:BP | GO:0055075 | potassium ion homeostasis | 18 | 22 | 3.18e-02 |
| GO:BP | GO:0030279 | negative regulation of ossification | 18 | 22 | 3.18e-02 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 191 | 325 | 3.18e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 35 | 49 | 3.24e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 47 | 69 | 3.28e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 170 | 287 | 3.34e-02 |
| GO:BP | GO:0016239 | positive regulation of macroautophagy | 44 | 64 | 3.34e-02 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 44 | 64 | 3.34e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 44 | 64 | 3.34e-02 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 41 | 59 | 3.36e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 88 | 140 | 3.41e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 72 | 112 | 3.42e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 76 | 119 | 3.45e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 61 | 93 | 3.46e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 30 | 41 | 3.49e-02 |
| GO:BP | GO:0045453 | bone resorption | 30 | 41 | 3.49e-02 |
| GO:BP | GO:0007600 | sensory perception | 150 | 251 | 3.50e-02 |
| GO:BP | GO:1902692 | regulation of neuroblast proliferation | 25 | 33 | 3.51e-02 |
| GO:BP | GO:0038093 | Fc receptor signaling pathway | 25 | 33 | 3.51e-02 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 51 | 76 | 3.58e-02 |
| GO:BP | GO:0060996 | dendritic spine development | 51 | 76 | 3.58e-02 |
| GO:BP | GO:0007219 | Notch signaling pathway | 89 | 142 | 3.63e-02 |
| GO:BP | GO:0030595 | leukocyte chemotaxis | 69 | 107 | 3.65e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 388 | 691 | 3.70e-02 |
| GO:BP | GO:0001655 | urogenital system development | 33 | 46 | 3.71e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 33 | 46 | 3.71e-02 |
| GO:BP | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 33 | 46 | 3.71e-02 |
| GO:BP | GO:0062014 | negative regulation of small molecule metabolic process | 48 | 71 | 3.71e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 33 | 46 | 3.71e-02 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 62 | 95 | 3.78e-02 |
| GO:BP | GO:0051153 | regulation of striated muscle cell differentiation | 45 | 66 | 3.80e-02 |
| GO:BP | GO:0006887 | exocytosis | 142 | 237 | 3.83e-02 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 36 | 51 | 3.83e-02 |
| GO:BP | GO:0043266 | regulation of potassium ion transport | 42 | 61 | 3.85e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 132 | 219 | 3.85e-02 |
| GO:BP | GO:0033273 | response to vitamin | 42 | 61 | 3.85e-02 |
| GO:BP | GO:0002088 | lens development in camera-type eye | 39 | 56 | 3.87e-02 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 66 | 102 | 3.87e-02 |
| GO:BP | GO:0052652 | cyclic purine nucleotide metabolic process | 23 | 30 | 3.88e-02 |
| GO:BP | GO:0014911 | positive regulation of smooth muscle cell migration | 23 | 30 | 3.88e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 82 | 130 | 3.93e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 28 | 38 | 3.94e-02 |
| GO:BP | GO:0006940 | regulation of smooth muscle contraction | 28 | 38 | 3.94e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 28 | 38 | 3.94e-02 |
| GO:BP | GO:0061005 | cell differentiation involved in kidney development | 28 | 38 | 3.94e-02 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 95 | 153 | 3.97e-02 |
| GO:BP | GO:0050773 | regulation of dendrite development | 52 | 78 | 3.97e-02 |
| GO:BP | GO:0046942 | carboxylic acid transport | 123 | 203 | 3.98e-02 |
| GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0048368 | lateral mesoderm development | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0003207 | cardiac chamber formation | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0055057 | neuroblast division | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0030539 | male genitalia development | 11 | 12 | 4.07e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 119 | 196 | 4.12e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 189 | 323 | 4.13e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 67 | 104 | 4.16e-02 |
| GO:BP | GO:0051651 | maintenance of location in cell | 105 | 171 | 4.16e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 587 | 1067 | 4.18e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 71 | 111 | 4.18e-02 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 21 | 27 | 4.18e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 21 | 27 | 4.18e-02 |
| GO:BP | GO:0010517 | regulation of phospholipase activity | 21 | 27 | 4.18e-02 |
| GO:BP | GO:0035909 | aorta morphogenesis | 21 | 27 | 4.18e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 75 | 118 | 4.18e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 21 | 27 | 4.18e-02 |
| GO:BP | GO:0032945 | negative regulation of mononuclear cell proliferation | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0050672 | negative regulation of lymphocyte proliferation | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 31 | 43 | 4.18e-02 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 46 | 68 | 4.20e-02 |
| GO:BP | GO:0010232 | vascular transport | 46 | 68 | 4.20e-02 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 101 | 164 | 4.24e-02 |
| GO:BP | GO:0001894 | tissue homeostasis | 101 | 164 | 4.24e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 440 | 790 | 4.24e-02 |
| GO:BP | GO:0060113 | inner ear receptor cell differentiation | 34 | 48 | 4.32e-02 |
| GO:BP | GO:0048488 | synaptic vesicle endocytosis | 40 | 58 | 4.38e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 40 | 58 | 4.38e-02 |
| GO:BP | GO:0007193 | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 26 | 35 | 4.38e-02 |
| GO:BP | GO:0034113 | heterotypic cell-cell adhesion | 26 | 35 | 4.38e-02 |
| GO:BP | GO:0010508 | positive regulation of autophagy | 80 | 127 | 4.43e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 76 | 120 | 4.47e-02 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0033280 | response to vitamin D | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0022011 | myelination in peripheral nervous system | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0001958 | endochondral ossification | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0098868 | bone growth | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0036075 | replacement ossification | 19 | 24 | 4.49e-02 |
| GO:BP | GO:0030534 | adult behavior | 57 | 87 | 4.50e-02 |
| GO:BP | GO:0042303 | molting cycle | 50 | 75 | 4.50e-02 |
| GO:BP | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 50 | 75 | 4.50e-02 |
| GO:BP | GO:0042633 | hair cycle | 50 | 75 | 4.50e-02 |
| GO:BP | GO:0097152 | mesenchymal cell apoptotic process | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0036462 | TRAIL-activated apoptotic signaling pathway | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0071389 | cellular response to mineralocorticoid stimulus | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0040034 | regulation of development, heterochronic | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0060982 | coronary artery morphogenesis | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0048505 | regulation of timing of cell differentiation | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0048715 | negative regulation of oligodendrocyte differentiation | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0032634 | interleukin-5 production | 8 | 8 | 4.56e-02 |
| GO:BP | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 8 | 8 | 4.56e-02 |
| GO:BP | GO:1900116 | extracellular negative regulation of signal transduction | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0099624 | atrial cardiac muscle cell membrane repolarization | 8 | 8 | 4.56e-02 |
| GO:BP | GO:1900115 | extracellular regulation of signal transduction | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0003149 | membranous septum morphogenesis | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 8 | 8 | 4.56e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 314 | 555 | 4.56e-02 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0051546 | keratinocyte migration | 13 | 15 | 4.58e-02 |
| GO:BP | GO:1902932 | positive regulation of alcohol biosynthetic process | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0072170 | metanephric tubule development | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0060413 | atrial septum morphogenesis | 13 | 15 | 4.58e-02 |
| GO:BP | GO:1902683 | regulation of receptor localization to synapse | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0032891 | negative regulation of organic acid transport | 13 | 15 | 4.58e-02 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 47 | 70 | 4.60e-02 |
| GO:BP | GO:1900745 | positive regulation of p38MAPK cascade | 17 | 21 | 4.66e-02 |
| GO:BP | GO:2000178 | negative regulation of neural precursor cell proliferation | 17 | 21 | 4.66e-02 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 879 | 1624 | 4.67e-02 |
| GO:BP | GO:0015849 | organic acid transport | 123 | 204 | 4.71e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 90 | 145 | 4.71e-02 |
| GO:BP | GO:0098727 | maintenance of cell number | 90 | 145 | 4.71e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 99 | 161 | 4.71e-02 |
| GO:BP | GO:0032925 | regulation of activin receptor signaling pathway | 15 | 18 | 4.74e-02 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 15 | 18 | 4.74e-02 |
| GO:BP | GO:0031069 | hair follicle morphogenesis | 15 | 18 | 4.74e-02 |
| GO:BP | GO:0033032 | regulation of myeloid cell apoptotic process | 15 | 18 | 4.74e-02 |
| GO:BP | GO:0007187 | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 15 | 18 | 4.74e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 178 | 304 | 4.77e-02 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0042220 | response to cocaine | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0062237 | protein localization to postsynapse | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0070884 | regulation of calcineurin-NFAT signaling cascade | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0106056 | regulation of calcineurin-mediated signaling | 24 | 32 | 4.78e-02 |
| GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 24 | 32 | 4.78e-02 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 32 | 45 | 4.80e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 32 | 45 | 4.80e-02 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 32 | 45 | 4.80e-02 |
| GO:BP | GO:0007548 | sex differentiation | 109 | 179 | 4.80e-02 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 32 | 45 | 4.80e-02 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 167 | 284 | 4.81e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 51 | 77 | 4.85e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 62 | 96 | 4.88e-02 |
| GO:BP | GO:0070527 | platelet aggregation | 35 | 50 | 4.88e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 38 | 55 | 4.88e-02 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 35 | 50 | 4.88e-02 |
| GO:BP | GO:0031016 | pancreas development | 35 | 50 | 4.88e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 78 | 124 | 4.90e-02 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 66 | 103 | 4.94e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 70 | 110 | 4.96e-02 |
ESRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 128 | 169 | 4.34e-09 |
| KEGG | KEGG:05200 | Pathways in cancer | 263 | 391 | 4.34e-09 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 123 | 161 | 4.34e-09 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 121 | 162 | 3.73e-08 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 64 | 75 | 3.73e-08 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 111 | 147 | 5.35e-08 |
| KEGG | KEGG:04360 | Axon guidance | 114 | 155 | 3.91e-07 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 98 | 133 | 3.28e-06 |
| KEGG | KEGG:04911 | Insulin secretion | 51 | 62 | 1.25e-05 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 64 | 82 | 1.36e-05 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 114 | 162 | 1.36e-05 |
| KEGG | KEGG:04970 | Salivary secretion | 45 | 54 | 2.12e-05 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 90 | 124 | 2.12e-05 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 93 | 129 | 2.14e-05 |
| KEGG | KEGG:04520 | Adherens junction | 64 | 83 | 2.19e-05 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 58 | 74 | 2.54e-05 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 39 | 46 | 3.73e-05 |
| KEGG | KEGG:04014 | Ras signaling pathway | 113 | 164 | 4.85e-05 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 52 | 66 | 5.79e-05 |
| KEGG | KEGG:04971 | Gastric acid secretion | 42 | 51 | 6.00e-05 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 152 | 231 | 6.12e-05 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 163 | 250 | 6.12e-05 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 91 | 129 | 7.77e-05 |
| KEGG | KEGG:04924 | Renin secretion | 41 | 50 | 8.12e-05 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 76 | 105 | 9.35e-05 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 52 | 67 | 9.52e-05 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 114 | 169 | 1.36e-04 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 58 | 77 | 1.36e-04 |
| KEGG | KEGG:04934 | Cushing syndrome | 84 | 119 | 1.36e-04 |
| KEGG | KEGG:04972 | Pancreatic secretion | 45 | 57 | 1.50e-04 |
| KEGG | KEGG:04725 | Cholinergic synapse | 61 | 82 | 1.50e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 80 | 113 | 1.66e-04 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 44 | 56 | 2.20e-04 |
| KEGG | KEGG:04611 | Platelet activation | 64 | 88 | 2.84e-04 |
| KEGG | KEGG:04713 | Circadian entrainment | 51 | 68 | 4.58e-04 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 56 | 76 | 4.58e-04 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 53 | 72 | 7.33e-04 |
| KEGG | KEGG:05224 | Breast cancer | 78 | 113 | 7.33e-04 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 51 | 69 | 8.01e-04 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 33 | 41 | 8.50e-04 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 74 | 107 | 9.33e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 56 | 78 | 1.27e-03 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 32 | 40 | 1.27e-03 |
| KEGG | KEGG:05032 | Morphine addiction | 41 | 54 | 1.28e-03 |
| KEGG | KEGG:05226 | Gastric cancer | 77 | 113 | 1.33e-03 |
| KEGG | KEGG:04916 | Melanogenesis | 54 | 75 | 1.37e-03 |
| KEGG | KEGG:04148 | Efferocytosis | 81 | 120 | 1.41e-03 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 91 | 137 | 1.41e-03 |
| KEGG | KEGG:05218 | Melanoma | 42 | 56 | 1.55e-03 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 67 | 97 | 1.66e-03 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 64 | 92 | 1.66e-03 |
| KEGG | KEGG:04726 | Serotonergic synapse | 43 | 58 | 1.91e-03 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 69 | 101 | 2.16e-03 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 81 | 122 | 2.82e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 70 | 104 | 3.70e-03 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 65 | 96 | 4.41e-03 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 154 | 252 | 4.67e-03 |
| KEGG | KEGG:04213 | Longevity regulating pathway - multiple species | 37 | 50 | 4.67e-03 |
| KEGG | KEGG:04929 | GnRH secretion | 37 | 50 | 4.67e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 102 | 160 | 4.67e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 67 | 100 | 5.25e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 61 | 90 | 5.53e-03 |
| KEGG | KEGG:04727 | GABAergic synapse | 38 | 52 | 5.68e-03 |
| KEGG | KEGG:04976 | Bile secretion | 31 | 41 | 6.23e-03 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 36 | 49 | 6.23e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 59 | 87 | 6.23e-03 |
| KEGG | KEGG:04530 | Tight junction | 83 | 129 | 8.32e-03 |
| KEGG | KEGG:04540 | Gap junction | 49 | 71 | 8.54e-03 |
| KEGG | KEGG:04742 | Taste transduction | 17 | 20 | 9.03e-03 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 41 | 58 | 9.57e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 61 | 92 | 1.11e-02 |
| KEGG | KEGG:05214 | Glioma | 45 | 65 | 1.12e-02 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 62 | 94 | 1.21e-02 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 66 | 101 | 1.25e-02 |
| KEGG | KEGG:05146 | Amoebiasis | 43 | 62 | 1.27e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 60 | 91 | 1.37e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 54 | 81 | 1.50e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 90 | 144 | 1.65e-02 |
| KEGG | KEGG:04720 | Long-term potentiation | 36 | 51 | 1.65e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 52 | 78 | 1.68e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 59 | 90 | 1.68e-02 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 50 | 75 | 1.96e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 54 | 82 | 2.04e-02 |
| KEGG | KEGG:01522 | Endocrine resistance | 54 | 82 | 2.04e-02 |
| KEGG | KEGG:05031 | Amphetamine addiction | 32 | 45 | 2.11e-02 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 66 | 103 | 2.16e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 48 | 72 | 2.19e-02 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 22 | 29 | 2.30e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 56 | 86 | 2.36e-02 |
| KEGG | KEGG:00000 | KEGG root term | 2855 | 5451 | 2.47e-02 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 20 | 26 | 2.47e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 20 | 26 | 2.47e-02 |
| KEGG | KEGG:04730 | Long-term depression | 28 | 39 | 2.65e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 37 | 54 | 2.68e-02 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 49 | 75 | 3.31e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 40 | 60 | 3.92e-02 |
| KEGG | KEGG:05131 | Shigellosis | 121 | 204 | 3.93e-02 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 81 | 132 | 3.98e-02 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 48 | 74 | 4.08e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 25 | 35 | 4.08e-02 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 48 | 74 | 4.08e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 25 | 35 | 4.08e-02 |
| KEGG | KEGG:04061 | Viral protein interaction with cytokine and cytokine receptor | 15 | 19 | 4.25e-02 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 9 | 10 | 4.35e-02 |
| KEGG | KEGG:05033 | Nicotine addiction | 9 | 10 | 4.35e-02 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 46 | 71 | 4.58e-02 |
| KEGG | KEGG:05030 | Cocaine addiction | 23 | 32 | 4.59e-02 |
| KEGG | KEGG:04080 | Neuroactive ligand-receptor interaction | 63 | 101 | 4.76e-02 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 51 | 80 | 4.91e-02 |
# LR_resgenes <- gost(query = LR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes,"data/GO_KEGG_analysis/LR_resgenes.RDS")
LRnom <- gostplot(LR_resgenes, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable <- LR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 3517 | 4504 | 2.85e-37 |
| GO:BP | GO:0048731 | system development | 2194 | 2719 | 1.88e-35 |
| GO:BP | GO:0007154 | cell communication | 3123 | 3983 | 2.81e-34 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1527 | 1844 | 8.13e-34 |
| GO:BP | GO:0048856 | anatomical structure development | 3035 | 3867 | 8.13e-34 |
| GO:BP | GO:0023052 | signaling | 3073 | 3918 | 8.13e-34 |
| GO:BP | GO:0007275 | multicellular organism development | 2520 | 3170 | 1.90e-33 |
| GO:BP | GO:0032502 | developmental process | 3261 | 4179 | 1.90e-33 |
| GO:BP | GO:0007165 | signal transduction | 2834 | 3611 | 9.26e-31 |
| GO:BP | GO:0050896 | response to stimulus | 4108 | 5379 | 4.91e-29 |
| GO:BP | GO:0051716 | cellular response to stimulus | 3575 | 4640 | 6.17e-29 |
| GO:BP | GO:0007399 | nervous system development | 1449 | 1775 | 5.17e-26 |
| GO:BP | GO:0022008 | neurogenesis | 1048 | 1251 | 8.68e-26 |
| GO:BP | GO:0048869 | cellular developmental process | 2217 | 2804 | 1.25e-25 |
| GO:BP | GO:0030154 | cell differentiation | 2216 | 2803 | 1.35e-25 |
| GO:BP | GO:0048513 | animal organ development | 1616 | 2004 | 1.66e-24 |
| GO:BP | GO:0050793 | regulation of developmental process | 1384 | 1697 | 2.10e-24 |
| GO:BP | GO:0048699 | generation of neurons | 907 | 1076 | 7.45e-24 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1460 | 1801 | 1.06e-23 |
| GO:BP | GO:0010646 | regulation of cell communication | 1940 | 2444 | 2.20e-23 |
| GO:BP | GO:0030182 | neuron differentiation | 856 | 1014 | 7.74e-23 |
| GO:BP | GO:0023051 | regulation of signaling | 1933 | 2438 | 8.19e-23 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1547 | 1924 | 2.85e-22 |
| GO:BP | GO:0016477 | cell migration | 848 | 1011 | 7.88e-21 |
| GO:BP | GO:0007155 | cell adhesion | 791 | 941 | 7.79e-20 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 581 | 673 | 1.35e-19 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 2124 | 2717 | 1.94e-19 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1713 | 2166 | 9.59e-19 |
| GO:BP | GO:0048468 | cell development | 1504 | 1886 | 1.08e-18 |
| GO:BP | GO:0048870 | cell motility | 924 | 1120 | 2.51e-18 |
| GO:BP | GO:0009888 | tissue development | 1096 | 1348 | 7.00e-18 |
| GO:BP | GO:0000902 | cell morphogenesis | 607 | 713 | 1.85e-17 |
| GO:BP | GO:0007267 | cell-cell signaling | 892 | 1082 | 1.86e-17 |
| GO:BP | GO:0003008 | system process | 935 | 1139 | 2.58e-17 |
| GO:BP | GO:0040012 | regulation of locomotion | 612 | 720 | 2.58e-17 |
| GO:BP | GO:2000145 | regulation of cell motility | 596 | 700 | 3.50e-17 |
| GO:BP | GO:0072359 | circulatory system development | 723 | 864 | 4.90e-17 |
| GO:BP | GO:0035295 | tube development | 663 | 787 | 6.44e-17 |
| GO:BP | GO:0030334 | regulation of cell migration | 570 | 668 | 7.71e-17 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 760 | 913 | 8.43e-17 |
| GO:BP | GO:0031175 | neuron projection development | 628 | 743 | 1.18e-16 |
| GO:BP | GO:0040011 | locomotion | 676 | 805 | 1.28e-16 |
| GO:BP | GO:0048666 | neuron development | 701 | 838 | 1.92e-16 |
| GO:BP | GO:0035239 | tube morphogenesis | 545 | 638 | 2.70e-16 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 505 | 588 | 5.26e-16 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 698 | 837 | 1.02e-15 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 3005 | 3954 | 1.16e-15 |
| GO:BP | GO:0050789 | regulation of biological process | 5544 | 7516 | 1.29e-15 |
| GO:BP | GO:0030030 | cell projection organization | 961 | 1182 | 1.55e-15 |
| GO:BP | GO:0048518 | positive regulation of biological process | 3254 | 4301 | 2.05e-15 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 784 | 951 | 2.95e-15 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 432 | 498 | 3.12e-15 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 935 | 1150 | 4.30e-15 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 603 | 717 | 4.94e-15 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 428 | 494 | 6.88e-15 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 416 | 479 | 7.60e-15 |
| GO:BP | GO:0001568 | blood vessel development | 452 | 525 | 1.08e-14 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 528 | 622 | 1.14e-14 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 874 | 1073 | 1.96e-14 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 517 | 609 | 2.32e-14 |
| GO:BP | GO:0050794 | regulation of cellular process | 5279 | 7153 | 2.55e-14 |
| GO:BP | GO:0001944 | vasculature development | 472 | 552 | 3.18e-14 |
| GO:BP | GO:0065007 | biological regulation | 5684 | 7734 | 8.19e-14 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 845 | 1040 | 2.20e-13 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 1051 | 1314 | 3.49e-13 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 377 | 435 | 4.36e-13 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 840 | 1035 | 4.46e-13 |
| GO:BP | GO:0065008 | regulation of biological quality | 1480 | 1893 | 1.18e-12 |
| GO:BP | GO:0034330 | cell junction organization | 461 | 545 | 3.79e-12 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1454 | 1862 | 4.53e-12 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 386 | 450 | 6.46e-12 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 496 | 591 | 6.75e-12 |
| GO:BP | GO:0098609 | cell-cell adhesion | 475 | 564 | 6.89e-12 |
| GO:BP | GO:0001503 | ossification | 268 | 302 | 8.52e-12 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 957 | 1197 | 8.53e-12 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2841 | 3764 | 8.92e-12 |
| GO:BP | GO:0048589 | developmental growth | 425 | 501 | 1.43e-11 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2682 | 3550 | 3.51e-11 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 385 | 452 | 6.08e-11 |
| GO:BP | GO:0072001 | renal system development | 219 | 244 | 1.04e-10 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 428 | 508 | 1.07e-10 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1511 | 1951 | 1.59e-10 |
| GO:BP | GO:0007409 | axonogenesis | 293 | 337 | 2.10e-10 |
| GO:BP | GO:0060429 | epithelium development | 645 | 792 | 2.40e-10 |
| GO:BP | GO:0044057 | regulation of system process | 330 | 384 | 2.44e-10 |
| GO:BP | GO:0007417 | central nervous system development | 570 | 694 | 2.75e-10 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 87 | 88 | 3.70e-10 |
| GO:BP | GO:0001822 | kidney development | 212 | 237 | 5.13e-10 |
| GO:BP | GO:0003013 | circulatory system process | 362 | 426 | 5.59e-10 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 306 | 355 | 6.78e-10 |
| GO:BP | GO:0051960 | regulation of nervous system development | 293 | 339 | 9.50e-10 |
| GO:BP | GO:0061564 | axon development | 319 | 372 | 9.59e-10 |
| GO:BP | GO:0006810 | transport | 2261 | 2984 | 9.59e-10 |
| GO:BP | GO:0051049 | regulation of transport | 873 | 1098 | 1.14e-09 |
| GO:BP | GO:0042221 | response to chemical | 1764 | 2304 | 1.45e-09 |
| GO:BP | GO:0051179 | localization | 2800 | 3731 | 1.60e-09 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 422 | 505 | 1.66e-09 |
| GO:BP | GO:0098657 | import into cell | 512 | 622 | 1.70e-09 |
| GO:BP | GO:0030900 | forebrain development | 239 | 272 | 1.84e-09 |
| GO:BP | GO:0060322 | head development | 448 | 539 | 1.95e-09 |
| GO:BP | GO:0032879 | regulation of localization | 1126 | 1439 | 1.96e-09 |
| GO:BP | GO:0070848 | response to growth factor | 454 | 547 | 2.15e-09 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 307 | 358 | 2.17e-09 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 430 | 516 | 2.26e-09 |
| GO:BP | GO:0001525 | angiogenesis | 325 | 381 | 2.26e-09 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 961 | 1218 | 2.40e-09 |
| GO:BP | GO:0048729 | tissue morphogenesis | 381 | 453 | 2.59e-09 |
| GO:BP | GO:0023056 | positive regulation of signaling | 963 | 1221 | 2.63e-09 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 575 | 706 | 3.23e-09 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 207 | 233 | 3.62e-09 |
| GO:BP | GO:0007423 | sensory organ development | 329 | 387 | 3.96e-09 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 307 | 359 | 4.12e-09 |
| GO:BP | GO:0001501 | skeletal system development | 297 | 347 | 6.89e-09 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 382 | 456 | 6.97e-09 |
| GO:BP | GO:0007420 | brain development | 414 | 498 | 9.84e-09 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 437 | 528 | 1.05e-08 |
| GO:BP | GO:0051234 | establishment of localization | 2438 | 3240 | 1.13e-08 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 228 | 261 | 1.72e-08 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 251 | 290 | 1.77e-08 |
| GO:BP | GO:0061448 | connective tissue development | 183 | 205 | 1.79e-08 |
| GO:BP | GO:0034329 | cell junction assembly | 277 | 323 | 1.82e-08 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1350 | 1751 | 2.34e-08 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 293 | 344 | 2.79e-08 |
| GO:BP | GO:0008015 | blood circulation | 303 | 357 | 3.22e-08 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 213 | 243 | 3.23e-08 |
| GO:BP | GO:0061061 | muscle structure development | 441 | 536 | 4.28e-08 |
| GO:BP | GO:0071310 | cellular response to organic substance | 1013 | 1297 | 4.30e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1166 | 1504 | 4.67e-08 |
| GO:BP | GO:0016043 | cellular component organization | 3556 | 4802 | 4.67e-08 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 861 | 1093 | 4.67e-08 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 353 | 422 | 4.79e-08 |
| GO:BP | GO:0006897 | endocytosis | 407 | 492 | 4.79e-08 |
| GO:BP | GO:0007507 | heart development | 412 | 499 | 6.15e-08 |
| GO:BP | GO:0051216 | cartilage development | 133 | 145 | 6.15e-08 |
| GO:BP | GO:0035265 | organ growth | 118 | 127 | 6.64e-08 |
| GO:BP | GO:0030001 | metal ion transport | 431 | 524 | 6.85e-08 |
| GO:BP | GO:0030029 | actin filament-based process | 519 | 640 | 9.17e-08 |
| GO:BP | GO:0006468 | protein phosphorylation | 757 | 958 | 1.97e-07 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 330 | 395 | 2.27e-07 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 340 | 408 | 2.34e-07 |
| GO:BP | GO:0048638 | regulation of developmental growth | 211 | 243 | 2.36e-07 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 141 | 156 | 2.55e-07 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 210 | 242 | 2.87e-07 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 190 | 217 | 3.19e-07 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 184 | 210 | 4.95e-07 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 273 | 323 | 5.14e-07 |
| GO:BP | GO:0016310 | phosphorylation | 894 | 1145 | 5.17e-07 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 365 | 442 | 5.21e-07 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 345 | 416 | 5.21e-07 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 105 | 113 | 5.34e-07 |
| GO:BP | GO:0009790 | embryo development | 652 | 821 | 5.82e-07 |
| GO:BP | GO:1903522 | regulation of blood circulation | 171 | 194 | 5.88e-07 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 272 | 322 | 5.89e-07 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 119 | 130 | 6.08e-07 |
| GO:BP | GO:0009987 | cellular process | 7680 | 10686 | 6.88e-07 |
| GO:BP | GO:0042592 | homeostatic process | 887 | 1137 | 7.63e-07 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 898 | 1152 | 7.94e-07 |
| GO:BP | GO:0060284 | regulation of cell development | 462 | 570 | 7.94e-07 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 308 | 369 | 8.32e-07 |
| GO:BP | GO:0072073 | kidney epithelium development | 103 | 111 | 8.68e-07 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 603 | 757 | 8.81e-07 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 999 | 1289 | 9.23e-07 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 148 | 166 | 9.45e-07 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 324 | 390 | 9.49e-07 |
| GO:BP | GO:0043010 | camera-type eye development | 199 | 230 | 1.11e-06 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 221 | 258 | 1.20e-06 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 672 | 850 | 1.22e-06 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 548 | 685 | 1.29e-06 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 927 | 1193 | 1.31e-06 |
| GO:BP | GO:0090132 | epithelium migration | 209 | 243 | 1.39e-06 |
| GO:BP | GO:0010631 | epithelial cell migration | 209 | 243 | 1.39e-06 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 133 | 148 | 1.50e-06 |
| GO:BP | GO:0001649 | osteoblast differentiation | 154 | 174 | 1.52e-06 |
| GO:BP | GO:0090130 | tissue migration | 212 | 247 | 1.57e-06 |
| GO:BP | GO:0014706 | striated muscle tissue development | 185 | 213 | 1.76e-06 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 177 | 203 | 1.85e-06 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 382 | 467 | 1.85e-06 |
| GO:BP | GO:0050808 | synapse organization | 282 | 337 | 1.90e-06 |
| GO:BP | GO:0099536 | synaptic signaling | 394 | 483 | 2.08e-06 |
| GO:BP | GO:0040007 | growth | 556 | 697 | 2.08e-06 |
| GO:BP | GO:0023057 | negative regulation of signaling | 809 | 1036 | 2.33e-06 |
| GO:BP | GO:0045165 | cell fate commitment | 135 | 151 | 2.47e-06 |
| GO:BP | GO:0001654 | eye development | 224 | 263 | 2.50e-06 |
| GO:BP | GO:0031214 | biomineral tissue development | 98 | 106 | 2.95e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 1003 | 1299 | 2.95e-06 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 378 | 463 | 3.20e-06 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 378 | 463 | 3.20e-06 |
| GO:BP | GO:0048880 | sensory system development | 226 | 266 | 3.30e-06 |
| GO:BP | GO:0021537 | telencephalon development | 170 | 195 | 3.35e-06 |
| GO:BP | GO:0008016 | regulation of heart contraction | 146 | 165 | 3.38e-06 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 166 | 190 | 3.38e-06 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 240 | 284 | 3.39e-06 |
| GO:BP | GO:1901652 | response to peptide | 305 | 368 | 3.54e-06 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 456 | 566 | 3.61e-06 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 351 | 428 | 3.63e-06 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 850 | 1093 | 3.66e-06 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1968 | 2622 | 3.98e-06 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 806 | 1034 | 4.01e-06 |
| GO:BP | GO:0003007 | heart morphogenesis | 188 | 218 | 4.02e-06 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 433 | 536 | 4.09e-06 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 101 | 110 | 4.40e-06 |
| GO:BP | GO:0150063 | visual system development | 224 | 264 | 4.48e-06 |
| GO:BP | GO:0010720 | positive regulation of cell development | 259 | 309 | 4.57e-06 |
| GO:BP | GO:0030278 | regulation of ossification | 75 | 79 | 4.77e-06 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 220 | 259 | 4.77e-06 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 164 | 188 | 4.82e-06 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 152 | 173 | 4.96e-06 |
| GO:BP | GO:0010033 | response to organic substance | 1322 | 1736 | 5.17e-06 |
| GO:BP | GO:1901698 | response to nitrogen compound | 583 | 736 | 5.60e-06 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 421 | 521 | 5.60e-06 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 759 | 972 | 5.63e-06 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 618 | 783 | 6.01e-06 |
| GO:BP | GO:0006811 | monoatomic ion transport | 570 | 719 | 6.22e-06 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 113 | 125 | 6.45e-06 |
| GO:BP | GO:0006812 | monoatomic cation transport | 491 | 614 | 6.45e-06 |
| GO:BP | GO:0003205 | cardiac chamber development | 134 | 151 | 7.05e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 108 | 119 | 7.29e-06 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 3665 | 4988 | 7.88e-06 |
| GO:BP | GO:0048771 | tissue remodeling | 103 | 113 | 8.09e-06 |
| GO:BP | GO:0008150 | biological_process | 8053 | 11244 | 8.24e-06 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 389 | 480 | 8.92e-06 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 442 | 550 | 9.09e-06 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 376 | 463 | 9.22e-06 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 376 | 463 | 9.22e-06 |
| GO:BP | GO:0060047 | heart contraction | 168 | 194 | 9.64e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 388 | 479 | 1.01e-05 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 317 | 386 | 1.06e-05 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 469 | 587 | 1.45e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 885 | 1146 | 1.58e-05 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 173 | 201 | 1.58e-05 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 184 | 215 | 1.61e-05 |
| GO:BP | GO:0097485 | neuron projection guidance | 150 | 172 | 1.61e-05 |
| GO:BP | GO:0007411 | axon guidance | 150 | 172 | 1.61e-05 |
| GO:BP | GO:0043434 | response to peptide hormone | 261 | 314 | 1.62e-05 |
| GO:BP | GO:0035108 | limb morphogenesis | 100 | 110 | 1.62e-05 |
| GO:BP | GO:0035107 | appendage morphogenesis | 100 | 110 | 1.62e-05 |
| GO:BP | GO:0043062 | extracellular structure organization | 191 | 224 | 1.66e-05 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 191 | 224 | 1.66e-05 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 307 | 374 | 1.72e-05 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 187 | 219 | 1.76e-05 |
| GO:BP | GO:0003231 | cardiac ventricle development | 104 | 115 | 1.79e-05 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 250 | 300 | 1.81e-05 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 503 | 633 | 1.84e-05 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 64 | 67 | 1.93e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 190 | 223 | 1.95e-05 |
| GO:BP | GO:0050877 | nervous system process | 478 | 600 | 2.01e-05 |
| GO:BP | GO:0007389 | pattern specification process | 239 | 286 | 2.02e-05 |
| GO:BP | GO:0003015 | heart process | 175 | 204 | 2.07e-05 |
| GO:BP | GO:0048568 | embryonic organ development | 252 | 303 | 2.23e-05 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 120 | 135 | 2.28e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1810 | 2415 | 2.60e-05 |
| GO:BP | GO:0030010 | establishment of cell polarity | 111 | 124 | 2.60e-05 |
| GO:BP | GO:0048588 | developmental cell growth | 155 | 179 | 2.61e-05 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 147 | 169 | 2.79e-05 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 209 | 248 | 2.92e-05 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 398 | 495 | 3.00e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 219 | 261 | 3.14e-05 |
| GO:BP | GO:0048592 | eye morphogenesis | 97 | 107 | 3.16e-05 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 62 | 65 | 3.31e-05 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 318 | 390 | 3.48e-05 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 232 | 278 | 3.53e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 1000 | 1306 | 3.75e-05 |
| GO:BP | GO:0042391 | regulation of membrane potential | 235 | 282 | 3.76e-05 |
| GO:BP | GO:0090257 | regulation of muscle system process | 153 | 177 | 3.77e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 346 | 427 | 3.77e-05 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 623 | 796 | 3.90e-05 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1437 | 1904 | 3.96e-05 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 171 | 200 | 4.20e-05 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 76 | 82 | 5.49e-05 |
| GO:BP | GO:0042330 | taxis | 205 | 244 | 5.62e-05 |
| GO:BP | GO:0006935 | chemotaxis | 205 | 244 | 5.62e-05 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 249 | 301 | 5.82e-05 |
| GO:BP | GO:0072006 | nephron development | 103 | 115 | 5.86e-05 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1420 | 1883 | 6.23e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 278 | 339 | 6.40e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1640 | 2186 | 6.55e-05 |
| GO:BP | GO:0031399 | regulation of protein modification process | 707 | 911 | 6.56e-05 |
| GO:BP | GO:0003281 | ventricular septum development | 65 | 69 | 6.56e-05 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 80 | 87 | 6.61e-05 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 80 | 87 | 6.61e-05 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 89 | 98 | 7.03e-05 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 59 | 62 | 7.48e-05 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 829 | 1077 | 8.19e-05 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 246 | 298 | 9.01e-05 |
| GO:BP | GO:0001823 | mesonephros development | 69 | 74 | 9.01e-05 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 706 | 911 | 9.37e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1745 | 2333 | 9.39e-05 |
| GO:BP | GO:0046903 | secretion | 491 | 622 | 9.45e-05 |
| GO:BP | GO:0060485 | mesenchyme development | 205 | 245 | 9.67e-05 |
| GO:BP | GO:0003279 | cardiac septum development | 92 | 102 | 9.77e-05 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 184 | 218 | 9.81e-05 |
| GO:BP | GO:0032835 | glomerulus development | 52 | 54 | 1.02e-04 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 335 | 415 | 1.03e-04 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 627 | 805 | 1.08e-04 |
| GO:BP | GO:0055123 | digestive system development | 87 | 96 | 1.11e-04 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 68 | 73 | 1.14e-04 |
| GO:BP | GO:0072164 | mesonephric tubule development | 68 | 73 | 1.14e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 402 | 504 | 1.14e-04 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 626 | 804 | 1.18e-04 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 179 | 212 | 1.25e-04 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 440 | 555 | 1.32e-04 |
| GO:BP | GO:0003012 | muscle system process | 266 | 325 | 1.35e-04 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 86 | 95 | 1.39e-04 |
| GO:BP | GO:0030282 | bone mineralization | 72 | 78 | 1.44e-04 |
| GO:BP | GO:0140352 | export from cell | 469 | 594 | 1.45e-04 |
| GO:BP | GO:0001657 | ureteric bud development | 67 | 72 | 1.46e-04 |
| GO:BP | GO:0007610 | behavior | 338 | 420 | 1.53e-04 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 156 | 183 | 1.62e-04 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 56 | 59 | 1.66e-04 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 126 | 145 | 1.68e-04 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 36 | 36 | 1.79e-04 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 346 | 431 | 1.79e-04 |
| GO:BP | GO:0050807 | regulation of synapse organization | 148 | 173 | 1.83e-04 |
| GO:BP | GO:0030100 | regulation of endocytosis | 166 | 196 | 1.84e-04 |
| GO:BP | GO:0007517 | muscle organ development | 221 | 267 | 1.84e-04 |
| GO:BP | GO:0003002 | regionalization | 214 | 258 | 1.92e-04 |
| GO:BP | GO:0048565 | digestive tract development | 80 | 88 | 1.94e-04 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 80 | 88 | 1.94e-04 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 80 | 88 | 1.94e-04 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 121 | 139 | 2.06e-04 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 97 | 109 | 2.06e-04 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 97 | 109 | 2.06e-04 |
| GO:BP | GO:0009605 | response to external stimulus | 1179 | 1559 | 2.07e-04 |
| GO:BP | GO:1990138 | neuron projection extension | 117 | 134 | 2.10e-04 |
| GO:BP | GO:0001764 | neuron migration | 113 | 129 | 2.13e-04 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 432 | 546 | 2.23e-04 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 319 | 396 | 2.28e-04 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 60 | 64 | 2.33e-04 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 35 | 35 | 2.39e-04 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 150 | 176 | 2.39e-04 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 79 | 87 | 2.41e-04 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 92 | 103 | 2.42e-04 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 157 | 185 | 2.46e-04 |
| GO:BP | GO:0051641 | cellular localization | 1950 | 2623 | 2.46e-04 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 232 | 282 | 2.48e-04 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 116 | 133 | 2.51e-04 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 235 | 286 | 2.58e-04 |
| GO:BP | GO:0033002 | muscle cell proliferation | 131 | 152 | 2.62e-04 |
| GO:BP | GO:1901653 | cellular response to peptide | 225 | 273 | 2.62e-04 |
| GO:BP | GO:0045666 | positive regulation of neuron differentiation | 54 | 57 | 2.73e-04 |
| GO:BP | GO:0055085 | transmembrane transport | 710 | 921 | 2.77e-04 |
| GO:BP | GO:0042063 | gliogenesis | 201 | 242 | 2.88e-04 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 156 | 184 | 2.88e-04 |
| GO:BP | GO:0061035 | regulation of cartilage development | 48 | 50 | 2.96e-04 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 78 | 86 | 2.97e-04 |
| GO:BP | GO:0009725 | response to hormone | 479 | 610 | 3.10e-04 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 107 | 122 | 3.12e-04 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 34 | 34 | 3.19e-04 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 82 | 91 | 3.25e-04 |
| GO:BP | GO:0016358 | dendrite development | 155 | 183 | 3.40e-04 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 176 | 210 | 3.40e-04 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 206 | 249 | 3.70e-04 |
| GO:BP | GO:0060993 | kidney morphogenesis | 63 | 68 | 3.81e-04 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 245 | 300 | 3.88e-04 |
| GO:BP | GO:0010721 | negative regulation of cell development | 154 | 182 | 4.03e-04 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 81 | 90 | 4.08e-04 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 117 | 135 | 4.31e-04 |
| GO:BP | GO:0032940 | secretion by cell | 434 | 551 | 4.55e-04 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 52 | 55 | 4.65e-04 |
| GO:BP | GO:0007015 | actin filament organization | 288 | 357 | 4.70e-04 |
| GO:BP | GO:0072009 | nephron epithelium development | 76 | 84 | 4.70e-04 |
| GO:BP | GO:0001656 | metanephros development | 57 | 61 | 4.93e-04 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 532 | 683 | 5.17e-04 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 46 | 48 | 5.17e-04 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 163 | 194 | 5.18e-04 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 145 | 171 | 5.55e-04 |
| GO:BP | GO:1901342 | regulation of vasculature development | 166 | 198 | 5.59e-04 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 88 | 99 | 5.59e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 96 | 109 | 5.76e-04 |
| GO:BP | GO:0001775 | cell activation | 490 | 627 | 5.92e-04 |
| GO:BP | GO:0045216 | cell-cell junction organization | 130 | 152 | 6.10e-04 |
| GO:BP | GO:0031032 | actomyosin structure organization | 155 | 184 | 6.10e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 56 | 60 | 6.33e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 137 | 161 | 6.34e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 298 | 371 | 6.34e-04 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 165 | 197 | 6.49e-04 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 39 | 40 | 6.49e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 448 | 571 | 6.53e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 70 | 77 | 6.59e-04 |
| GO:BP | GO:0021987 | cerebral cortex development | 83 | 93 | 6.59e-04 |
| GO:BP | GO:0006816 | calcium ion transport | 215 | 262 | 6.66e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 218 | 266 | 6.91e-04 |
| GO:BP | GO:0043542 | endothelial cell migration | 147 | 174 | 7.07e-04 |
| GO:BP | GO:0043583 | ear development | 129 | 151 | 7.16e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 554 | 714 | 7.24e-04 |
| GO:BP | GO:0060419 | heart growth | 65 | 71 | 7.27e-04 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 143 | 169 | 7.61e-04 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 31 | 31 | 8.05e-04 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 139 | 164 | 8.23e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 153 | 182 | 8.31e-04 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 197 | 239 | 8.31e-04 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 280 | 348 | 8.43e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 117 | 136 | 8.45e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 344 | 433 | 8.75e-04 |
| GO:BP | GO:0046620 | regulation of organ growth | 64 | 70 | 9.22e-04 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 310 | 388 | 9.34e-04 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 59 | 64 | 1.00e-03 |
| GO:BP | GO:0048645 | animal organ formation | 49 | 52 | 1.00e-03 |
| GO:BP | GO:0021543 | pallium development | 116 | 135 | 1.02e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 162 | 194 | 1.03e-03 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 303 | 379 | 1.03e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 234 | 288 | 1.08e-03 |
| GO:BP | GO:0098900 | regulation of action potential | 37 | 38 | 1.15e-03 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 137 | 162 | 1.15e-03 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 137 | 162 | 1.15e-03 |
| GO:BP | GO:0061005 | cell differentiation involved in kidney development | 37 | 38 | 1.15e-03 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 76 | 85 | 1.20e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 161 | 193 | 1.20e-03 |
| GO:BP | GO:0032409 | regulation of transporter activity | 126 | 148 | 1.20e-03 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 96 | 110 | 1.23e-03 |
| GO:BP | GO:0043588 | skin development | 147 | 175 | 1.24e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 499 | 642 | 1.27e-03 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 174 | 210 | 1.29e-03 |
| GO:BP | GO:0010633 | negative regulation of epithelial cell migration | 48 | 51 | 1.29e-03 |
| GO:BP | GO:0061326 | renal tubule development | 67 | 74 | 1.29e-03 |
| GO:BP | GO:0021954 | central nervous system neuron development | 53 | 57 | 1.31e-03 |
| GO:BP | GO:0035148 | tube formation | 107 | 124 | 1.33e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 103 | 119 | 1.39e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 190 | 231 | 1.39e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 260 | 323 | 1.43e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1197 | 1595 | 1.44e-03 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 29 | 29 | 1.47e-03 |
| GO:BP | GO:0044409 | symbiont entry into host | 95 | 109 | 1.48e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 42 | 44 | 1.49e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 471 | 605 | 1.52e-03 |
| GO:BP | GO:0006814 | sodium ion transport | 117 | 137 | 1.61e-03 |
| GO:BP | GO:0071772 | response to BMP | 102 | 118 | 1.67e-03 |
| GO:BP | GO:0060348 | bone development | 124 | 146 | 1.67e-03 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 47 | 50 | 1.67e-03 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 102 | 118 | 1.67e-03 |
| GO:BP | GO:0050900 | leukocyte migration | 162 | 195 | 1.70e-03 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 98 | 113 | 1.73e-03 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 61 | 67 | 1.82e-03 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 61 | 67 | 1.82e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 61 | 67 | 1.82e-03 |
| GO:BP | GO:0022612 | gland morphogenesis | 82 | 93 | 1.87e-03 |
| GO:BP | GO:0007416 | synapse assembly | 116 | 136 | 1.91e-03 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 41 | 43 | 1.95e-03 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 41 | 43 | 1.95e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 369 | 469 | 1.98e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 28 | 28 | 1.99e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 101 | 117 | 1.99e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 65 | 72 | 1.99e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 56 | 61 | 1.99e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 46 | 49 | 2.11e-03 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 51 | 55 | 2.11e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 46 | 49 | 2.11e-03 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 51 | 55 | 2.11e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 93 | 107 | 2.14e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 484 | 624 | 2.20e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 225 | 278 | 2.21e-03 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 77 | 87 | 2.24e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 77 | 87 | 2.24e-03 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 302 | 380 | 2.24e-03 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 60 | 66 | 2.25e-03 |
| GO:BP | GO:0060541 | respiratory system development | 136 | 162 | 2.30e-03 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 173 | 210 | 2.34e-03 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 156 | 188 | 2.47e-03 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 118 | 139 | 2.47e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 682 | 893 | 2.49e-03 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 55 | 60 | 2.49e-03 |
| GO:BP | GO:0002064 | epithelial cell development | 125 | 148 | 2.49e-03 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 301 | 379 | 2.49e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 92 | 106 | 2.55e-03 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 68 | 76 | 2.59e-03 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 68 | 76 | 2.59e-03 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 34 | 35 | 2.59e-03 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 114 | 134 | 2.62e-03 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 27 | 27 | 2.64e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 27 | 27 | 2.64e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 72 | 81 | 2.66e-03 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 110 | 129 | 2.79e-03 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 59 | 65 | 2.79e-03 |
| GO:BP | GO:0008361 | regulation of cell size | 124 | 147 | 2.92e-03 |
| GO:BP | GO:0030509 | BMP signaling pathway | 95 | 110 | 2.94e-03 |
| GO:BP | GO:0072080 | nephron tubule development | 63 | 70 | 3.04e-03 |
| GO:BP | GO:0046849 | bone remodeling | 54 | 59 | 3.14e-03 |
| GO:BP | GO:0071695 | anatomical structure maturation | 127 | 151 | 3.16e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 505 | 654 | 3.25e-03 |
| GO:BP | GO:0060840 | artery development | 75 | 85 | 3.32e-03 |
| GO:BP | GO:0061337 | cardiac conduction | 75 | 85 | 3.32e-03 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 75 | 85 | 3.32e-03 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 123 | 146 | 3.43e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 112 | 132 | 3.69e-03 |
| GO:BP | GO:0036211 | protein modification process | 1696 | 2291 | 3.69e-03 |
| GO:BP | GO:0014013 | regulation of gliogenesis | 62 | 69 | 3.80e-03 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 108 | 127 | 3.95e-03 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 53 | 58 | 3.95e-03 |
| GO:BP | GO:0072028 | nephron morphogenesis | 53 | 58 | 3.95e-03 |
| GO:BP | GO:0048864 | stem cell development | 66 | 74 | 3.95e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 108 | 127 | 3.95e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 66 | 74 | 3.95e-03 |
| GO:BP | GO:0098727 | maintenance of cell number | 122 | 145 | 4.00e-03 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 122 | 145 | 4.00e-03 |
| GO:BP | GO:0031623 | receptor internalization | 78 | 89 | 4.00e-03 |
| GO:BP | GO:0060173 | limb development | 115 | 136 | 4.00e-03 |
| GO:BP | GO:0048736 | appendage development | 115 | 136 | 4.00e-03 |
| GO:BP | GO:0042476 | odontogenesis | 70 | 79 | 4.00e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 516 | 670 | 4.18e-03 |
| GO:BP | GO:0000003 | reproduction | 672 | 882 | 4.19e-03 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 48 | 52 | 4.27e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 111 | 131 | 4.30e-03 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 89 | 103 | 4.40e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 43 | 46 | 4.41e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 107 | 126 | 4.64e-03 |
| GO:BP | GO:0030324 | lung development | 121 | 144 | 4.68e-03 |
| GO:BP | GO:0031099 | regeneration | 121 | 144 | 4.68e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 65 | 73 | 4.84e-03 |
| GO:BP | GO:0060349 | bone morphogenesis | 65 | 73 | 4.84e-03 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 25 | 25 | 4.84e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 69 | 78 | 4.91e-03 |
| GO:BP | GO:0050890 | cognition | 174 | 213 | 4.91e-03 |
| GO:BP | GO:0030323 | respiratory tube development | 124 | 148 | 5.02e-03 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 127 | 152 | 5.40e-03 |
| GO:BP | GO:0042733 | embryonic digit morphogenesis | 47 | 51 | 5.44e-03 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 56 | 62 | 5.44e-03 |
| GO:BP | GO:0045778 | positive regulation of ossification | 37 | 39 | 5.46e-03 |
| GO:BP | GO:0019827 | stem cell population maintenance | 120 | 143 | 5.48e-03 |
| GO:BP | GO:0040008 | regulation of growth | 361 | 462 | 5.58e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 780 | 1031 | 5.58e-03 |
| GO:BP | GO:0023061 | signal release | 251 | 315 | 5.62e-03 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 571 | 746 | 5.64e-03 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 80 | 92 | 5.70e-03 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 102 | 120 | 5.86e-03 |
| GO:BP | GO:0086004 | regulation of cardiac muscle cell contraction | 31 | 32 | 5.94e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 91 | 106 | 5.94e-03 |
| GO:BP | GO:0035850 | epithelial cell differentiation involved in kidney development | 31 | 32 | 5.94e-03 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 91 | 106 | 5.94e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 68 | 77 | 5.96e-03 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 51 | 56 | 6.14e-03 |
| GO:BP | GO:0048708 | astrocyte differentiation | 51 | 56 | 6.14e-03 |
| GO:BP | GO:0010817 | regulation of hormone levels | 253 | 318 | 6.26e-03 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 443 | 573 | 6.28e-03 |
| GO:BP | GO:0001894 | tissue homeostasis | 136 | 164 | 6.30e-03 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 136 | 164 | 6.30e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 119 | 142 | 6.32e-03 |
| GO:BP | GO:0048839 | inner ear development | 112 | 133 | 6.38e-03 |
| GO:BP | GO:0071875 | adrenergic receptor signaling pathway | 24 | 24 | 6.47e-03 |
| GO:BP | GO:0098868 | bone growth | 24 | 24 | 6.47e-03 |
| GO:BP | GO:0010001 | glial cell differentiation | 149 | 181 | 6.53e-03 |
| GO:BP | GO:0048469 | cell maturation | 94 | 110 | 6.60e-03 |
| GO:BP | GO:0031016 | pancreas development | 46 | 50 | 6.74e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 46 | 50 | 6.74e-03 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 79 | 91 | 6.76e-03 |
| GO:BP | GO:0043149 | stress fiber assembly | 79 | 91 | 6.76e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 101 | 119 | 6.78e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 101 | 119 | 6.78e-03 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 115 | 137 | 6.81e-03 |
| GO:BP | GO:0010596 | negative regulation of endothelial cell migration | 36 | 38 | 6.91e-03 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 75 | 86 | 6.95e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 90 | 105 | 6.95e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 41 | 44 | 7.04e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 41 | 44 | 7.04e-03 |
| GO:BP | GO:0022414 | reproductive process | 664 | 874 | 7.20e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 800 | 1060 | 7.23e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 592 | 776 | 7.41e-03 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 50 | 55 | 7.57e-03 |
| GO:BP | GO:0048732 | gland development | 245 | 308 | 7.60e-03 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 30 | 31 | 7.69e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 82 | 95 | 7.72e-03 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 93 | 109 | 7.74e-03 |
| GO:BP | GO:0061458 | reproductive system development | 167 | 205 | 7.87e-03 |
| GO:BP | GO:0008544 | epidermis development | 170 | 209 | 8.09e-03 |
| GO:BP | GO:0021675 | nerve development | 54 | 60 | 8.17e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 229 | 287 | 8.29e-03 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 74 | 85 | 8.37e-03 |
| GO:BP | GO:0007369 | gastrulation | 117 | 140 | 8.48e-03 |
| GO:BP | GO:0003170 | heart valve development | 58 | 65 | 8.52e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 58 | 65 | 8.52e-03 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 96 | 113 | 8.54e-03 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 127 | 153 | 8.56e-03 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 23 | 23 | 8.56e-03 |
| GO:BP | GO:0003416 | endochondral bone growth | 23 | 23 | 8.56e-03 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 103 | 122 | 8.56e-03 |
| GO:BP | GO:0002063 | chondrocyte development | 23 | 23 | 8.56e-03 |
| GO:BP | GO:0060037 | pharyngeal system development | 23 | 23 | 8.56e-03 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 103 | 122 | 8.56e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 66 | 75 | 8.57e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 66 | 75 | 8.57e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1366 | 1841 | 8.68e-03 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 35 | 37 | 8.77e-03 |
| GO:BP | GO:0002090 | regulation of receptor internalization | 40 | 43 | 8.85e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 410 | 530 | 8.87e-03 |
| GO:BP | GO:0006813 | potassium ion transport | 113 | 135 | 9.08e-03 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 113 | 135 | 9.08e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 228 | 286 | 9.08e-03 |
| GO:BP | GO:0042552 | myelination | 99 | 117 | 9.19e-03 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 49 | 54 | 9.22e-03 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 49 | 54 | 9.22e-03 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 49 | 54 | 9.22e-03 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 175 | 216 | 9.37e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 200 | 249 | 9.41e-03 |
| GO:BP | GO:0001659 | temperature homeostasis | 109 | 130 | 9.82e-03 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 126 | 152 | 9.82e-03 |
| GO:BP | GO:0035270 | endocrine system development | 73 | 84 | 9.82e-03 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 109 | 130 | 9.82e-03 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 149 | 182 | 9.82e-03 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 29 | 30 | 9.82e-03 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 29 | 30 | 9.82e-03 |
| GO:BP | GO:0021700 | developmental maturation | 165 | 203 | 9.84e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 102 | 121 | 9.84e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 102 | 121 | 9.84e-03 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 165 | 203 | 9.84e-03 |
| GO:BP | GO:0007346 | regulation of mitotic cell cycle | 328 | 420 | 9.87e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1376 | 1856 | 9.87e-03 |
| GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 69 | 79 | 1.00e-02 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 84 | 98 | 1.00e-02 |
| GO:BP | GO:0030031 | cell projection assembly | 348 | 447 | 1.01e-02 |
| GO:BP | GO:0042110 | T cell activation | 242 | 305 | 1.01e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 57 | 64 | 1.01e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 44 | 48 | 1.02e-02 |
| GO:BP | GO:0014032 | neural crest cell development | 61 | 69 | 1.02e-02 |
| GO:BP | GO:0001755 | neural crest cell migration | 44 | 48 | 1.02e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 304 | 388 | 1.04e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 98 | 116 | 1.05e-02 |
| GO:BP | GO:0099173 | postsynapse organization | 122 | 147 | 1.05e-02 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 80 | 93 | 1.05e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 720 | 953 | 1.07e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 528 | 691 | 1.08e-02 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 115 | 138 | 1.09e-02 |
| GO:BP | GO:0031641 | regulation of myelination | 34 | 36 | 1.10e-02 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 34 | 36 | 1.10e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 164 | 202 | 1.10e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 1702 | 2309 | 1.10e-02 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 164 | 202 | 1.10e-02 |
| GO:BP | GO:0003177 | pulmonary valve development | 22 | 22 | 1.11e-02 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 22 | 22 | 1.11e-02 |
| GO:BP | GO:0050921 | positive regulation of chemotaxis | 72 | 83 | 1.15e-02 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 118 | 142 | 1.15e-02 |
| GO:BP | GO:0007611 | learning or memory | 154 | 189 | 1.16e-02 |
| GO:BP | GO:0051235 | maintenance of location | 201 | 251 | 1.16e-02 |
| GO:BP | GO:0006936 | muscle contraction | 204 | 255 | 1.17e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 52 | 58 | 1.18e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 52 | 58 | 1.18e-02 |
| GO:BP | GO:0021915 | neural tube development | 111 | 133 | 1.18e-02 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 52 | 58 | 1.18e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 273 | 347 | 1.19e-02 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 160 | 197 | 1.21e-02 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 340 | 437 | 1.21e-02 |
| GO:BP | GO:0007492 | endoderm development | 56 | 63 | 1.21e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 56 | 63 | 1.21e-02 |
| GO:BP | GO:0032535 | regulation of cellular component size | 228 | 287 | 1.21e-02 |
| GO:BP | GO:0010232 | vascular transport | 60 | 68 | 1.21e-02 |
| GO:BP | GO:0019915 | lipid storage | 60 | 68 | 1.21e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 60 | 68 | 1.21e-02 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 60 | 68 | 1.21e-02 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 60 | 68 | 1.21e-02 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 28 | 29 | 1.24e-02 |
| GO:BP | GO:0060563 | neuroepithelial cell differentiation | 28 | 29 | 1.24e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 28 | 29 | 1.24e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 43 | 47 | 1.24e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 43 | 47 | 1.24e-02 |
| GO:BP | GO:0014015 | positive regulation of gliogenesis | 43 | 47 | 1.24e-02 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 150 | 184 | 1.26e-02 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 75 | 87 | 1.29e-02 |
| GO:BP | GO:0008104 | protein localization | 1478 | 2000 | 1.34e-02 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 427 | 555 | 1.34e-02 |
| GO:BP | GO:1905314 | semi-lunar valve development | 38 | 41 | 1.35e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 143 | 175 | 1.35e-02 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 38 | 41 | 1.35e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 38 | 41 | 1.35e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 82 | 96 | 1.37e-02 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1485 | 2010 | 1.38e-02 |
| GO:BP | GO:0045444 | fat cell differentiation | 146 | 179 | 1.39e-02 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 96 | 114 | 1.40e-02 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 193 | 241 | 1.40e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 67 | 77 | 1.40e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 165 | 204 | 1.40e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 309 | 396 | 1.43e-02 |
| GO:BP | GO:1904892 | regulation of receptor signaling pathway via STAT | 51 | 57 | 1.43e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 63 | 72 | 1.43e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 63 | 72 | 1.43e-02 |
| GO:BP | GO:0008589 | regulation of smoothened signaling pathway | 63 | 72 | 1.43e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 208 | 261 | 1.44e-02 |
| GO:BP | GO:0060384 | innervation | 21 | 21 | 1.45e-02 |
| GO:BP | GO:0042634 | regulation of hair cycle | 21 | 21 | 1.45e-02 |
| GO:BP | GO:0007224 | smoothened signaling pathway | 99 | 118 | 1.50e-02 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 42 | 46 | 1.55e-02 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 42 | 46 | 1.55e-02 |
| GO:BP | GO:0003197 | endocardial cushion development | 42 | 46 | 1.55e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 42 | 46 | 1.55e-02 |
| GO:BP | GO:0032868 | response to insulin | 164 | 203 | 1.58e-02 |
| GO:BP | GO:0016266 | O-glycan processing | 27 | 28 | 1.60e-02 |
| GO:BP | GO:0048675 | axon extension | 81 | 95 | 1.60e-02 |
| GO:BP | GO:0098739 | import across plasma membrane | 102 | 122 | 1.60e-02 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1326 | 1791 | 1.60e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 88 | 104 | 1.64e-02 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 46 | 51 | 1.68e-02 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 138 | 169 | 1.70e-02 |
| GO:BP | GO:0048286 | lung alveolus development | 37 | 40 | 1.71e-02 |
| GO:BP | GO:0002376 | immune system process | 1050 | 1410 | 1.72e-02 |
| GO:BP | GO:0006954 | inflammatory response | 330 | 425 | 1.72e-02 |
| GO:BP | GO:0006915 | apoptotic process | 1026 | 1377 | 1.74e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 50 | 56 | 1.75e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 84 | 99 | 1.77e-02 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 58 | 66 | 1.77e-02 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 54 | 61 | 1.78e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 286 | 366 | 1.81e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 73 | 85 | 1.82e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 277 | 354 | 1.85e-02 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 150 | 185 | 1.87e-02 |
| GO:BP | GO:0001704 | formation of primary germ layer | 80 | 94 | 1.90e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 69 | 80 | 1.93e-02 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 41 | 45 | 1.94e-02 |
| GO:BP | GO:0090183 | regulation of kidney development | 20 | 20 | 1.96e-02 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 20 | 20 | 1.96e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 463 | 606 | 2.10e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 45 | 50 | 2.10e-02 |
| GO:BP | GO:0072210 | metanephric nephron development | 26 | 27 | 2.11e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 26 | 27 | 2.11e-02 |
| GO:BP | GO:0060416 | response to growth hormone | 26 | 27 | 2.11e-02 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 26 | 27 | 2.11e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 49 | 55 | 2.16e-02 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 36 | 39 | 2.16e-02 |
| GO:BP | GO:0021536 | diencephalon development | 36 | 39 | 2.16e-02 |
| GO:BP | GO:0046425 | regulation of receptor signaling pathway via JAK-STAT | 49 | 55 | 2.16e-02 |
| GO:BP | GO:0051983 | regulation of chromosome segregation | 100 | 120 | 2.17e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 53 | 60 | 2.17e-02 |
| GO:BP | GO:0051301 | cell division | 415 | 541 | 2.17e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 79 | 93 | 2.24e-02 |
| GO:BP | GO:0001508 | action potential | 86 | 102 | 2.26e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 315 | 406 | 2.34e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 400 | 521 | 2.36e-02 |
| GO:BP | GO:0007548 | sex differentiation | 145 | 179 | 2.36e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 148 | 183 | 2.41e-02 |
| GO:BP | GO:0006638 | neutral lipid metabolic process | 75 | 88 | 2.41e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 75 | 88 | 2.41e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 239 | 304 | 2.42e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 64 | 74 | 2.42e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1161 | 1566 | 2.42e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 89 | 106 | 2.43e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 82 | 97 | 2.44e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 297 | 382 | 2.48e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 99 | 119 | 2.51e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 109 | 132 | 2.51e-02 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 44 | 49 | 2.57e-02 |
| GO:BP | GO:0046942 | carboxylic acid transport | 163 | 203 | 2.57e-02 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 71 | 83 | 2.57e-02 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 56 | 64 | 2.60e-02 |
| GO:BP | GO:0060740 | prostate gland epithelium morphogenesis | 19 | 19 | 2.62e-02 |
| GO:BP | GO:0010878 | cholesterol storage | 19 | 19 | 2.62e-02 |
| GO:BP | GO:0060512 | prostate gland morphogenesis | 19 | 19 | 2.62e-02 |
| GO:BP | GO:0048566 | embryonic digestive tract development | 19 | 19 | 2.62e-02 |
| GO:BP | GO:0071378 | cellular response to growth hormone stimulus | 19 | 19 | 2.62e-02 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 19 | 19 | 2.62e-02 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 52 | 59 | 2.63e-02 |
| GO:BP | GO:0046503 | glycerolipid catabolic process | 35 | 38 | 2.70e-02 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 35 | 38 | 2.70e-02 |
| GO:BP | GO:0002066 | columnar/cuboidal epithelial cell development | 35 | 38 | 2.70e-02 |
| GO:BP | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 35 | 38 | 2.70e-02 |
| GO:BP | GO:0050773 | regulation of dendrite development | 67 | 78 | 2.71e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 67 | 78 | 2.71e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 293 | 377 | 2.71e-02 |
| GO:BP | GO:0010092 | specification of animal organ identity | 25 | 26 | 2.72e-02 |
| GO:BP | GO:0000278 | mitotic cell cycle | 577 | 763 | 2.73e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 156 | 194 | 2.80e-02 |
| GO:BP | GO:0006639 | acylglycerol metabolic process | 74 | 87 | 2.81e-02 |
| GO:BP | GO:0007613 | memory | 74 | 87 | 2.81e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 389 | 507 | 2.83e-02 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 30 | 32 | 2.85e-02 |
| GO:BP | GO:0071604 | transforming growth factor beta production | 30 | 32 | 2.85e-02 |
| GO:BP | GO:0072583 | clathrin-dependent endocytosis | 39 | 43 | 3.00e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 189 | 238 | 3.02e-02 |
| GO:BP | GO:0044784 | metaphase/anaphase transition of cell cycle | 77 | 91 | 3.08e-02 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 77 | 91 | 3.08e-02 |
| GO:BP | GO:0006637 | acyl-CoA metabolic process | 55 | 63 | 3.11e-02 |
| GO:BP | GO:0002688 | regulation of leukocyte chemotaxis | 55 | 63 | 3.11e-02 |
| GO:BP | GO:0035383 | thioester metabolic process | 55 | 63 | 3.11e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 245 | 313 | 3.13e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 43 | 48 | 3.15e-02 |
| GO:BP | GO:0008219 | cell death | 1056 | 1423 | 3.15e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 94 | 113 | 3.16e-02 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 51 | 58 | 3.17e-02 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 158 | 197 | 3.17e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 51 | 58 | 3.17e-02 |
| GO:BP | GO:0012501 | programmed cell death | 1053 | 1419 | 3.20e-02 |
| GO:BP | GO:0032526 | response to retinoic acid | 66 | 77 | 3.20e-02 |
| GO:BP | GO:0033993 | response to lipid | 437 | 573 | 3.31e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 123 | 151 | 3.37e-02 |
| GO:BP | GO:0003176 | aortic valve development | 34 | 37 | 3.39e-02 |
| GO:BP | GO:0070169 | positive regulation of biomineral tissue development | 34 | 37 | 3.39e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 34 | 37 | 3.39e-02 |
| GO:BP | GO:0009611 | response to wounding | 296 | 382 | 3.43e-02 |
| GO:BP | GO:0016049 | cell growth | 296 | 382 | 3.43e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 148 | 184 | 3.44e-02 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 90 | 108 | 3.45e-02 |
| GO:BP | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 18 | 18 | 3.49e-02 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 18 | 18 | 3.49e-02 |
| GO:BP | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 18 | 18 | 3.49e-02 |
| GO:BP | GO:0060396 | growth hormone receptor signaling pathway | 18 | 18 | 3.49e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 310 | 401 | 3.49e-02 |
| GO:BP | GO:0006909 | phagocytosis | 113 | 138 | 3.49e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 113 | 138 | 3.49e-02 |
| GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 24 | 25 | 3.50e-02 |
| GO:BP | GO:0099171 | presynaptic modulation of chemical synaptic transmission | 24 | 25 | 3.50e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 24 | 25 | 3.50e-02 |
| GO:BP | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle | 76 | 90 | 3.57e-02 |
| GO:BP | GO:0015849 | organic acid transport | 163 | 204 | 3.57e-02 |
| GO:BP | GO:0007219 | Notch signaling pathway | 116 | 142 | 3.58e-02 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 103 | 125 | 3.58e-02 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 29 | 31 | 3.59e-02 |
| GO:BP | GO:0045687 | positive regulation of glial cell differentiation | 29 | 31 | 3.59e-02 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 29 | 31 | 3.59e-02 |
| GO:BP | GO:1904645 | response to amyloid-beta | 29 | 31 | 3.59e-02 |
| GO:BP | GO:0060688 | regulation of morphogenesis of a branching structure | 29 | 31 | 3.59e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 93 | 112 | 3.59e-02 |
| GO:BP | GO:0019058 | viral life cycle | 184 | 232 | 3.64e-02 |
| GO:BP | GO:0051591 | response to cAMP | 54 | 62 | 3.68e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 141 | 175 | 3.71e-02 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 144 | 179 | 3.77e-02 |
| GO:BP | GO:0051899 | membrane depolarization | 50 | 57 | 3.78e-02 |
| GO:BP | GO:0097009 | energy homeostasis | 50 | 57 | 3.78e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 50 | 57 | 3.78e-02 |
| GO:BP | GO:0033555 | multicellular organismal response to stress | 50 | 57 | 3.78e-02 |
| GO:BP | GO:0009953 | dorsal/ventral pattern formation | 42 | 47 | 3.79e-02 |
| GO:BP | GO:0051653 | spindle localization | 46 | 52 | 3.82e-02 |
| GO:BP | GO:0001708 | cell fate specification | 46 | 52 | 3.82e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 153 | 191 | 3.87e-02 |
| GO:BP | GO:0006629 | lipid metabolic process | 692 | 923 | 3.92e-02 |
| GO:BP | GO:0033045 | regulation of sister chromatid segregation | 82 | 98 | 4.09e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 92 | 111 | 4.16e-02 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 92 | 111 | 4.16e-02 |
| GO:BP | GO:0010876 | lipid localization | 233 | 298 | 4.16e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 118 | 145 | 4.17e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 33 | 36 | 4.19e-02 |
| GO:BP | GO:0044272 | sulfur compound biosynthetic process | 105 | 128 | 4.24e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 95 | 115 | 4.35e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 95 | 115 | 4.35e-02 |
| GO:BP | GO:0046649 | lymphocyte activation | 341 | 444 | 4.38e-02 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 53 | 61 | 4.43e-02 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 53 | 61 | 4.43e-02 |
| GO:BP | GO:0042303 | molting cycle | 64 | 75 | 4.44e-02 |
| GO:BP | GO:0042633 | hair cycle | 64 | 75 | 4.44e-02 |
| GO:BP | GO:0045453 | bone resorption | 37 | 41 | 4.48e-02 |
| GO:BP | GO:0048872 | homeostasis of number of cells | 176 | 222 | 4.48e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0022029 | telencephalon cell migration | 37 | 41 | 4.48e-02 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 37 | 41 | 4.48e-02 |
| GO:BP | GO:0003272 | endocardial cushion formation | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 37 | 41 | 4.48e-02 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 170 | 214 | 4.48e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 185 | 234 | 4.48e-02 |
| GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0050919 | negative chemotaxis | 37 | 41 | 4.48e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 23 | 24 | 4.48e-02 |
| GO:BP | GO:0046661 | male sex differentiation | 88 | 106 | 4.50e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 28 | 30 | 4.50e-02 |
| GO:BP | GO:0060914 | heart formation | 28 | 30 | 4.50e-02 |
| GO:BP | GO:0001974 | blood vessel remodeling | 28 | 30 | 4.50e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 28 | 30 | 4.50e-02 |
| GO:BP | GO:1901990 | regulation of mitotic cell cycle phase transition | 229 | 293 | 4.51e-02 |
| GO:BP | GO:0016032 | viral process | 255 | 328 | 4.53e-02 |
| GO:BP | GO:0034505 | tooth mineralization | 17 | 17 | 4.53e-02 |
| GO:BP | GO:0009065 | glutamine family amino acid catabolic process | 17 | 17 | 4.53e-02 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 17 | 17 | 4.53e-02 |
| GO:BP | GO:0032528 | microvillus organization | 17 | 17 | 4.53e-02 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 17 | 17 | 4.53e-02 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 45 | 51 | 4.57e-02 |
| GO:BP | GO:0006865 | amino acid transport | 81 | 97 | 4.64e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 142 | 177 | 4.64e-02 |
| GO:BP | GO:0070482 | response to oxygen levels | 208 | 265 | 4.71e-02 |
| GO:BP | GO:0006869 | lipid transport | 205 | 261 | 4.73e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 104 | 127 | 4.74e-02 |
| GO:BP | GO:0008593 | regulation of Notch signaling pathway | 67 | 79 | 4.76e-02 |
| GO:BP | GO:0035303 | regulation of dephosphorylation | 67 | 79 | 4.76e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 123 | 152 | 4.81e-02 |
| GO:BP | GO:0006887 | exocytosis | 187 | 237 | 4.84e-02 |
| GO:BP | GO:0001942 | hair follicle development | 56 | 65 | 4.93e-02 |
LRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:05200 | Pathways in cancer | 328 | 391 | 3.55e-07 |
| KEGG | KEGG:04360 | Axon guidance | 137 | 155 | 2.59e-05 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 142 | 162 | 3.40e-05 |
| KEGG | KEGG:04971 | Gastric acid secretion | 50 | 51 | 4.56e-05 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 118 | 133 | 4.79e-05 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 129 | 147 | 5.16e-05 |
| KEGG | KEGG:04510 | Focal adhesion | 146 | 169 | 7.29e-05 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 140 | 162 | 8.94e-05 |
| KEGG | KEGG:04970 | Salivary secretion | 52 | 54 | 8.94e-05 |
| KEGG | KEGG:04014 | Ras signaling pathway | 141 | 164 | 1.28e-04 |
| KEGG | KEGG:04520 | Adherens junction | 76 | 83 | 1.28e-04 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 113 | 129 | 1.52e-04 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 90 | 101 | 2.61e-04 |
| KEGG | KEGG:04611 | Platelet activation | 79 | 88 | 4.18e-04 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 137 | 161 | 4.18e-04 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 143 | 169 | 4.86e-04 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 135 | 160 | 9.35e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 70 | 78 | 9.35e-04 |
| KEGG | KEGG:04924 | Renin secretion | 47 | 50 | 9.35e-04 |
| KEGG | KEGG:04911 | Insulin secretion | 57 | 62 | 9.35e-04 |
| KEGG | KEGG:05146 | Amoebiasis | 57 | 62 | 9.35e-04 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 60 | 66 | 1.17e-03 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 81 | 92 | 1.17e-03 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 189 | 231 | 1.24e-03 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 67 | 75 | 1.55e-03 |
| KEGG | KEGG:04916 | Melanogenesis | 67 | 75 | 1.55e-03 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 49 | 53 | 1.59e-03 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 43 | 46 | 2.09e-03 |
| KEGG | KEGG:04972 | Pancreatic secretion | 52 | 57 | 2.29e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 202 | 250 | 2.43e-03 |
| KEGG | KEGG:04148 | Efferocytosis | 102 | 120 | 2.50e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 76 | 87 | 2.50e-03 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 109 | 129 | 2.50e-03 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 51 | 56 | 2.53e-03 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 105 | 124 | 2.57e-03 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 202 | 252 | 4.72e-03 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 83 | 97 | 5.30e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 60 | 68 | 5.44e-03 |
| KEGG | KEGG:04976 | Bile secretion | 38 | 41 | 6.05e-03 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 63 | 72 | 6.33e-03 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 59 | 67 | 6.33e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 85 | 100 | 6.37e-03 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 37 | 40 | 7.11e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 77 | 90 | 7.11e-03 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 118 | 143 | 7.35e-03 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 45 | 50 | 8.33e-03 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 90 | 107 | 8.33e-03 |
| KEGG | KEGG:04730 | Long-term depression | 36 | 39 | 8.49e-03 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 71 | 83 | 1.00e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 44 | 49 | 1.00e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 81 | 96 | 1.09e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 88 | 105 | 1.09e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 91 | 109 | 1.13e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 70 | 82 | 1.13e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 110 | 134 | 1.28e-02 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 76 | 90 | 1.34e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 65 | 76 | 1.41e-02 |
| KEGG | KEGG:05135 | Yersinia infection | 89 | 107 | 1.46e-02 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 108 | 132 | 1.63e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 52 | 60 | 2.00e-02 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 59 | 69 | 2.11e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 93 | 113 | 2.12e-02 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 86 | 104 | 2.23e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 69 | 82 | 2.25e-02 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 85 | 103 | 2.51e-02 |
| KEGG | KEGG:00000 | KEGG root term | 3931 | 5451 | 2.51e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 68 | 81 | 2.57e-02 |
| KEGG | KEGG:04726 | Serotonergic synapse | 50 | 58 | 2.69e-02 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 70 | 84 | 3.20e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 20 | 21 | 3.56e-02 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 41 | 47 | 3.59e-02 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 62 | 74 | 3.77e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 62 | 74 | 3.77e-02 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 119 | 149 | 3.95e-02 |
| KEGG | KEGG:04720 | Long-term potentiation | 44 | 51 | 3.96e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 115 | 144 | 4.31e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 36 | 41 | 4.31e-02 |
| KEGG | KEGG:04742 | Taste transduction | 19 | 20 | 4.32e-02 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 64 | 77 | 4.43e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 96 | 119 | 4.45e-02 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 114 | 143 | 4.67e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 60 | 72 | 4.78e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 46 | 54 | 4.96e-02 |
# NR_resgenes <- gost(query = NR_NG_list$ENTREZID,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes,"data/GO_KEGG_analysis/NR_resgenes.RDS")
NRnom <- gostplot(NR_resgenes, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable <- NR_resgenes$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0007275 | multicellular organism development | 3082 | 3170 | 4.30e-05 |
| GO:BP | GO:0032501 | multicellular organismal process | 4362 | 4504 | 4.30e-05 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 3446 | 3550 | 4.40e-05 |
| GO:BP | GO:0051716 | cellular response to stimulus | 4491 | 4640 | 4.44e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 1127 | 1146 | 7.38e-05 |
| GO:BP | GO:0048731 | system development | 2645 | 2719 | 7.49e-05 |
| GO:BP | GO:0048856 | anatomical structure development | 3748 | 3867 | 7.49e-05 |
| GO:BP | GO:0050896 | response to stimulus | 5196 | 5379 | 8.02e-05 |
| GO:BP | GO:0050794 | regulation of cellular process | 6888 | 7153 | 2.38e-04 |
| GO:BP | GO:0065007 | biological regulation | 7441 | 7734 | 3.22e-04 |
| GO:BP | GO:0007154 | cell communication | 3855 | 3983 | 3.67e-04 |
| GO:BP | GO:0048519 | negative regulation of biological process | 3645 | 3764 | 3.67e-04 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1799 | 1844 | 3.67e-04 |
| GO:BP | GO:0050789 | regulation of biological process | 7232 | 7516 | 3.99e-04 |
| GO:BP | GO:0023052 | signaling | 3792 | 3918 | 4.48e-04 |
| GO:BP | GO:0032502 | developmental process | 4042 | 4179 | 4.62e-04 |
| GO:BP | GO:0008150 | biological_process | 10770 | 11244 | 6.46e-04 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1815 | 1862 | 6.81e-04 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 1016 | 1035 | 6.93e-04 |
| GO:BP | GO:0050793 | regulation of developmental process | 1655 | 1697 | 1.16e-03 |
| GO:BP | GO:0007165 | signal transduction | 3495 | 3611 | 1.16e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 2368 | 2438 | 1.48e-03 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 2636 | 2717 | 1.58e-03 |
| GO:BP | GO:0009966 | regulation of signal transduction | 2106 | 2166 | 1.65e-03 |
| GO:BP | GO:0007399 | nervous system development | 1729 | 1775 | 2.13e-03 |
| GO:BP | GO:0016477 | cell migration | 991 | 1011 | 2.73e-03 |
| GO:BP | GO:0022008 | neurogenesis | 1223 | 1251 | 2.76e-03 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 601 | 609 | 2.83e-03 |
| GO:BP | GO:0000902 | cell morphogenesis | 702 | 713 | 2.92e-03 |
| GO:BP | GO:0010646 | regulation of cell communication | 2372 | 2444 | 2.95e-03 |
| GO:BP | GO:0030029 | actin filament-based process | 631 | 640 | 3.04e-03 |
| GO:BP | GO:0048518 | positive regulation of biological process | 4153 | 4301 | 3.42e-03 |
| GO:BP | GO:0009888 | tissue development | 1316 | 1348 | 3.77e-03 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 3820 | 3954 | 4.19e-03 |
| GO:BP | GO:0048699 | generation of neurons | 1053 | 1076 | 4.37e-03 |
| GO:BP | GO:0007155 | cell adhesion | 922 | 941 | 6.18e-03 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 821 | 837 | 8.05e-03 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 1169 | 1197 | 8.05e-03 |
| GO:BP | GO:0016043 | cellular component organization | 4630 | 4802 | 8.05e-03 |
| GO:BP | GO:0009987 | cellular process | 10236 | 10686 | 8.78e-03 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 558 | 566 | 8.78e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 992 | 1014 | 8.85e-03 |
| GO:BP | GO:0048513 | animal organ development | 1946 | 2004 | 1.02e-02 |
| GO:BP | GO:0065008 | regulation of biological quality | 1839 | 1893 | 1.13e-02 |
| GO:BP | GO:0035295 | tube development | 772 | 787 | 1.14e-02 |
| GO:BP | GO:0048870 | cell motility | 1094 | 1120 | 1.14e-02 |
| GO:BP | GO:0048869 | cellular developmental process | 2714 | 2804 | 1.27e-02 |
| GO:BP | GO:0030154 | cell differentiation | 2713 | 2803 | 1.27e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 1057 | 1082 | 1.32e-02 |
| GO:BP | GO:0007015 | actin filament organization | 354 | 357 | 1.44e-02 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1868 | 1924 | 1.54e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 260 | 261 | 1.76e-02 |
| GO:BP | GO:0048468 | cell development | 1831 | 1886 | 1.89e-02 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 257 | 258 | 1.90e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 1067 | 1093 | 1.90e-02 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 622 | 633 | 2.02e-02 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 298 | 300 | 2.24e-02 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1893 | 1951 | 2.27e-02 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 578 | 588 | 2.81e-02 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 4802 | 4988 | 4.57e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 1189 | 1221 | 4.59e-02 |
| GO:BP | GO:0006996 | organelle organization | 2721 | 2815 | 4.63e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 1186 | 1218 | 4.77e-02 |
NRnomtable %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR neargenes") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| NA | NA | NA | NA | NA | NA |
| :—— | :——- | :——— | —————–: | ———: | :——- |
# exp_neargene_table <- read_delim("data/n45_bedfiles/exp_neargene_table.tsv",
# delim = "\t", escape_double = FALSE,
# trim_ws = TRUE)
# col_ng_peak <- exp_neargene_table %>%
# group_by(chr, start, end, peakid) %>%
# summarise(NCBI_gene = paste(unique(ENTREZID),collapse=","),
# ensembl_ID= paste(unique(ensembl_id),collapse = ","),
# SYMBOL= paste(unique(SYMBOL),collapse = ",") ,
# dist_to_NG =min(dist_to_NG)) %>%
# ungroup()
# write.csv(col_ng_peak, "data/Collapsed_expressed_NG_peak_table.csv")
col_ng_peak <- read.csv("data/Collapsed_expressed_NG_peak_table.csv", row.names = 1)
EAR_peak_list_20k <- col_ng_peak %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% EAR_df$id)
ESR_peak_list_20k <- col_ng_peak %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% ESR_df$id)
LR_peak_list_20k <- col_ng_peak %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% LR_df$id)
NR_peak_list_20k <- col_ng_peak %>%
dplyr::filter(dist_to_NG<20000) %>%
dplyr::filter(peakid %in% NR_df$id) # EAR_resgenes_20k <- gost(query = EAR_peak_list_20k$NCBI_gene,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes_20k,"data/GO_KEGG_analysis/EAR_resgenes_20k.RDS")
EARnom <- gostplot(EAR_resgenes_20k, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable_20k <- EAR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 664 | 1844 | 1.76e-27 |
| GO:BP | GO:0048856 | anatomical structure development | 1222 | 3867 | 1.87e-27 |
| GO:BP | GO:0032502 | developmental process | 1302 | 4179 | 3.82e-27 |
| GO:BP | GO:0050789 | regulation of biological process | 2134 | 7516 | 3.87e-27 |
| GO:BP | GO:0032501 | multicellular organismal process | 1379 | 4504 | 9.73e-26 |
| GO:BP | GO:0065007 | biological regulation | 2176 | 7734 | 2.92e-25 |
| GO:BP | GO:0050794 | regulation of cellular process | 2033 | 7153 | 2.09e-24 |
| GO:BP | GO:0007275 | multicellular organism development | 1014 | 3170 | 2.16e-23 |
| GO:BP | GO:0048731 | system development | 890 | 2719 | 3.41e-23 |
| GO:BP | GO:0048869 | cellular developmental process | 913 | 2804 | 3.61e-23 |
| GO:BP | GO:0030154 | cell differentiation | 912 | 2803 | 4.74e-23 |
| GO:BP | GO:0050793 | regulation of developmental process | 598 | 1697 | 2.61e-22 |
| GO:BP | GO:0007154 | cell communication | 1223 | 3983 | 4.14e-22 |
| GO:BP | GO:0023052 | signaling | 1205 | 3918 | 5.84e-22 |
| GO:BP | GO:0007165 | signal transduction | 1113 | 3611 | 7.32e-20 |
| GO:BP | GO:0050896 | response to stimulus | 1566 | 5379 | 2.68e-19 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 650 | 1924 | 2.68e-19 |
| GO:BP | GO:0051716 | cellular response to stimulus | 1374 | 4640 | 1.21e-18 |
| GO:BP | GO:0016477 | cell migration | 374 | 1011 | 1.03e-16 |
| GO:BP | GO:0048699 | generation of neurons | 393 | 1076 | 1.32e-16 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1134 | 3764 | 1.65e-16 |
| GO:BP | GO:0048468 | cell development | 626 | 1886 | 1.79e-16 |
| GO:BP | GO:0022008 | neurogenesis | 444 | 1251 | 1.81e-16 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1271 | 4301 | 4.19e-16 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1074 | 3550 | 6.13e-16 |
| GO:BP | GO:0072359 | circulatory system development | 325 | 864 | 1.43e-15 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1177 | 3954 | 1.69e-15 |
| GO:BP | GO:0048870 | cell motility | 401 | 1120 | 2.01e-15 |
| GO:BP | GO:0048513 | animal organ development | 652 | 2004 | 3.81e-15 |
| GO:BP | GO:0030182 | neuron differentiation | 368 | 1014 | 4.80e-15 |
| GO:BP | GO:2000145 | regulation of cell motility | 272 | 700 | 6.99e-15 |
| GO:BP | GO:0030334 | regulation of cell migration | 261 | 668 | 1.42e-14 |
| GO:BP | GO:0007399 | nervous system development | 584 | 1775 | 2.29e-14 |
| GO:BP | GO:0040012 | regulation of locomotion | 276 | 720 | 2.92e-14 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 606 | 1862 | 6.33e-14 |
| GO:BP | GO:0034330 | cell junction organization | 220 | 545 | 6.65e-14 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 450 | 1314 | 9.82e-14 |
| GO:BP | GO:0040011 | locomotion | 299 | 805 | 1.84e-13 |
| GO:BP | GO:0010646 | regulation of cell communication | 762 | 2444 | 2.91e-13 |
| GO:BP | GO:0035556 | intracellular signal transduction | 626 | 1951 | 4.52e-13 |
| GO:BP | GO:0048666 | neuron development | 306 | 838 | 1.06e-12 |
| GO:BP | GO:0000902 | cell morphogenesis | 268 | 713 | 1.17e-12 |
| GO:BP | GO:0023051 | regulation of signaling | 756 | 2438 | 1.52e-12 |
| GO:BP | GO:0031175 | neuron projection development | 276 | 743 | 2.30e-12 |
| GO:BP | GO:0007155 | cell adhesion | 335 | 941 | 2.53e-12 |
| GO:BP | GO:0030029 | actin filament-based process | 244 | 640 | 3.13e-12 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 233 | 609 | 8.09e-12 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 323 | 913 | 1.96e-11 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 151 | 355 | 2.06e-11 |
| GO:BP | GO:0009966 | regulation of signal transduction | 675 | 2166 | 2.24e-11 |
| GO:BP | GO:0065008 | regulation of biological quality | 598 | 1893 | 5.64e-11 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 201 | 516 | 6.27e-11 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 249 | 673 | 7.21e-11 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 197 | 505 | 8.97e-11 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 331 | 951 | 9.48e-11 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 365 | 1073 | 1.88e-10 |
| GO:BP | GO:0009987 | cellular process | 2769 | 10686 | 2.94e-10 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 353 | 1035 | 3.07e-10 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 294 | 837 | 6.17e-10 |
| GO:BP | GO:0009888 | tissue development | 438 | 1348 | 1.90e-09 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 810 | 2717 | 2.02e-09 |
| GO:BP | GO:0035295 | tube development | 277 | 787 | 2.04e-09 |
| GO:BP | GO:0042221 | response to chemical | 699 | 2304 | 2.51e-09 |
| GO:BP | GO:0035239 | tube morphogenesis | 232 | 638 | 2.98e-09 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 183 | 479 | 4.27e-09 |
| GO:BP | GO:0008150 | biological_process | 2884 | 11244 | 4.89e-09 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 216 | 588 | 5.01e-09 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 393 | 1197 | 5.02e-09 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 209 | 566 | 5.99e-09 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 187 | 494 | 5.99e-09 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 560 | 1801 | 6.09e-09 |
| GO:BP | GO:0030030 | cell projection organization | 388 | 1182 | 6.65e-09 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 188 | 498 | 6.67e-09 |
| GO:BP | GO:0003008 | system process | 375 | 1139 | 9.41e-09 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 378 | 1150 | 9.77e-09 |
| GO:BP | GO:0001568 | blood vessel development | 195 | 525 | 1.42e-08 |
| GO:BP | GO:0001944 | vasculature development | 203 | 552 | 1.57e-08 |
| GO:BP | GO:0007507 | heart development | 186 | 499 | 2.71e-08 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 88 | 193 | 2.79e-08 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 152 | 390 | 3.31e-08 |
| GO:BP | GO:0007423 | sensory organ development | 151 | 387 | 3.40e-08 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 541 | 1751 | 3.83e-08 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 170 | 450 | 4.80e-08 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 212 | 591 | 7.07e-08 |
| GO:BP | GO:0016043 | cellular component organization | 1336 | 4802 | 7.51e-08 |
| GO:BP | GO:0007417 | central nervous system development | 242 | 694 | 8.89e-08 |
| GO:BP | GO:0070848 | response to growth factor | 198 | 547 | 1.11e-07 |
| GO:BP | GO:0034329 | cell junction assembly | 129 | 323 | 1.14e-07 |
| GO:BP | GO:0048589 | developmental growth | 184 | 501 | 1.18e-07 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 192 | 528 | 1.27e-07 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 410 | 1289 | 1.51e-07 |
| GO:BP | GO:0001525 | angiogenesis | 146 | 381 | 2.54e-07 |
| GO:BP | GO:0016358 | dendrite development | 82 | 183 | 2.70e-07 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 258 | 757 | 2.70e-07 |
| GO:BP | GO:0050808 | synapse organization | 132 | 337 | 2.94e-07 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 246 | 717 | 3.17e-07 |
| GO:BP | GO:0001501 | skeletal system development | 135 | 347 | 3.17e-07 |
| GO:BP | GO:0007267 | cell-cell signaling | 350 | 1082 | 3.40e-07 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 162 | 435 | 3.50e-07 |
| GO:BP | GO:0048880 | sensory system development | 109 | 266 | 3.75e-07 |
| GO:BP | GO:0001654 | eye development | 108 | 263 | 3.81e-07 |
| GO:BP | GO:0060322 | head development | 193 | 539 | 4.19e-07 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 1375 | 4988 | 4.78e-07 |
| GO:BP | GO:0150063 | visual system development | 108 | 264 | 4.78e-07 |
| GO:BP | GO:0008360 | regulation of cell shape | 54 | 106 | 5.61e-07 |
| GO:BP | GO:0030900 | forebrain development | 110 | 272 | 7.21e-07 |
| GO:BP | GO:0040007 | growth | 238 | 697 | 8.53e-07 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 148 | 395 | 9.73e-07 |
| GO:BP | GO:0007010 | cytoskeleton organization | 365 | 1146 | 9.94e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 335 | 1040 | 1.14e-06 |
| GO:BP | GO:0009790 | embryo development | 273 | 821 | 1.14e-06 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 281 | 850 | 1.28e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 215 | 622 | 1.44e-06 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 157 | 427 | 1.46e-06 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 151 | 408 | 1.67e-06 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 181 | 508 | 1.72e-06 |
| GO:BP | GO:0007420 | brain development | 178 | 498 | 1.73e-06 |
| GO:BP | GO:0043010 | camera-type eye development | 95 | 230 | 2.00e-06 |
| GO:BP | GO:0060284 | regulation of cell development | 199 | 570 | 2.02e-06 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 348 | 1093 | 2.18e-06 |
| GO:BP | GO:0006468 | protein phosphorylation | 310 | 958 | 2.33e-06 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 643 | 2186 | 3.46e-06 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 152 | 416 | 3.68e-06 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 164 | 456 | 3.70e-06 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 216 | 633 | 3.91e-06 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 103 | 258 | 3.95e-06 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 95 | 233 | 3.95e-06 |
| GO:BP | GO:0007015 | actin filament organization | 133 | 357 | 6.80e-06 |
| GO:BP | GO:0071310 | cellular response to organic substance | 401 | 1297 | 7.10e-06 |
| GO:BP | GO:0023056 | positive regulation of signaling | 380 | 1221 | 7.36e-06 |
| GO:BP | GO:0010033 | response to organic substance | 520 | 1736 | 7.36e-06 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 379 | 1218 | 7.72e-06 |
| GO:BP | GO:0099536 | synaptic signaling | 170 | 483 | 1.06e-05 |
| GO:BP | GO:0007409 | axonogenesis | 126 | 337 | 1.13e-05 |
| GO:BP | GO:0000165 | MAPK cascade | 176 | 504 | 1.15e-05 |
| GO:BP | GO:0001764 | neuron migration | 59 | 129 | 1.31e-05 |
| GO:BP | GO:0061061 | muscle structure development | 185 | 536 | 1.39e-05 |
| GO:BP | GO:0098609 | cell-cell adhesion | 193 | 564 | 1.50e-05 |
| GO:BP | GO:0061564 | axon development | 136 | 372 | 1.60e-05 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 326 | 1034 | 1.60e-05 |
| GO:BP | GO:0044057 | regulation of system process | 139 | 384 | 2.28e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 696 | 2415 | 2.41e-05 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 109 | 286 | 2.42e-05 |
| GO:BP | GO:0048588 | developmental cell growth | 75 | 179 | 2.45e-05 |
| GO:BP | GO:0023057 | negative regulation of signaling | 325 | 1036 | 2.76e-05 |
| GO:BP | GO:0016049 | cell growth | 138 | 382 | 2.77e-05 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 69 | 162 | 3.37e-05 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 126 | 344 | 3.75e-05 |
| GO:BP | GO:0051179 | localization | 1035 | 3731 | 3.96e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 748 | 2622 | 4.08e-05 |
| GO:BP | GO:0051960 | regulation of nervous system development | 124 | 339 | 4.90e-05 |
| GO:BP | GO:0014706 | striated muscle tissue development | 85 | 213 | 4.90e-05 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 162 | 467 | 5.12e-05 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 112 | 300 | 5.18e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 355 | 1152 | 5.18e-05 |
| GO:BP | GO:0032879 | regulation of localization | 433 | 1439 | 5.34e-05 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 81 | 201 | 5.39e-05 |
| GO:BP | GO:0051049 | regulation of transport | 340 | 1098 | 5.39e-05 |
| GO:BP | GO:0006897 | endocytosis | 169 | 492 | 5.78e-05 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 49 | 105 | 5.79e-05 |
| GO:BP | GO:0048638 | regulation of developmental growth | 94 | 243 | 6.38e-05 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 160 | 463 | 7.31e-05 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 160 | 463 | 7.31e-05 |
| GO:BP | GO:0060429 | epithelium development | 254 | 792 | 7.64e-05 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 449 | 1504 | 8.09e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 669 | 2333 | 8.45e-05 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 108 | 290 | 8.63e-05 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 76 | 188 | 9.43e-05 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 72 | 176 | 1.04e-04 |
| GO:BP | GO:0050807 | regulation of synapse organization | 71 | 173 | 1.06e-04 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 107 | 288 | 1.07e-04 |
| GO:BP | GO:0048592 | eye morphogenesis | 49 | 107 | 1.07e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 85 | 217 | 1.07e-04 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 147 | 422 | 1.12e-04 |
| GO:BP | GO:0010631 | epithelial cell migration | 93 | 243 | 1.14e-04 |
| GO:BP | GO:0090132 | epithelium migration | 93 | 243 | 1.14e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 55 | 125 | 1.18e-04 |
| GO:BP | GO:0003013 | circulatory system process | 148 | 426 | 1.20e-04 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 117 | 322 | 1.24e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 90 | 234 | 1.28e-04 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 50 | 111 | 1.45e-04 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 117 | 323 | 1.45e-04 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 56 | 129 | 1.55e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 98 | 261 | 1.57e-04 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 82 | 210 | 1.74e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 110 | 301 | 1.75e-04 |
| GO:BP | GO:0048729 | tissue morphogenesis | 155 | 453 | 1.79e-04 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 62 | 148 | 1.92e-04 |
| GO:BP | GO:0051216 | cartilage development | 61 | 145 | 1.93e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 133 | 379 | 2.02e-04 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 92 | 243 | 2.02e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 227 | 706 | 2.02e-04 |
| GO:BP | GO:0060537 | muscle tissue development | 121 | 339 | 2.14e-04 |
| GO:BP | GO:0050773 | regulation of dendrite development | 38 | 78 | 2.19e-04 |
| GO:BP | GO:0016310 | phosphorylation | 348 | 1145 | 2.22e-04 |
| GO:BP | GO:0061448 | connective tissue development | 80 | 205 | 2.22e-04 |
| GO:BP | GO:1990090 | cellular response to nerve growth factor stimulus | 24 | 41 | 2.25e-04 |
| GO:BP | GO:0090130 | tissue migration | 93 | 247 | 2.25e-04 |
| GO:BP | GO:1990089 | response to nerve growth factor | 24 | 41 | 2.25e-04 |
| GO:BP | GO:0051641 | cellular localization | 740 | 2623 | 2.25e-04 |
| GO:BP | GO:1990138 | neuron projection extension | 57 | 134 | 2.49e-04 |
| GO:BP | GO:0006810 | transport | 833 | 2984 | 2.56e-04 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 117 | 327 | 2.56e-04 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 404 | 1354 | 2.56e-04 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 75 | 190 | 2.56e-04 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 198 | 606 | 2.56e-04 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 21 | 34 | 2.65e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 558 | 1934 | 3.04e-04 |
| GO:BP | GO:0097485 | neuron projection guidance | 69 | 172 | 3.07e-04 |
| GO:BP | GO:0007411 | axon guidance | 69 | 172 | 3.07e-04 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 47 | 105 | 3.07e-04 |
| GO:BP | GO:0040008 | regulation of growth | 156 | 462 | 3.43e-04 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 60 | 145 | 3.85e-04 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 181 | 550 | 3.85e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 370 | 1234 | 3.97e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 83 | 218 | 4.11e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 369 | 1231 | 4.16e-04 |
| GO:BP | GO:0098657 | import into cell | 201 | 622 | 4.52e-04 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 298 | 972 | 4.84e-04 |
| GO:BP | GO:0042592 | homeostatic process | 343 | 1137 | 4.84e-04 |
| GO:BP | GO:0007610 | behavior | 143 | 420 | 4.86e-04 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 43 | 95 | 5.01e-04 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 133 | 386 | 5.01e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 47 | 107 | 5.34e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 32 | 64 | 5.40e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 152 | 452 | 5.40e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 599 | 2100 | 5.45e-04 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 69 | 175 | 5.68e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 226 | 714 | 5.93e-04 |
| GO:BP | GO:0048568 | embryonic organ development | 108 | 303 | 6.25e-04 |
| GO:BP | GO:0021537 | telencephalon development | 75 | 195 | 6.77e-04 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 44 | 99 | 6.77e-04 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 45 | 102 | 6.80e-04 |
| GO:BP | GO:0099643 | signal release from synapse | 45 | 102 | 6.80e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 68 | 173 | 7.16e-04 |
| GO:BP | GO:0008283 | cell population proliferation | 387 | 1306 | 7.35e-04 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 325 | 1077 | 7.61e-04 |
| GO:BP | GO:0051234 | establishment of localization | 893 | 3240 | 7.68e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 64 | 161 | 8.15e-04 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 40 | 88 | 8.24e-04 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 133 | 390 | 8.24e-04 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 329 | 1093 | 8.28e-04 |
| GO:BP | GO:0007254 | JNK cascade | 53 | 127 | 8.36e-04 |
| GO:BP | GO:0035265 | organ growth | 53 | 127 | 8.36e-04 |
| GO:BP | GO:0001503 | ossification | 107 | 302 | 8.62e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 109 | 309 | 8.97e-04 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 24 | 44 | 9.50e-04 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 62 | 156 | 1.06e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 199 | 624 | 1.09e-03 |
| GO:BP | GO:0022030 | telencephalon glial cell migration | 14 | 20 | 1.09e-03 |
| GO:BP | GO:0021801 | cerebral cortex radial glia-guided migration | 14 | 20 | 1.09e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 42 | 95 | 1.12e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 66 | 169 | 1.12e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 650 | 2309 | 1.14e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 105 | 298 | 1.28e-03 |
| GO:BP | GO:0021543 | pallium development | 55 | 135 | 1.28e-03 |
| GO:BP | GO:0140352 | export from cell | 190 | 594 | 1.32e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 79 | 212 | 1.36e-03 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 37 | 81 | 1.36e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 354 | 1193 | 1.40e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 59 | 148 | 1.41e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 39 | 87 | 1.41e-03 |
| GO:BP | GO:0030001 | metal ion transport | 170 | 524 | 1.43e-03 |
| GO:BP | GO:0001508 | action potential | 44 | 102 | 1.46e-03 |
| GO:BP | GO:0008015 | blood circulation | 122 | 357 | 1.47e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 112 | 323 | 1.50e-03 |
| GO:BP | GO:0009725 | response to hormone | 194 | 610 | 1.54e-03 |
| GO:BP | GO:0065009 | regulation of molecular function | 382 | 1299 | 1.55e-03 |
| GO:BP | GO:0050877 | nervous system process | 191 | 600 | 1.65e-03 |
| GO:BP | GO:0007623 | circadian rhythm | 60 | 152 | 1.65e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 35 | 76 | 1.69e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 35 | 76 | 1.69e-03 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 471 | 1635 | 1.71e-03 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 69 | 181 | 1.72e-03 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 468 | 1624 | 1.73e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 512 | 1791 | 1.77e-03 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 152 | 463 | 1.79e-03 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 152 | 463 | 1.79e-03 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 39 | 88 | 1.82e-03 |
| GO:BP | GO:0021885 | forebrain cell migration | 23 | 43 | 1.87e-03 |
| GO:BP | GO:0048511 | rhythmic process | 81 | 221 | 1.97e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 266 | 874 | 2.04e-03 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 64 | 166 | 2.08e-03 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 276 | 911 | 2.09e-03 |
| GO:BP | GO:0099173 | postsynapse organization | 58 | 147 | 2.11e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 68 | 179 | 2.11e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 528 | 1856 | 2.20e-03 |
| GO:BP | GO:0007611 | learning or memory | 71 | 189 | 2.21e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 524 | 1841 | 2.21e-03 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 78 | 212 | 2.24e-03 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 457 | 1588 | 2.35e-03 |
| GO:BP | GO:0048675 | axon extension | 41 | 95 | 2.37e-03 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 25 | 49 | 2.41e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 53 | 132 | 2.43e-03 |
| GO:BP | GO:0022029 | telencephalon cell migration | 22 | 41 | 2.43e-03 |
| GO:BP | GO:0043583 | ear development | 59 | 151 | 2.45e-03 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 437 | 1514 | 2.54e-03 |
| GO:BP | GO:0050890 | cognition | 78 | 213 | 2.61e-03 |
| GO:BP | GO:0003281 | ventricular septum development | 32 | 69 | 2.72e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 32 | 69 | 2.72e-03 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 69 | 184 | 2.85e-03 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 27 | 55 | 2.87e-03 |
| GO:BP | GO:0003012 | muscle system process | 111 | 325 | 2.91e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 44 | 105 | 2.93e-03 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 38 | 87 | 3.02e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 38 | 87 | 3.02e-03 |
| GO:BP | GO:0006935 | chemotaxis | 87 | 244 | 3.04e-03 |
| GO:BP | GO:0042330 | taxis | 87 | 244 | 3.04e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 51 | 127 | 3.14e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 551 | 1951 | 3.14e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 30 | 64 | 3.41e-03 |
| GO:BP | GO:0001558 | regulation of cell growth | 110 | 323 | 3.46e-03 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 64 | 169 | 3.47e-03 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 68 | 182 | 3.47e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 208 | 670 | 3.47e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 176 | 555 | 3.49e-03 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 31 | 67 | 3.49e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 22 | 42 | 3.62e-03 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 314 | 1060 | 3.75e-03 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 123 | 369 | 3.89e-03 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 50 | 125 | 3.96e-03 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 68 | 183 | 4.11e-03 |
| GO:BP | GO:0030198 | extracellular matrix organization | 80 | 223 | 4.34e-03 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 141 | 433 | 4.35e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 135 | 412 | 4.39e-03 |
| GO:BP | GO:0003170 | heart valve development | 30 | 65 | 4.61e-03 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 21 | 40 | 4.82e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 41 | 98 | 4.84e-03 |
| GO:BP | GO:0045927 | positive regulation of growth | 68 | 184 | 4.84e-03 |
| GO:BP | GO:0060419 | heart growth | 32 | 71 | 4.84e-03 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 71 | 194 | 4.91e-03 |
| GO:BP | GO:0030516 | regulation of axon extension | 33 | 74 | 4.91e-03 |
| GO:BP | GO:1903522 | regulation of blood circulation | 71 | 194 | 4.91e-03 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 91 | 261 | 4.92e-03 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 564 | 2010 | 4.92e-03 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 80 | 224 | 4.92e-03 |
| GO:BP | GO:0043062 | extracellular structure organization | 80 | 224 | 4.92e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 77 | 214 | 4.92e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 305 | 1031 | 4.93e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 140 | 431 | 4.96e-03 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 143 | 442 | 5.19e-03 |
| GO:BP | GO:0007416 | synapse assembly | 53 | 136 | 5.22e-03 |
| GO:BP | GO:0008104 | protein localization | 561 | 2000 | 5.22e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 220 | 719 | 5.26e-03 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 45 | 111 | 5.46e-03 |
| GO:BP | GO:0003407 | neural retina development | 23 | 46 | 5.86e-03 |
| GO:BP | GO:0097061 | dendritic spine organization | 29 | 63 | 5.86e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 29 | 63 | 5.86e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 42 | 102 | 5.86e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 153 | 479 | 6.01e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 237 | 783 | 6.06e-03 |
| GO:BP | GO:0060021 | roof of mouth development | 31 | 69 | 6.12e-03 |
| GO:BP | GO:2001222 | regulation of neuron migration | 20 | 38 | 6.12e-03 |
| GO:BP | GO:0045995 | regulation of embryonic development | 32 | 72 | 6.15e-03 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 38 | 90 | 6.15e-03 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 103 | 304 | 6.15e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 32 | 72 | 6.15e-03 |
| GO:BP | GO:0032940 | secretion by cell | 173 | 551 | 6.18e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 98 | 287 | 6.27e-03 |
| GO:BP | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration | 6 | 6 | 6.66e-03 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 60 | 160 | 6.68e-03 |
| GO:BP | GO:0007517 | muscle organ development | 92 | 267 | 6.71e-03 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 73 | 203 | 6.80e-03 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 21 | 41 | 6.80e-03 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 44 | 109 | 6.80e-03 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 26 | 55 | 6.95e-03 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 72 | 200 | 7.14e-03 |
| GO:BP | GO:0031399 | regulation of protein modification process | 271 | 911 | 7.22e-03 |
| GO:BP | GO:0090505 | epiboly involved in wound healing | 16 | 28 | 7.27e-03 |
| GO:BP | GO:0044319 | wound healing, spreading of cells | 16 | 28 | 7.27e-03 |
| GO:BP | GO:0051050 | positive regulation of transport | 178 | 571 | 7.28e-03 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 22 | 44 | 7.45e-03 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 28 | 61 | 7.45e-03 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 99 | 292 | 7.45e-03 |
| GO:BP | GO:0046903 | secretion | 192 | 622 | 7.45e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 57 | 151 | 7.45e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 47 | 119 | 7.46e-03 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 47 | 119 | 7.46e-03 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 124 | 379 | 7.46e-03 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 118 | 358 | 7.46e-03 |
| GO:BP | GO:0006836 | neurotransmitter transport | 52 | 135 | 7.53e-03 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 52 | 135 | 7.53e-03 |
| GO:BP | GO:0031032 | actomyosin structure organization | 67 | 184 | 7.61e-03 |
| GO:BP | GO:0042391 | regulation of membrane potential | 96 | 282 | 7.63e-03 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 31 | 70 | 7.70e-03 |
| GO:BP | GO:1901698 | response to nitrogen compound | 223 | 736 | 7.94e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 83 | 238 | 8.00e-03 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 209 | 685 | 8.03e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 182 | 587 | 8.07e-03 |
| GO:BP | GO:0007612 | learning | 44 | 110 | 8.08e-03 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 118 | 359 | 8.16e-03 |
| GO:BP | GO:0060065 | uterus development | 10 | 14 | 8.32e-03 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 24 | 50 | 8.32e-03 |
| GO:BP | GO:0002363 | alpha-beta T cell lineage commitment | 10 | 14 | 8.32e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 57 | 152 | 8.64e-03 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 91 | 266 | 8.72e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 97 | 287 | 9.11e-03 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 15 | 26 | 9.11e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 39 | 95 | 9.11e-03 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 26 | 56 | 9.11e-03 |
| GO:BP | GO:0048839 | inner ear development | 51 | 133 | 9.27e-03 |
| GO:BP | GO:0045176 | apical protein localization | 9 | 12 | 9.38e-03 |
| GO:BP | GO:0032486 | Rap protein signal transduction | 9 | 12 | 9.38e-03 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 62 | 169 | 9.48e-03 |
| GO:BP | GO:0051591 | response to cAMP | 28 | 62 | 9.57e-03 |
| GO:BP | GO:0042060 | wound healing | 98 | 291 | 9.66e-03 |
| GO:BP | GO:0008219 | cell death | 406 | 1423 | 9.72e-03 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 128 | 396 | 9.72e-03 |
| GO:BP | GO:0106027 | neuron projection organization | 31 | 71 | 9.82e-03 |
| GO:BP | GO:0046834 | lipid phosphorylation | 8 | 10 | 9.82e-03 |
| GO:BP | GO:0038203 | TORC2 signaling | 8 | 10 | 9.82e-03 |
| GO:BP | GO:0050709 | negative regulation of protein secretion | 22 | 45 | 1.01e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 48 | 124 | 1.03e-02 |
| GO:BP | GO:0055001 | muscle cell development | 60 | 163 | 1.03e-02 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 47 | 121 | 1.07e-02 |
| GO:BP | GO:0006887 | exocytosis | 82 | 237 | 1.07e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 23 | 48 | 1.07e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 196 | 642 | 1.09e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 133 | 415 | 1.09e-02 |
| GO:BP | GO:0090504 | epiboly | 16 | 29 | 1.09e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 16 | 29 | 1.09e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 46 | 118 | 1.09e-02 |
| GO:BP | GO:0002360 | T cell lineage commitment | 12 | 19 | 1.09e-02 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 50 | 131 | 1.13e-02 |
| GO:BP | GO:0021987 | cerebral cortex development | 38 | 93 | 1.13e-02 |
| GO:BP | GO:0006915 | apoptotic process | 393 | 1377 | 1.13e-02 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 119 | 366 | 1.14e-02 |
| GO:BP | GO:0048048 | embryonic eye morphogenesis | 14 | 24 | 1.15e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 635 | 2305 | 1.17e-02 |
| GO:BP | GO:0007389 | pattern specification process | 96 | 286 | 1.18e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 56 | 151 | 1.22e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 33 | 78 | 1.23e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 31 | 72 | 1.25e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 29 | 66 | 1.25e-02 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 121 | 374 | 1.25e-02 |
| GO:BP | GO:0061572 | actin filament bundle organization | 50 | 132 | 1.35e-02 |
| GO:BP | GO:0051046 | regulation of secretion | 127 | 396 | 1.35e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 11 | 17 | 1.36e-02 |
| GO:BP | GO:0009611 | response to wounding | 123 | 382 | 1.37e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 185 | 605 | 1.37e-02 |
| GO:BP | GO:0008347 | glial cell migration | 22 | 46 | 1.39e-02 |
| GO:BP | GO:0012501 | programmed cell death | 403 | 1419 | 1.39e-02 |
| GO:BP | GO:1903531 | negative regulation of secretion by cell | 38 | 94 | 1.39e-02 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 44 | 113 | 1.41e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 56 | 152 | 1.43e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 18 | 35 | 1.44e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 43 | 110 | 1.45e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 43 | 110 | 1.45e-02 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 449 | 1595 | 1.45e-02 |
| GO:BP | GO:0014902 | myotube differentiation | 35 | 85 | 1.49e-02 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 35 | 85 | 1.49e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 47 | 123 | 1.50e-02 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 239 | 805 | 1.53e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 33 | 79 | 1.54e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 187 | 614 | 1.55e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 41 | 104 | 1.55e-02 |
| GO:BP | GO:0060348 | bone development | 54 | 146 | 1.55e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 28 | 64 | 1.59e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 45 | 117 | 1.62e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 94 | 282 | 1.63e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 154 | 495 | 1.64e-02 |
| GO:BP | GO:0060323 | head morphogenesis | 16 | 30 | 1.65e-02 |
| GO:BP | GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 10 | 15 | 1.65e-02 |
| GO:BP | GO:0048546 | digestive tract morphogenesis | 16 | 30 | 1.65e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 73 | 210 | 1.65e-02 |
| GO:BP | GO:0036211 | protein modification process | 629 | 2291 | 1.67e-02 |
| GO:BP | GO:0010171 | body morphogenesis | 20 | 41 | 1.68e-02 |
| GO:BP | GO:0045807 | positive regulation of endocytosis | 38 | 95 | 1.68e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 84 | 248 | 1.73e-02 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 236 | 796 | 1.73e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 51 | 137 | 1.76e-02 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 21 | 44 | 1.78e-02 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 238 | 804 | 1.79e-02 |
| GO:BP | GO:0002521 | leukocyte differentiation | 119 | 371 | 1.82e-02 |
| GO:BP | GO:0035025 | positive regulation of Rho protein signal transduction | 14 | 25 | 1.82e-02 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 57 | 157 | 1.82e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 440 | 1566 | 1.83e-02 |
| GO:BP | GO:0043368 | positive T cell selection | 12 | 20 | 1.86e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 122 | 382 | 1.87e-02 |
| GO:BP | GO:0033993 | response to lipid | 175 | 573 | 1.87e-02 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 234 | 790 | 1.87e-02 |
| GO:BP | GO:0045055 | regulated exocytosis | 53 | 144 | 1.87e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 205 | 683 | 1.88e-02 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 170 | 555 | 1.89e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 23 | 50 | 1.89e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 40 | 102 | 1.89e-02 |
| GO:BP | GO:0043542 | endothelial cell migration | 62 | 174 | 1.89e-02 |
| GO:BP | GO:0048041 | focal adhesion assembly | 32 | 77 | 1.90e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 67 | 191 | 1.93e-02 |
| GO:BP | GO:0007398 | ectoderm development | 9 | 13 | 1.95e-02 |
| GO:BP | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration | 5 | 5 | 1.95e-02 |
| GO:BP | GO:0035696 | monocyte extravasation | 5 | 5 | 1.95e-02 |
| GO:BP | GO:0061038 | uterus morphogenesis | 5 | 5 | 1.95e-02 |
| GO:BP | GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 5 | 5 | 1.95e-02 |
| GO:BP | GO:0003186 | tricuspid valve morphogenesis | 5 | 5 | 1.95e-02 |
| GO:BP | GO:2000177 | regulation of neural precursor cell proliferation | 29 | 68 | 1.96e-02 |
| GO:BP | GO:0061001 | regulation of dendritic spine morphogenesis | 18 | 36 | 1.99e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 18 | 36 | 1.99e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 38 | 96 | 1.99e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 51 | 138 | 2.01e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 149 | 480 | 2.02e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 37 | 93 | 2.06e-02 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 42 | 109 | 2.09e-02 |
| GO:BP | GO:0030521 | androgen receptor signaling pathway | 19 | 39 | 2.14e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 86 | 257 | 2.14e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 41 | 106 | 2.17e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 160 | 521 | 2.23e-02 |
| GO:BP | GO:0046777 | protein autophosphorylation | 52 | 142 | 2.25e-02 |
| GO:BP | GO:0086009 | membrane repolarization | 20 | 42 | 2.26e-02 |
| GO:BP | GO:0021895 | cerebral cortex neuron differentiation | 8 | 11 | 2.27e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 55 | 152 | 2.27e-02 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 135 | 431 | 2.28e-02 |
| GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 13 | 23 | 2.29e-02 |
| GO:BP | GO:0046339 | diacylglycerol metabolic process | 13 | 23 | 2.29e-02 |
| GO:BP | GO:0002063 | chondrocyte development | 13 | 23 | 2.29e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 44 | 116 | 2.29e-02 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 21 | 45 | 2.34e-02 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 16 | 31 | 2.35e-02 |
| GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 16 | 31 | 2.35e-02 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 54 | 149 | 2.36e-02 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 57 | 159 | 2.36e-02 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 43 | 113 | 2.38e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 38 | 97 | 2.39e-02 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 50 | 136 | 2.44e-02 |
| GO:BP | GO:0006936 | muscle contraction | 85 | 255 | 2.49e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 24 | 54 | 2.49e-02 |
| GO:BP | GO:0009950 | dorsal/ventral axis specification | 7 | 9 | 2.49e-02 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 26 | 60 | 2.50e-02 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 1120 | 4231 | 2.50e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 45 | 120 | 2.59e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 45 | 120 | 2.59e-02 |
| GO:BP | GO:0023061 | signal release | 102 | 315 | 2.60e-02 |
| GO:BP | GO:0048732 | gland development | 100 | 308 | 2.61e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 35 | 88 | 2.63e-02 |
| GO:BP | GO:0045058 | T cell selection | 14 | 26 | 2.69e-02 |
| GO:BP | GO:0097484 | dendrite extension | 14 | 26 | 2.69e-02 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 14 | 26 | 2.69e-02 |
| GO:BP | GO:0021761 | limbic system development | 34 | 85 | 2.70e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 34 | 85 | 2.70e-02 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 81 | 242 | 2.72e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 18 | 37 | 2.74e-02 |
| GO:BP | GO:0010038 | response to metal ion | 83 | 249 | 2.74e-02 |
| GO:BP | GO:0051258 | protein polymerization | 76 | 225 | 2.82e-02 |
| GO:BP | GO:0008361 | regulation of cell size | 53 | 147 | 2.84e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 38 | 98 | 2.86e-02 |
| GO:BP | GO:0050795 | regulation of behavior | 19 | 40 | 2.90e-02 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 31 | 76 | 2.92e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 73 | 215 | 2.92e-02 |
| GO:BP | GO:0086011 | membrane repolarization during action potential | 12 | 21 | 2.93e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 12 | 21 | 2.93e-02 |
| GO:BP | GO:0097581 | lamellipodium organization | 30 | 73 | 2.98e-02 |
| GO:BP | GO:0009605 | response to external stimulus | 435 | 1559 | 3.01e-02 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 15 | 29 | 3.04e-02 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 36 | 92 | 3.07e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 74 | 219 | 3.12e-02 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 1039 | 3918 | 3.17e-02 |
| GO:BP | GO:0061614 | miRNA transcription | 26 | 61 | 3.17e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 25 | 58 | 3.19e-02 |
| GO:BP | GO:0030032 | lamellipodium assembly | 24 | 55 | 3.19e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 43 | 115 | 3.31e-02 |
| GO:BP | GO:0090278 | negative regulation of peptide hormone secretion | 16 | 32 | 3.35e-02 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 63 | 182 | 3.41e-02 |
| GO:BP | GO:0003002 | regionalization | 85 | 258 | 3.41e-02 |
| GO:BP | GO:0002682 | regulation of immune system process | 252 | 868 | 3.49e-02 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 144 | 469 | 3.49e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 13 | 24 | 3.52e-02 |
| GO:BP | GO:0034113 | heterotypic cell-cell adhesion | 17 | 35 | 3.60e-02 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 31 | 77 | 3.60e-02 |
| GO:BP | GO:0010842 | retina layer formation | 9 | 14 | 3.67e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 30 | 74 | 3.71e-02 |
| GO:BP | GO:0048260 | positive regulation of receptor-mediated endocytosis | 18 | 38 | 3.80e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 85 | 259 | 3.80e-02 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 29 | 71 | 3.80e-02 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 50 | 139 | 3.81e-02 |
| GO:BP | GO:0055003 | cardiac myofibril assembly | 11 | 19 | 3.82e-02 |
| GO:BP | GO:2000647 | negative regulation of stem cell proliferation | 11 | 19 | 3.82e-02 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 28 | 68 | 3.87e-02 |
| GO:BP | GO:1905314 | semi-lunar valve development | 19 | 41 | 3.93e-02 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 27 | 65 | 3.95e-02 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 34 | 87 | 3.98e-02 |
| GO:BP | GO:0042063 | gliogenesis | 80 | 242 | 3.98e-02 |
| GO:BP | GO:0060325 | face morphogenesis | 14 | 27 | 3.99e-02 |
| GO:BP | GO:0060324 | face development | 20 | 44 | 4.01e-02 |
| GO:BP | GO:0003015 | heart process | 69 | 204 | 4.04e-02 |
| GO:BP | GO:0002088 | lens development in camera-type eye | 24 | 56 | 4.09e-02 |
| GO:BP | GO:0035270 | endocrine system development | 33 | 84 | 4.10e-02 |
| GO:BP | GO:0030199 | collagen fibril organization | 22 | 50 | 4.10e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 79 | 239 | 4.19e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 37 | 97 | 4.25e-02 |
| GO:BP | GO:0001678 | intracellular glucose homeostasis | 41 | 110 | 4.25e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 452 | 1633 | 4.36e-02 |
| GO:BP | GO:0046676 | negative regulation of insulin secretion | 15 | 30 | 4.39e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 47 | 130 | 4.39e-02 |
| GO:BP | GO:0010035 | response to inorganic substance | 118 | 378 | 4.42e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 169 | 564 | 4.52e-02 |
| GO:BP | GO:0060766 | negative regulation of androgen receptor signaling pathway | 8 | 12 | 4.52e-02 |
| GO:BP | GO:0043373 | CD4-positive, alpha-beta T cell lineage commitment | 8 | 12 | 4.52e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 30 | 75 | 4.52e-02 |
| GO:BP | GO:0030539 | male genitalia development | 8 | 12 | 4.52e-02 |
| GO:BP | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 8 | 12 | 4.52e-02 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 12 | 22 | 4.57e-02 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 39 | 104 | 4.62e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 64 | 188 | 4.64e-02 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 16 | 33 | 4.66e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 1208 | 4603 | 4.72e-02 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 48 | 134 | 4.80e-02 |
| GO:BP | GO:0030010 | establishment of cell polarity | 45 | 124 | 4.80e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 273 | 953 | 4.80e-02 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 38 | 101 | 4.80e-02 |
| GO:BP | GO:0021766 | hippocampus development | 27 | 66 | 4.87e-02 |
| GO:BP | GO:0061337 | cardiac conduction | 33 | 85 | 4.93e-02 |
EARnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04510 | Focal adhesion | 77 | 169 | 1.03e-06 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 72 | 162 | 5.93e-06 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 68 | 162 | 1.27e-04 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 58 | 133 | 1.33e-04 |
| KEGG | KEGG:04360 | Axon guidance | 65 | 155 | 1.35e-04 |
| KEGG | KEGG:04520 | Adherens junction | 40 | 83 | 1.88e-04 |
| KEGG | KEGG:05200 | Pathways in cancer | 133 | 391 | 1.09e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 32 | 68 | 2.39e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 33 | 73 | 4.39e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 60 | 160 | 6.21e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 34 | 78 | 6.21e-03 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 30 | 66 | 6.21e-03 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 40 | 96 | 6.21e-03 |
| KEGG | KEGG:04530 | Tight junction | 50 | 129 | 7.50e-03 |
| KEGG | KEGG:04730 | Long-term depression | 20 | 39 | 7.59e-03 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 43 | 109 | 9.16e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 24 | 51 | 9.16e-03 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 80 | 231 | 9.16e-03 |
| KEGG | KEGG:04014 | Ras signaling pathway | 60 | 164 | 9.16e-03 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 42 | 107 | 1.01e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 34 | 82 | 1.01e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 61 | 169 | 1.01e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 44 | 113 | 1.01e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 48 | 129 | 1.64e-02 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 29 | 69 | 1.72e-02 |
| KEGG | KEGG:05135 | Yersinia infection | 41 | 107 | 1.75e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 12 | 21 | 1.92e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 31 | 76 | 1.92e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 45 | 122 | 2.25e-02 |
| KEGG | KEGG:02010 | ABC transporters | 13 | 24 | 2.25e-02 |
| KEGG | KEGG:00561 | Glycerolipid metabolism | 20 | 44 | 2.37e-02 |
| KEGG | KEGG:04218 | Cellular senescence | 49 | 136 | 2.37e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 26 | 62 | 2.37e-02 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 37 | 97 | 2.46e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 51 | 144 | 2.69e-02 |
| KEGG | KEGG:04611 | Platelet activation | 34 | 88 | 2.69e-02 |
| KEGG | KEGG:04725 | Cholinergic synapse | 32 | 82 | 2.80e-02 |
| KEGG | KEGG:04972 | Pancreatic secretion | 24 | 57 | 2.80e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 43 | 119 | 3.19e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 27 | 67 | 3.19e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 33 | 86 | 3.19e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 34 | 90 | 3.50e-02 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 33 | 87 | 3.55e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 28 | 71 | 3.55e-02 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 44 | 124 | 3.86e-02 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 29 | 75 | 3.99e-02 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 23 | 56 | 3.99e-02 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 80 | 250 | 4.20e-02 |
| KEGG | KEGG:04144 | Endocytosis | 70 | 216 | 4.83e-02 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 80 | 252 | 4.90e-02 |
| KEGG | KEGG:04970 | Salivary secretion | 22 | 54 | 4.90e-02 |
| KEGG | KEGG:04971 | Gastric acid secretion | 21 | 51 | 4.90e-02 |
# EAR_resgenes_20k_enh <- gost(query = unique(EAR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(EAR_resgenes_20k_enh,"data/GO_KEGG_analysis/EAR_resgenes_20k_enh.RDS")
# EARnom <- gostplot(EAR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# EARnom
EARnomtable_20k_enh <- EAR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
EARnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in EAR enhancer neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050789 | regulation of biological process | 579 | 7516 | 8.40e-13 |
| GO:BP | GO:0050794 | regulation of cellular process | 556 | 7153 | 1.41e-12 |
| GO:BP | GO:0065007 | biological regulation | 587 | 7734 | 5.33e-12 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 344 | 3954 | 1.64e-10 |
| GO:BP | GO:0048518 | positive regulation of biological process | 366 | 4301 | 2.84e-10 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 146 | 1354 | 1.67e-08 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 135 | 1231 | 3.06e-08 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 135 | 1234 | 3.18e-08 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 304 | 3550 | 5.73e-08 |
| GO:BP | GO:0048519 | negative regulation of biological process | 318 | 3764 | 7.00e-08 |
| GO:BP | GO:0032502 | developmental process | 339 | 4179 | 1.68e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 171 | 1791 | 1.77e-06 |
| GO:BP | GO:0050793 | regulation of developmental process | 164 | 1697 | 1.77e-06 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 150 | 1514 | 1.77e-06 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 174 | 1844 | 2.80e-06 |
| GO:BP | GO:0048856 | anatomical structure development | 316 | 3867 | 3.01e-06 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 173 | 1841 | 3.77e-06 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 174 | 1856 | 3.79e-06 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 230 | 2663 | 1.11e-05 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 172 | 1862 | 1.25e-05 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 166 | 1787 | 1.51e-05 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 226 | 2622 | 1.60e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 194 | 2186 | 2.42e-05 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 171 | 1879 | 3.04e-05 |
| GO:BP | GO:0048869 | cellular developmental process | 237 | 2804 | 3.04e-05 |
| GO:BP | GO:0030154 | cell differentiation | 237 | 2803 | 3.04e-05 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 209 | 2410 | 3.31e-05 |
| GO:BP | GO:0032501 | multicellular organismal process | 351 | 4504 | 3.63e-05 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 209 | 2415 | 3.63e-05 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 209 | 2422 | 4.41e-05 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 311 | 3918 | 5.45e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 202 | 2333 | 5.65e-05 |
| GO:BP | GO:0006351 | DNA-templated transcription | 214 | 2510 | 6.90e-05 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 281 | 3486 | 7.41e-05 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 92 | 874 | 8.52e-05 |
| GO:BP | GO:0007275 | multicellular organism development | 259 | 3170 | 8.66e-05 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 240 | 2895 | 8.81e-05 |
| GO:BP | GO:0010468 | regulation of gene expression | 273 | 3379 | 8.99e-05 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 315 | 4015 | 1.10e-04 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 214 | 2533 | 1.10e-04 |
| GO:BP | GO:0040007 | growth | 77 | 697 | 1.10e-04 |
| GO:BP | GO:0048731 | system development | 227 | 2719 | 1.10e-04 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 285 | 3569 | 1.11e-04 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 286 | 3595 | 1.42e-04 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 170 | 1924 | 1.42e-04 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 170 | 1934 | 1.90e-04 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 148 | 1635 | 2.08e-04 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 147 | 1624 | 2.23e-04 |
| GO:BP | GO:0050896 | response to stimulus | 401 | 5379 | 2.36e-04 |
| GO:BP | GO:0072359 | circulatory system development | 89 | 864 | 2.36e-04 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 144 | 1588 | 2.49e-04 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 123 | 1314 | 3.34e-04 |
| GO:BP | GO:0009987 | cellular process | 713 | 10686 | 3.95e-04 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 325 | 4231 | 3.95e-04 |
| GO:BP | GO:0019222 | regulation of metabolic process | 349 | 4603 | 4.36e-04 |
| GO:BP | GO:0008150 | biological_process | 741 | 11244 | 5.30e-04 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 179 | 2100 | 5.42e-04 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 110 | 1157 | 5.42e-04 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 103 | 1067 | 5.71e-04 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 232 | 2867 | 6.18e-04 |
| GO:BP | GO:0010586 | miRNA metabolic process | 18 | 87 | 6.29e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 120 | 1297 | 6.70e-04 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 323 | 4233 | 7.16e-04 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 66 | 609 | 8.43e-04 |
| GO:BP | GO:0001568 | blood vessel development | 59 | 525 | 8.47e-04 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 90 | 913 | 9.42e-04 |
| GO:BP | GO:0001944 | vasculature development | 61 | 552 | 9.79e-04 |
| GO:BP | GO:0010033 | response to organic substance | 151 | 1736 | 1.06e-03 |
| GO:BP | GO:0051716 | cellular response to stimulus | 348 | 4640 | 1.11e-03 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 50 | 427 | 1.28e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 143 | 1633 | 1.30e-03 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 93 | 965 | 1.50e-03 |
| GO:BP | GO:0048589 | developmental growth | 56 | 501 | 1.50e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 98 | 1034 | 1.69e-03 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 98 | 1035 | 1.73e-03 |
| GO:BP | GO:0023052 | signaling | 299 | 3918 | 1.79e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 93 | 973 | 1.92e-03 |
| GO:BP | GO:0007154 | cell communication | 303 | 3983 | 1.92e-03 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 232 | 2927 | 2.12e-03 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 232 | 2928 | 2.15e-03 |
| GO:BP | GO:0060419 | heart growth | 15 | 71 | 2.15e-03 |
| GO:BP | GO:0040008 | regulation of growth | 52 | 462 | 2.22e-03 |
| GO:BP | GO:0061061 | muscle structure development | 58 | 536 | 2.42e-03 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 14 | 64 | 2.53e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 97 | 1036 | 2.63e-03 |
| GO:BP | GO:0048468 | cell development | 159 | 1886 | 2.63e-03 |
| GO:BP | GO:0016477 | cell migration | 95 | 1011 | 2.67e-03 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 109 | 1197 | 2.67e-03 |
| GO:BP | GO:0016043 | cellular component organization | 355 | 4802 | 2.67e-03 |
| GO:BP | GO:0000165 | MAPK cascade | 55 | 504 | 2.84e-03 |
| GO:BP | GO:0048513 | animal organ development | 167 | 2004 | 2.85e-03 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 163 | 1951 | 3.09e-03 |
| GO:BP | GO:0035556 | intracellular signal transduction | 163 | 1951 | 3.09e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 237 | 3026 | 3.23e-03 |
| GO:BP | GO:0010646 | regulation of cell communication | 197 | 2444 | 3.50e-03 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 50 | 450 | 3.76e-03 |
| GO:BP | GO:0035295 | tube development | 77 | 787 | 3.79e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 11 | 44 | 4.08e-03 |
| GO:BP | GO:0016070 | RNA metabolic process | 258 | 3352 | 4.08e-03 |
| GO:BP | GO:0023051 | regulation of signaling | 196 | 2438 | 4.08e-03 |
| GO:BP | GO:0001525 | angiogenesis | 44 | 381 | 4.08e-03 |
| GO:BP | GO:0016049 | cell growth | 44 | 382 | 4.22e-03 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 365 | 4988 | 4.22e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 13 | 60 | 4.24e-03 |
| GO:BP | GO:0007165 | signal transduction | 275 | 3611 | 4.24e-03 |
| GO:BP | GO:0060644 | mammary gland epithelial cell differentiation | 6 | 13 | 4.24e-03 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 89 | 951 | 4.62e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 13 | 61 | 4.94e-03 |
| GO:BP | GO:0042221 | response to chemical | 186 | 2304 | 4.94e-03 |
| GO:BP | GO:0046328 | regulation of JNK cascade | 18 | 105 | 4.99e-03 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 147 | 1751 | 5.34e-03 |
| GO:BP | GO:0048870 | cell motility | 101 | 1120 | 6.04e-03 |
| GO:BP | GO:0010842 | retina layer formation | 6 | 14 | 6.58e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 14 | 72 | 7.29e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 80 | 850 | 8.39e-03 |
| GO:BP | GO:0033500 | carbohydrate homeostasis | 24 | 170 | 8.62e-03 |
| GO:BP | GO:0001678 | intracellular glucose homeostasis | 18 | 110 | 8.69e-03 |
| GO:BP | GO:0051641 | cellular localization | 206 | 2623 | 8.73e-03 |
| GO:BP | GO:2000145 | regulation of cell motility | 68 | 700 | 1.04e-02 |
| GO:BP | GO:0035239 | tube morphogenesis | 63 | 638 | 1.14e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 11 | 50 | 1.15e-02 |
| GO:BP | GO:0048699 | generation of neurons | 96 | 1076 | 1.22e-02 |
| GO:BP | GO:0097240 | chromosome attachment to the nuclear envelope | 3 | 3 | 1.27e-02 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 78 | 837 | 1.29e-02 |
| GO:BP | GO:0040012 | regulation of locomotion | 69 | 720 | 1.32e-02 |
| GO:BP | GO:0006325 | chromatin organization | 60 | 604 | 1.32e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 37 | 323 | 1.38e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 17 | 105 | 1.38e-02 |
| GO:BP | GO:0030182 | neuron differentiation | 91 | 1014 | 1.38e-02 |
| GO:BP | GO:0061117 | negative regulation of heart growth | 6 | 16 | 1.38e-02 |
| GO:BP | GO:0055022 | negative regulation of cardiac muscle tissue growth | 6 | 16 | 1.38e-02 |
| GO:BP | GO:0042592 | homeostatic process | 100 | 1137 | 1.40e-02 |
| GO:BP | GO:0051179 | localization | 278 | 3731 | 1.50e-02 |
| GO:BP | GO:0035265 | organ growth | 19 | 127 | 1.67e-02 |
| GO:BP | GO:0042593 | glucose homeostasis | 23 | 169 | 1.73e-02 |
| GO:BP | GO:0014706 | striated muscle tissue development | 27 | 213 | 1.79e-02 |
| GO:BP | GO:0030029 | actin filament-based process | 62 | 640 | 1.87e-02 |
| GO:BP | GO:0032879 | regulation of localization | 121 | 1439 | 1.87e-02 |
| GO:BP | GO:0030334 | regulation of cell migration | 64 | 668 | 2.00e-02 |
| GO:BP | GO:0060044 | negative regulation of cardiac muscle cell proliferation | 4 | 7 | 2.09e-02 |
| GO:BP | GO:0060159 | regulation of dopamine receptor signaling pathway | 4 | 7 | 2.09e-02 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 65 | 683 | 2.12e-02 |
| GO:BP | GO:0022008 | neurogenesis | 107 | 1251 | 2.21e-02 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 94 | 1073 | 2.26e-02 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 33 | 286 | 2.27e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 24 | 184 | 2.27e-02 |
| GO:BP | GO:0040011 | locomotion | 74 | 805 | 2.34e-02 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 12 | 64 | 2.37e-02 |
| GO:BP | GO:0009725 | response to hormone | 59 | 610 | 2.46e-02 |
| GO:BP | GO:0033993 | response to lipid | 56 | 573 | 2.61e-02 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 95 | 1093 | 2.61e-02 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 260 | 3495 | 2.61e-02 |
| GO:BP | GO:0097306 | cellular response to alcohol | 13 | 74 | 2.63e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 45 | 435 | 2.65e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 66 | 704 | 2.65e-02 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 86 | 972 | 2.68e-02 |
| GO:BP | GO:0014741 | negative regulation of muscle hypertrophy | 7 | 25 | 2.69e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 180 | 2309 | 2.85e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 37 | 339 | 2.87e-02 |
| GO:BP | GO:0009966 | regulation of signal transduction | 170 | 2166 | 3.01e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 63 | 670 | 3.12e-02 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 52 | 528 | 3.15e-02 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 25 | 201 | 3.20e-02 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 51 | 516 | 3.22e-02 |
| GO:BP | GO:0006810 | transport | 225 | 2984 | 3.23e-02 |
| GO:BP | GO:0051726 | regulation of cell cycle | 79 | 885 | 3.24e-02 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 207 | 2717 | 3.28e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 38 | 355 | 3.35e-02 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 50 | 505 | 3.37e-02 |
| GO:BP | GO:1903294 | regulation of glutamate secretion, neurotransmission | 3 | 4 | 3.51e-02 |
| GO:BP | GO:0007254 | JNK cascade | 18 | 127 | 3.56e-02 |
| GO:BP | GO:0007015 | actin filament organization | 38 | 357 | 3.64e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 28 | 238 | 3.66e-02 |
| GO:BP | GO:0070848 | response to growth factor | 53 | 547 | 3.81e-02 |
| GO:BP | GO:0007399 | nervous system development | 142 | 1775 | 3.82e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 64 | 691 | 3.82e-02 |
| GO:BP | GO:0043933 | protein-containing complex organization | 148 | 1863 | 3.91e-02 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 11 | 60 | 4.01e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 32 | 287 | 4.01e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 19 | 140 | 4.17e-02 |
| GO:BP | GO:0006338 | chromatin remodeling | 48 | 486 | 4.17e-02 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 32 | 288 | 4.17e-02 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 16 | 109 | 4.28e-02 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 276 | 3777 | 4.28e-02 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 56 | 591 | 4.40e-02 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 17 | 120 | 4.50e-02 |
| GO:BP | GO:0033002 | muscle cell proliferation | 20 | 152 | 4.50e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 13 | 80 | 4.56e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 28 | 243 | 4.61e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 22 | 175 | 4.78e-02 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 40 | 390 | 4.91e-02 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 89 | 1040 | 4.91e-02 |
| GO:BP | GO:0048511 | rhythmic process | 26 | 221 | 4.91e-02 |
| GO:BP | GO:0048103 | somatic stem cell division | 4 | 9 | 4.91e-02 |
| GO:BP | GO:0034380 | high-density lipoprotein particle assembly | 4 | 9 | 4.91e-02 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 58 | 622 | 4.98e-02 |
EARnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in EAR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:05203 | Viral carcinogenesis | 22 | 142 | 2.18e-02 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 23 | 162 | 2.93e-02 |
# ESR_resgenes_20k <- gost(query = ESR_peak_list_20k$NCBI_gene,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes_20k,"data/GO_KEGG_analysis/ESR_resgenes_20k.RDS")
# ESRnom <- gostplot(ESR_resgenes_20k, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable_20k <- ESR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR nESRgenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 2163 | 4504 | 4.70e-52 |
| GO:BP | GO:0007154 | cell communication | 1928 | 3983 | 7.73e-47 |
| GO:BP | GO:0048856 | anatomical structure development | 1879 | 3867 | 7.73e-47 |
| GO:BP | GO:0023052 | signaling | 1900 | 3918 | 7.73e-47 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1004 | 1844 | 9.17e-46 |
| GO:BP | GO:0007275 | multicellular organism development | 1562 | 3170 | 1.59e-40 |
| GO:BP | GO:0032502 | developmental process | 1980 | 4179 | 1.91e-40 |
| GO:BP | GO:0007165 | signal transduction | 1736 | 3611 | 4.02e-38 |
| GO:BP | GO:0048731 | system development | 1359 | 2719 | 8.77e-38 |
| GO:BP | GO:0050896 | response to stimulus | 2449 | 5379 | 1.17e-37 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2143 | 4640 | 2.57e-35 |
| GO:BP | GO:0030154 | cell differentiation | 1374 | 2803 | 8.22e-33 |
| GO:BP | GO:0048869 | cellular developmental process | 1374 | 2804 | 9.55e-33 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 990 | 1924 | 1.54e-31 |
| GO:BP | GO:0010646 | regulation of cell communication | 1201 | 2444 | 3.73e-28 |
| GO:BP | GO:0009888 | tissue development | 721 | 1348 | 4.60e-28 |
| GO:BP | GO:0023051 | regulation of signaling | 1196 | 2438 | 1.19e-27 |
| GO:BP | GO:0048513 | animal organ development | 1008 | 2004 | 2.46e-27 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 481 | 837 | 7.99e-27 |
| GO:BP | GO:0048468 | cell development | 953 | 1886 | 1.73e-26 |
| GO:BP | GO:0050789 | regulation of biological process | 3216 | 7516 | 1.73e-26 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 915 | 1801 | 2.76e-26 |
| GO:BP | GO:0007155 | cell adhesion | 528 | 941 | 2.95e-26 |
| GO:BP | GO:0050793 | regulation of developmental process | 869 | 1697 | 3.21e-26 |
| GO:BP | GO:0007399 | nervous system development | 902 | 1775 | 6.20e-26 |
| GO:BP | GO:0048870 | cell motility | 605 | 1120 | 1.39e-24 |
| GO:BP | GO:0065007 | biological regulation | 3286 | 7734 | 2.19e-24 |
| GO:BP | GO:0016477 | cell migration | 553 | 1011 | 5.60e-24 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 352 | 588 | 1.67e-23 |
| GO:BP | GO:0000902 | cell morphogenesis | 412 | 713 | 1.94e-23 |
| GO:BP | GO:0050794 | regulation of cellular process | 3058 | 7153 | 4.69e-23 |
| GO:BP | GO:0003008 | system process | 607 | 1139 | 9.41e-23 |
| GO:BP | GO:0030029 | actin filament-based process | 375 | 640 | 9.89e-23 |
| GO:BP | GO:0035239 | tube morphogenesis | 374 | 638 | 9.91e-23 |
| GO:BP | GO:0034330 | cell junction organization | 328 | 545 | 2.05e-22 |
| GO:BP | GO:0022008 | neurogenesis | 656 | 1251 | 2.05e-22 |
| GO:BP | GO:0007267 | cell-cell signaling | 578 | 1082 | 6.51e-22 |
| GO:BP | GO:0035295 | tube development | 442 | 787 | 7.50e-22 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 356 | 609 | 2.69e-21 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 679 | 1314 | 4.00e-21 |
| GO:BP | GO:0048699 | generation of neurons | 572 | 1076 | 4.94e-21 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 331 | 566 | 9.57e-20 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 402 | 717 | 1.51e-19 |
| GO:BP | GO:0030182 | neuron differentiation | 538 | 1014 | 2.02e-19 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1040 | 2166 | 2.02e-19 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 296 | 498 | 5.41e-19 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 294 | 494 | 5.55e-19 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 548 | 1040 | 5.63e-19 |
| GO:BP | GO:0031175 | neuron projection development | 412 | 743 | 6.37e-19 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 507 | 951 | 8.77e-19 |
| GO:BP | GO:0072359 | circulatory system development | 467 | 864 | 1.08e-18 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 378 | 673 | 1.57e-18 |
| GO:BP | GO:0048518 | positive regulation of biological process | 1912 | 4301 | 1.77e-18 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 595 | 1150 | 1.95e-18 |
| GO:BP | GO:0065008 | regulation of biological quality | 918 | 1893 | 2.45e-18 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 1769 | 3954 | 5.63e-18 |
| GO:BP | GO:0048729 | tissue morphogenesis | 271 | 453 | 6.60e-18 |
| GO:BP | GO:0048666 | neuron development | 452 | 838 | 7.52e-18 |
| GO:BP | GO:0030030 | cell projection organization | 606 | 1182 | 1.12e-17 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1261 | 2717 | 1.12e-17 |
| GO:BP | GO:0040011 | locomotion | 436 | 805 | 1.29e-17 |
| GO:BP | GO:0035556 | intracellular signal transduction | 938 | 1951 | 1.93e-17 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 282 | 479 | 2.48e-17 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 897 | 1862 | 7.69e-17 |
| GO:BP | GO:0001568 | blood vessel development | 302 | 525 | 1.34e-16 |
| GO:BP | GO:2000145 | regulation of cell motility | 384 | 700 | 1.43e-16 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 258 | 435 | 2.32e-16 |
| GO:BP | GO:0001944 | vasculature development | 314 | 552 | 2.45e-16 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 480 | 913 | 2.95e-16 |
| GO:BP | GO:0030334 | regulation of cell migration | 368 | 668 | 3.05e-16 |
| GO:BP | GO:0048519 | negative regulation of biological process | 1680 | 3764 | 3.46e-16 |
| GO:BP | GO:0044057 | regulation of system process | 232 | 384 | 5.57e-16 |
| GO:BP | GO:0040012 | regulation of locomotion | 391 | 720 | 5.91e-16 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 264 | 450 | 6.20e-16 |
| GO:BP | GO:0007010 | cytoskeleton organization | 580 | 1146 | 2.29e-15 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 529 | 1035 | 6.53e-15 |
| GO:BP | GO:0060485 | mesenchyme development | 159 | 245 | 1.19e-14 |
| GO:BP | GO:0098657 | import into cell | 341 | 622 | 1.43e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 1582 | 3550 | 1.53e-14 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 286 | 505 | 1.73e-14 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 291 | 516 | 1.97e-14 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 287 | 508 | 2.31e-14 |
| GO:BP | GO:0051049 | regulation of transport | 554 | 1098 | 2.73e-14 |
| GO:BP | GO:0034329 | cell junction assembly | 197 | 323 | 4.35e-14 |
| GO:BP | GO:0003013 | circulatory system process | 247 | 426 | 4.90e-14 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 261 | 456 | 6.30e-14 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 541 | 1073 | 7.43e-14 |
| GO:BP | GO:0030001 | metal ion transport | 292 | 524 | 1.38e-13 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 594 | 1197 | 1.40e-13 |
| GO:BP | GO:0060429 | epithelium development | 414 | 792 | 2.24e-13 |
| GO:BP | GO:0007409 | axonogenesis | 201 | 337 | 5.46e-13 |
| GO:BP | GO:0009790 | embryo development | 425 | 821 | 7.04e-13 |
| GO:BP | GO:0001525 | angiogenesis | 222 | 381 | 7.07e-13 |
| GO:BP | GO:0042221 | response to chemical | 1059 | 2304 | 8.84e-13 |
| GO:BP | GO:0051960 | regulation of nervous system development | 201 | 339 | 1.22e-12 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 131 | 200 | 1.77e-12 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 215 | 369 | 1.85e-12 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 225 | 390 | 1.95e-12 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 208 | 355 | 2.23e-12 |
| GO:BP | GO:0061564 | axon development | 216 | 372 | 2.58e-12 |
| GO:BP | GO:0070848 | response to growth factor | 298 | 547 | 3.17e-12 |
| GO:BP | GO:0006810 | transport | 1334 | 2984 | 4.32e-12 |
| GO:BP | GO:0008015 | blood circulation | 208 | 357 | 4.75e-12 |
| GO:BP | GO:0061061 | muscle structure development | 292 | 536 | 5.67e-12 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 595 | 1218 | 5.67e-12 |
| GO:BP | GO:0023056 | positive regulation of signaling | 596 | 1221 | 6.44e-12 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 288 | 528 | 6.80e-12 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 159 | 258 | 7.30e-12 |
| GO:BP | GO:0048589 | developmental growth | 275 | 501 | 9.34e-12 |
| GO:BP | GO:0098609 | cell-cell adhesion | 304 | 564 | 9.73e-12 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 146 | 233 | 1.12e-11 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 391 | 757 | 1.19e-11 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 316 | 591 | 1.19e-11 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 368 | 706 | 1.27e-11 |
| GO:BP | GO:0023057 | negative regulation of signaling | 514 | 1036 | 1.30e-11 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 109 | 162 | 1.66e-11 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 237 | 422 | 1.88e-11 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 72 | 95 | 2.17e-11 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 512 | 1034 | 2.17e-11 |
| GO:BP | GO:0099536 | synaptic signaling | 265 | 483 | 2.62e-11 |
| GO:BP | GO:0003012 | muscle system process | 190 | 325 | 3.37e-11 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 257 | 467 | 3.81e-11 |
| GO:BP | GO:0016043 | cellular component organization | 2055 | 4802 | 4.44e-11 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 188 | 322 | 5.19e-11 |
| GO:BP | GO:0006897 | endocytosis | 268 | 492 | 5.55e-11 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 176 | 298 | 7.04e-11 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 188 | 323 | 7.52e-11 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 254 | 463 | 7.83e-11 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 198 | 344 | 7.83e-11 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 254 | 463 | 7.83e-11 |
| GO:BP | GO:0032879 | regulation of localization | 683 | 1439 | 8.32e-11 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 67 | 88 | 9.18e-11 |
| GO:BP | GO:0006816 | calcium ion transport | 158 | 262 | 9.46e-11 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 132 | 210 | 1.01e-10 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 331 | 633 | 1.18e-10 |
| GO:BP | GO:0050808 | synapse organization | 194 | 337 | 1.25e-10 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 256 | 469 | 1.26e-10 |
| GO:BP | GO:0051179 | localization | 1623 | 3731 | 1.73e-10 |
| GO:BP | GO:0010720 | positive regulation of cell development | 180 | 309 | 1.92e-10 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 216 | 386 | 3.06e-10 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 170 | 290 | 3.75e-10 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 103 | 156 | 3.80e-10 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 615 | 1289 | 4.06e-10 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 278 | 521 | 4.13e-10 |
| GO:BP | GO:0140352 | export from cell | 311 | 594 | 4.47e-10 |
| GO:BP | GO:0060284 | regulation of cell development | 300 | 570 | 4.84e-10 |
| GO:BP | GO:0097485 | neuron projection guidance | 111 | 172 | 5.02e-10 |
| GO:BP | GO:0007411 | axon guidance | 111 | 172 | 5.02e-10 |
| GO:BP | GO:0008283 | cell population proliferation | 621 | 1306 | 6.50e-10 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 225 | 408 | 7.16e-10 |
| GO:BP | GO:0006468 | protein phosphorylation | 471 | 958 | 7.20e-10 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 477 | 972 | 7.44e-10 |
| GO:BP | GO:0007015 | actin filament organization | 201 | 357 | 7.49e-10 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 228 | 416 | 1.14e-09 |
| GO:BP | GO:0006811 | monoatomic ion transport | 365 | 719 | 1.20e-09 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 306 | 587 | 1.20e-09 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 807 | 1751 | 1.20e-09 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 571 | 1193 | 1.25e-09 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 528 | 1093 | 1.28e-09 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 218 | 395 | 1.29e-09 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 119 | 190 | 1.54e-09 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 154 | 261 | 1.67e-09 |
| GO:BP | GO:0006936 | muscle contraction | 151 | 255 | 1.78e-09 |
| GO:BP | GO:0048568 | embryonic organ development | 174 | 303 | 1.98e-09 |
| GO:BP | GO:0016310 | phosphorylation | 549 | 1145 | 2.18e-09 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 263 | 495 | 2.50e-09 |
| GO:BP | GO:0051234 | establishment of localization | 1415 | 3240 | 2.56e-09 |
| GO:BP | GO:0046903 | secretion | 320 | 622 | 2.94e-09 |
| GO:BP | GO:0007417 | central nervous system development | 352 | 694 | 3.01e-09 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 255 | 480 | 4.98e-09 |
| GO:BP | GO:0048041 | focal adhesion assembly | 58 | 77 | 5.10e-09 |
| GO:BP | GO:0009605 | response to external stimulus | 722 | 1559 | 5.53e-09 |
| GO:BP | GO:0007423 | sensory organ development | 212 | 387 | 5.70e-09 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 107 | 169 | 5.70e-09 |
| GO:BP | GO:0014706 | striated muscle tissue development | 129 | 213 | 5.77e-09 |
| GO:BP | GO:0055085 | transmembrane transport | 450 | 921 | 5.89e-09 |
| GO:BP | GO:0006812 | monoatomic cation transport | 315 | 614 | 6.08e-09 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 419 | 850 | 6.17e-09 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 517 | 1077 | 6.58e-09 |
| GO:BP | GO:0060322 | head development | 281 | 539 | 7.29e-09 |
| GO:BP | GO:0050877 | nervous system process | 308 | 600 | 8.92e-09 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 141 | 239 | 1.05e-08 |
| GO:BP | GO:0007507 | heart development | 262 | 499 | 1.23e-08 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 145 | 248 | 1.41e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 696 | 1504 | 1.45e-08 |
| GO:BP | GO:0048588 | developmental cell growth | 111 | 179 | 1.51e-08 |
| GO:BP | GO:0032940 | secretion by cell | 285 | 551 | 1.55e-08 |
| GO:BP | GO:0040007 | growth | 349 | 697 | 2.43e-08 |
| GO:BP | GO:0071310 | cellular response to organic substance | 607 | 1297 | 2.69e-08 |
| GO:BP | GO:0023061 | signal release | 176 | 315 | 2.72e-08 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 89 | 137 | 2.87e-08 |
| GO:BP | GO:0007420 | brain development | 260 | 498 | 2.89e-08 |
| GO:BP | GO:0060537 | muscle tissue development | 187 | 339 | 3.17e-08 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 160 | 282 | 3.63e-08 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 315 | 622 | 3.63e-08 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 137 | 234 | 3.66e-08 |
| GO:BP | GO:0007610 | behavior | 224 | 420 | 3.98e-08 |
| GO:BP | GO:0003007 | heart morphogenesis | 129 | 218 | 4.42e-08 |
| GO:BP | GO:0042692 | muscle cell differentiation | 179 | 323 | 4.44e-08 |
| GO:BP | GO:0048638 | regulation of developmental growth | 141 | 243 | 4.73e-08 |
| GO:BP | GO:0065009 | regulation of molecular function | 606 | 1299 | 5.01e-08 |
| GO:BP | GO:1903522 | regulation of blood circulation | 117 | 194 | 5.40e-08 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 120 | 201 | 7.91e-08 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1067 | 2415 | 7.92e-08 |
| GO:BP | GO:0001501 | skeletal system development | 189 | 347 | 9.55e-08 |
| GO:BP | GO:0009987 | cellular process | 4263 | 10686 | 9.61e-08 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 268 | 521 | 9.95e-08 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 80 | 122 | 1.03e-07 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 63 | 90 | 1.06e-07 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 124 | 210 | 1.07e-07 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 383 | 783 | 1.19e-07 |
| GO:BP | GO:0010033 | response to organic substance | 786 | 1736 | 1.24e-07 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 113 | 188 | 1.31e-07 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 160 | 286 | 1.33e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 111 | 184 | 1.33e-07 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 167 | 301 | 1.36e-07 |
| GO:BP | GO:0042330 | taxis | 140 | 244 | 1.39e-07 |
| GO:BP | GO:0006935 | chemotaxis | 140 | 244 | 1.39e-07 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 46 | 60 | 1.39e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1149 | 2622 | 1.39e-07 |
| GO:BP | GO:0042391 | regulation of membrane potential | 158 | 282 | 1.40e-07 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 43 | 55 | 1.55e-07 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 43 | 55 | 1.55e-07 |
| GO:BP | GO:0030900 | forebrain development | 153 | 272 | 1.70e-07 |
| GO:BP | GO:0006915 | apoptotic process | 635 | 1377 | 1.74e-07 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 81 | 125 | 1.74e-07 |
| GO:BP | GO:0009611 | response to wounding | 204 | 382 | 1.76e-07 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 130 | 224 | 1.85e-07 |
| GO:BP | GO:0043062 | extracellular structure organization | 130 | 224 | 1.85e-07 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 231 | 442 | 2.05e-07 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 103 | 169 | 2.12e-07 |
| GO:BP | GO:0043009 | chordate embryonic development | 260 | 507 | 2.28e-07 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 207 | 390 | 2.56e-07 |
| GO:BP | GO:0060047 | heart contraction | 115 | 194 | 2.70e-07 |
| GO:BP | GO:0030198 | extracellular matrix organization | 129 | 223 | 2.74e-07 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2090 | 4988 | 2.94e-07 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 74 | 113 | 3.97e-07 |
| GO:BP | GO:0001775 | cell activation | 312 | 627 | 3.97e-07 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 187 | 348 | 4.05e-07 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 114 | 193 | 4.07e-07 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 123 | 212 | 4.73e-07 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 59 | 85 | 4.94e-07 |
| GO:BP | GO:0001823 | mesonephros development | 53 | 74 | 4.94e-07 |
| GO:BP | GO:0003015 | heart process | 119 | 204 | 5.26e-07 |
| GO:BP | GO:0003205 | cardiac chamber development | 93 | 151 | 5.31e-07 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 93 | 151 | 5.31e-07 |
| GO:BP | GO:0042060 | wound healing | 160 | 291 | 5.97e-07 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 72 | 110 | 6.25e-07 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 111 | 188 | 6.35e-07 |
| GO:BP | GO:0090130 | tissue migration | 139 | 247 | 7.67e-07 |
| GO:BP | GO:0061572 | actin filament bundle organization | 83 | 132 | 8.15e-07 |
| GO:BP | GO:0090132 | epithelium migration | 137 | 243 | 8.22e-07 |
| GO:BP | GO:0010631 | epithelial cell migration | 137 | 243 | 8.22e-07 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 52 | 73 | 8.74e-07 |
| GO:BP | GO:0072164 | mesonephric tubule development | 52 | 73 | 8.74e-07 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 158 | 288 | 8.74e-07 |
| GO:BP | GO:0008219 | cell death | 649 | 1423 | 8.84e-07 |
| GO:BP | GO:0030048 | actin filament-based movement | 70 | 107 | 9.85e-07 |
| GO:BP | GO:0016358 | dendrite development | 108 | 183 | 9.89e-07 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 103 | 173 | 1.10e-06 |
| GO:BP | GO:0051046 | regulation of secretion | 207 | 396 | 1.15e-06 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 163 | 300 | 1.24e-06 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 93 | 153 | 1.26e-06 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 82 | 131 | 1.27e-06 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 113 | 194 | 1.27e-06 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 244 | 479 | 1.27e-06 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 89 | 145 | 1.27e-06 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 86 | 139 | 1.27e-06 |
| GO:BP | GO:0012501 | programmed cell death | 646 | 1419 | 1.30e-06 |
| GO:BP | GO:0008150 | biological_process | 4455 | 11244 | 1.34e-06 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1022 | 2333 | 1.37e-06 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 108 | 184 | 1.42e-06 |
| GO:BP | GO:0001657 | ureteric bud development | 51 | 72 | 1.52e-06 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 136 | 243 | 1.58e-06 |
| GO:BP | GO:0051050 | positive regulation of transport | 284 | 571 | 1.75e-06 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 75 | 118 | 1.84e-06 |
| GO:BP | GO:0071772 | response to BMP | 75 | 118 | 1.84e-06 |
| GO:BP | GO:1990138 | neuron projection extension | 83 | 134 | 1.98e-06 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 198 | 379 | 2.28e-06 |
| GO:BP | GO:0090257 | regulation of muscle system process | 104 | 177 | 2.28e-06 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 333 | 685 | 2.40e-06 |
| GO:BP | GO:0008016 | regulation of heart contraction | 98 | 165 | 2.61e-06 |
| GO:BP | GO:0055001 | muscle cell development | 97 | 163 | 2.65e-06 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 221 | 431 | 2.77e-06 |
| GO:BP | GO:0045165 | cell fate commitment | 91 | 151 | 2.91e-06 |
| GO:BP | GO:0099173 | postsynapse organization | 89 | 147 | 2.98e-06 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 75 | 119 | 2.99e-06 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 85 | 139 | 3.06e-06 |
| GO:BP | GO:0035265 | organ growth | 79 | 127 | 3.07e-06 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 298 | 606 | 3.07e-06 |
| GO:BP | GO:0061448 | connective tissue development | 117 | 205 | 3.15e-06 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 154 | 284 | 3.18e-06 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 52 | 75 | 3.25e-06 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 103 | 176 | 3.34e-06 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 531 | 1152 | 3.39e-06 |
| GO:BP | GO:1901698 | response to nitrogen compound | 354 | 736 | 3.54e-06 |
| GO:BP | GO:0001654 | eye development | 144 | 263 | 3.74e-06 |
| GO:BP | GO:0045216 | cell-cell junction organization | 91 | 152 | 4.31e-06 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 344 | 714 | 4.34e-06 |
| GO:BP | GO:0032409 | regulation of transporter activity | 89 | 148 | 4.42e-06 |
| GO:BP | GO:0048880 | sensory system development | 145 | 266 | 4.80e-06 |
| GO:BP | GO:0150063 | visual system development | 144 | 264 | 5.02e-06 |
| GO:BP | GO:0050807 | regulation of synapse organization | 101 | 173 | 5.10e-06 |
| GO:BP | GO:0060395 | SMAD protein signal transduction | 52 | 76 | 6.19e-06 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 187 | 359 | 6.42e-06 |
| GO:BP | GO:0007517 | muscle organ development | 145 | 267 | 6.42e-06 |
| GO:BP | GO:0045321 | leukocyte activation | 263 | 530 | 6.48e-06 |
| GO:BP | GO:0072073 | kidney epithelium development | 70 | 111 | 7.30e-06 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 121 | 216 | 7.31e-06 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 142 | 261 | 7.33e-06 |
| GO:BP | GO:0021915 | neural tube development | 81 | 133 | 7.34e-06 |
| GO:BP | GO:0003231 | cardiac ventricle development | 72 | 115 | 7.36e-06 |
| GO:BP | GO:0042592 | homeostatic process | 522 | 1137 | 7.88e-06 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 186 | 358 | 8.54e-06 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 114 | 202 | 9.56e-06 |
| GO:BP | GO:0033002 | muscle cell proliferation | 90 | 152 | 9.69e-06 |
| GO:BP | GO:0015833 | peptide transport | 103 | 179 | 9.91e-06 |
| GO:BP | GO:0007389 | pattern specification process | 153 | 286 | 9.96e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 87 | 146 | 1.02e-05 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 68 | 108 | 1.14e-05 |
| GO:BP | GO:0030509 | BMP signaling pathway | 69 | 110 | 1.15e-05 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 77 | 126 | 1.16e-05 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 45 | 64 | 1.16e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 953 | 2186 | 1.17e-05 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 40 | 55 | 1.23e-05 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 40 | 55 | 1.23e-05 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 502 | 1093 | 1.25e-05 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 232 | 463 | 1.25e-05 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 232 | 463 | 1.25e-05 |
| GO:BP | GO:1905314 | semi-lunar valve development | 32 | 41 | 1.25e-05 |
| GO:BP | GO:0048878 | chemical homeostasis | 322 | 670 | 1.37e-05 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 272 | 555 | 1.46e-05 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 268 | 546 | 1.50e-05 |
| GO:BP | GO:0051216 | cartilage development | 86 | 145 | 1.51e-05 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 86 | 145 | 1.51e-05 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 117 | 210 | 1.57e-05 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 382 | 811 | 1.58e-05 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 37 | 50 | 1.60e-05 |
| GO:BP | GO:0061035 | regulation of cartilage development | 37 | 50 | 1.60e-05 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 81 | 135 | 1.64e-05 |
| GO:BP | GO:0007611 | learning or memory | 107 | 189 | 1.65e-05 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 77 | 127 | 1.72e-05 |
| GO:BP | GO:0031644 | regulation of nervous system process | 50 | 74 | 1.73e-05 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 43 | 61 | 1.78e-05 |
| GO:BP | GO:0046879 | hormone secretion | 113 | 202 | 1.81e-05 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 188 | 366 | 1.87e-05 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 52 | 78 | 1.95e-05 |
| GO:BP | GO:1901342 | regulation of vasculature development | 111 | 198 | 1.96e-05 |
| GO:BP | GO:0016049 | cell growth | 195 | 382 | 2.01e-05 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 109 | 194 | 2.11e-05 |
| GO:BP | GO:0060348 | bone development | 86 | 146 | 2.18e-05 |
| GO:BP | GO:0009914 | hormone transport | 115 | 207 | 2.28e-05 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 46 | 67 | 2.35e-05 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 46 | 67 | 2.35e-05 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 46 | 67 | 2.35e-05 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 57 | 88 | 2.37e-05 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 58 | 90 | 2.43e-05 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 215 | 428 | 2.44e-05 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 80 | 134 | 2.44e-05 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 826 | 1883 | 2.50e-05 |
| GO:BP | GO:0045927 | positive regulation of growth | 104 | 184 | 2.50e-05 |
| GO:BP | GO:0072001 | renal system development | 132 | 244 | 2.55e-05 |
| GO:BP | GO:0003279 | cardiac septum development | 64 | 102 | 2.67e-05 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 118 | 214 | 2.67e-05 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 71 | 116 | 2.67e-05 |
| GO:BP | GO:0060419 | heart growth | 48 | 71 | 2.67e-05 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 50 | 75 | 3.03e-05 |
| GO:BP | GO:0042472 | inner ear morphogenesis | 42 | 60 | 3.06e-05 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 214 | 427 | 3.12e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 225 | 452 | 3.14e-05 |
| GO:BP | GO:0002521 | leukocyte differentiation | 189 | 371 | 3.35e-05 |
| GO:BP | GO:0002790 | peptide secretion | 95 | 166 | 3.41e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 125 | 230 | 3.50e-05 |
| GO:BP | GO:0006836 | neurotransmitter transport | 80 | 135 | 3.56e-05 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 373 | 796 | 3.73e-05 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 56 | 87 | 3.79e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 109 | 196 | 3.86e-05 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 57 | 89 | 3.87e-05 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 190 | 374 | 3.91e-05 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 45 | 66 | 3.93e-05 |
| GO:BP | GO:0072006 | nephron development | 70 | 115 | 4.10e-05 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 68 | 111 | 4.15e-05 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 88 | 152 | 4.18e-05 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 832 | 1904 | 4.48e-05 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 421 | 911 | 4.63e-05 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 812 | 1856 | 4.93e-05 |
| GO:BP | GO:0048562 | embryonic organ morphogenesis | 102 | 182 | 5.07e-05 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 102 | 182 | 5.07e-05 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 35 | 48 | 5.12e-05 |
| GO:BP | GO:1901890 | positive regulation of cell junction assembly | 50 | 76 | 5.20e-05 |
| GO:BP | GO:2000027 | regulation of animal organ morphogenesis | 41 | 59 | 5.25e-05 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 51 | 78 | 5.40e-05 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 785 | 1791 | 5.40e-05 |
| GO:BP | GO:0050919 | negative chemotaxis | 31 | 41 | 5.47e-05 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 306 | 642 | 5.63e-05 |
| GO:BP | GO:0040008 | regulation of growth | 228 | 462 | 5.63e-05 |
| GO:BP | GO:0048863 | stem cell differentiation | 106 | 191 | 5.83e-05 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 73 | 122 | 5.88e-05 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 72 | 120 | 5.97e-05 |
| GO:BP | GO:0042886 | amide transport | 112 | 204 | 6.08e-05 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 118 | 217 | 6.21e-05 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 58 | 92 | 6.26e-05 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 203 | 406 | 6.65e-05 |
| GO:BP | GO:0050890 | cognition | 116 | 213 | 6.80e-05 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 102 | 183 | 6.81e-05 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 137 | 259 | 7.34e-05 |
| GO:BP | GO:0003281 | ventricular septum development | 46 | 69 | 7.42e-05 |
| GO:BP | GO:0006813 | potassium ion transport | 79 | 135 | 7.58e-05 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 78 | 133 | 7.77e-05 |
| GO:BP | GO:0006949 | syncytium formation | 29 | 38 | 8.22e-05 |
| GO:BP | GO:0048168 | regulation of neuronal synaptic plasticity | 29 | 38 | 8.22e-05 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 129 | 242 | 8.35e-05 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 123 | 229 | 8.53e-05 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 198 | 396 | 8.61e-05 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 803 | 1841 | 9.27e-05 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 200 | 401 | 9.43e-05 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 68 | 113 | 9.43e-05 |
| GO:BP | GO:0014902 | myotube differentiation | 54 | 85 | 9.53e-05 |
| GO:BP | GO:1902414 | protein localization to cell junction | 54 | 85 | 9.53e-05 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 66 | 109 | 9.61e-05 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 155 | 300 | 9.72e-05 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 114 | 210 | 9.74e-05 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 59 | 95 | 9.85e-05 |
| GO:BP | GO:0002376 | immune system process | 626 | 1410 | 9.85e-05 |
| GO:BP | GO:0022612 | gland morphogenesis | 58 | 93 | 9.85e-05 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 135 | 256 | 1.02e-04 |
| GO:BP | GO:0060390 | regulation of SMAD protein signal transduction | 35 | 49 | 1.02e-04 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 42 | 62 | 1.02e-04 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 43 | 64 | 1.09e-04 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 468 | 1031 | 1.22e-04 |
| GO:BP | GO:0001822 | kidney development | 126 | 237 | 1.24e-04 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 373 | 805 | 1.24e-04 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 348 | 746 | 1.25e-04 |
| GO:BP | GO:0035148 | tube formation | 73 | 124 | 1.25e-04 |
| GO:BP | GO:0099565 | chemical synaptic transmission, postsynaptic | 46 | 70 | 1.26e-04 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 410 | 893 | 1.27e-04 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 93 | 166 | 1.30e-04 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 264 | 550 | 1.33e-04 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 92 | 164 | 1.35e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 244 | 504 | 1.39e-04 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 32 | 44 | 1.39e-04 |
| GO:BP | GO:0030072 | peptide hormone secretion | 91 | 162 | 1.40e-04 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 117 | 218 | 1.44e-04 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 64 | 106 | 1.46e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 64 | 106 | 1.46e-04 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 372 | 804 | 1.47e-04 |
| GO:BP | GO:0031399 | regulation of protein modification process | 417 | 911 | 1.49e-04 |
| GO:BP | GO:0003158 | endothelium development | 61 | 100 | 1.49e-04 |
| GO:BP | GO:0003176 | aortic valve development | 28 | 37 | 1.49e-04 |
| GO:BP | GO:0006814 | sodium ion transport | 79 | 137 | 1.50e-04 |
| GO:BP | GO:0003177 | pulmonary valve development | 19 | 22 | 1.58e-04 |
| GO:BP | GO:0097120 | receptor localization to synapse | 33 | 46 | 1.58e-04 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 479 | 1060 | 1.62e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 189 | 379 | 1.62e-04 |
| GO:BP | GO:0003002 | regionalization | 135 | 258 | 1.63e-04 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 144 | 278 | 1.65e-04 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 86 | 152 | 1.65e-04 |
| GO:BP | GO:0032535 | regulation of cellular component size | 148 | 287 | 1.69e-04 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 74 | 127 | 1.72e-04 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 34 | 48 | 1.77e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 106 | 195 | 1.79e-04 |
| GO:BP | GO:0021537 | telencephalon development | 106 | 195 | 1.79e-04 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 72 | 123 | 1.80e-04 |
| GO:BP | GO:0003184 | pulmonary valve morphogenesis | 17 | 19 | 1.81e-04 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 320 | 683 | 1.81e-04 |
| GO:BP | GO:0007215 | glutamate receptor signaling pathway | 22 | 27 | 1.83e-04 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 43 | 65 | 1.85e-04 |
| GO:BP | GO:0003170 | heart valve development | 43 | 65 | 1.85e-04 |
| GO:BP | GO:0050708 | regulation of protein secretion | 98 | 178 | 1.88e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 90 | 161 | 1.92e-04 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 44 | 67 | 1.92e-04 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 44 | 67 | 1.92e-04 |
| GO:BP | GO:0048771 | tissue remodeling | 67 | 113 | 2.00e-04 |
| GO:BP | GO:0007369 | gastrulation | 80 | 140 | 2.00e-04 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 65 | 109 | 2.07e-04 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 65 | 109 | 2.07e-04 |
| GO:BP | GO:0098815 | modulation of excitatory postsynaptic potential | 30 | 41 | 2.08e-04 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 30 | 41 | 2.08e-04 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 64 | 107 | 2.10e-04 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 62 | 103 | 2.16e-04 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 49 | 77 | 2.18e-04 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 307 | 654 | 2.21e-04 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 204 | 415 | 2.21e-04 |
| GO:BP | GO:0099175 | regulation of postsynapse organization | 51 | 81 | 2.23e-04 |
| GO:BP | GO:0048675 | axon extension | 58 | 95 | 2.24e-04 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 58 | 95 | 2.24e-04 |
| GO:BP | GO:0061337 | cardiac conduction | 53 | 85 | 2.25e-04 |
| GO:BP | GO:0060840 | artery development | 53 | 85 | 2.25e-04 |
| GO:BP | GO:0007613 | memory | 54 | 87 | 2.25e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 31 | 43 | 2.37e-04 |
| GO:BP | GO:0060038 | cardiac muscle cell proliferation | 31 | 43 | 2.37e-04 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 38 | 56 | 2.43e-04 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 90 | 162 | 2.58e-04 |
| GO:BP | GO:0098739 | import across plasma membrane | 71 | 122 | 2.58e-04 |
| GO:BP | GO:0048844 | artery morphogenesis | 39 | 58 | 2.58e-04 |
| GO:BP | GO:0072028 | nephron morphogenesis | 39 | 58 | 2.58e-04 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 27 | 36 | 2.65e-04 |
| GO:BP | GO:0140253 | cell-cell fusion | 27 | 36 | 2.65e-04 |
| GO:BP | GO:0060675 | ureteric bud morphogenesis | 32 | 45 | 2.67e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 40 | 60 | 2.71e-04 |
| GO:BP | GO:0051641 | cellular localization | 1113 | 2623 | 2.96e-04 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 77 | 135 | 3.04e-04 |
| GO:BP | GO:0009306 | protein secretion | 131 | 252 | 3.07e-04 |
| GO:BP | GO:0035592 | establishment of protein localization to extracellular region | 131 | 252 | 3.07e-04 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 63 | 106 | 3.11e-04 |
| GO:BP | GO:0010721 | negative regulation of cell development | 99 | 182 | 3.12e-04 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 135 | 261 | 3.14e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 44 | 68 | 3.16e-04 |
| GO:BP | GO:0007269 | neurotransmitter secretion | 61 | 102 | 3.20e-04 |
| GO:BP | GO:0099643 | signal release from synapse | 61 | 102 | 3.20e-04 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 45 | 70 | 3.22e-04 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 45 | 70 | 3.22e-04 |
| GO:BP | GO:0046632 | alpha-beta T cell differentiation | 45 | 70 | 3.22e-04 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 58 | 96 | 3.33e-04 |
| GO:BP | GO:0048864 | stem cell development | 47 | 74 | 3.34e-04 |
| GO:BP | GO:0007498 | mesoderm development | 52 | 84 | 3.47e-04 |
| GO:BP | GO:0110110 | positive regulation of animal organ morphogenesis | 21 | 26 | 3.50e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 137 | 266 | 3.52e-04 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 35 | 51 | 3.52e-04 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 29 | 40 | 3.64e-04 |
| GO:BP | GO:0046777 | protein autophosphorylation | 80 | 142 | 3.73e-04 |
| GO:BP | GO:0031503 | protein-containing complex localization | 87 | 157 | 3.87e-04 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 100 | 185 | 3.88e-04 |
| GO:BP | GO:0008544 | epidermis development | 111 | 209 | 3.92e-04 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 121 | 231 | 3.93e-04 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 25 | 33 | 3.99e-04 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 67 | 115 | 4.04e-04 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 67 | 115 | 4.04e-04 |
| GO:BP | GO:0046649 | lymphocyte activation | 215 | 444 | 4.11e-04 |
| GO:BP | GO:0007416 | synapse assembly | 77 | 136 | 4.12e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 77 | 136 | 4.12e-04 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 98 | 181 | 4.22e-04 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 201 | 412 | 4.25e-04 |
| GO:BP | GO:0043583 | ear development | 84 | 151 | 4.32e-04 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 233 | 486 | 4.33e-04 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 64 | 109 | 4.33e-04 |
| GO:BP | GO:0002791 | regulation of peptide secretion | 75 | 132 | 4.40e-04 |
| GO:BP | GO:0046883 | regulation of hormone secretion | 90 | 164 | 4.52e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 40 | 61 | 4.57e-04 |
| GO:BP | GO:0060976 | coronary vasculature development | 31 | 44 | 4.57e-04 |
| GO:BP | GO:2000463 | positive regulation of excitatory postsynaptic potential | 22 | 28 | 4.65e-04 |
| GO:BP | GO:0008361 | regulation of cell size | 82 | 147 | 4.65e-04 |
| GO:BP | GO:0061036 | positive regulation of cartilage development | 19 | 23 | 4.78e-04 |
| GO:BP | GO:0060079 | excitatory postsynaptic potential | 42 | 65 | 4.86e-04 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 58 | 97 | 4.88e-04 |
| GO:BP | GO:0072171 | mesonephric tubule morphogenesis | 32 | 46 | 5.03e-04 |
| GO:BP | GO:0006939 | smooth muscle contraction | 44 | 69 | 5.06e-04 |
| GO:BP | GO:0014032 | neural crest cell development | 44 | 69 | 5.06e-04 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 53 | 87 | 5.20e-04 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 52 | 85 | 5.21e-04 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 52 | 85 | 5.21e-04 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 52 | 85 | 5.21e-04 |
| GO:BP | GO:0006954 | inflammatory response | 206 | 425 | 5.43e-04 |
| GO:BP | GO:0001755 | neural crest cell migration | 33 | 48 | 5.44e-04 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 92 | 169 | 5.44e-04 |
| GO:BP | GO:0030073 | insulin secretion | 77 | 137 | 5.60e-04 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 163 | 327 | 5.81e-04 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 34 | 50 | 5.85e-04 |
| GO:BP | GO:0048839 | inner ear development | 75 | 133 | 6.04e-04 |
| GO:BP | GO:0007612 | learning | 64 | 110 | 6.15e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 64 | 110 | 6.15e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 64 | 110 | 6.15e-04 |
| GO:BP | GO:0048645 | animal organ formation | 35 | 52 | 6.21e-04 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 82 | 148 | 6.23e-04 |
| GO:BP | GO:0050922 | negative regulation of chemotaxis | 28 | 39 | 6.33e-04 |
| GO:BP | GO:0001764 | neuron migration | 73 | 129 | 6.44e-04 |
| GO:BP | GO:0031214 | biomineral tissue development | 62 | 106 | 6.44e-04 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 62 | 106 | 6.44e-04 |
| GO:BP | GO:0051235 | maintenance of location | 129 | 251 | 6.44e-04 |
| GO:BP | GO:0072078 | nephron tubule morphogenesis | 36 | 54 | 6.51e-04 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 145 | 287 | 6.59e-04 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 61 | 104 | 6.59e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 208 | 431 | 6.74e-04 |
| GO:BP | GO:0072088 | nephron epithelium morphogenesis | 37 | 56 | 6.80e-04 |
| GO:BP | GO:0006873 | intracellular monoatomic ion homeostasis | 177 | 360 | 7.06e-04 |
| GO:BP | GO:0061333 | renal tubule morphogenesis | 38 | 58 | 7.07e-04 |
| GO:BP | GO:0048488 | synaptic vesicle endocytosis | 38 | 58 | 7.07e-04 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 24 | 32 | 7.15e-04 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 24 | 32 | 7.15e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 135 | 265 | 7.22e-04 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 298 | 642 | 7.31e-04 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 15 | 17 | 7.67e-04 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 53 | 88 | 7.67e-04 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 53 | 88 | 7.67e-04 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 52 | 86 | 7.77e-04 |
| GO:BP | GO:0030239 | myofibril assembly | 42 | 66 | 7.77e-04 |
| GO:BP | GO:0060173 | limb development | 76 | 136 | 7.79e-04 |
| GO:BP | GO:0048736 | appendage development | 76 | 136 | 7.79e-04 |
| GO:BP | GO:0072175 | epithelial tube formation | 67 | 117 | 7.79e-04 |
| GO:BP | GO:0060993 | kidney morphogenesis | 43 | 68 | 7.83e-04 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 45 | 72 | 7.96e-04 |
| GO:BP | GO:0042471 | ear morphogenesis | 46 | 74 | 7.97e-04 |
| GO:BP | GO:0090087 | regulation of peptide transport | 75 | 134 | 8.06e-04 |
| GO:BP | GO:0043217 | myelin maintenance | 13 | 14 | 8.14e-04 |
| GO:BP | GO:0071868 | cellular response to monoamine stimulus | 25 | 34 | 8.38e-04 |
| GO:BP | GO:0071870 | cellular response to catecholamine stimulus | 25 | 34 | 8.38e-04 |
| GO:BP | GO:0090276 | regulation of peptide hormone secretion | 73 | 130 | 8.69e-04 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 73 | 130 | 8.69e-04 |
| GO:BP | GO:0007009 | plasma membrane organization | 62 | 107 | 9.07e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 208 | 433 | 9.19e-04 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 18 | 22 | 9.27e-04 |
| GO:BP | GO:0030031 | cell projection assembly | 214 | 447 | 9.31e-04 |
| GO:BP | GO:0071869 | response to catecholamine | 26 | 36 | 9.68e-04 |
| GO:BP | GO:0071867 | response to monoamine | 26 | 36 | 9.68e-04 |
| GO:BP | GO:0030003 | intracellular monoatomic cation homeostasis | 174 | 355 | 9.68e-04 |
| GO:BP | GO:0001707 | mesoderm formation | 34 | 51 | 1.01e-03 |
| GO:BP | GO:0072132 | mesenchyme morphogenesis | 34 | 51 | 1.01e-03 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 35 | 53 | 1.06e-03 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 56 | 95 | 1.06e-03 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 287 | 619 | 1.07e-03 |
| GO:BP | GO:0061384 | heart trabecula morphogenesis | 22 | 29 | 1.08e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 22 | 29 | 1.08e-03 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 22 | 29 | 1.08e-03 |
| GO:BP | GO:0002274 | myeloid leukocyte activation | 67 | 118 | 1.08e-03 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 54 | 91 | 1.10e-03 |
| GO:BP | GO:0043149 | stress fiber assembly | 54 | 91 | 1.10e-03 |
| GO:BP | GO:0014020 | primary neural tube formation | 52 | 87 | 1.14e-03 |
| GO:BP | GO:0048732 | gland development | 153 | 308 | 1.14e-03 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 38 | 59 | 1.16e-03 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 38 | 59 | 1.16e-03 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 51 | 85 | 1.16e-03 |
| GO:BP | GO:0002027 | regulation of heart rate | 50 | 83 | 1.17e-03 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 39 | 61 | 1.18e-03 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 49 | 81 | 1.19e-03 |
| GO:BP | GO:0097061 | dendritic spine organization | 40 | 63 | 1.20e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 48 | 79 | 1.20e-03 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 183 | 377 | 1.20e-03 |
| GO:BP | GO:0030316 | osteoclast differentiation | 41 | 65 | 1.21e-03 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 72 | 129 | 1.21e-03 |
| GO:BP | GO:0106027 | neuron projection organization | 44 | 71 | 1.22e-03 |
| GO:BP | GO:0003272 | endocardial cushion formation | 19 | 24 | 1.25e-03 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 106 | 203 | 1.25e-03 |
| GO:BP | GO:0032878 | regulation of establishment or maintenance of cell polarity | 19 | 24 | 1.25e-03 |
| GO:BP | GO:0021700 | developmental maturation | 106 | 203 | 1.25e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 143 | 286 | 1.28e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 110 | 212 | 1.29e-03 |
| GO:BP | GO:0019725 | cellular homeostasis | 263 | 564 | 1.30e-03 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 70 | 125 | 1.31e-03 |
| GO:BP | GO:0010817 | regulation of hormone levels | 157 | 318 | 1.33e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 68 | 121 | 1.42e-03 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 93 | 175 | 1.45e-03 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 93 | 175 | 1.45e-03 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 57 | 98 | 1.46e-03 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 280 | 605 | 1.46e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 67 | 119 | 1.46e-03 |
| GO:BP | GO:0060541 | respiratory system development | 87 | 162 | 1.48e-03 |
| GO:BP | GO:0032924 | activin receptor signaling pathway | 24 | 33 | 1.48e-03 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 97 | 184 | 1.52e-03 |
| GO:BP | GO:0001704 | formation of primary germ layer | 55 | 94 | 1.53e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 139 | 278 | 1.57e-03 |
| GO:BP | GO:0001841 | neural tube formation | 54 | 92 | 1.57e-03 |
| GO:BP | GO:0050796 | regulation of insulin secretion | 64 | 113 | 1.63e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 208 | 437 | 1.68e-03 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 51 | 86 | 1.69e-03 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 126 | 249 | 1.69e-03 |
| GO:BP | GO:0072009 | nephron epithelium development | 50 | 84 | 1.72e-03 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 35 | 54 | 1.75e-03 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 35 | 54 | 1.75e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 172 | 354 | 1.77e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 121 | 238 | 1.77e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 47 | 78 | 1.81e-03 |
| GO:BP | GO:0060996 | dendritic spine development | 46 | 76 | 1.83e-03 |
| GO:BP | GO:0030516 | regulation of axon extension | 45 | 74 | 1.84e-03 |
| GO:BP | GO:0035418 | protein localization to synapse | 38 | 60 | 1.84e-03 |
| GO:BP | GO:0061326 | renal tubule development | 45 | 74 | 1.84e-03 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 38 | 60 | 1.84e-03 |
| GO:BP | GO:0060326 | cell chemotaxis | 82 | 152 | 1.85e-03 |
| GO:BP | GO:0014812 | muscle cell migration | 44 | 72 | 1.85e-03 |
| GO:BP | GO:0030517 | negative regulation of axon extension | 26 | 37 | 1.86e-03 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 40 | 64 | 1.86e-03 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 40 | 64 | 1.86e-03 |
| GO:BP | GO:0051251 | positive regulation of lymphocyte activation | 97 | 185 | 1.92e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 92 | 174 | 1.92e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 21 | 28 | 1.93e-03 |
| GO:BP | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 21 | 28 | 1.93e-03 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 21 | 28 | 1.93e-03 |
| GO:BP | GO:0003171 | atrioventricular valve development | 21 | 28 | 1.93e-03 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 58 | 101 | 1.97e-03 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 101 | 194 | 1.98e-03 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 101 | 194 | 1.98e-03 |
| GO:BP | GO:0002064 | epithelial cell development | 80 | 148 | 2.00e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 134 | 268 | 2.00e-03 |
| GO:BP | GO:0001658 | branching involved in ureteric bud morphogenesis | 27 | 39 | 2.01e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 589 | 1354 | 2.02e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 118 | 232 | 2.02e-03 |
| GO:BP | GO:0014888 | striated muscle adaptation | 28 | 41 | 2.17e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 136 | 273 | 2.19e-03 |
| GO:BP | GO:0031099 | regeneration | 78 | 144 | 2.19e-03 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 112 | 219 | 2.22e-03 |
| GO:BP | GO:0006887 | exocytosis | 120 | 237 | 2.25e-03 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 53 | 91 | 2.28e-03 |
| GO:BP | GO:0009880 | embryonic pattern specification | 29 | 43 | 2.31e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 538 | 1231 | 2.33e-03 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 52 | 89 | 2.33e-03 |
| GO:BP | GO:0031623 | receptor internalization | 52 | 89 | 2.33e-03 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 102 | 197 | 2.36e-03 |
| GO:BP | GO:0097529 | myeloid leukocyte migration | 62 | 110 | 2.36e-03 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 51 | 87 | 2.39e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 539 | 1234 | 2.44e-03 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 15 | 18 | 2.45e-03 |
| GO:BP | GO:0042063 | gliogenesis | 122 | 242 | 2.48e-03 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 75 | 138 | 2.49e-03 |
| GO:BP | GO:0050865 | regulation of cell activation | 168 | 347 | 2.49e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 48 | 81 | 2.56e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 286 | 624 | 2.59e-03 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 67 | 121 | 2.64e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 46 | 77 | 2.66e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 45 | 75 | 2.71e-03 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 153 | 313 | 2.71e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 44 | 73 | 2.74e-03 |
| GO:BP | GO:0097581 | lamellipodium organization | 44 | 73 | 2.74e-03 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 42 | 69 | 2.82e-03 |
| GO:BP | GO:0036465 | synaptic vesicle recycling | 41 | 67 | 2.84e-03 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 37 | 59 | 2.85e-03 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 38 | 61 | 2.86e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 24 | 34 | 2.87e-03 |
| GO:BP | GO:0003230 | cardiac atrium development | 24 | 34 | 2.87e-03 |
| GO:BP | GO:0055023 | positive regulation of cardiac muscle tissue growth | 19 | 25 | 2.91e-03 |
| GO:BP | GO:0055123 | digestive system development | 55 | 96 | 3.01e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 122 | 243 | 3.01e-03 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 25 | 36 | 3.16e-03 |
| GO:BP | GO:0003203 | endocardial cushion morphogenesis | 25 | 36 | 3.16e-03 |
| GO:BP | GO:0032906 | transforming growth factor beta2 production | 9 | 9 | 3.29e-03 |
| GO:BP | GO:0032909 | regulation of transforming growth factor beta2 production | 9 | 9 | 3.29e-03 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 104 | 203 | 3.32e-03 |
| GO:BP | GO:0030010 | establishment of cell polarity | 68 | 124 | 3.39e-03 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 90 | 172 | 3.40e-03 |
| GO:BP | GO:0048565 | digestive tract development | 51 | 88 | 3.41e-03 |
| GO:BP | GO:0070570 | regulation of neuron projection regeneration | 20 | 27 | 3.49e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 20 | 27 | 3.49e-03 |
| GO:BP | GO:0030323 | respiratory tube development | 79 | 148 | 3.53e-03 |
| GO:BP | GO:0060606 | tube closure | 49 | 84 | 3.61e-03 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 59 | 105 | 3.61e-03 |
| GO:BP | GO:0050795 | regulation of behavior | 27 | 40 | 3.63e-03 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 684 | 1595 | 3.64e-03 |
| GO:BP | GO:0030307 | positive regulation of cell growth | 66 | 120 | 3.67e-03 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 48 | 82 | 3.69e-03 |
| GO:BP | GO:0072578 | neurotransmitter-gated ion channel clustering | 11 | 12 | 3.75e-03 |
| GO:BP | GO:0003222 | ventricular trabecula myocardium morphogenesis | 11 | 12 | 3.75e-03 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 11 | 12 | 3.75e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 47 | 80 | 3.78e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 28 | 42 | 3.80e-03 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 101 | 197 | 3.84e-03 |
| GO:BP | GO:0045055 | regulated exocytosis | 77 | 144 | 3.84e-03 |
| GO:BP | GO:0030324 | lung development | 77 | 144 | 3.84e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 109 | 215 | 3.89e-03 |
| GO:BP | GO:0051963 | regulation of synapse assembly | 45 | 76 | 3.94e-03 |
| GO:BP | GO:0034332 | adherens junction organization | 29 | 44 | 3.95e-03 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 29 | 44 | 3.95e-03 |
| GO:BP | GO:0051703 | biological process involved in intraspecies interaction between organisms | 21 | 29 | 3.99e-03 |
| GO:BP | GO:0035176 | social behavior | 21 | 29 | 3.99e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 44 | 74 | 4.01e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 30 | 46 | 4.07e-03 |
| GO:BP | GO:0003197 | endocardial cushion development | 30 | 46 | 4.07e-03 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 148 | 304 | 4.09e-03 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 63 | 114 | 4.12e-03 |
| GO:BP | GO:0045926 | negative regulation of growth | 95 | 184 | 4.13e-03 |
| GO:BP | GO:0072080 | nephron tubule development | 42 | 70 | 4.14e-03 |
| GO:BP | GO:0016079 | synaptic vesicle exocytosis | 42 | 70 | 4.14e-03 |
| GO:BP | GO:0010232 | vascular transport | 41 | 68 | 4.20e-03 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 41 | 68 | 4.20e-03 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 32 | 50 | 4.22e-03 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 32 | 50 | 4.22e-03 |
| GO:BP | GO:0051249 | regulation of lymphocyte activation | 137 | 279 | 4.22e-03 |
| GO:BP | GO:0048814 | regulation of dendrite morphogenesis | 32 | 50 | 4.22e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 40 | 66 | 4.24e-03 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 33 | 52 | 4.28e-03 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 33 | 52 | 4.28e-03 |
| GO:BP | GO:0045859 | regulation of protein kinase activity | 160 | 332 | 4.28e-03 |
| GO:BP | GO:0003148 | outflow tract septum morphogenesis | 17 | 22 | 4.31e-03 |
| GO:BP | GO:0060045 | positive regulation of cardiac muscle cell proliferation | 17 | 22 | 4.31e-03 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 36 | 58 | 4.32e-03 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 36 | 58 | 4.32e-03 |
| GO:BP | GO:0010469 | regulation of signaling receptor activity | 36 | 58 | 4.32e-03 |
| GO:BP | GO:1903351 | cellular response to dopamine | 22 | 31 | 4.40e-03 |
| GO:BP | GO:0060043 | regulation of cardiac muscle cell proliferation | 22 | 31 | 4.40e-03 |
| GO:BP | GO:0001558 | regulation of cell growth | 156 | 323 | 4.42e-03 |
| GO:BP | GO:0043500 | muscle adaptation | 51 | 89 | 4.67e-03 |
| GO:BP | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0048169 | regulation of long-term neuronal synaptic plasticity | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0060977 | coronary vasculature morphogenesis | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 14 | 17 | 4.74e-03 |
| GO:BP | GO:0042110 | T cell activation | 148 | 305 | 4.74e-03 |
| GO:BP | GO:0030534 | adult behavior | 50 | 87 | 4.79e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 50 | 87 | 4.79e-03 |
| GO:BP | GO:0006950 | response to stress | 1062 | 2540 | 4.82e-03 |
| GO:BP | GO:0030902 | hindbrain development | 58 | 104 | 4.95e-03 |
| GO:BP | GO:0001843 | neural tube closure | 48 | 83 | 5.10e-03 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 265 | 580 | 5.10e-03 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 48 | 83 | 5.10e-03 |
| GO:BP | GO:0001508 | action potential | 57 | 102 | 5.14e-03 |
| GO:BP | GO:0045124 | regulation of bone resorption | 18 | 24 | 5.20e-03 |
| GO:BP | GO:0008038 | neuron recognition | 24 | 35 | 5.20e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 24 | 35 | 5.20e-03 |
| GO:BP | GO:0051894 | positive regulation of focal adhesion assembly | 18 | 24 | 5.20e-03 |
| GO:BP | GO:0001816 | cytokine production | 206 | 441 | 5.48e-03 |
| GO:BP | GO:0010001 | glial cell differentiation | 93 | 181 | 5.60e-03 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 62 | 113 | 5.64e-03 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 387 | 874 | 5.64e-03 |
| GO:BP | GO:0003014 | renal system process | 43 | 73 | 5.86e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 123 | 249 | 5.95e-03 |
| GO:BP | GO:0030041 | actin filament polymerization | 67 | 124 | 5.97e-03 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 42 | 71 | 5.99e-03 |
| GO:BP | GO:0009725 | response to hormone | 277 | 610 | 6.00e-03 |
| GO:BP | GO:0001817 | regulation of cytokine production | 204 | 437 | 6.03e-03 |
| GO:BP | GO:0003209 | cardiac atrium morphogenesis | 19 | 26 | 6.08e-03 |
| GO:BP | GO:1905330 | regulation of morphogenesis of an epithelium | 27 | 41 | 6.08e-03 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 27 | 41 | 6.08e-03 |
| GO:BP | GO:0003181 | atrioventricular valve morphogenesis | 19 | 26 | 6.08e-03 |
| GO:BP | GO:1902656 | calcium ion import into cytosol | 19 | 26 | 6.08e-03 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 52 | 92 | 6.20e-03 |
| GO:BP | GO:0051588 | regulation of neurotransmitter transport | 40 | 67 | 6.21e-03 |
| GO:BP | GO:0051047 | positive regulation of secretion | 103 | 204 | 6.29e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 59 | 107 | 6.34e-03 |
| GO:BP | GO:0098810 | neurotransmitter reuptake | 15 | 19 | 6.34e-03 |
| GO:BP | GO:0099637 | neurotransmitter receptor transport | 15 | 19 | 6.34e-03 |
| GO:BP | GO:1990806 | ligand-gated ion channel signaling pathway | 15 | 19 | 6.34e-03 |
| GO:BP | GO:0099590 | neurotransmitter receptor internalization | 15 | 19 | 6.34e-03 |
| GO:BP | GO:0060997 | dendritic spine morphogenesis | 29 | 45 | 6.36e-03 |
| GO:BP | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane | 12 | 14 | 6.36e-03 |
| GO:BP | GO:0007492 | endoderm development | 38 | 63 | 6.36e-03 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 38 | 63 | 6.36e-03 |
| GO:BP | GO:1903540 | establishment of protein localization to postsynaptic membrane | 12 | 14 | 6.36e-03 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 37 | 61 | 6.44e-03 |
| GO:BP | GO:0035249 | synaptic transmission, glutamatergic | 37 | 61 | 6.44e-03 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 31 | 49 | 6.52e-03 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 35 | 57 | 6.52e-03 |
| GO:BP | GO:0021954 | central nervous system neuron development | 35 | 57 | 6.52e-03 |
| GO:BP | GO:0051899 | membrane depolarization | 35 | 57 | 6.52e-03 |
| GO:BP | GO:0045685 | regulation of glial cell differentiation | 31 | 49 | 6.52e-03 |
| GO:BP | GO:0060420 | regulation of heart growth | 31 | 49 | 6.52e-03 |
| GO:BP | GO:0043434 | response to peptide hormone | 151 | 314 | 6.52e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 58 | 105 | 6.53e-03 |
| GO:BP | GO:0046847 | filopodium assembly | 33 | 53 | 6.55e-03 |
| GO:BP | GO:0048713 | regulation of oligodendrocyte differentiation | 20 | 28 | 6.77e-03 |
| GO:BP | GO:0032674 | regulation of interleukin-5 production | 8 | 8 | 7.30e-03 |
| GO:BP | GO:0032634 | interleukin-5 production | 8 | 8 | 7.30e-03 |
| GO:BP | GO:0003418 | growth plate cartilage chondrocyte differentiation | 8 | 8 | 7.30e-03 |
| GO:BP | GO:0003190 | atrioventricular valve formation | 8 | 8 | 7.30e-03 |
| GO:BP | GO:0060896 | neural plate pattern specification | 8 | 8 | 7.30e-03 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 55 | 99 | 7.42e-03 |
| GO:BP | GO:0007616 | long-term memory | 21 | 30 | 7.48e-03 |
| GO:BP | GO:0048512 | circadian behavior | 21 | 30 | 7.48e-03 |
| GO:BP | GO:0030513 | positive regulation of BMP signaling pathway | 21 | 30 | 7.48e-03 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 21 | 30 | 7.48e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 253 | 555 | 7.59e-03 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 67 | 125 | 7.60e-03 |
| GO:BP | GO:0051923 | sulfation | 10 | 11 | 7.74e-03 |
| GO:BP | GO:0021670 | lateral ventricle development | 10 | 11 | 7.74e-03 |
| GO:BP | GO:0002682 | regulation of immune system process | 383 | 868 | 7.81e-03 |
| GO:BP | GO:0071887 | leukocyte apoptotic process | 44 | 76 | 7.97e-03 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 44 | 76 | 7.97e-03 |
| GO:BP | GO:0007622 | rhythmic behavior | 22 | 32 | 8.07e-03 |
| GO:BP | GO:1903350 | response to dopamine | 22 | 32 | 8.07e-03 |
| GO:BP | GO:1903539 | protein localization to postsynaptic membrane | 22 | 32 | 8.07e-03 |
| GO:BP | GO:0062237 | protein localization to postsynapse | 22 | 32 | 8.07e-03 |
| GO:BP | GO:0051592 | response to calcium ion | 59 | 108 | 8.34e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 70 | 132 | 8.52e-03 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 23 | 34 | 8.63e-03 |
| GO:BP | GO:0046620 | regulation of organ growth | 41 | 70 | 8.68e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 64 | 119 | 8.74e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 64 | 119 | 8.74e-03 |
| GO:BP | GO:0042552 | myelination | 63 | 117 | 9.18e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 13 | 16 | 9.18e-03 |
| GO:BP | GO:0070168 | negative regulation of biomineral tissue development | 13 | 16 | 9.18e-03 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 99 | 197 | 9.30e-03 |
| GO:BP | GO:0002063 | chondrocyte development | 17 | 23 | 9.31e-03 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 17 | 23 | 9.31e-03 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 17 | 23 | 9.31e-03 |
| GO:BP | GO:0048668 | collateral sprouting | 17 | 23 | 9.31e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 49 | 87 | 9.32e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 49 | 87 | 9.32e-03 |
| GO:BP | GO:0043113 | receptor clustering | 25 | 38 | 9.39e-03 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 37 | 62 | 9.47e-03 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 82 | 159 | 9.49e-03 |
| GO:BP | GO:0010876 | lipid localization | 143 | 298 | 9.67e-03 |
| GO:BP | GO:0007599 | hemostasis | 77 | 148 | 9.72e-03 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 35 | 58 | 9.79e-03 |
| GO:BP | GO:0008543 | fibroblast growth factor receptor signaling pathway | 35 | 58 | 9.79e-03 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 27 | 42 | 9.87e-03 |
| GO:BP | GO:0046928 | regulation of neurotransmitter secretion | 34 | 56 | 9.92e-03 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 81 | 157 | 9.96e-03 |
| GO:BP | GO:0055021 | regulation of cardiac muscle tissue growth | 28 | 44 | 9.97e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 28 | 44 | 9.97e-03 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 47 | 83 | 9.97e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 28 | 44 | 9.97e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 33 | 54 | 9.97e-03 |
| GO:BP | GO:0001708 | cell fate specification | 32 | 52 | 1.00e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 32 | 52 | 1.00e-02 |
| GO:BP | GO:0031102 | neuron projection regeneration | 30 | 48 | 1.01e-02 |
| GO:BP | GO:0140115 | export across plasma membrane | 30 | 48 | 1.01e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 76 | 146 | 1.01e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 71 | 135 | 1.02e-02 |
| GO:BP | GO:0001701 | in utero embryonic development | 157 | 331 | 1.03e-02 |
| GO:BP | GO:0098703 | calcium ion import across plasma membrane | 18 | 25 | 1.05e-02 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 18 | 25 | 1.05e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 18 | 25 | 1.05e-02 |
| GO:BP | GO:0007596 | blood coagulation | 75 | 144 | 1.06e-02 |
| GO:BP | GO:0007605 | sensory perception of sound | 53 | 96 | 1.06e-02 |
| GO:BP | GO:0044344 | cellular response to fibroblast growth factor stimulus | 45 | 79 | 1.06e-02 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 79 | 153 | 1.09e-02 |
| GO:BP | GO:0030595 | leukocyte chemotaxis | 58 | 107 | 1.13e-02 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 259 | 573 | 1.13e-02 |
| GO:BP | GO:0050905 | neuromuscular process | 58 | 107 | 1.13e-02 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 51 | 92 | 1.16e-02 |
| GO:BP | GO:0021591 | ventricular system development | 19 | 27 | 1.17e-02 |
| GO:BP | GO:0120033 | negative regulation of plasma membrane bounded cell projection assembly | 19 | 27 | 1.17e-02 |
| GO:BP | GO:0038094 | Fc-gamma receptor signaling pathway | 14 | 18 | 1.18e-02 |
| GO:BP | GO:0032925 | regulation of activin receptor signaling pathway | 14 | 18 | 1.18e-02 |
| GO:BP | GO:0060349 | bone morphogenesis | 42 | 73 | 1.18e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 57 | 105 | 1.18e-02 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 41 | 71 | 1.22e-02 |
| GO:BP | GO:0006909 | phagocytosis | 72 | 138 | 1.23e-02 |
| GO:BP | GO:0033036 | macromolecule localization | 963 | 2309 | 1.25e-02 |
| GO:BP | GO:0097106 | postsynaptic density organization | 20 | 29 | 1.27e-02 |
| GO:BP | GO:0046579 | positive regulation of Ras protein signal transduction | 11 | 13 | 1.27e-02 |
| GO:BP | GO:0046321 | positive regulation of fatty acid oxidation | 11 | 13 | 1.27e-02 |
| GO:BP | GO:0050817 | coagulation | 76 | 147 | 1.27e-02 |
| GO:BP | GO:0035150 | regulation of tube size | 55 | 101 | 1.30e-02 |
| GO:BP | GO:0035296 | regulation of tube diameter | 55 | 101 | 1.30e-02 |
| GO:BP | GO:0097746 | blood vessel diameter maintenance | 55 | 101 | 1.30e-02 |
| GO:BP | GO:0022414 | reproductive process | 383 | 874 | 1.32e-02 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 38 | 65 | 1.33e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 38 | 65 | 1.33e-02 |
| GO:BP | GO:1901652 | response to peptide | 172 | 368 | 1.34e-02 |
| GO:BP | GO:0060391 | positive regulation of SMAD protein signal transduction | 21 | 31 | 1.34e-02 |
| GO:BP | GO:0043393 | regulation of protein binding | 60 | 112 | 1.35e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 54 | 99 | 1.35e-02 |
| GO:BP | GO:0035270 | endocrine system development | 47 | 84 | 1.35e-02 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 37 | 63 | 1.36e-02 |
| GO:BP | GO:0006869 | lipid transport | 126 | 261 | 1.38e-02 |
| GO:BP | GO:0001890 | placenta development | 59 | 110 | 1.41e-02 |
| GO:BP | GO:0071774 | response to fibroblast growth factor | 46 | 82 | 1.41e-02 |
| GO:BP | GO:2000114 | regulation of establishment of cell polarity | 15 | 20 | 1.42e-02 |
| GO:BP | GO:0046849 | bone remodeling | 35 | 59 | 1.42e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 415 | 953 | 1.43e-02 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 90 | 179 | 1.44e-02 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 34 | 57 | 1.45e-02 |
| GO:BP | GO:0043954 | cellular component maintenance | 34 | 57 | 1.45e-02 |
| GO:BP | GO:0043549 | regulation of kinase activity | 167 | 357 | 1.48e-02 |
| GO:BP | GO:0070509 | calcium ion import | 33 | 55 | 1.48e-02 |
| GO:BP | GO:0042116 | macrophage activation | 33 | 55 | 1.48e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 33 | 55 | 1.48e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 24 | 37 | 1.49e-02 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 68 | 130 | 1.49e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 192 | 416 | 1.49e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 63 | 119 | 1.49e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 24 | 37 | 1.49e-02 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 63 | 119 | 1.49e-02 |
| GO:BP | GO:0043367 | CD4-positive, alpha-beta T cell differentiation | 32 | 53 | 1.49e-02 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 124 | 257 | 1.51e-02 |
| GO:BP | GO:0019935 | cyclic-nucleotide-mediated signaling | 31 | 51 | 1.51e-02 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 25 | 39 | 1.52e-02 |
| GO:BP | GO:0071621 | granulocyte chemotaxis | 30 | 49 | 1.53e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 29 | 47 | 1.54e-02 |
| GO:BP | GO:0045214 | sarcomere organization | 27 | 43 | 1.54e-02 |
| GO:BP | GO:0042100 | B cell proliferation | 28 | 45 | 1.54e-02 |
| GO:BP | GO:1903532 | positive regulation of secretion by cell | 96 | 193 | 1.54e-02 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 76 | 148 | 1.56e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 139 | 292 | 1.56e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 88 | 175 | 1.57e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 80 | 157 | 1.57e-02 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0042451 | purine nucleoside biosynthetic process | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0071625 | vocalization behavior | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0042455 | ribonucleoside biosynthetic process | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0099149 | regulation of postsynaptic neurotransmitter receptor internalization | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0022410 | circadian sleep/wake cycle process | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0046129 | purine ribonucleoside biosynthetic process | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0030431 | sleep | 9 | 10 | 1.60e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 56 | 104 | 1.60e-02 |
| GO:BP | GO:0097306 | cellular response to alcohol | 42 | 74 | 1.60e-02 |
| GO:BP | GO:0030279 | negative regulation of ossification | 16 | 22 | 1.61e-02 |
| GO:BP | GO:0060343 | trabecula formation | 16 | 22 | 1.61e-02 |
| GO:BP | GO:0048499 | synaptic vesicle membrane organization | 16 | 22 | 1.61e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 41 | 72 | 1.66e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 55 | 102 | 1.66e-02 |
| GO:BP | GO:0048709 | oligodendrocyte differentiation | 41 | 72 | 1.66e-02 |
| GO:BP | GO:0003188 | heart valve formation | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 48 | 87 | 1.71e-02 |
| GO:BP | GO:0060571 | morphogenesis of an epithelial fold | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0070571 | negative regulation of neuron projection regeneration | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0098877 | neurotransmitter receptor transport to plasma membrane | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0097091 | synaptic vesicle clustering | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0046128 | purine ribonucleoside metabolic process | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0001759 | organ induction | 12 | 15 | 1.71e-02 |
| GO:BP | GO:0051651 | maintenance of location in cell | 86 | 171 | 1.72e-02 |
| GO:BP | GO:0050679 | positive regulation of epithelial cell proliferation | 73 | 142 | 1.78e-02 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 17 | 24 | 1.78e-02 |
| GO:BP | GO:1905332 | positive regulation of morphogenesis of an epithelium | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 59 | 111 | 1.78e-02 |
| GO:BP | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0060074 | synapse maturation | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0048679 | regulation of axon regeneration | 17 | 24 | 1.78e-02 |
| GO:BP | GO:0010038 | response to metal ion | 120 | 249 | 1.80e-02 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 77 | 151 | 1.80e-02 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 237 | 525 | 1.81e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 38 | 66 | 1.81e-02 |
| GO:BP | GO:0000082 | G1/S transition of mitotic cell cycle | 92 | 185 | 1.85e-02 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 76 | 149 | 1.90e-02 |
| GO:BP | GO:0007212 | dopamine receptor signaling pathway | 18 | 26 | 1.94e-02 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 18 | 26 | 1.94e-02 |
| GO:BP | GO:0010092 | specification of animal organ identity | 18 | 26 | 1.94e-02 |
| GO:BP | GO:0009913 | epidermal cell differentiation | 62 | 118 | 1.95e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 71 | 138 | 1.97e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 118 | 245 | 1.99e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 66 | 127 | 2.03e-02 |
| GO:BP | GO:0000003 | reproduction | 384 | 882 | 2.05e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 61 | 116 | 2.05e-02 |
| GO:BP | GO:0002263 | cell activation involved in immune response | 78 | 154 | 2.12e-02 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 241 | 536 | 2.12e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 100 | 204 | 2.13e-02 |
| GO:BP | GO:0060392 | negative regulation of SMAD protein signal transduction | 13 | 17 | 2.13e-02 |
| GO:BP | GO:0060445 | branching involved in salivary gland morphogenesis | 13 | 17 | 2.13e-02 |
| GO:BP | GO:0072673 | lamellipodium morphogenesis | 13 | 17 | 2.13e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 421 | 973 | 2.13e-02 |
| GO:BP | GO:0002252 | immune effector process | 141 | 299 | 2.15e-02 |
| GO:BP | GO:0032835 | glomerulus development | 32 | 54 | 2.15e-02 |
| GO:BP | GO:0001937 | negative regulation of endothelial cell proliferation | 20 | 30 | 2.16e-02 |
| GO:BP | GO:0060914 | heart formation | 20 | 30 | 2.16e-02 |
| GO:BP | GO:0042113 | B cell activation | 81 | 161 | 2.21e-02 |
| GO:BP | GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 77 | 152 | 2.22e-02 |
| GO:BP | GO:0051223 | regulation of protein transport | 152 | 325 | 2.22e-02 |
| GO:BP | GO:0060711 | labyrinthine layer development | 21 | 32 | 2.24e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 30 | 50 | 2.24e-02 |
| GO:BP | GO:0048145 | regulation of fibroblast proliferation | 41 | 73 | 2.25e-02 |
| GO:BP | GO:0030888 | regulation of B cell proliferation | 22 | 34 | 2.29e-02 |
| GO:BP | GO:0010659 | cardiac muscle cell apoptotic process | 22 | 34 | 2.29e-02 |
| GO:BP | GO:0099084 | postsynaptic specialization organization | 22 | 34 | 2.29e-02 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 22 | 34 | 2.29e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 22 | 34 | 2.29e-02 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 115 | 239 | 2.30e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 23 | 36 | 2.32e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 23 | 36 | 2.32e-02 |
| GO:BP | GO:0030593 | neutrophil chemotaxis | 23 | 36 | 2.32e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 27 | 44 | 2.32e-02 |
| GO:BP | GO:0070613 | regulation of protein processing | 27 | 44 | 2.32e-02 |
| GO:BP | GO:0050714 | positive regulation of protein secretion | 53 | 99 | 2.32e-02 |
| GO:BP | GO:0048146 | positive regulation of fibroblast proliferation | 26 | 42 | 2.32e-02 |
| GO:BP | GO:0048013 | ephrin receptor signaling pathway | 24 | 38 | 2.32e-02 |
| GO:BP | GO:0051489 | regulation of filopodium assembly | 26 | 42 | 2.32e-02 |
| GO:BP | GO:2000117 | negative regulation of cysteine-type endopeptidase activity | 24 | 38 | 2.32e-02 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 63 | 121 | 2.32e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 24 | 38 | 2.32e-02 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 136 | 288 | 2.34e-02 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 67 | 130 | 2.38e-02 |
| GO:BP | GO:0006955 | immune response | 377 | 867 | 2.40e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 417 | 965 | 2.40e-02 |
| GO:BP | GO:0061154 | endothelial tube morphogenesis | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 175 | 380 | 2.40e-02 |
| GO:BP | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 120 | 251 | 2.40e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 120 | 251 | 2.40e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 52 | 97 | 2.40e-02 |
| GO:BP | GO:0045651 | positive regulation of macrophage differentiation | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0007600 | sensory perception | 120 | 251 | 2.40e-02 |
| GO:BP | GO:0099505 | regulation of presynaptic membrane potential | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0003159 | morphogenesis of an endothelium | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 10 | 12 | 2.40e-02 |
| GO:BP | GO:0072089 | stem cell proliferation | 46 | 84 | 2.40e-02 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 227 | 504 | 2.42e-02 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 269 | 605 | 2.42e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 956 | 2305 | 2.43e-02 |
| GO:BP | GO:0042278 | purine nucleoside metabolic process | 14 | 19 | 2.43e-02 |
| GO:BP | GO:0003156 | regulation of animal organ formation | 14 | 19 | 2.43e-02 |
| GO:BP | GO:0062009 | secondary palate development | 14 | 19 | 2.43e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 14 | 19 | 2.43e-02 |
| GO:BP | GO:0001892 | embryonic placenta development | 38 | 67 | 2.46e-02 |
| GO:BP | GO:0045621 | positive regulation of lymphocyte differentiation | 45 | 82 | 2.50e-02 |
| GO:BP | GO:0071674 | mononuclear cell migration | 51 | 95 | 2.50e-02 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 874 | 2100 | 2.51e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 61 | 117 | 2.52e-02 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 61 | 117 | 2.52e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 56 | 106 | 2.54e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 639 | 1514 | 2.54e-02 |
| GO:BP | GO:0036211 | protein modification process | 950 | 2291 | 2.56e-02 |
| GO:BP | GO:1901655 | cellular response to ketone | 44 | 80 | 2.61e-02 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 458 | 1067 | 2.63e-02 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 136 | 289 | 2.66e-02 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 178 | 388 | 2.66e-02 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 55 | 104 | 2.66e-02 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 108 | 224 | 2.70e-02 |
| GO:BP | GO:0051098 | regulation of binding | 98 | 201 | 2.72e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 43 | 78 | 2.73e-02 |
| GO:BP | GO:0010737 | protein kinase A signaling | 15 | 21 | 2.73e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 15 | 21 | 2.73e-02 |
| GO:BP | GO:0061037 | negative regulation of cartilage development | 15 | 21 | 2.73e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 80 | 160 | 2.74e-02 |
| GO:BP | GO:0071695 | anatomical structure maturation | 76 | 151 | 2.76e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 129 | 273 | 2.79e-02 |
| GO:BP | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 34 | 59 | 2.81e-02 |
| GO:BP | GO:0033993 | response to lipid | 255 | 573 | 2.87e-02 |
| GO:BP | GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 71 | 140 | 2.92e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 659 | 1566 | 2.92e-02 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 122 | 257 | 2.93e-02 |
| GO:BP | GO:0060037 | pharyngeal system development | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0051491 | positive regulation of filopodium assembly | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0031128 | developmental induction | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0043537 | negative regulation of blood vessel endothelial cell migration | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0000578 | embryonic axis specification | 16 | 23 | 2.97e-02 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 32 | 55 | 2.99e-02 |
| GO:BP | GO:0030032 | lamellipodium assembly | 32 | 55 | 2.99e-02 |
| GO:BP | GO:0030168 | platelet activation | 47 | 87 | 3.00e-02 |
| GO:BP | GO:0034097 | response to cytokine | 261 | 588 | 3.00e-02 |
| GO:BP | GO:0050680 | negative regulation of epithelial cell proliferation | 52 | 98 | 3.07e-02 |
| GO:BP | GO:0010827 | regulation of glucose transmembrane transport | 31 | 53 | 3.08e-02 |
| GO:BP | GO:0002793 | positive regulation of peptide secretion | 40 | 72 | 3.08e-02 |
| GO:BP | GO:0038166 | angiotensin-activated signaling pathway | 11 | 14 | 3.14e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 11 | 14 | 3.14e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 61 | 118 | 3.15e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 61 | 118 | 3.15e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 30 | 51 | 3.16e-02 |
| GO:BP | GO:0016311 | dephosphorylation | 111 | 232 | 3.17e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 98 | 202 | 3.20e-02 |
| GO:BP | GO:0061626 | pharyngeal arch artery morphogenesis | 8 | 9 | 3.20e-02 |
| GO:BP | GO:0038065 | collagen-activated signaling pathway | 8 | 9 | 3.20e-02 |
| GO:BP | GO:0050802 | circadian sleep/wake cycle, sleep | 8 | 9 | 3.20e-02 |
| GO:BP | GO:0097475 | motor neuron migration | 8 | 9 | 3.20e-02 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 51 | 96 | 3.20e-02 |
| GO:BP | GO:0045931 | positive regulation of mitotic cell cycle | 56 | 107 | 3.20e-02 |
| GO:BP | GO:0061024 | membrane organization | 276 | 625 | 3.20e-02 |
| GO:BP | GO:0003162 | atrioventricular node development | 8 | 9 | 3.20e-02 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 29 | 49 | 3.21e-02 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 29 | 49 | 3.21e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 45 | 83 | 3.26e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 28 | 47 | 3.27e-02 |
| GO:BP | GO:0046888 | negative regulation of hormone secretion | 28 | 47 | 3.27e-02 |
| GO:BP | GO:0031279 | regulation of cyclase activity | 18 | 27 | 3.27e-02 |
| GO:BP | GO:0060341 | regulation of cellular localization | 338 | 776 | 3.27e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 60 | 116 | 3.27e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 80 | 161 | 3.27e-02 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 18 | 27 | 3.27e-02 |
| GO:BP | GO:1904018 | positive regulation of vasculature development | 60 | 116 | 3.27e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 87 | 177 | 3.29e-02 |
| GO:BP | GO:0051640 | organelle localization | 229 | 512 | 3.30e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 303 | 691 | 3.32e-02 |
| GO:BP | GO:0051606 | detection of stimulus | 55 | 105 | 3.33e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 122 | 258 | 3.33e-02 |
| GO:BP | GO:0002275 | myeloid cell activation involved in immune response | 27 | 45 | 3.33e-02 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 27 | 45 | 3.33e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 19 | 29 | 3.37e-02 |
| GO:BP | GO:0086019 | cell-cell signaling involved in cardiac conduction | 19 | 29 | 3.37e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0002090 | regulation of receptor internalization | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 26 | 43 | 3.38e-02 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0010770 | positive regulation of cell morphogenesis | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0034405 | response to fluid shear stress | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0010665 | regulation of cardiac muscle cell apoptotic process | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0045453 | bone resorption | 25 | 41 | 3.40e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 59 | 114 | 3.40e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0071396 | cellular response to lipid | 177 | 388 | 3.40e-02 |
| GO:BP | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis | 20 | 31 | 3.40e-02 |
| GO:BP | GO:0031103 | axon regeneration | 25 | 41 | 3.40e-02 |
| GO:BP | GO:1903903 | regulation of establishment of T cell polarity | 6 | 6 | 3.41e-02 |
| GO:BP | GO:2000192 | negative regulation of fatty acid transport | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0033173 | calcineurin-NFAT signaling cascade | 23 | 37 | 3.41e-02 |
| GO:BP | GO:0046635 | positive regulation of alpha-beta T cell activation | 21 | 33 | 3.41e-02 |
| GO:BP | GO:0060897 | neural plate regionalization | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0003175 | tricuspid valve development | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0008542 | visual learning | 22 | 35 | 3.41e-02 |
| GO:BP | GO:0015800 | acidic amino acid transport | 23 | 37 | 3.41e-02 |
| GO:BP | GO:0023041 | neuronal signal transduction | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0001771 | immunological synapse formation | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0060710 | chorio-allantoic fusion | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0050861 | positive regulation of B cell receptor signaling pathway | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0051965 | positive regulation of synapse assembly | 24 | 39 | 3.41e-02 |
| GO:BP | GO:0019933 | cAMP-mediated signaling | 22 | 35 | 3.41e-02 |
| GO:BP | GO:0072173 | metanephric tubule morphogenesis | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0014031 | mesenchymal cell development | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0002792 | negative regulation of peptide secretion | 21 | 33 | 3.41e-02 |
| GO:BP | GO:0051639 | actin filament network formation | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0099024 | plasma membrane invagination | 23 | 37 | 3.41e-02 |
| GO:BP | GO:0032754 | positive regulation of interleukin-5 production | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0031223 | auditory behavior | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0099545 | trans-synaptic signaling by trans-synaptic complex | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0003415 | chondrocyte hypertrophy | 6 | 6 | 3.41e-02 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 22 | 35 | 3.41e-02 |
| GO:BP | GO:0061458 | reproductive system development | 99 | 205 | 3.42e-02 |
| GO:BP | GO:0042476 | odontogenesis | 43 | 79 | 3.43e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 43 | 79 | 3.43e-02 |
| GO:BP | GO:0019217 | regulation of fatty acid metabolic process | 36 | 64 | 3.44e-02 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 105 | 219 | 3.48e-02 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 95 | 196 | 3.55e-02 |
| GO:BP | GO:0098661 | inorganic anion transmembrane transport | 35 | 62 | 3.59e-02 |
| GO:BP | GO:0048339 | paraxial mesoderm development | 12 | 16 | 3.61e-02 |
| GO:BP | GO:0006817 | phosphate ion transport | 12 | 16 | 3.61e-02 |
| GO:BP | GO:0001964 | startle response | 12 | 16 | 3.61e-02 |
| GO:BP | GO:0071474 | cellular hyperosmotic response | 12 | 16 | 3.61e-02 |
| GO:BP | GO:0050954 | sensory perception of mechanical stimulus | 57 | 110 | 3.67e-02 |
| GO:BP | GO:0097530 | granulocyte migration | 34 | 60 | 3.73e-02 |
| GO:BP | GO:0042303 | molting cycle | 41 | 75 | 3.76e-02 |
| GO:BP | GO:0042633 | hair cycle | 41 | 75 | 3.76e-02 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 804 | 1934 | 3.91e-02 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 46 | 86 | 3.92e-02 |
| GO:BP | GO:0030308 | negative regulation of cell growth | 72 | 144 | 3.94e-02 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 209 | 466 | 3.95e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 68 | 135 | 3.98e-02 |
| GO:BP | GO:0006996 | organelle organization | 1154 | 2815 | 4.01e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 89 | 183 | 4.08e-02 |
| GO:BP | GO:0002366 | leukocyte activation involved in immune response | 75 | 151 | 4.09e-02 |
| GO:BP | GO:0001503 | ossification | 140 | 302 | 4.11e-02 |
| GO:BP | GO:0003228 | atrial cardiac muscle tissue development | 13 | 18 | 4.12e-02 |
| GO:BP | GO:0051968 | positive regulation of synaptic transmission, glutamatergic | 13 | 18 | 4.12e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 13 | 18 | 4.12e-02 |
| GO:BP | GO:0090277 | positive regulation of peptide hormone secretion | 39 | 71 | 4.12e-02 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 31 | 54 | 4.16e-02 |
| GO:BP | GO:0050848 | regulation of calcium-mediated signaling | 31 | 54 | 4.16e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 67 | 133 | 4.18e-02 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 683 | 1633 | 4.22e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 38 | 69 | 4.31e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 810 | 1951 | 4.33e-02 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 29 | 50 | 4.46e-02 |
| GO:BP | GO:0002011 | morphogenesis of an epithelial sheet | 29 | 50 | 4.46e-02 |
| GO:BP | GO:0035864 | response to potassium ion | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0022404 | molting cycle process | 37 | 67 | 4.49e-02 |
| GO:BP | GO:0042745 | circadian sleep/wake cycle | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0060033 | anatomical structure regression | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0038083 | peptidyl-tyrosine autophosphorylation | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0022405 | hair cycle process | 37 | 67 | 4.49e-02 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 37 | 67 | 4.49e-02 |
| GO:BP | GO:0035435 | phosphate ion transmembrane transport | 9 | 11 | 4.49e-02 |
| GO:BP | GO:0035024 | negative regulation of Rho protein signal transduction | 14 | 20 | 4.49e-02 |
| GO:BP | GO:0032102 | negative regulation of response to external stimulus | 118 | 251 | 4.49e-02 |
| GO:BP | GO:0031281 | positive regulation of cyclase activity | 14 | 20 | 4.49e-02 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 14 | 20 | 4.49e-02 |
| GO:BP | GO:0097028 | dendritic cell differentiation | 14 | 20 | 4.49e-02 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 53 | 102 | 4.49e-02 |
| GO:BP | GO:0008104 | protein localization | 829 | 2000 | 4.63e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 36 | 65 | 4.67e-02 |
| GO:BP | GO:0001942 | hair follicle development | 36 | 65 | 4.67e-02 |
| GO:BP | GO:1990266 | neutrophil migration | 27 | 46 | 4.69e-02 |
| GO:BP | GO:0003407 | neural retina development | 27 | 46 | 4.69e-02 |
| GO:BP | GO:0035019 | somatic stem cell population maintenance | 27 | 46 | 4.69e-02 |
| GO:BP | GO:0030282 | bone mineralization | 42 | 78 | 4.70e-02 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 52 | 100 | 4.71e-02 |
| GO:BP | GO:0048144 | fibroblast proliferation | 47 | 89 | 4.77e-02 |
| GO:BP | GO:0003382 | epithelial cell morphogenesis | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0099558 | maintenance of synapse structure | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0009119 | ribonucleoside metabolic process | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0002021 | response to dietary excess | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0097205 | renal filtration | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0051497 | negative regulation of stress fiber assembly | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0032768 | regulation of monooxygenase activity | 15 | 22 | 4.77e-02 |
| GO:BP | GO:0045123 | cellular extravasation | 25 | 42 | 4.93e-02 |
| GO:BP | GO:0043588 | skin development | 85 | 175 | 4.95e-02 |
| GO:BP | GO:0032292 | peripheral nervous system axon ensheathment | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0022011 | myelination in peripheral nervous system | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0098868 | bone growth | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0035640 | exploration behavior | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0045923 | positive regulation of fatty acid metabolic process | 16 | 24 | 4.99e-02 |
| GO:BP | GO:0046660 | female sex differentiation | 46 | 87 | 4.99e-02 |
ESRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR nESRgenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:05200 | Pathways in cancer | 220 | 391 | 3.79e-10 |
| KEGG | KEGG:04510 | Focal adhesion | 110 | 169 | 6.04e-10 |
| KEGG | KEGG:04360 | Axon guidance | 102 | 155 | 9.14e-10 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 104 | 162 | 3.23e-09 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 104 | 162 | 3.23e-09 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 103 | 161 | 4.51e-09 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 92 | 147 | 2.07e-07 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 57 | 82 | 7.24e-07 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 83 | 133 | 9.98e-07 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 81 | 129 | 9.98e-07 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 52 | 74 | 1.26e-06 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 78 | 124 | 1.31e-06 |
| KEGG | KEGG:04611 | Platelet activation | 59 | 88 | 1.97e-06 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 52 | 75 | 2.01e-06 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 71 | 113 | 4.48e-06 |
| KEGG | KEGG:04911 | Insulin secretion | 44 | 62 | 6.12e-06 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 52 | 77 | 6.27e-06 |
| KEGG | KEGG:04713 | Circadian entrainment | 47 | 68 | 7.60e-06 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 49 | 72 | 8.57e-06 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 66 | 105 | 8.79e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 97 | 169 | 1.09e-05 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 135 | 250 | 1.09e-05 |
| KEGG | KEGG:04014 | Ras signaling pathway | 94 | 164 | 1.64e-05 |
| KEGG | KEGG:04520 | Adherens junction | 54 | 83 | 1.64e-05 |
| KEGG | KEGG:04934 | Cushing syndrome | 72 | 119 | 1.74e-05 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 45 | 66 | 1.74e-05 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 34 | 46 | 1.82e-05 |
| KEGG | KEGG:04924 | Renin secretion | 36 | 50 | 2.37e-05 |
| KEGG | KEGG:04725 | Cholinergic synapse | 53 | 82 | 2.37e-05 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 58 | 92 | 2.48e-05 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 76 | 129 | 3.19e-05 |
| KEGG | KEGG:04726 | Serotonergic synapse | 40 | 58 | 3.43e-05 |
| KEGG | KEGG:04971 | Gastric acid secretion | 36 | 51 | 4.44e-05 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 123 | 231 | 5.42e-05 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 64 | 107 | 8.47e-05 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 59 | 97 | 8.81e-05 |
| KEGG | KEGG:04970 | Salivary secretion | 37 | 54 | 8.81e-05 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 38 | 56 | 9.27e-05 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 89 | 160 | 1.00e-04 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 48 | 76 | 1.29e-04 |
| KEGG | KEGG:04972 | Pancreatic secretion | 38 | 57 | 1.62e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 43 | 67 | 1.91e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 69 | 120 | 2.02e-04 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 77 | 137 | 2.09e-04 |
| KEGG | KEGG:04730 | Long-term depression | 28 | 39 | 2.35e-04 |
| KEGG | KEGG:05032 | Morphine addiction | 36 | 54 | 2.38e-04 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 80 | 144 | 2.41e-04 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 59 | 100 | 2.44e-04 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 54 | 90 | 2.66e-04 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 129 | 252 | 2.74e-04 |
| KEGG | KEGG:04530 | Tight junction | 72 | 129 | 4.34e-04 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 28 | 40 | 4.34e-04 |
| KEGG | KEGG:04929 | GnRH secretion | 33 | 50 | 5.97e-04 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 47 | 78 | 6.40e-04 |
| KEGG | KEGG:00000 | KEGG root term | 2218 | 5451 | 6.40e-04 |
| KEGG | KEGG:05146 | Amoebiasis | 39 | 62 | 6.54e-04 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 59 | 104 | 9.62e-04 |
| KEGG | KEGG:04916 | Melanogenesis | 45 | 75 | 9.76e-04 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 55 | 96 | 1.08e-03 |
| KEGG | KEGG:05226 | Gastric cancer | 63 | 113 | 1.10e-03 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 50 | 86 | 1.24e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 50 | 87 | 1.79e-03 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 44 | 75 | 2.11e-03 |
| KEGG | KEGG:05224 | Breast cancer | 62 | 113 | 2.11e-03 |
| KEGG | KEGG:04540 | Gap junction | 42 | 71 | 2.19e-03 |
| KEGG | KEGG:04976 | Bile secretion | 27 | 41 | 2.20e-03 |
| KEGG | KEGG:05031 | Amphetamine addiction | 29 | 45 | 2.31e-03 |
| KEGG | KEGG:04370 | VEGF signaling pathway | 30 | 47 | 2.32e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 32 | 51 | 2.34e-03 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 45 | 78 | 2.78e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 43 | 74 | 2.93e-03 |
| KEGG | KEGG:04814 | Motor proteins | 74 | 141 | 3.18e-03 |
| KEGG | KEGG:04740 | Olfactory transduction | 18 | 25 | 3.81e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 58 | 107 | 4.07e-03 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 43 | 75 | 4.07e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 42 | 73 | 4.17e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 55 | 101 | 4.58e-03 |
| KEGG | KEGG:05214 | Glioma | 38 | 65 | 4.65e-03 |
| KEGG | KEGG:01522 | Endocrine resistance | 46 | 82 | 4.92e-03 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 30 | 49 | 5.35e-03 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 26 | 41 | 5.35e-03 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 41 | 72 | 5.84e-03 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 60 | 113 | 5.93e-03 |
| KEGG | KEGG:05017 | Spinocerebellar ataxia | 63 | 120 | 6.55e-03 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 35 | 60 | 6.92e-03 |
| KEGG | KEGG:04060 | Cytokine-cytokine receptor interaction | 51 | 94 | 6.92e-03 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 50 | 92 | 7.13e-03 |
| KEGG | KEGG:05131 | Shigellosis | 100 | 204 | 7.30e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 49 | 90 | 7.33e-03 |
| KEGG | KEGG:05030 | Cocaine addiction | 21 | 32 | 7.56e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 44 | 80 | 9.20e-03 |
| KEGG | KEGG:04931 | Insulin resistance | 49 | 91 | 9.54e-03 |
| KEGG | KEGG:00052 | Galactose metabolism | 15 | 21 | 9.54e-03 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 63 | 122 | 9.88e-03 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 57 | 109 | 1.06e-02 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 31 | 53 | 1.06e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 45 | 83 | 1.13e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 44 | 81 | 1.18e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 22 | 35 | 1.20e-02 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 67 | 132 | 1.20e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 53 | 101 | 1.25e-02 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 74 | 149 | 1.49e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 44 | 82 | 1.49e-02 |
| KEGG | KEGG:04727 | GABAergic synapse | 30 | 52 | 1.49e-02 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 38 | 69 | 1.49e-02 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 65 | 129 | 1.61e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 56 | 109 | 1.67e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 67 | 134 | 1.75e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 17 | 26 | 1.75e-02 |
| KEGG | KEGG:00051 | Fructose and mannose metabolism | 17 | 26 | 1.75e-02 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 40 | 74 | 1.75e-02 |
| KEGG | KEGG:05142 | Chagas disease | 39 | 72 | 1.82e-02 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 53 | 103 | 1.88e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 28 | 49 | 2.18e-02 |
| KEGG | KEGG:05223 | Non-small cell lung cancer | 35 | 64 | 2.19e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 38 | 71 | 2.51e-02 |
| KEGG | KEGG:05230 | Central carbon metabolism in cancer | 32 | 58 | 2.51e-02 |
| KEGG | KEGG:05218 | Melanoma | 31 | 56 | 2.62e-02 |
| KEGG | KEGG:05219 | Bladder cancer | 21 | 35 | 2.64e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 79 | 164 | 2.64e-02 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 18 | 29 | 2.74e-02 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 16 | 25 | 2.74e-02 |
| KEGG | KEGG:04614 | Renin-angiotensin system | 8 | 10 | 2.84e-02 |
| KEGG | KEGG:05033 | Nicotine addiction | 8 | 10 | 2.84e-02 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 24 | 42 | 3.44e-02 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 69 | 143 | 3.71e-02 |
| KEGG | KEGG:05034 | Alcoholism | 51 | 102 | 3.86e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 33 | 62 | 4.07e-02 |
| KEGG | KEGG:04613 | Neutrophil extracellular trap formation | 45 | 89 | 4.33e-02 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 15 | 24 | 4.35e-02 |
# ESR_resgenes_20k_enh <- gost(query = unique(ESR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(ESR_resgenes_20k_enh,"data/GO_KEGG_analysis/ESR_resgenes_20k_enh.RDS")
# ESRnom <- gostplot(ESR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# ESRnom
ESRnomtable_20k_enh <- ESR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
ESRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in ESR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 623 | 4504 | 2.35e-19 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 318 | 1924 | 1.69e-17 |
| GO:BP | GO:0030154 | cell differentiation | 415 | 2803 | 1.63e-15 |
| GO:BP | GO:0048856 | anatomical structure development | 536 | 3867 | 1.63e-15 |
| GO:BP | GO:0048869 | cellular developmental process | 415 | 2804 | 1.63e-15 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 299 | 1844 | 2.56e-15 |
| GO:BP | GO:0032502 | developmental process | 567 | 4179 | 4.03e-15 |
| GO:BP | GO:0007154 | cell communication | 533 | 3983 | 2.17e-12 |
| GO:BP | GO:0050896 | response to stimulus | 680 | 5379 | 3.74e-12 |
| GO:BP | GO:0072359 | circulatory system development | 161 | 864 | 4.11e-12 |
| GO:BP | GO:0048731 | system development | 389 | 2719 | 5.72e-12 |
| GO:BP | GO:0007275 | multicellular organism development | 440 | 3170 | 5.72e-12 |
| GO:BP | GO:0023052 | signaling | 523 | 3918 | 5.72e-12 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 156 | 837 | 8.14e-12 |
| GO:BP | GO:0050789 | regulation of biological process | 891 | 7516 | 9.21e-12 |
| GO:BP | GO:0003013 | circulatory system process | 96 | 426 | 1.43e-11 |
| GO:BP | GO:0008015 | blood circulation | 85 | 357 | 1.64e-11 |
| GO:BP | GO:0065007 | biological regulation | 908 | 7734 | 5.15e-11 |
| GO:BP | GO:0003008 | system process | 193 | 1139 | 5.57e-11 |
| GO:BP | GO:0007165 | signal transduction | 483 | 3611 | 6.96e-11 |
| GO:BP | GO:0030029 | actin filament-based process | 125 | 640 | 9.97e-11 |
| GO:BP | GO:0050793 | regulation of developmental process | 260 | 1697 | 2.48e-10 |
| GO:BP | GO:0061061 | muscle structure development | 109 | 536 | 2.48e-10 |
| GO:BP | GO:0048468 | cell development | 282 | 1886 | 3.66e-10 |
| GO:BP | GO:0060047 | heart contraction | 54 | 194 | 9.51e-10 |
| GO:BP | GO:0051716 | cellular response to stimulus | 587 | 4640 | 1.20e-09 |
| GO:BP | GO:0050794 | regulation of cellular process | 842 | 7153 | 2.34e-09 |
| GO:BP | GO:0048518 | positive regulation of biological process | 547 | 4301 | 5.59e-09 |
| GO:BP | GO:0003015 | heart process | 54 | 204 | 6.73e-09 |
| GO:BP | GO:0009888 | tissue development | 211 | 1348 | 6.73e-09 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 192 | 1197 | 7.02e-09 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 508 | 3954 | 9.71e-09 |
| GO:BP | GO:0048519 | negative regulation of biological process | 487 | 3764 | 1.11e-08 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 170 | 1035 | 1.58e-08 |
| GO:BP | GO:0008016 | regulation of heart contraction | 46 | 165 | 2.64e-08 |
| GO:BP | GO:0016477 | cell migration | 165 | 1011 | 4.95e-08 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 106 | 566 | 5.58e-08 |
| GO:BP | GO:0003012 | muscle system process | 71 | 325 | 6.70e-08 |
| GO:BP | GO:0035239 | tube morphogenesis | 115 | 638 | 9.94e-08 |
| GO:BP | GO:0040011 | locomotion | 137 | 805 | 1.11e-07 |
| GO:BP | GO:0042692 | muscle cell differentiation | 70 | 323 | 1.17e-07 |
| GO:BP | GO:2000145 | regulation of cell motility | 123 | 700 | 1.17e-07 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 457 | 3550 | 1.22e-07 |
| GO:BP | GO:0044057 | regulation of system process | 79 | 384 | 1.22e-07 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 259 | 1801 | 1.39e-07 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 91 | 469 | 1.39e-07 |
| GO:BP | GO:0035295 | tube development | 134 | 787 | 1.44e-07 |
| GO:BP | GO:0055001 | muscle cell development | 44 | 163 | 1.50e-07 |
| GO:BP | GO:0040012 | regulation of locomotion | 125 | 720 | 1.56e-07 |
| GO:BP | GO:0030334 | regulation of cell migration | 118 | 668 | 1.62e-07 |
| GO:BP | GO:1903522 | regulation of blood circulation | 49 | 194 | 1.90e-07 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 55 | 234 | 3.18e-07 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 109 | 609 | 3.24e-07 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 87 | 450 | 3.38e-07 |
| GO:BP | GO:0030048 | actin filament-based movement | 33 | 107 | 4.41e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 197 | 1306 | 4.49e-07 |
| GO:BP | GO:0001568 | blood vessel development | 97 | 525 | 4.54e-07 |
| GO:BP | GO:0048870 | cell motility | 174 | 1120 | 4.71e-07 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 29 | 87 | 5.05e-07 |
| GO:BP | GO:0048513 | animal organ development | 279 | 2004 | 5.79e-07 |
| GO:BP | GO:0007507 | heart development | 93 | 499 | 5.79e-07 |
| GO:BP | GO:0001944 | vasculature development | 100 | 552 | 6.93e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 163 | 1040 | 7.78e-07 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 34 | 116 | 9.47e-07 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 121 | 717 | 1.26e-06 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 115 | 673 | 1.45e-06 |
| GO:BP | GO:0060537 | muscle tissue development | 69 | 339 | 1.53e-06 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 108 | 622 | 1.68e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 166 | 1077 | 1.71e-06 |
| GO:BP | GO:0007155 | cell adhesion | 149 | 941 | 1.73e-06 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 150 | 951 | 1.98e-06 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 165 | 1073 | 2.15e-06 |
| GO:BP | GO:0006936 | muscle contraction | 56 | 255 | 2.18e-06 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 356 | 2717 | 2.43e-06 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 92 | 508 | 2.45e-06 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 69 | 344 | 2.50e-06 |
| GO:BP | GO:0000902 | cell morphogenesis | 119 | 713 | 2.72e-06 |
| GO:BP | GO:0014706 | striated muscle tissue development | 49 | 213 | 3.34e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 47 | 201 | 3.68e-06 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 54 | 248 | 4.82e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 116 | 706 | 9.39e-06 |
| GO:BP | GO:0006941 | striated muscle contraction | 37 | 146 | 1.14e-05 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 106 | 633 | 1.29e-05 |
| GO:BP | GO:0023051 | regulation of signaling | 320 | 2438 | 1.32e-05 |
| GO:BP | GO:0001525 | angiogenesis | 72 | 381 | 1.38e-05 |
| GO:BP | GO:0065009 | regulation of molecular function | 188 | 1299 | 1.64e-05 |
| GO:BP | GO:0010646 | regulation of cell communication | 320 | 2444 | 1.64e-05 |
| GO:BP | GO:0003007 | heart morphogenesis | 48 | 218 | 1.70e-05 |
| GO:BP | GO:0090130 | tissue migration | 52 | 247 | 2.38e-05 |
| GO:BP | GO:0070848 | response to growth factor | 93 | 547 | 3.56e-05 |
| GO:BP | GO:0002027 | regulation of heart rate | 25 | 83 | 3.56e-05 |
| GO:BP | GO:0098657 | import into cell | 102 | 622 | 5.64e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 25 | 85 | 5.74e-05 |
| GO:BP | GO:0065008 | regulation of biological quality | 254 | 1893 | 6.06e-05 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 78 | 442 | 6.81e-05 |
| GO:BP | GO:0009605 | response to external stimulus | 215 | 1559 | 7.27e-05 |
| GO:BP | GO:0090132 | epithelium migration | 50 | 243 | 7.54e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 50 | 243 | 7.54e-05 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 97 | 588 | 7.57e-05 |
| GO:BP | GO:0031032 | actomyosin structure organization | 41 | 184 | 8.32e-05 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 89 | 528 | 8.37e-05 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 137 | 913 | 1.13e-04 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 82 | 479 | 1.17e-04 |
| GO:BP | GO:0048568 | embryonic organ development | 58 | 303 | 1.20e-04 |
| GO:BP | GO:0042221 | response to chemical | 298 | 2304 | 1.33e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 41 | 188 | 1.41e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 78 | 452 | 1.48e-04 |
| GO:BP | GO:0009966 | regulation of signal transduction | 282 | 2166 | 1.54e-04 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 108 | 685 | 1.54e-04 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 16 | 43 | 1.64e-04 |
| GO:BP | GO:0003205 | cardiac chamber development | 35 | 151 | 1.76e-04 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 300 | 2333 | 1.91e-04 |
| GO:BP | GO:0003231 | cardiac ventricle development | 29 | 115 | 2.10e-04 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 123 | 811 | 2.13e-04 |
| GO:BP | GO:0007517 | muscle organ development | 52 | 267 | 2.20e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 181 | 1297 | 2.45e-04 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 28 | 110 | 2.45e-04 |
| GO:BP | GO:0035556 | intracellular signal transduction | 256 | 1951 | 2.67e-04 |
| GO:BP | GO:0048729 | tissue morphogenesis | 77 | 453 | 2.78e-04 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 71 | 408 | 2.81e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 19 | 60 | 2.85e-04 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 233 | 1751 | 2.86e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 72 | 416 | 2.87e-04 |
| GO:BP | GO:0030239 | myofibril assembly | 20 | 66 | 3.35e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 19 | 61 | 3.63e-04 |
| GO:BP | GO:0007010 | cytoskeleton organization | 162 | 1146 | 3.76e-04 |
| GO:BP | GO:0014888 | striated muscle adaptation | 15 | 41 | 3.76e-04 |
| GO:BP | GO:0090257 | regulation of muscle system process | 38 | 177 | 4.07e-04 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 94 | 591 | 4.20e-04 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 329 | 2622 | 4.43e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 112 | 736 | 4.49e-04 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 181 | 1314 | 4.90e-04 |
| GO:BP | GO:0055002 | striated muscle cell development | 20 | 68 | 5.16e-04 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 68 | 395 | 5.83e-04 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 40 | 194 | 6.23e-04 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 19 | 64 | 7.16e-04 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 19 | 64 | 7.16e-04 |
| GO:BP | GO:0070482 | response to oxygen levels | 50 | 265 | 7.16e-04 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 107 | 704 | 7.20e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 56 | 309 | 7.42e-04 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 304 | 2415 | 8.12e-04 |
| GO:BP | GO:1901342 | regulation of vasculature development | 40 | 198 | 9.82e-04 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 153 | 1093 | 1.06e-03 |
| GO:BP | GO:0043500 | muscle adaptation | 23 | 89 | 1.10e-03 |
| GO:BP | GO:0006915 | apoptotic process | 186 | 1377 | 1.10e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 29 | 126 | 1.10e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 20 | 72 | 1.19e-03 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 18 | 61 | 1.23e-03 |
| GO:BP | GO:0022008 | neurogenesis | 171 | 1251 | 1.24e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 66 | 390 | 1.24e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 46 | 243 | 1.30e-03 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 39 | 194 | 1.31e-03 |
| GO:BP | GO:0048589 | developmental growth | 80 | 501 | 1.50e-03 |
| GO:BP | GO:0010033 | response to organic substance | 226 | 1736 | 1.50e-03 |
| GO:BP | GO:0014902 | myotube differentiation | 22 | 85 | 1.51e-03 |
| GO:BP | GO:0071260 | cellular response to mechanical stimulus | 17 | 57 | 1.68e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 239 | 1856 | 1.76e-03 |
| GO:BP | GO:0007015 | actin filament organization | 61 | 357 | 1.77e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 18 | 63 | 1.86e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 116 | 796 | 1.86e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 10 | 23 | 1.89e-03 |
| GO:BP | GO:0042092 | type 2 immune response | 9 | 19 | 2.02e-03 |
| GO:BP | GO:0014074 | response to purine-containing compound | 25 | 106 | 2.31e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 25 | 106 | 2.31e-03 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 181 | 1354 | 2.33e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 38 | 193 | 2.44e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 45 | 243 | 2.51e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 236 | 1841 | 2.52e-03 |
| GO:BP | GO:0012501 | programmed cell death | 188 | 1419 | 2.69e-03 |
| GO:BP | GO:0009790 | embryo development | 118 | 821 | 2.76e-03 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 212 | 1633 | 2.99e-03 |
| GO:BP | GO:0034330 | cell junction organization | 84 | 545 | 3.09e-03 |
| GO:BP | GO:0008219 | cell death | 188 | 1423 | 3.09e-03 |
| GO:BP | GO:0009725 | response to hormone | 92 | 610 | 3.16e-03 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 11 | 29 | 3.26e-03 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 18 | 66 | 3.30e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 43 | 232 | 3.37e-03 |
| GO:BP | GO:0035272 | exocrine system development | 12 | 34 | 3.45e-03 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 161 | 1193 | 3.63e-03 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 237 | 1862 | 3.63e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 229 | 1791 | 3.67e-03 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 68 | 422 | 3.73e-03 |
| GO:BP | GO:0032879 | regulation of localization | 189 | 1439 | 3.87e-03 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 10 | 25 | 3.87e-03 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 18 | 67 | 3.87e-03 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 18 | 67 | 3.87e-03 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 135 | 973 | 3.94e-03 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 146 | 1067 | 3.95e-03 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 165 | 1231 | 3.96e-03 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 134 | 965 | 3.96e-03 |
| GO:BP | GO:0048699 | generation of neurons | 147 | 1076 | 3.96e-03 |
| GO:BP | GO:0051960 | regulation of nervous system development | 57 | 339 | 4.09e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 36 | 185 | 4.21e-03 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 72 | 456 | 4.22e-03 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 165 | 1234 | 4.34e-03 |
| GO:BP | GO:0086091 | regulation of heart rate by cardiac conduction | 12 | 35 | 4.34e-03 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 69 | 433 | 4.34e-03 |
| GO:BP | GO:0023057 | negative regulation of signaling | 142 | 1036 | 4.34e-03 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 156 | 1157 | 4.46e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 86 | 570 | 4.67e-03 |
| GO:BP | GO:0051049 | regulation of transport | 149 | 1098 | 4.67e-03 |
| GO:BP | GO:0007399 | nervous system development | 226 | 1775 | 4.81e-03 |
| GO:BP | GO:0007267 | cell-cell signaling | 147 | 1082 | 4.88e-03 |
| GO:BP | GO:0032944 | regulation of mononuclear cell proliferation | 26 | 119 | 5.19e-03 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 20 | 81 | 5.26e-03 |
| GO:BP | GO:0030001 | metal ion transport | 80 | 524 | 5.27e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 19 | 75 | 5.28e-03 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 50 | 290 | 5.28e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 51 | 298 | 5.43e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 47 | 268 | 5.43e-03 |
| GO:BP | GO:0043542 | endothelial cell migration | 34 | 174 | 5.43e-03 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 141 | 1034 | 5.43e-03 |
| GO:BP | GO:0038084 | vascular endothelial growth factor signaling pathway | 12 | 36 | 5.43e-03 |
| GO:BP | GO:0040007 | growth | 101 | 697 | 5.54e-03 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 24 | 107 | 5.74e-03 |
| GO:BP | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential | 6 | 10 | 5.82e-03 |
| GO:BP | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance | 6 | 10 | 5.82e-03 |
| GO:BP | GO:0036363 | transforming growth factor beta activation | 6 | 10 | 5.82e-03 |
| GO:BP | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance | 6 | 10 | 5.82e-03 |
| GO:BP | GO:0045064 | T-helper 2 cell differentiation | 6 | 10 | 5.82e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 27 | 127 | 5.83e-03 |
| GO:BP | GO:0099625 | ventricular cardiac muscle cell membrane repolarization | 9 | 22 | 5.97e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 261 | 2100 | 6.08e-03 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 51 | 300 | 6.08e-03 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 77 | 504 | 6.28e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 138 | 1014 | 6.61e-03 |
| GO:BP | GO:1990573 | potassium ion import across plasma membrane | 10 | 27 | 6.76e-03 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 270 | 2186 | 6.85e-03 |
| GO:BP | GO:0048846 | axon extension involved in axon guidance | 11 | 32 | 6.94e-03 |
| GO:BP | GO:1902284 | neuron projection extension involved in neuron projection guidance | 11 | 32 | 6.94e-03 |
| GO:BP | GO:0098739 | import across plasma membrane | 26 | 122 | 7.02e-03 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 28 | 136 | 7.51e-03 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 45 | 258 | 7.63e-03 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 15 | 54 | 7.78e-03 |
| GO:BP | GO:0006897 | endocytosis | 75 | 492 | 7.79e-03 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 19 | 78 | 8.05e-03 |
| GO:BP | GO:0070663 | regulation of leukocyte proliferation | 27 | 130 | 8.14e-03 |
| GO:BP | GO:0001817 | regulation of cytokine production | 68 | 437 | 8.20e-03 |
| GO:BP | GO:0030224 | monocyte differentiation | 9 | 23 | 8.26e-03 |
| GO:BP | GO:0002026 | regulation of the force of heart contraction | 9 | 23 | 8.26e-03 |
| GO:BP | GO:0045444 | fat cell differentiation | 34 | 179 | 8.34e-03 |
| GO:BP | GO:0048588 | developmental cell growth | 34 | 179 | 8.34e-03 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 12 | 38 | 8.48e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 123 | 893 | 8.49e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 110 | 783 | 8.49e-03 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 139 | 1031 | 8.77e-03 |
| GO:BP | GO:0048841 | regulation of axon extension involved in axon guidance | 10 | 28 | 8.79e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 42 | 238 | 8.82e-03 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 241 | 1934 | 8.82e-03 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 67 | 431 | 8.90e-03 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 15 | 55 | 9.02e-03 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 132 | 972 | 9.02e-03 |
| GO:BP | GO:0042592 | homeostatic process | 151 | 1137 | 9.32e-03 |
| GO:BP | GO:0003151 | outflow tract morphogenesis | 17 | 67 | 9.32e-03 |
| GO:BP | GO:0060976 | coronary vasculature development | 13 | 44 | 9.36e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 13 | 44 | 9.36e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 48 | 284 | 9.36e-03 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 26 | 125 | 9.36e-03 |
| GO:BP | GO:0043501 | skeletal muscle adaptation | 8 | 19 | 9.36e-03 |
| GO:BP | GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 13 | 44 | 9.36e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 38 | 210 | 9.66e-03 |
| GO:BP | GO:0001816 | cytokine production | 68 | 441 | 9.72e-03 |
| GO:BP | GO:0014733 | regulation of skeletal muscle adaptation | 6 | 11 | 9.75e-03 |
| GO:BP | GO:1902307 | positive regulation of sodium ion transmembrane transport | 6 | 11 | 9.75e-03 |
| GO:BP | GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 14 | 50 | 1.01e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 19 | 80 | 1.01e-02 |
| GO:BP | GO:0002828 | regulation of type 2 immune response | 7 | 15 | 1.02e-02 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 41 | 233 | 1.02e-02 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 50 | 301 | 1.03e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 15 | 56 | 1.04e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 21 | 93 | 1.04e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 16 | 62 | 1.06e-02 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 9 | 24 | 1.06e-02 |
| GO:BP | GO:0010586 | miRNA metabolic process | 20 | 87 | 1.10e-02 |
| GO:BP | GO:0007009 | plasma membrane organization | 23 | 107 | 1.18e-02 |
| GO:BP | GO:0014896 | muscle hypertrophy | 18 | 75 | 1.21e-02 |
| GO:BP | GO:0002376 | immune system process | 181 | 1410 | 1.23e-02 |
| GO:BP | GO:0048638 | regulation of developmental growth | 42 | 243 | 1.24e-02 |
| GO:BP | GO:0002286 | T cell activation involved in immune response | 15 | 57 | 1.24e-02 |
| GO:BP | GO:0016049 | cell growth | 60 | 382 | 1.24e-02 |
| GO:BP | GO:0050873 | brown fat cell differentiation | 12 | 40 | 1.25e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 141 | 1060 | 1.25e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 43 | 251 | 1.27e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 43 | 251 | 1.27e-02 |
| GO:BP | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 5 | 8 | 1.30e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 44 | 259 | 1.31e-02 |
| GO:BP | GO:0006935 | chemotaxis | 42 | 244 | 1.31e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 47 | 282 | 1.31e-02 |
| GO:BP | GO:0042330 | taxis | 42 | 244 | 1.31e-02 |
| GO:BP | GO:0006468 | protein phosphorylation | 129 | 958 | 1.31e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 21 | 95 | 1.32e-02 |
| GO:BP | GO:1901490 | regulation of lymphangiogenesis | 4 | 5 | 1.33e-02 |
| GO:BP | GO:0009987 | cellular process | 1129 | 10686 | 1.35e-02 |
| GO:BP | GO:0060485 | mesenchyme development | 42 | 245 | 1.38e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 17 | 70 | 1.38e-02 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 38 | 215 | 1.38e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 119 | 874 | 1.38e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 17 | 70 | 1.38e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 22 | 102 | 1.38e-02 |
| GO:BP | GO:0045321 | leukocyte activation | 78 | 530 | 1.39e-02 |
| GO:BP | GO:0030198 | extracellular matrix organization | 39 | 223 | 1.42e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 74 | 498 | 1.44e-02 |
| GO:BP | GO:0001843 | neural tube closure | 19 | 83 | 1.45e-02 |
| GO:BP | GO:0050670 | regulation of lymphocyte proliferation | 24 | 116 | 1.45e-02 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 40 | 231 | 1.47e-02 |
| GO:BP | GO:0045165 | cell fate commitment | 29 | 151 | 1.51e-02 |
| GO:BP | GO:0043062 | extracellular structure organization | 39 | 224 | 1.52e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 39 | 224 | 1.52e-02 |
| GO:BP | GO:0060419 | heart growth | 17 | 71 | 1.56e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 59 | 379 | 1.56e-02 |
| GO:BP | GO:1903038 | negative regulation of leukocyte cell-cell adhesion | 17 | 71 | 1.56e-02 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 59 | 379 | 1.56e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 38 | 217 | 1.56e-02 |
| GO:BP | GO:0070664 | negative regulation of leukocyte proliferation | 13 | 47 | 1.56e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 11 | 36 | 1.61e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 16 | 65 | 1.61e-02 |
| GO:BP | GO:0035148 | tube formation | 25 | 124 | 1.62e-02 |
| GO:BP | GO:0061564 | axon development | 58 | 372 | 1.62e-02 |
| GO:BP | GO:0060606 | tube closure | 19 | 84 | 1.62e-02 |
| GO:BP | GO:0014912 | negative regulation of smooth muscle cell migration | 8 | 21 | 1.70e-02 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 190 | 1504 | 1.71e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 73 | 494 | 1.72e-02 |
| GO:BP | GO:0040008 | regulation of growth | 69 | 462 | 1.76e-02 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 191 | 1514 | 1.76e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 24 | 118 | 1.76e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 26 | 132 | 1.78e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 33 | 182 | 1.78e-02 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 38 | 219 | 1.78e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 17 | 72 | 1.78e-02 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 21 | 98 | 1.79e-02 |
| GO:BP | GO:0001819 | positive regulation of cytokine production | 43 | 257 | 1.80e-02 |
| GO:BP | GO:0001570 | vasculogenesis | 16 | 66 | 1.83e-02 |
| GO:BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 16 | 66 | 1.83e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 13 | 48 | 1.83e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 22 | 105 | 1.84e-02 |
| GO:BP | GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 14 | 54 | 1.85e-02 |
| GO:BP | GO:0046323 | glucose import | 14 | 54 | 1.85e-02 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 34 | 190 | 1.85e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 30 | 161 | 1.86e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 11 | 37 | 1.93e-02 |
| GO:BP | GO:0021915 | neural tube development | 26 | 133 | 1.93e-02 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 17 | 73 | 2.00e-02 |
| GO:BP | GO:0030903 | notochord development | 7 | 17 | 2.00e-02 |
| GO:BP | GO:0010954 | positive regulation of protein processing | 7 | 17 | 2.00e-02 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 30 | 162 | 2.03e-02 |
| GO:BP | GO:0042129 | regulation of T cell proliferation | 19 | 86 | 2.03e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 86 | 606 | 2.03e-02 |
| GO:BP | GO:0007409 | axonogenesis | 53 | 337 | 2.03e-02 |
| GO:BP | GO:0002293 | alpha-beta T cell differentiation involved in immune response | 12 | 43 | 2.04e-02 |
| GO:BP | GO:0002287 | alpha-beta T cell activation involved in immune response | 12 | 43 | 2.04e-02 |
| GO:BP | GO:0042093 | T-helper cell differentiation | 12 | 43 | 2.04e-02 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 48 | 298 | 2.04e-02 |
| GO:BP | GO:0045214 | sarcomere organization | 12 | 43 | 2.04e-02 |
| GO:BP | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response | 12 | 43 | 2.04e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 16 | 67 | 2.04e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 24 | 120 | 2.06e-02 |
| GO:BP | GO:0043434 | response to peptide hormone | 50 | 314 | 2.07e-02 |
| GO:BP | GO:0035265 | organ growth | 25 | 127 | 2.07e-02 |
| GO:BP | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 5 | 9 | 2.12e-02 |
| GO:BP | GO:0007405 | neuroblast proliferation | 14 | 55 | 2.12e-02 |
| GO:BP | GO:1901388 | regulation of transforming growth factor beta activation | 5 | 9 | 2.12e-02 |
| GO:BP | GO:0032673 | regulation of interleukin-4 production | 6 | 13 | 2.19e-02 |
| GO:BP | GO:1903729 | regulation of plasma membrane organization | 6 | 13 | 2.19e-02 |
| GO:BP | GO:0032633 | interleukin-4 production | 6 | 13 | 2.19e-02 |
| GO:BP | GO:0048666 | neuron development | 113 | 838 | 2.21e-02 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 17 | 74 | 2.22e-02 |
| GO:BP | GO:0014020 | primary neural tube formation | 19 | 87 | 2.22e-02 |
| GO:BP | GO:0006811 | monoatomic ion transport | 99 | 719 | 2.24e-02 |
| GO:BP | GO:1901491 | negative regulation of lymphangiogenesis | 3 | 3 | 2.24e-02 |
| GO:BP | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential | 3 | 3 | 2.24e-02 |
| GO:BP | GO:0045760 | positive regulation of action potential | 3 | 3 | 2.24e-02 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 31 | 171 | 2.24e-02 |
| GO:BP | GO:0006949 | syncytium formation | 11 | 38 | 2.25e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 16 | 68 | 2.30e-02 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 54 | 348 | 2.32e-02 |
| GO:BP | GO:0001775 | cell activation | 88 | 627 | 2.32e-02 |
| GO:BP | GO:0032943 | mononuclear cell proliferation | 29 | 157 | 2.34e-02 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 40 | 239 | 2.35e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 87 | 619 | 2.35e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 93 | 670 | 2.39e-02 |
| GO:BP | GO:0097485 | neuron projection guidance | 31 | 172 | 2.41e-02 |
| GO:BP | GO:0007411 | axon guidance | 31 | 172 | 2.41e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 23 | 115 | 2.42e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 23 | 115 | 2.42e-02 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 72 | 495 | 2.42e-02 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 19 | 88 | 2.43e-02 |
| GO:BP | GO:0046631 | alpha-beta T cell activation | 19 | 88 | 2.43e-02 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 20 | 95 | 2.54e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 36 | 210 | 2.54e-02 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 75 | 521 | 2.54e-02 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 103 | 757 | 2.54e-02 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 36 | 210 | 2.54e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 46 | 287 | 2.57e-02 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 70 | 480 | 2.57e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 16 | 69 | 2.57e-02 |
| GO:BP | GO:0001508 | action potential | 21 | 102 | 2.57e-02 |
| GO:BP | GO:1903319 | positive regulation of protein maturation | 7 | 18 | 2.59e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 26 | 137 | 2.60e-02 |
| GO:BP | GO:0032868 | response to insulin | 35 | 203 | 2.61e-02 |
| GO:BP | GO:0009266 | response to temperature stimulus | 23 | 116 | 2.62e-02 |
| GO:BP | GO:0006812 | monoatomic cation transport | 86 | 614 | 2.63e-02 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 148 | 1150 | 2.63e-02 |
| GO:BP | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis | 4 | 6 | 2.66e-02 |
| GO:BP | GO:0048843 | negative regulation of axon extension involved in axon guidance | 8 | 23 | 2.67e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 237 | 1951 | 2.67e-02 |
| GO:BP | GO:0006950 | response to stress | 301 | 2540 | 2.67e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 8 | 23 | 2.67e-02 |
| GO:BP | GO:0009612 | response to mechanical stimulus | 28 | 152 | 2.71e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 28 | 152 | 2.71e-02 |
| GO:BP | GO:0002292 | T cell differentiation involved in immune response | 12 | 45 | 2.72e-02 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 23 | 117 | 2.87e-02 |
| GO:BP | GO:0072175 | epithelial tube formation | 23 | 117 | 2.87e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 34 | 197 | 2.88e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 89 | 642 | 2.90e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 57 | 377 | 2.90e-02 |
| GO:BP | GO:0016310 | phosphorylation | 147 | 1145 | 2.92e-02 |
| GO:BP | GO:0043114 | regulation of vascular permeability | 10 | 34 | 2.94e-02 |
| GO:BP | GO:0070661 | leukocyte proliferation | 31 | 175 | 2.94e-02 |
| GO:BP | GO:0050868 | negative regulation of T cell activation | 15 | 64 | 3.02e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 15 | 64 | 3.02e-02 |
| GO:BP | GO:0010885 | regulation of cholesterol storage | 6 | 14 | 3.03e-02 |
| GO:BP | GO:0050996 | positive regulation of lipid catabolic process | 6 | 14 | 3.03e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 54 | 354 | 3.06e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 32 | 183 | 3.06e-02 |
| GO:BP | GO:0046324 | regulation of glucose import | 11 | 40 | 3.11e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 23 | 118 | 3.11e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 14 | 58 | 3.11e-02 |
| GO:BP | GO:0071772 | response to BMP | 23 | 118 | 3.11e-02 |
| GO:BP | GO:0002521 | leukocyte differentiation | 56 | 371 | 3.19e-02 |
| GO:BP | GO:0001501 | skeletal system development | 53 | 347 | 3.21e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 518 | 4603 | 3.21e-02 |
| GO:BP | GO:0033275 | actin-myosin filament sliding | 5 | 10 | 3.22e-02 |
| GO:BP | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis | 5 | 10 | 3.22e-02 |
| GO:BP | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 5 | 10 | 3.22e-02 |
| GO:BP | GO:0010832 | negative regulation of myotube differentiation | 5 | 10 | 3.22e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 30 | 169 | 3.22e-02 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 218 | 1787 | 3.22e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 32 | 184 | 3.23e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 121 | 921 | 3.23e-02 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 32 | 184 | 3.23e-02 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 82 | 587 | 3.31e-02 |
| GO:BP | GO:0060429 | epithelium development | 106 | 792 | 3.31e-02 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 8 | 24 | 3.31e-02 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 42 | 261 | 3.31e-02 |
| GO:BP | GO:0014887 | cardiac muscle adaptation | 8 | 24 | 3.31e-02 |
| GO:BP | GO:0071398 | cellular response to fatty acid | 8 | 24 | 3.31e-02 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 42 | 261 | 3.31e-02 |
| GO:BP | GO:0014898 | cardiac muscle hypertrophy in response to stress | 8 | 24 | 3.31e-02 |
| GO:BP | GO:0003299 | muscle hypertrophy in response to stress | 8 | 24 | 3.31e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 17 | 78 | 3.33e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 27 | 148 | 3.43e-02 |
| GO:BP | GO:0070228 | regulation of lymphocyte apoptotic process | 10 | 35 | 3.46e-02 |
| GO:BP | GO:0050994 | regulation of lipid catabolic process | 10 | 35 | 3.46e-02 |
| GO:BP | GO:0060840 | artery development | 18 | 85 | 3.47e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 18 | 85 | 3.47e-02 |
| GO:BP | GO:0006816 | calcium ion transport | 42 | 262 | 3.51e-02 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 228 | 1883 | 3.52e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 16 | 72 | 3.53e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 44 | 278 | 3.53e-02 |
| GO:BP | GO:0001841 | neural tube formation | 19 | 92 | 3.53e-02 |
| GO:BP | GO:0098609 | cell-cell adhesion | 79 | 564 | 3.53e-02 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 19 | 92 | 3.53e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 16 | 72 | 3.53e-02 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 44 | 278 | 3.53e-02 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 21 | 106 | 3.62e-02 |
| GO:BP | GO:0030097 | hemopoiesis | 86 | 624 | 3.64e-02 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 140 | 1093 | 3.68e-02 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 17 | 79 | 3.70e-02 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 230 | 1904 | 3.70e-02 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 29 | 164 | 3.74e-02 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 154 | 1218 | 3.75e-02 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 50 | 327 | 3.80e-02 |
| GO:BP | GO:0014904 | myotube cell development | 9 | 30 | 3.80e-02 |
| GO:BP | GO:0006813 | potassium ion transport | 25 | 135 | 3.81e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 14 | 60 | 3.94e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 16 | 73 | 3.97e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 16 | 73 | 3.97e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 36 | 218 | 4.06e-02 |
| GO:BP | GO:0023056 | positive regulation of signaling | 154 | 1221 | 4.07e-02 |
| GO:BP | GO:0071320 | cellular response to cAMP | 10 | 36 | 4.09e-02 |
| GO:BP | GO:0042475 | odontogenesis of dentin-containing tooth | 13 | 54 | 4.09e-02 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 10 | 36 | 4.09e-02 |
| GO:BP | GO:0042130 | negative regulation of T cell proliferation | 10 | 36 | 4.09e-02 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 55 | 369 | 4.10e-02 |
| GO:BP | GO:0007435 | salivary gland morphogenesis | 8 | 25 | 4.11e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 43 | 273 | 4.13e-02 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 32 | 188 | 4.15e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 12 | 48 | 4.16e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 63 | 435 | 4.17e-02 |
| GO:BP | GO:0086009 | membrane repolarization | 11 | 42 | 4.17e-02 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 7 | 20 | 4.23e-02 |
| GO:BP | GO:0046651 | lymphocyte proliferation | 27 | 151 | 4.23e-02 |
| GO:BP | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus | 7 | 20 | 4.23e-02 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 23 | 122 | 4.23e-02 |
| GO:BP | GO:0030308 | negative regulation of cell growth | 26 | 144 | 4.35e-02 |
| GO:BP | GO:0042391 | regulation of membrane potential | 44 | 282 | 4.37e-02 |
| GO:BP | GO:0001823 | mesonephros development | 16 | 74 | 4.41e-02 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 9 | 31 | 4.51e-02 |
| GO:BP | GO:0045657 | positive regulation of monocyte differentiation | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0044351 | macropinocytosis | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0042060 | wound healing | 45 | 291 | 4.51e-02 |
| GO:BP | GO:1900373 | positive regulation of purine nucleotide biosynthetic process | 4 | 7 | 4.51e-02 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 23 | 123 | 4.51e-02 |
| GO:BP | GO:0010830 | regulation of myotube differentiation | 9 | 31 | 4.51e-02 |
| GO:BP | GO:1903351 | cellular response to dopamine | 9 | 31 | 4.51e-02 |
| GO:BP | GO:0002830 | positive regulation of type 2 immune response | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0032753 | positive regulation of interleukin-4 production | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 49 | 323 | 4.51e-02 |
| GO:BP | GO:0014883 | transition between fast and slow fiber | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 68 | 479 | 4.51e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 53 | 355 | 4.51e-02 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 9 | 31 | 4.51e-02 |
| GO:BP | GO:0045628 | regulation of T-helper 2 cell differentiation | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0030810 | positive regulation of nucleotide biosynthetic process | 4 | 7 | 4.51e-02 |
| GO:BP | GO:0071634 | regulation of transforming growth factor beta production | 9 | 31 | 4.51e-02 |
| GO:BP | GO:0008150 | biological_process | 1175 | 11244 | 4.51e-02 |
| GO:BP | GO:0099622 | cardiac muscle cell membrane repolarization | 9 | 31 | 4.51e-02 |
| GO:BP | GO:0030030 | cell projection organization | 149 | 1182 | 4.51e-02 |
| GO:BP | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis | 5 | 11 | 4.52e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 5 | 11 | 4.52e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 18 | 88 | 4.53e-02 |
| GO:BP | GO:0031175 | neuron projection development | 99 | 743 | 4.54e-02 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 15 | 68 | 4.56e-02 |
| GO:BP | GO:0009894 | regulation of catabolic process | 109 | 830 | 4.56e-02 |
| GO:BP | GO:0010232 | vascular transport | 15 | 68 | 4.56e-02 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 25 | 138 | 4.67e-02 |
| GO:BP | GO:0050672 | negative regulation of lymphocyte proliferation | 11 | 43 | 4.72e-02 |
| GO:BP | GO:0032945 | negative regulation of mononuclear cell proliferation | 11 | 43 | 4.72e-02 |
| GO:BP | GO:0051591 | response to cAMP | 14 | 62 | 4.90e-02 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 8 | 26 | 4.94e-02 |
| GO:BP | GO:0007431 | salivary gland development | 8 | 26 | 4.94e-02 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 8 | 26 | 4.94e-02 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 476 | 4233 | 4.98e-02 |
ESRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in ESR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 37 | 124 | 3.15e-07 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 37 | 129 | 5.30e-07 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 25 | 75 | 4.82e-06 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 26 | 82 | 6.21e-06 |
| KEGG | KEGG:05200 | Pathways in cancer | 73 | 391 | 1.30e-05 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 35 | 147 | 6.89e-05 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 22 | 77 | 2.45e-04 |
| KEGG | KEGG:04976 | Bile secretion | 15 | 41 | 2.45e-04 |
| KEGG | KEGG:04931 | Insulin resistance | 24 | 91 | 3.33e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 27 | 113 | 6.15e-04 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 34 | 161 | 7.81e-04 |
| KEGG | KEGG:04360 | Axon guidance | 33 | 155 | 7.81e-04 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 15 | 46 | 7.81e-04 |
| KEGG | KEGG:04725 | Cholinergic synapse | 21 | 82 | 1.14e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 24 | 100 | 1.14e-03 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 30 | 142 | 1.66e-03 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 33 | 164 | 1.93e-03 |
| KEGG | KEGG:04911 | Insulin secretion | 17 | 62 | 1.94e-03 |
| KEGG | KEGG:04971 | Gastric acid secretion | 15 | 51 | 1.95e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 19 | 78 | 3.91e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 25 | 119 | 5.26e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 20 | 87 | 5.63e-03 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 31 | 162 | 5.79e-03 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 16 | 63 | 5.98e-03 |
| KEGG | KEGG:04740 | Olfactory transduction | 9 | 25 | 6.49e-03 |
| KEGG | KEGG:04014 | Ras signaling pathway | 31 | 164 | 6.49e-03 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 13 | 47 | 7.20e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 20 | 90 | 7.20e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 22 | 104 | 7.64e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 30 | 160 | 7.77e-03 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 19 | 86 | 9.32e-03 |
| KEGG | KEGG:05030 | Cocaine addiction | 10 | 32 | 9.39e-03 |
| KEGG | KEGG:04713 | Circadian entrainment | 16 | 68 | 1.07e-02 |
| KEGG | KEGG:04520 | Adherens junction | 18 | 83 | 1.44e-02 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 20 | 97 | 1.51e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 17 | 78 | 1.71e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 11 | 41 | 1.75e-02 |
| KEGG | KEGG:04814 | Motor proteins | 26 | 141 | 1.75e-02 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 19 | 92 | 1.75e-02 |
| KEGG | KEGG:00000 | KEGG root term | 604 | 5451 | 1.96e-02 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 40 | 250 | 2.10e-02 |
| KEGG | KEGG:04916 | Melanogenesis | 16 | 75 | 2.48e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 8 | 26 | 2.51e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 19 | 96 | 2.53e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 16 | 76 | 2.66e-02 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 24 | 133 | 2.76e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 20 | 105 | 2.98e-02 |
| KEGG | KEGG:05031 | Amphetamine addiction | 11 | 45 | 3.12e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 21 | 113 | 3.13e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 15 | 72 | 3.48e-02 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 25 | 144 | 3.51e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 10 | 40 | 3.57e-02 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 13 | 60 | 4.01e-02 |
| KEGG | KEGG:05034 | Alcoholism | 19 | 102 | 4.02e-02 |
| KEGG | KEGG:04510 | Focal adhesion | 28 | 169 | 4.02e-02 |
| KEGG | KEGG:04970 | Salivary secretion | 12 | 54 | 4.08e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 12 | 54 | 4.08e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 13 | 62 | 4.79e-02 |
| KEGG | KEGG:05146 | Amoebiasis | 13 | 62 | 4.79e-02 |
| KEGG | KEGG:04721 | Synaptic vesicle cycle | 11 | 49 | 4.91e-02 |
# LR_resgenes_20k <- gost(query = LR_peak_list_20k$NCBI_gene,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes_20k,"data/GO_KEGG_analysis/LR_resgenes_20k.RDS")
# LRnom <- gostplot(LR_resgenes_20k, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable_20k <- LR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR nESRgenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0032501 | multicellular organismal process | 3113 | 4504 | 3.59e-52 |
| GO:BP | GO:0048856 | anatomical structure development | 2677 | 3867 | 1.51e-42 |
| GO:BP | GO:0007154 | cell communication | 2745 | 3983 | 1.40e-41 |
| GO:BP | GO:0048731 | system development | 1943 | 2719 | 1.98e-41 |
| GO:BP | GO:0007275 | multicellular organism development | 2230 | 3170 | 3.83e-41 |
| GO:BP | GO:0023052 | signaling | 2701 | 3918 | 4.65e-41 |
| GO:BP | GO:0032502 | developmental process | 2860 | 4179 | 3.33e-40 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1364 | 1844 | 4.80e-39 |
| GO:BP | GO:0050896 | response to stimulus | 3588 | 5379 | 6.06e-38 |
| GO:BP | GO:0007165 | signal transduction | 2490 | 3611 | 8.34e-37 |
| GO:BP | GO:0048869 | cellular developmental process | 1969 | 2804 | 2.62e-34 |
| GO:BP | GO:0030154 | cell differentiation | 1968 | 2803 | 2.96e-34 |
| GO:BP | GO:0051716 | cellular response to stimulus | 3116 | 4640 | 6.33e-34 |
| GO:BP | GO:0022008 | neurogenesis | 936 | 1251 | 2.61e-28 |
| GO:BP | GO:0007399 | nervous system development | 1281 | 1775 | 4.75e-28 |
| GO:BP | GO:0048468 | cell development | 1348 | 1886 | 1.13e-26 |
| GO:BP | GO:0048699 | generation of neurons | 813 | 1076 | 1.48e-26 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1372 | 1924 | 1.48e-26 |
| GO:BP | GO:0048513 | animal organ development | 1423 | 2004 | 2.19e-26 |
| GO:BP | GO:0050793 | regulation of developmental process | 1222 | 1697 | 5.77e-26 |
| GO:BP | GO:0050789 | regulation of biological process | 4805 | 7516 | 7.12e-26 |
| GO:BP | GO:0010646 | regulation of cell communication | 1703 | 2444 | 7.12e-26 |
| GO:BP | GO:0023051 | regulation of signaling | 1696 | 2438 | 3.60e-25 |
| GO:BP | GO:0031175 | neuron projection development | 581 | 743 | 7.99e-25 |
| GO:BP | GO:0030182 | neuron differentiation | 765 | 1014 | 1.34e-24 |
| GO:BP | GO:0000902 | cell morphogenesis | 558 | 713 | 6.08e-24 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1281 | 1801 | 7.47e-24 |
| GO:BP | GO:0065007 | biological regulation | 4917 | 7734 | 4.26e-23 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1863 | 2717 | 4.26e-23 |
| GO:BP | GO:0048666 | neuron development | 641 | 838 | 5.49e-23 |
| GO:BP | GO:0050794 | regulation of cellular process | 4571 | 7153 | 1.00e-22 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 849 | 1150 | 1.78e-22 |
| GO:BP | GO:0030030 | cell projection organization | 870 | 1182 | 2.04e-22 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 467 | 588 | 2.58e-22 |
| GO:BP | GO:0016477 | cell migration | 754 | 1011 | 8.34e-22 |
| GO:BP | GO:0003008 | system process | 839 | 1139 | 1.01e-21 |
| GO:BP | GO:0048870 | cell motility | 826 | 1120 | 1.28e-21 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 401 | 498 | 4.24e-21 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 387 | 479 | 7.70e-21 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2835 | 4301 | 1.16e-20 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 397 | 494 | 1.36e-20 |
| GO:BP | GO:0007155 | cell adhesion | 703 | 941 | 1.40e-20 |
| GO:BP | GO:0009888 | tissue development | 970 | 1348 | 6.24e-20 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2615 | 3954 | 1.22e-19 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1495 | 2166 | 1.94e-19 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 352 | 435 | 4.15e-19 |
| GO:BP | GO:0007267 | cell-cell signaling | 791 | 1082 | 7.20e-19 |
| GO:BP | GO:0072359 | circulatory system development | 643 | 864 | 5.38e-18 |
| GO:BP | GO:0065008 | regulation of biological quality | 1312 | 1893 | 1.27e-17 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 672 | 913 | 6.61e-17 |
| GO:BP | GO:0040012 | regulation of locomotion | 542 | 720 | 1.13e-16 |
| GO:BP | GO:0040011 | locomotion | 599 | 805 | 1.22e-16 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 620 | 837 | 1.58e-16 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 289 | 355 | 3.12e-16 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 394 | 505 | 3.15e-16 |
| GO:BP | GO:2000145 | regulation of cell motility | 527 | 700 | 3.18e-16 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 775 | 1073 | 3.30e-16 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 538 | 717 | 4.33e-16 |
| GO:BP | GO:0001568 | blood vessel development | 407 | 525 | 5.90e-16 |
| GO:BP | GO:0007409 | axonogenesis | 275 | 337 | 1.04e-15 |
| GO:BP | GO:0034330 | cell junction organization | 420 | 545 | 1.07e-15 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 400 | 516 | 1.13e-15 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1282 | 1862 | 1.20e-15 |
| GO:BP | GO:0061564 | axon development | 299 | 372 | 2.32e-15 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 928 | 1314 | 3.09e-15 |
| GO:BP | GO:0035295 | tube development | 582 | 787 | 3.09e-15 |
| GO:BP | GO:0030334 | regulation of cell migration | 502 | 668 | 3.42e-15 |
| GO:BP | GO:0001944 | vasculature development | 423 | 552 | 4.26e-15 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 505 | 673 | 4.36e-15 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 461 | 609 | 7.63e-15 |
| GO:BP | GO:0016043 | cellular component organization | 3100 | 4802 | 1.31e-14 |
| GO:BP | GO:0098657 | import into cell | 469 | 622 | 1.36e-14 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 688 | 951 | 1.53e-14 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2462 | 3764 | 2.92e-14 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 745 | 1040 | 3.41e-14 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2329 | 3550 | 4.09e-14 |
| GO:BP | GO:0035239 | tube morphogenesis | 478 | 638 | 4.76e-14 |
| GO:BP | GO:0009987 | cellular process | 6567 | 10686 | 4.76e-14 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 446 | 591 | 5.80e-14 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1327 | 1951 | 1.46e-13 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 739 | 1035 | 1.48e-13 |
| GO:BP | GO:0008150 | biological_process | 6876 | 11244 | 1.86e-13 |
| GO:BP | GO:0051179 | localization | 2435 | 3731 | 2.34e-13 |
| GO:BP | GO:0030029 | actin filament-based process | 477 | 640 | 2.39e-13 |
| GO:BP | GO:0006810 | transport | 1970 | 2984 | 6.81e-13 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 841 | 1197 | 8.01e-13 |
| GO:BP | GO:0003013 | circulatory system process | 329 | 426 | 2.06e-12 |
| GO:BP | GO:0006897 | endocytosis | 374 | 492 | 2.20e-12 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 461 | 622 | 3.50e-12 |
| GO:BP | GO:0032879 | regulation of localization | 992 | 1439 | 6.88e-12 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 422 | 566 | 9.42e-12 |
| GO:BP | GO:0042221 | response to chemical | 1538 | 2304 | 1.01e-11 |
| GO:BP | GO:0048589 | developmental growth | 378 | 501 | 1.05e-11 |
| GO:BP | GO:0044057 | regulation of system process | 298 | 384 | 1.16e-11 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 343 | 450 | 1.37e-11 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1188 | 1751 | 1.89e-11 |
| GO:BP | GO:0007010 | cytoskeleton organization | 801 | 1146 | 2.34e-11 |
| GO:BP | GO:0051234 | establishment of localization | 2116 | 3240 | 3.48e-11 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 381 | 508 | 3.54e-11 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 345 | 456 | 6.53e-11 |
| GO:BP | GO:0051049 | regulation of transport | 767 | 1098 | 9.69e-11 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 190 | 233 | 1.07e-10 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 605 | 850 | 1.61e-10 |
| GO:BP | GO:0023056 | positive regulation of signaling | 845 | 1221 | 1.61e-10 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 843 | 1218 | 1.65e-10 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 298 | 390 | 3.17e-10 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 461 | 633 | 3.42e-10 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 3176 | 4988 | 3.83e-10 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 333 | 442 | 3.99e-10 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 798 | 1152 | 5.19e-10 |
| GO:BP | GO:0071310 | cellular response to organic substance | 889 | 1297 | 1.15e-09 |
| GO:BP | GO:0099536 | synaptic signaling | 359 | 483 | 1.24e-09 |
| GO:BP | GO:0098609 | cell-cell adhesion | 413 | 564 | 1.30e-09 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 338 | 452 | 1.36e-09 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 348 | 467 | 1.44e-09 |
| GO:BP | GO:0007417 | central nervous system development | 498 | 694 | 2.12e-09 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1019 | 1504 | 2.14e-09 |
| GO:BP | GO:0006468 | protein phosphorylation | 669 | 958 | 3.18e-09 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 344 | 463 | 3.44e-09 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 344 | 463 | 3.44e-09 |
| GO:BP | GO:0016310 | phosphorylation | 789 | 1145 | 3.51e-09 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 249 | 323 | 3.59e-09 |
| GO:BP | GO:0008015 | blood circulation | 272 | 357 | 4.38e-09 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 248 | 322 | 4.58e-09 |
| GO:BP | GO:0001525 | angiogenesis | 288 | 381 | 5.49e-09 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 80 | 88 | 7.81e-09 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 108 | 125 | 8.06e-09 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 353 | 479 | 1.02e-08 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 225 | 290 | 1.02e-08 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 489 | 685 | 1.06e-08 |
| GO:BP | GO:0060284 | regulation of cell development | 413 | 570 | 1.30e-08 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 502 | 706 | 1.55e-08 |
| GO:BP | GO:0034329 | cell junction assembly | 247 | 323 | 1.69e-08 |
| GO:BP | GO:0061061 | muscle structure development | 390 | 536 | 1.72e-08 |
| GO:BP | GO:0007507 | heart development | 365 | 499 | 2.26e-08 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 751 | 1093 | 2.37e-08 |
| GO:BP | GO:0060429 | epithelium development | 557 | 792 | 2.48e-08 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 221 | 286 | 2.76e-08 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1263 | 1904 | 3.05e-08 |
| GO:BP | GO:1901698 | response to nitrogen compound | 520 | 736 | 3.29e-08 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 284 | 379 | 3.43e-08 |
| GO:BP | GO:0007015 | actin filament organization | 269 | 357 | 3.76e-08 |
| GO:BP | GO:0023057 | negative regulation of signaling | 713 | 1036 | 4.27e-08 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 813 | 1193 | 4.77e-08 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 303 | 408 | 4.77e-08 |
| GO:BP | GO:0030001 | metal ion transport | 380 | 524 | 5.49e-08 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 269 | 358 | 5.97e-08 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 308 | 416 | 5.98e-08 |
| GO:BP | GO:0051960 | regulation of nervous system development | 256 | 339 | 6.53e-08 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1247 | 1883 | 7.14e-08 |
| GO:BP | GO:0048638 | regulation of developmental growth | 190 | 243 | 7.95e-08 |
| GO:BP | GO:0030900 | forebrain development | 210 | 272 | 7.99e-08 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 710 | 1034 | 8.29e-08 |
| GO:BP | GO:0001501 | skeletal system development | 261 | 347 | 8.61e-08 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 269 | 359 | 9.23e-08 |
| GO:BP | GO:0010720 | positive regulation of cell development | 235 | 309 | 1.00e-07 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 200 | 258 | 1.05e-07 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 293 | 395 | 1.05e-07 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 747 | 1093 | 1.07e-07 |
| GO:BP | GO:0010033 | response to organic substance | 1153 | 1736 | 1.24e-07 |
| GO:BP | GO:0060322 | head development | 388 | 539 | 1.51e-07 |
| GO:BP | GO:0048729 | tissue morphogenesis | 331 | 453 | 1.62e-07 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 530 | 757 | 1.71e-07 |
| GO:BP | GO:0070848 | response to growth factor | 393 | 547 | 1.72e-07 |
| GO:BP | GO:0040007 | growth | 491 | 697 | 1.75e-07 |
| GO:BP | GO:0009790 | embryo development | 571 | 821 | 1.99e-07 |
| GO:BP | GO:0097485 | neuron projection guidance | 139 | 172 | 2.52e-07 |
| GO:BP | GO:0007411 | axon guidance | 139 | 172 | 2.52e-07 |
| GO:BP | GO:0140352 | export from cell | 423 | 594 | 2.64e-07 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 869 | 1289 | 2.69e-07 |
| GO:BP | GO:0061448 | connective tissue development | 162 | 205 | 3.00e-07 |
| GO:BP | GO:0046903 | secretion | 441 | 622 | 3.03e-07 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 277 | 374 | 3.53e-07 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1700 | 2622 | 3.86e-07 |
| GO:BP | GO:0050808 | synapse organization | 252 | 337 | 3.86e-07 |
| GO:BP | GO:0032535 | regulation of cellular component size | 218 | 287 | 4.27e-07 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 666 | 972 | 4.37e-07 |
| GO:BP | GO:0030010 | establishment of cell polarity | 104 | 124 | 4.75e-07 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 200 | 261 | 5.15e-07 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 134 | 166 | 5.19e-07 |
| GO:BP | GO:0048588 | developmental cell growth | 143 | 179 | 6.12e-07 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 378 | 528 | 6.33e-07 |
| GO:BP | GO:1901652 | response to peptide | 272 | 368 | 6.45e-07 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 552 | 796 | 6.63e-07 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 100 | 119 | 7.24e-07 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 543 | 783 | 8.68e-07 |
| GO:BP | GO:0001503 | ossification | 227 | 302 | 9.67e-07 |
| GO:BP | GO:0031032 | actomyosin structure organization | 146 | 184 | 9.67e-07 |
| GO:BP | GO:0050877 | nervous system process | 424 | 600 | 1.08e-06 |
| GO:BP | GO:0007420 | brain development | 357 | 498 | 1.24e-06 |
| GO:BP | GO:0048771 | tissue remodeling | 95 | 113 | 1.57e-06 |
| GO:BP | GO:0051216 | cartilage development | 118 | 145 | 1.58e-06 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 285 | 390 | 1.80e-06 |
| GO:BP | GO:0051641 | cellular localization | 1694 | 2623 | 1.95e-06 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 254 | 344 | 2.19e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 869 | 1299 | 2.19e-06 |
| GO:BP | GO:0009725 | response to hormone | 429 | 610 | 2.19e-06 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 414 | 587 | 2.23e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 1032 | 1559 | 2.48e-06 |
| GO:BP | GO:0014706 | striated muscle tissue development | 165 | 213 | 2.53e-06 |
| GO:BP | GO:0006811 | monoatomic ion transport | 499 | 719 | 2.76e-06 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 58 | 64 | 2.88e-06 |
| GO:BP | GO:0032940 | secretion by cell | 390 | 551 | 2.88e-06 |
| GO:BP | GO:0072001 | renal system development | 186 | 244 | 3.03e-06 |
| GO:BP | GO:0016358 | dendrite development | 144 | 183 | 3.03e-06 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 380 | 536 | 3.16e-06 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 113 | 139 | 3.24e-06 |
| GO:BP | GO:0043434 | response to peptide hormone | 233 | 314 | 3.78e-06 |
| GO:BP | GO:0045216 | cell-cell junction organization | 122 | 152 | 3.96e-06 |
| GO:BP | GO:0003012 | muscle system process | 240 | 325 | 4.80e-06 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 184 | 242 | 4.83e-06 |
| GO:BP | GO:1901653 | cellular response to peptide | 205 | 273 | 4.90e-06 |
| GO:BP | GO:0007610 | behavior | 303 | 420 | 4.98e-06 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 151 | 194 | 5.08e-06 |
| GO:BP | GO:0042391 | regulation of membrane potential | 211 | 282 | 5.08e-06 |
| GO:BP | GO:1903522 | regulation of blood circulation | 151 | 194 | 5.08e-06 |
| GO:BP | GO:0018212 | peptidyl-tyrosine modification | 130 | 164 | 5.80e-06 |
| GO:BP | GO:0042592 | homeostatic process | 763 | 1137 | 7.02e-06 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 184 | 243 | 7.84e-06 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 171 | 224 | 8.16e-06 |
| GO:BP | GO:0043062 | extracellular structure organization | 171 | 224 | 8.16e-06 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1559 | 2415 | 9.04e-06 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 368 | 521 | 9.05e-06 |
| GO:BP | GO:0007423 | sensory organ development | 280 | 387 | 9.57e-06 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 303 | 422 | 9.92e-06 |
| GO:BP | GO:0018108 | peptidyl-tyrosine phosphorylation | 128 | 162 | 9.92e-06 |
| GO:BP | GO:0030198 | extracellular matrix organization | 170 | 223 | 1.02e-05 |
| GO:BP | GO:0003015 | heart process | 157 | 204 | 1.02e-05 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 222 | 300 | 1.02e-05 |
| GO:BP | GO:0001654 | eye development | 197 | 263 | 1.11e-05 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 310 | 433 | 1.11e-05 |
| GO:BP | GO:0060047 | heart contraction | 150 | 194 | 1.12e-05 |
| GO:BP | GO:0048880 | sensory system development | 199 | 266 | 1.12e-05 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 618 | 911 | 1.20e-05 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 156 | 203 | 1.28e-05 |
| GO:BP | GO:1990138 | neuron projection extension | 108 | 134 | 1.33e-05 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 147 | 190 | 1.35e-05 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 175 | 231 | 1.37e-05 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 93 | 113 | 1.41e-05 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 80 | 95 | 1.41e-05 |
| GO:BP | GO:0001822 | kidney development | 179 | 237 | 1.43e-05 |
| GO:BP | GO:0008361 | regulation of cell size | 117 | 147 | 1.50e-05 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 222 | 301 | 1.50e-05 |
| GO:BP | GO:0006812 | monoatomic cation transport | 427 | 614 | 1.55e-05 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 267 | 369 | 1.67e-05 |
| GO:BP | GO:0150063 | visual system development | 197 | 264 | 1.68e-05 |
| GO:BP | GO:0060537 | muscle tissue development | 247 | 339 | 1.80e-05 |
| GO:BP | GO:0010976 | positive regulation of neuron projection development | 104 | 129 | 2.06e-05 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 339 | 480 | 2.56e-05 |
| GO:BP | GO:0055085 | transmembrane transport | 622 | 921 | 2.69e-05 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 148 | 193 | 3.06e-05 |
| GO:BP | GO:0090257 | regulation of muscle system process | 137 | 177 | 3.09e-05 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 451 | 654 | 3.26e-05 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 141 | 183 | 3.41e-05 |
| GO:BP | GO:0043010 | camera-type eye development | 173 | 230 | 3.44e-05 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 348 | 495 | 3.64e-05 |
| GO:BP | GO:0035265 | organ growth | 102 | 127 | 3.65e-05 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1411 | 2186 | 3.90e-05 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 327 | 463 | 3.91e-05 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 327 | 463 | 3.91e-05 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 211 | 287 | 4.09e-05 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 74 | 88 | 4.09e-05 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 153 | 201 | 4.23e-05 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 131 | 169 | 4.49e-05 |
| GO:BP | GO:0042330 | taxis | 182 | 244 | 4.53e-05 |
| GO:BP | GO:0006935 | chemotaxis | 182 | 244 | 4.53e-05 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1501 | 2333 | 4.53e-05 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 218 | 298 | 4.91e-05 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 126 | 162 | 5.10e-05 |
| GO:BP | GO:0007186 | G protein-coupled receptor signaling pathway | 276 | 386 | 5.27e-05 |
| GO:BP | GO:0008016 | regulation of heart contraction | 128 | 165 | 5.38e-05 |
| GO:BP | GO:0090132 | epithelium migration | 181 | 243 | 5.57e-05 |
| GO:BP | GO:0010631 | epithelial cell migration | 181 | 243 | 5.57e-05 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 380 | 546 | 5.58e-05 |
| GO:BP | GO:0061572 | actin filament bundle organization | 105 | 132 | 5.69e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 862 | 1306 | 5.91e-05 |
| GO:BP | GO:0009611 | response to wounding | 273 | 382 | 6.29e-05 |
| GO:BP | GO:0030100 | regulation of endocytosis | 149 | 196 | 6.35e-05 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 116 | 148 | 6.48e-05 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 75 | 90 | 6.69e-05 |
| GO:BP | GO:0045165 | cell fate commitment | 118 | 151 | 6.91e-05 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 85 | 104 | 7.00e-05 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 382 | 550 | 7.04e-05 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 104 | 131 | 7.38e-05 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 163 | 217 | 7.45e-05 |
| GO:BP | GO:0021537 | telencephalon development | 148 | 195 | 7.90e-05 |
| GO:BP | GO:0090130 | tissue migration | 183 | 247 | 8.46e-05 |
| GO:BP | GO:0001775 | cell activation | 431 | 627 | 8.78e-05 |
| GO:BP | GO:0050890 | cognition | 160 | 213 | 9.12e-05 |
| GO:BP | GO:1901888 | regulation of cell junction assembly | 121 | 156 | 9.98e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 192 | 261 | 1.06e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 86 | 106 | 1.07e-04 |
| GO:BP | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 76 | 92 | 1.08e-04 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 544 | 805 | 1.10e-04 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 140 | 184 | 1.14e-04 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 543 | 804 | 1.25e-04 |
| GO:BP | GO:0001764 | neuron migration | 102 | 129 | 1.26e-04 |
| GO:BP | GO:0036211 | protein modification process | 1470 | 2291 | 1.31e-04 |
| GO:BP | GO:0033036 | macromolecule localization | 1481 | 2309 | 1.33e-04 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 293 | 415 | 1.33e-04 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1039 | 1595 | 1.39e-04 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 220 | 304 | 1.45e-04 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 715 | 1077 | 1.45e-04 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 303 | 431 | 1.61e-04 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 383 | 555 | 1.73e-04 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 157 | 210 | 1.73e-04 |
| GO:BP | GO:0006898 | receptor-mediated endocytosis | 138 | 182 | 1.79e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 163 | 219 | 1.79e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 393 | 571 | 1.92e-04 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 300 | 427 | 1.92e-04 |
| GO:BP | GO:0048592 | eye morphogenesis | 86 | 107 | 2.11e-04 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 100 | 127 | 2.11e-04 |
| GO:BP | GO:0010232 | vascular transport | 58 | 68 | 2.12e-04 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 58 | 68 | 2.12e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 160 | 215 | 2.18e-04 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 71 | 86 | 2.25e-04 |
| GO:BP | GO:0060348 | bone development | 113 | 146 | 2.37e-04 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 52 | 60 | 2.40e-04 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 104 | 133 | 2.40e-04 |
| GO:BP | GO:0033043 | regulation of organelle organization | 635 | 953 | 2.51e-04 |
| GO:BP | GO:0006816 | calcium ion transport | 191 | 262 | 2.75e-04 |
| GO:BP | GO:0046777 | protein autophosphorylation | 110 | 142 | 2.87e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 123 | 161 | 2.93e-04 |
| GO:BP | GO:0031399 | regulation of protein modification process | 608 | 911 | 2.93e-04 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 70 | 85 | 3.04e-04 |
| GO:BP | GO:0050900 | leukocyte migration | 146 | 195 | 3.06e-04 |
| GO:BP | GO:0002063 | chondrocyte development | 23 | 23 | 3.07e-04 |
| GO:BP | GO:0032409 | regulation of transporter activity | 114 | 148 | 3.13e-04 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 414 | 606 | 3.24e-04 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 289 | 412 | 3.30e-04 |
| GO:BP | GO:0046849 | bone remodeling | 51 | 59 | 3.36e-04 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 77 | 95 | 3.41e-04 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 205 | 284 | 3.72e-04 |
| GO:BP | GO:0030097 | hemopoiesis | 425 | 624 | 3.89e-04 |
| GO:BP | GO:0000165 | MAPK cascade | 348 | 504 | 3.96e-04 |
| GO:BP | GO:0043149 | stress fiber assembly | 74 | 91 | 3.96e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 64 | 77 | 3.96e-04 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 74 | 91 | 3.96e-04 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 157 | 212 | 3.96e-04 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 128 | 169 | 3.96e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 161 | 218 | 3.99e-04 |
| GO:BP | GO:0051046 | regulation of secretion | 278 | 396 | 4.26e-04 |
| GO:BP | GO:0006814 | sodium ion transport | 106 | 137 | 4.34e-04 |
| GO:BP | GO:0002376 | immune system process | 919 | 1410 | 4.36e-04 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 71 | 87 | 4.64e-04 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 174 | 238 | 4.90e-04 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 44 | 50 | 4.99e-04 |
| GO:BP | GO:0042692 | muscle cell differentiation | 230 | 323 | 5.09e-04 |
| GO:BP | GO:0030048 | actin filament-based movement | 85 | 107 | 5.11e-04 |
| GO:BP | GO:1903530 | regulation of secretion by cell | 258 | 366 | 5.28e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 87 | 110 | 5.55e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 87 | 110 | 5.55e-04 |
| GO:BP | GO:0007611 | learning or memory | 141 | 189 | 5.57e-04 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 107 | 139 | 5.76e-04 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 155 | 210 | 5.88e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 261 | 371 | 5.89e-04 |
| GO:BP | GO:0061614 | miRNA transcription | 52 | 61 | 6.02e-04 |
| GO:BP | GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 52 | 61 | 6.02e-04 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 82 | 103 | 6.04e-04 |
| GO:BP | GO:0031345 | negative regulation of cell projection organization | 111 | 145 | 6.19e-04 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 130 | 173 | 6.30e-04 |
| GO:BP | GO:0050807 | regulation of synapse organization | 130 | 173 | 6.30e-04 |
| GO:BP | GO:0021954 | central nervous system neuron development | 49 | 57 | 6.45e-04 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 277 | 396 | 6.46e-04 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 84 | 106 | 6.53e-04 |
| GO:BP | GO:0010721 | negative regulation of cell development | 136 | 182 | 6.55e-04 |
| GO:BP | GO:0003205 | cardiac chamber development | 115 | 151 | 6.55e-04 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 57 | 68 | 6.67e-04 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 140 | 188 | 6.69e-04 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 104 | 135 | 6.82e-04 |
| GO:BP | GO:0010977 | negative regulation of neuron projection development | 86 | 109 | 7.00e-04 |
| GO:BP | GO:0051962 | positive regulation of nervous system development | 156 | 212 | 7.00e-04 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 106 | 138 | 7.05e-04 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 79 | 99 | 7.05e-04 |
| GO:BP | GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 106 | 138 | 7.05e-04 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 97 | 125 | 7.45e-04 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 127 | 169 | 7.51e-04 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 187 | 259 | 7.78e-04 |
| GO:BP | GO:0061337 | cardiac conduction | 69 | 85 | 7.93e-04 |
| GO:BP | GO:0045927 | positive regulation of growth | 137 | 184 | 8.06e-04 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 51 | 60 | 8.09e-04 |
| GO:BP | GO:0006835 | dicarboxylic acid transport | 51 | 60 | 8.09e-04 |
| GO:BP | GO:0000003 | reproduction | 586 | 882 | 8.11e-04 |
| GO:BP | GO:0040008 | regulation of growth | 319 | 462 | 8.14e-04 |
| GO:BP | GO:0048675 | axon extension | 76 | 95 | 8.28e-04 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 202 | 282 | 8.31e-04 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 103 | 134 | 8.46e-04 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1287 | 2010 | 8.78e-04 |
| GO:BP | GO:0061387 | regulation of extent of cell growth | 71 | 88 | 8.80e-04 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 94 | 121 | 8.84e-04 |
| GO:BP | GO:0007517 | muscle organ development | 192 | 267 | 8.84e-04 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 188 | 261 | 9.02e-04 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 61 | 74 | 9.18e-04 |
| GO:BP | GO:0001649 | osteoblast differentiation | 130 | 174 | 9.40e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 265 | 379 | 9.41e-04 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 87 | 111 | 9.41e-04 |
| GO:BP | GO:0021955 | central nervous system neuron axonogenesis | 29 | 31 | 9.65e-04 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 170 | 234 | 9.72e-04 |
| GO:BP | GO:0001659 | temperature homeostasis | 100 | 130 | 1.02e-03 |
| GO:BP | GO:0008104 | protein localization | 1280 | 2000 | 1.02e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 592 | 893 | 1.03e-03 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 191 | 266 | 1.04e-03 |
| GO:BP | GO:0010876 | lipid localization | 212 | 298 | 1.04e-03 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 63 | 77 | 1.05e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 204 | 286 | 1.11e-03 |
| GO:BP | GO:0042063 | gliogenesis | 175 | 242 | 1.13e-03 |
| GO:BP | GO:0050803 | regulation of synapse structure or activity | 131 | 176 | 1.16e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 459 | 683 | 1.16e-03 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 47 | 55 | 1.19e-03 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 47 | 55 | 1.19e-03 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 137 | 185 | 1.19e-03 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 110 | 145 | 1.19e-03 |
| GO:BP | GO:0046942 | carboxylic acid transport | 149 | 203 | 1.20e-03 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 147 | 200 | 1.20e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 60 | 73 | 1.21e-03 |
| GO:BP | GO:0071695 | anatomical structure maturation | 114 | 151 | 1.24e-03 |
| GO:BP | GO:0055001 | muscle cell development | 122 | 163 | 1.35e-03 |
| GO:BP | GO:0021987 | cerebral cortex development | 74 | 93 | 1.38e-03 |
| GO:BP | GO:0006909 | phagocytosis | 105 | 138 | 1.40e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 377 | 555 | 1.40e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 92 | 119 | 1.40e-03 |
| GO:BP | GO:0006996 | organelle organization | 1778 | 2815 | 1.42e-03 |
| GO:BP | GO:0046850 | regulation of bone remodeling | 28 | 30 | 1.42e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 517 | 776 | 1.46e-03 |
| GO:BP | GO:0098739 | import across plasma membrane | 94 | 122 | 1.46e-03 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 69 | 86 | 1.48e-03 |
| GO:BP | GO:0006936 | muscle contraction | 183 | 255 | 1.50e-03 |
| GO:BP | GO:0099173 | postsynapse organization | 111 | 147 | 1.50e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 85 | 109 | 1.51e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 198 | 278 | 1.57e-03 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 54 | 65 | 1.58e-03 |
| GO:BP | GO:0060291 | long-term synaptic potentiation | 54 | 65 | 1.58e-03 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 59 | 72 | 1.60e-03 |
| GO:BP | GO:0010638 | positive regulation of organelle organization | 283 | 409 | 1.61e-03 |
| GO:BP | GO:0023061 | signal release | 222 | 315 | 1.69e-03 |
| GO:BP | GO:0032330 | regulation of chondrocyte differentiation | 31 | 34 | 1.70e-03 |
| GO:BP | GO:0071711 | basement membrane organization | 31 | 34 | 1.70e-03 |
| GO:BP | GO:0015849 | organic acid transport | 149 | 204 | 1.72e-03 |
| GO:BP | GO:0007389 | pattern specification process | 203 | 286 | 1.74e-03 |
| GO:BP | GO:0022414 | reproductive process | 578 | 874 | 1.75e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 295 | 428 | 1.75e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 178 | 248 | 1.80e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 61 | 75 | 1.81e-03 |
| GO:BP | GO:0060485 | mesenchyme development | 176 | 245 | 1.82e-03 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 40 | 46 | 1.83e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 321 | 469 | 1.97e-03 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 158 | 218 | 2.00e-03 |
| GO:BP | GO:0060249 | anatomical structure homeostasis | 122 | 164 | 2.00e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 204 | 288 | 2.00e-03 |
| GO:BP | GO:0001894 | tissue homeostasis | 122 | 164 | 2.00e-03 |
| GO:BP | GO:0016049 | cell growth | 265 | 382 | 2.00e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 63 | 78 | 2.02e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 63 | 78 | 2.02e-03 |
| GO:BP | GO:1990776 | response to angiotensin | 27 | 29 | 2.07e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 431 | 642 | 2.07e-03 |
| GO:BP | GO:0120031 | plasma membrane bounded cell projection assembly | 300 | 437 | 2.35e-03 |
| GO:BP | GO:0048864 | stem cell development | 60 | 74 | 2.40e-03 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 476 | 714 | 2.46e-03 |
| GO:BP | GO:0006950 | response to stress | 1606 | 2540 | 2.62e-03 |
| GO:BP | GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 87 | 113 | 2.69e-03 |
| GO:BP | GO:0007613 | memory | 69 | 87 | 2.73e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 69 | 87 | 2.73e-03 |
| GO:BP | GO:0030031 | cell projection assembly | 306 | 447 | 2.73e-03 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 18 | 18 | 2.81e-03 |
| GO:BP | GO:0031099 | regeneration | 108 | 144 | 2.83e-03 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 286 | 416 | 2.84e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 213 | 303 | 2.84e-03 |
| GO:BP | GO:0007272 | ensheathment of neurons | 91 | 119 | 2.87e-03 |
| GO:BP | GO:0008366 | axon ensheathment | 91 | 119 | 2.87e-03 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 152 | 210 | 2.90e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 144 | 198 | 2.99e-03 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 171 | 239 | 3.08e-03 |
| GO:BP | GO:0050806 | positive regulation of synaptic transmission | 82 | 106 | 3.08e-03 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 84 | 109 | 3.23e-03 |
| GO:BP | GO:0030500 | regulation of bone mineralization | 41 | 48 | 3.34e-03 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 41 | 48 | 3.34e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 86 | 112 | 3.37e-03 |
| GO:BP | GO:0003231 | cardiac ventricle development | 88 | 115 | 3.50e-03 |
| GO:BP | GO:0032868 | response to insulin | 147 | 203 | 3.54e-03 |
| GO:BP | GO:0034103 | regulation of tissue remodeling | 38 | 44 | 3.60e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 141 | 194 | 3.62e-03 |
| GO:BP | GO:0051057 | positive regulation of small GTPase mediated signal transduction | 46 | 55 | 3.71e-03 |
| GO:BP | GO:0001508 | action potential | 79 | 102 | 3.72e-03 |
| GO:BP | GO:0003279 | cardiac septum development | 79 | 102 | 3.72e-03 |
| GO:BP | GO:0032880 | regulation of protein localization | 460 | 691 | 3.73e-03 |
| GO:BP | GO:0006869 | lipid transport | 185 | 261 | 3.73e-03 |
| GO:BP | GO:0006954 | inflammatory response | 291 | 425 | 3.74e-03 |
| GO:BP | GO:0031623 | receptor internalization | 70 | 89 | 3.75e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 358 | 530 | 3.76e-03 |
| GO:BP | GO:0030278 | regulation of ossification | 63 | 79 | 3.82e-03 |
| GO:BP | GO:0048259 | regulation of receptor-mediated endocytosis | 63 | 79 | 3.82e-03 |
| GO:BP | GO:0010817 | regulation of hormone levels | 222 | 318 | 3.83e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 98 | 130 | 3.96e-03 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 154 | 214 | 4.00e-03 |
| GO:BP | GO:0006082 | organic acid metabolic process | 418 | 625 | 4.04e-03 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 58 | 72 | 4.11e-03 |
| GO:BP | GO:0033993 | response to lipid | 385 | 573 | 4.12e-03 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 85 | 111 | 4.17e-03 |
| GO:BP | GO:0007265 | Ras protein signal transduction | 74 | 95 | 4.21e-03 |
| GO:BP | GO:0006887 | exocytosis | 169 | 237 | 4.22e-03 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 112 | 151 | 4.33e-03 |
| GO:BP | GO:0032528 | microvillus organization | 17 | 17 | 4.33e-03 |
| GO:BP | GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 116 | 157 | 4.37e-03 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 118 | 160 | 4.37e-03 |
| GO:BP | GO:0006629 | lipid metabolic process | 605 | 923 | 4.39e-03 |
| GO:BP | GO:0042552 | myelination | 89 | 117 | 4.41e-03 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 76 | 98 | 4.41e-03 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 241 | 348 | 4.42e-03 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 25 | 27 | 4.48e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 40 | 47 | 4.48e-03 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 91 | 120 | 4.51e-03 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 415 | 621 | 4.56e-03 |
| GO:BP | GO:0042060 | wound healing | 204 | 291 | 4.62e-03 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 69 | 88 | 4.71e-03 |
| GO:BP | GO:0019915 | lipid storage | 55 | 68 | 4.77e-03 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 45 | 54 | 4.88e-03 |
| GO:BP | GO:0030282 | bone mineralization | 62 | 78 | 4.88e-03 |
| GO:BP | GO:0048678 | response to axon injury | 50 | 61 | 4.93e-03 |
| GO:BP | GO:0021543 | pallium development | 101 | 135 | 4.96e-03 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 71 | 91 | 4.99e-03 |
| GO:BP | GO:0046578 | regulation of Ras protein signal transduction | 34 | 39 | 5.13e-03 |
| GO:BP | GO:0048469 | cell maturation | 84 | 110 | 5.13e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 84 | 110 | 5.13e-03 |
| GO:BP | GO:0060491 | regulation of cell projection assembly | 117 | 159 | 5.18e-03 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 297 | 436 | 5.18e-03 |
| GO:BP | GO:0045663 | positive regulation of myoblast differentiation | 31 | 35 | 5.18e-03 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 125 | 171 | 5.18e-03 |
| GO:BP | GO:0046622 | positive regulation of organ growth | 31 | 35 | 5.18e-03 |
| GO:BP | GO:0008038 | neuron recognition | 31 | 35 | 5.18e-03 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1182 | 1856 | 5.19e-03 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 199 | 284 | 5.55e-03 |
| GO:BP | GO:0035270 | endocrine system development | 66 | 84 | 5.61e-03 |
| GO:BP | GO:0030516 | regulation of axon extension | 59 | 74 | 5.77e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 195 | 278 | 5.80e-03 |
| GO:BP | GO:0044272 | sulfur compound biosynthetic process | 96 | 128 | 5.88e-03 |
| GO:BP | GO:0048863 | stem cell differentiation | 138 | 191 | 5.93e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 68 | 87 | 5.93e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 68 | 87 | 5.93e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 68 | 87 | 5.93e-03 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1172 | 1841 | 5.93e-03 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 136 | 188 | 5.95e-03 |
| GO:BP | GO:0031667 | response to nutrient levels | 244 | 354 | 6.02e-03 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 39 | 46 | 6.03e-03 |
| GO:BP | GO:0007369 | gastrulation | 104 | 140 | 6.10e-03 |
| GO:BP | GO:0031214 | biomineral tissue development | 81 | 106 | 6.12e-03 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 61 | 77 | 6.19e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 112 | 152 | 6.21e-03 |
| GO:BP | GO:0002682 | regulation of immune system process | 569 | 868 | 6.24e-03 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 83 | 109 | 6.29e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 209 | 300 | 6.38e-03 |
| GO:BP | GO:0021846 | cell proliferation in forebrain | 16 | 16 | 6.58e-03 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 56 | 70 | 6.79e-03 |
| GO:BP | GO:0055123 | digestive system development | 74 | 96 | 6.87e-03 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 404 | 606 | 6.91e-03 |
| GO:BP | GO:0030041 | actin filament polymerization | 93 | 124 | 7.05e-03 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 65 | 83 | 7.09e-03 |
| GO:BP | GO:0050921 | positive regulation of chemotaxis | 65 | 83 | 7.09e-03 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 95 | 127 | 7.13e-03 |
| GO:BP | GO:1904707 | positive regulation of vascular associated smooth muscle cell proliferation | 27 | 30 | 7.13e-03 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 51 | 63 | 7.21e-03 |
| GO:BP | GO:0060998 | regulation of dendritic spine development | 41 | 49 | 7.28e-03 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 41 | 49 | 7.28e-03 |
| GO:BP | GO:0060173 | limb development | 101 | 136 | 7.31e-03 |
| GO:BP | GO:0048736 | appendage development | 101 | 136 | 7.31e-03 |
| GO:BP | GO:0060349 | bone morphogenesis | 58 | 73 | 7.32e-03 |
| GO:BP | GO:0006631 | fatty acid metabolic process | 184 | 262 | 7.33e-03 |
| GO:BP | GO:0002064 | epithelial cell development | 109 | 148 | 7.42e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 109 | 148 | 7.42e-03 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 226 | 327 | 7.48e-03 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 80 | 105 | 7.53e-03 |
| GO:BP | GO:0015711 | organic anion transport | 180 | 256 | 7.62e-03 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 178 | 253 | 7.79e-03 |
| GO:BP | GO:0071396 | cellular response to lipid | 265 | 388 | 7.96e-03 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 387 | 580 | 8.03e-03 |
| GO:BP | GO:0051653 | spindle localization | 43 | 52 | 8.58e-03 |
| GO:BP | GO:0014032 | neural crest cell development | 55 | 69 | 8.74e-03 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 55 | 69 | 8.74e-03 |
| GO:BP | GO:0003002 | regionalization | 181 | 258 | 8.74e-03 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 98 | 132 | 8.86e-03 |
| GO:BP | GO:0006813 | potassium ion transport | 100 | 135 | 8.91e-03 |
| GO:BP | GO:0031103 | axon regeneration | 35 | 41 | 9.02e-03 |
| GO:BP | GO:0021700 | developmental maturation | 145 | 203 | 9.10e-03 |
| GO:BP | GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 23 | 25 | 9.41e-03 |
| GO:BP | GO:0071702 | organic substance transport | 1096 | 1722 | 9.43e-03 |
| GO:BP | GO:0003006 | developmental process involved in reproduction | 382 | 573 | 9.49e-03 |
| GO:BP | GO:0015800 | acidic amino acid transport | 32 | 37 | 9.77e-03 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 32 | 37 | 9.77e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 349 | 521 | 9.77e-03 |
| GO:BP | GO:0001755 | neural crest cell migration | 40 | 48 | 9.77e-03 |
| GO:BP | GO:0031102 | neuron projection regeneration | 40 | 48 | 9.77e-03 |
| GO:BP | GO:0003073 | regulation of systemic arterial blood pressure | 45 | 55 | 9.81e-03 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 83 | 110 | 9.84e-03 |
| GO:BP | GO:0048732 | gland development | 213 | 308 | 9.97e-03 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1138 | 1791 | 1.01e-02 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 26 | 29 | 1.01e-02 |
| GO:BP | GO:1903034 | regulation of response to wounding | 89 | 119 | 1.03e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 52 | 65 | 1.03e-02 |
| GO:BP | GO:0035264 | multicellular organism growth | 89 | 119 | 1.03e-02 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 117 | 161 | 1.06e-02 |
| GO:BP | GO:0001704 | formation of primary germ layer | 72 | 94 | 1.07e-02 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 47 | 58 | 1.10e-02 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 37 | 44 | 1.10e-02 |
| GO:BP | GO:0046661 | male sex differentiation | 80 | 106 | 1.20e-02 |
| GO:BP | GO:0043588 | skin development | 126 | 175 | 1.22e-02 |
| GO:BP | GO:0060419 | heart growth | 56 | 71 | 1.22e-02 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 67 | 87 | 1.26e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 86 | 115 | 1.26e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 86 | 115 | 1.26e-02 |
| GO:BP | GO:0043412 | macromolecule modification | 1564 | 2489 | 1.26e-02 |
| GO:BP | GO:0001823 | mesonephros development | 58 | 74 | 1.30e-02 |
| GO:BP | GO:0031644 | regulation of nervous system process | 58 | 74 | 1.30e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 401 | 605 | 1.31e-02 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 96 | 130 | 1.31e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 106 | 145 | 1.31e-02 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 39 | 47 | 1.32e-02 |
| GO:BP | GO:0046683 | response to organophosphorus | 71 | 93 | 1.34e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 51 | 64 | 1.35e-02 |
| GO:BP | GO:0038179 | neurotrophin signaling pathway | 31 | 36 | 1.35e-02 |
| GO:BP | GO:0098868 | bone growth | 22 | 24 | 1.36e-02 |
| GO:BP | GO:0002431 | Fc receptor mediated stimulatory signaling pathway | 22 | 24 | 1.36e-02 |
| GO:BP | GO:0021952 | central nervous system projection neuron axonogenesis | 22 | 24 | 1.36e-02 |
| GO:BP | GO:0045124 | regulation of bone resorption | 22 | 24 | 1.36e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 339 | 507 | 1.36e-02 |
| GO:BP | GO:0006790 | sulfur compound metabolic process | 163 | 232 | 1.38e-02 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 174 | 249 | 1.40e-02 |
| GO:BP | GO:0043542 | endothelial cell migration | 125 | 174 | 1.43e-02 |
| GO:BP | GO:1901343 | negative regulation of vasculature development | 53 | 67 | 1.44e-02 |
| GO:BP | GO:0033555 | multicellular organismal response to stress | 46 | 57 | 1.44e-02 |
| GO:BP | GO:2000181 | negative regulation of blood vessel morphogenesis | 53 | 67 | 1.44e-02 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 46 | 57 | 1.44e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 53 | 67 | 1.44e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 77 | 102 | 1.44e-02 |
| GO:BP | GO:0008217 | regulation of blood pressure | 79 | 105 | 1.46e-02 |
| GO:BP | GO:0071526 | semaphorin-plexin signaling pathway | 36 | 43 | 1.48e-02 |
| GO:BP | GO:0090497 | mesenchymal cell migration | 41 | 50 | 1.50e-02 |
| GO:BP | GO:0031016 | pancreas development | 41 | 50 | 1.50e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 83 | 111 | 1.50e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 256 | 377 | 1.53e-02 |
| GO:BP | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 87 | 117 | 1.53e-02 |
| GO:BP | GO:0046620 | regulation of organ growth | 55 | 70 | 1.54e-02 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 93 | 126 | 1.56e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 48 | 60 | 1.58e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 68 | 89 | 1.60e-02 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 456 | 694 | 1.62e-02 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 160 | 228 | 1.62e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 57 | 73 | 1.63e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 57 | 73 | 1.63e-02 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 72 | 95 | 1.70e-02 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 189 | 273 | 1.71e-02 |
| GO:BP | GO:0060996 | dendritic spine development | 59 | 76 | 1.72e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 80 | 107 | 1.83e-02 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 488 | 746 | 1.86e-02 |
| GO:BP | GO:0016525 | negative regulation of angiogenesis | 52 | 66 | 1.86e-02 |
| GO:BP | GO:0007584 | response to nutrient | 84 | 113 | 1.87e-02 |
| GO:BP | GO:0045860 | positive regulation of protein kinase activity | 131 | 184 | 1.87e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 86 | 116 | 1.87e-02 |
| GO:BP | GO:0002065 | columnar/cuboidal epithelial cell differentiation | 63 | 82 | 1.88e-02 |
| GO:BP | GO:0009914 | hormone transport | 146 | 207 | 1.88e-02 |
| GO:BP | GO:1901880 | negative regulation of protein depolymerization | 45 | 56 | 1.88e-02 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 90 | 122 | 1.88e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 65 | 85 | 1.94e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 65 | 85 | 1.94e-02 |
| GO:BP | GO:0048640 | negative regulation of developmental growth | 65 | 85 | 1.94e-02 |
| GO:BP | GO:0060840 | artery development | 65 | 85 | 1.94e-02 |
| GO:BP | GO:0070372 | regulation of ERK1 and ERK2 cascade | 125 | 175 | 1.94e-02 |
| GO:BP | GO:0003281 | ventricular septum development | 54 | 69 | 1.95e-02 |
| GO:BP | GO:1904752 | regulation of vascular associated smooth muscle cell migration | 21 | 23 | 1.95e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 21 | 23 | 1.95e-02 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 123 | 172 | 1.96e-02 |
| GO:BP | GO:1904645 | response to amyloid-beta | 27 | 31 | 1.96e-02 |
| GO:BP | GO:0071825 | protein-lipid complex organization | 27 | 31 | 1.96e-02 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 40 | 49 | 1.96e-02 |
| GO:BP | GO:0048565 | digestive tract development | 67 | 88 | 1.96e-02 |
| GO:BP | GO:0019229 | regulation of vasoconstriction | 35 | 42 | 1.96e-02 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 35 | 42 | 1.96e-02 |
| GO:BP | GO:0006915 | apoptotic process | 879 | 1377 | 1.96e-02 |
| GO:BP | GO:0006638 | neutral lipid metabolic process | 67 | 88 | 1.96e-02 |
| GO:BP | GO:0050865 | regulation of cell activation | 236 | 347 | 1.99e-02 |
| GO:BP | GO:1904646 | cellular response to amyloid-beta | 24 | 27 | 2.00e-02 |
| GO:BP | GO:0098901 | regulation of cardiac muscle cell action potential | 24 | 27 | 2.00e-02 |
| GO:BP | GO:0014855 | striated muscle cell proliferation | 47 | 59 | 2.01e-02 |
| GO:BP | GO:0001657 | ureteric bud development | 56 | 72 | 2.03e-02 |
| GO:BP | GO:0014812 | muscle cell migration | 56 | 72 | 2.03e-02 |
| GO:BP | GO:0051648 | vesicle localization | 134 | 189 | 2.06e-02 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 262 | 388 | 2.07e-02 |
| GO:BP | GO:0042110 | T cell activation | 209 | 305 | 2.07e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 160 | 229 | 2.08e-02 |
| GO:BP | GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 73 | 97 | 2.08e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 73 | 97 | 2.08e-02 |
| GO:BP | GO:0006865 | amino acid transport | 73 | 97 | 2.08e-02 |
| GO:BP | GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 58 | 75 | 2.12e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 79 | 106 | 2.18e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 97 | 133 | 2.21e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 32 | 38 | 2.21e-02 |
| GO:BP | GO:0046503 | glycerolipid catabolic process | 32 | 38 | 2.21e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 32 | 38 | 2.21e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 87 | 118 | 2.21e-02 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 93 | 127 | 2.21e-02 |
| GO:BP | GO:0033674 | positive regulation of kinase activity | 139 | 197 | 2.26e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 139 | 197 | 2.26e-02 |
| GO:BP | GO:0070371 | ERK1 and ERK2 cascade | 137 | 194 | 2.30e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 161 | 231 | 2.34e-02 |
| GO:BP | GO:0042246 | tissue regeneration | 44 | 55 | 2.39e-02 |
| GO:BP | GO:0030033 | microvillus assembly | 13 | 13 | 2.39e-02 |
| GO:BP | GO:0001574 | ganglioside biosynthetic process | 13 | 13 | 2.39e-02 |
| GO:BP | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway | 17 | 18 | 2.39e-02 |
| GO:BP | GO:0010996 | response to auditory stimulus | 17 | 18 | 2.39e-02 |
| GO:BP | GO:0035336 | long-chain fatty-acyl-CoA metabolic process | 17 | 18 | 2.39e-02 |
| GO:BP | GO:0043304 | regulation of mast cell degranulation | 17 | 18 | 2.39e-02 |
| GO:BP | GO:0006639 | acylglycerol metabolic process | 66 | 87 | 2.41e-02 |
| GO:BP | GO:0051258 | protein polymerization | 157 | 225 | 2.44e-02 |
| GO:BP | GO:0021795 | cerebral cortex cell migration | 29 | 34 | 2.45e-02 |
| GO:BP | GO:0046879 | hormone secretion | 142 | 202 | 2.52e-02 |
| GO:BP | GO:0051293 | establishment of spindle localization | 39 | 48 | 2.55e-02 |
| GO:BP | GO:0106027 | neuron projection organization | 55 | 71 | 2.55e-02 |
| GO:BP | GO:0051261 | protein depolymerization | 72 | 96 | 2.55e-02 |
| GO:BP | GO:0045661 | regulation of myoblast differentiation | 46 | 58 | 2.57e-02 |
| GO:BP | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 46 | 58 | 2.57e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 74 | 99 | 2.58e-02 |
| GO:BP | GO:0045453 | bone resorption | 34 | 41 | 2.59e-02 |
| GO:BP | GO:0007626 | locomotory behavior | 98 | 135 | 2.59e-02 |
| GO:BP | GO:0050870 | positive regulation of T cell activation | 98 | 135 | 2.59e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 98 | 135 | 2.59e-02 |
| GO:BP | GO:0022607 | cellular component assembly | 1446 | 2305 | 2.61e-02 |
| GO:BP | GO:0051592 | response to calcium ion | 80 | 108 | 2.63e-02 |
| GO:BP | GO:1904375 | regulation of protein localization to cell periphery | 82 | 111 | 2.64e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 86 | 117 | 2.65e-02 |
| GO:BP | GO:0001974 | blood vessel remodeling | 26 | 30 | 2.65e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 20 | 22 | 2.74e-02 |
| GO:BP | GO:0051668 | localization within membrane | 374 | 567 | 2.76e-02 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 167 | 241 | 2.77e-02 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 23 | 26 | 2.78e-02 |
| GO:BP | GO:0021799 | cerebral cortex radially oriented cell migration | 23 | 26 | 2.78e-02 |
| GO:BP | GO:0048806 | genitalia development | 23 | 26 | 2.78e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 41 | 51 | 2.78e-02 |
| GO:BP | GO:0050771 | negative regulation of axonogenesis | 41 | 51 | 2.78e-02 |
| GO:BP | GO:0051649 | establishment of localization in cell | 993 | 1566 | 2.80e-02 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 61 | 80 | 2.81e-02 |
| GO:BP | GO:0050863 | regulation of T cell activation | 143 | 204 | 2.81e-02 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 128 | 181 | 2.85e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 109 | 152 | 2.86e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 63 | 83 | 2.88e-02 |
| GO:BP | GO:0016239 | positive regulation of macroautophagy | 50 | 64 | 2.88e-02 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 172 | 249 | 2.92e-02 |
| GO:BP | GO:0006941 | striated muscle contraction | 105 | 146 | 2.93e-02 |
| GO:BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 105 | 146 | 2.93e-02 |
| GO:BP | GO:0090100 | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 65 | 86 | 2.93e-02 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 43 | 54 | 3.03e-02 |
| GO:BP | GO:0032835 | glomerulus development | 43 | 54 | 3.03e-02 |
| GO:BP | GO:0015918 | sterol transport | 69 | 92 | 3.04e-02 |
| GO:BP | GO:0017157 | regulation of exocytosis | 95 | 131 | 3.09e-02 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 89 | 122 | 3.15e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 77 | 104 | 3.16e-02 |
| GO:BP | GO:0099587 | inorganic ion import across plasma membrane | 54 | 70 | 3.16e-02 |
| GO:BP | GO:0098659 | inorganic cation import across plasma membrane | 54 | 70 | 3.16e-02 |
| GO:BP | GO:0051899 | membrane depolarization | 45 | 57 | 3.26e-02 |
| GO:BP | GO:0045666 | positive regulation of neuron differentiation | 45 | 57 | 3.26e-02 |
| GO:BP | GO:0007260 | tyrosine phosphorylation of STAT protein | 28 | 33 | 3.31e-02 |
| GO:BP | GO:0001558 | regulation of cell growth | 219 | 323 | 3.37e-02 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 58 | 76 | 3.40e-02 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 348 | 527 | 3.41e-02 |
| GO:BP | GO:0098927 | vesicle-mediated transport between endosomal compartments | 33 | 40 | 3.42e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 278 | 416 | 3.42e-02 |
| GO:BP | GO:1904377 | positive regulation of protein localization to cell periphery | 47 | 60 | 3.47e-02 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 136 | 194 | 3.47e-02 |
| GO:BP | GO:0098884 | postsynaptic neurotransmitter receptor internalization | 16 | 17 | 3.50e-02 |
| GO:BP | GO:0140239 | postsynaptic endocytosis | 16 | 17 | 3.50e-02 |
| GO:BP | GO:0035313 | wound healing, spreading of epidermal cells | 16 | 17 | 3.50e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 371 | 564 | 3.61e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 40 | 50 | 3.61e-02 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 255 | 380 | 3.62e-02 |
| GO:BP | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 25 | 29 | 3.62e-02 |
| GO:BP | GO:0071827 | plasma lipoprotein particle organization | 25 | 29 | 3.62e-02 |
| GO:BP | GO:0032332 | positive regulation of chondrocyte differentiation | 12 | 12 | 3.62e-02 |
| GO:BP | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis | 12 | 12 | 3.62e-02 |
| GO:BP | GO:1902414 | protein localization to cell junction | 64 | 85 | 3.62e-02 |
| GO:BP | GO:0045780 | positive regulation of bone resorption | 12 | 12 | 3.62e-02 |
| GO:BP | GO:0005513 | detection of calcium ion | 12 | 12 | 3.62e-02 |
| GO:BP | GO:0007492 | endoderm development | 49 | 63 | 3.62e-02 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 49 | 63 | 3.62e-02 |
| GO:BP | GO:0061458 | reproductive system development | 143 | 205 | 3.62e-02 |
| GO:BP | GO:0060541 | respiratory system development | 115 | 162 | 3.67e-02 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2686 | 4354 | 3.68e-02 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 141 | 202 | 3.71e-02 |
| GO:BP | GO:1903531 | negative regulation of secretion by cell | 70 | 94 | 3.73e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 86 | 118 | 3.73e-02 |
| GO:BP | GO:0071772 | response to BMP | 86 | 118 | 3.73e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 86 | 118 | 3.73e-02 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 51 | 66 | 3.77e-02 |
| GO:BP | GO:0044409 | symbiont entry into host | 80 | 109 | 3.77e-02 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 150 | 216 | 3.77e-02 |
| GO:BP | GO:0007548 | sex differentiation | 126 | 179 | 3.78e-02 |
| GO:BP | GO:0015833 | peptide transport | 126 | 179 | 3.78e-02 |
| GO:BP | GO:0030705 | cytoskeleton-dependent intracellular transport | 126 | 179 | 3.78e-02 |
| GO:BP | GO:0045665 | negative regulation of neuron differentiation | 35 | 43 | 3.80e-02 |
| GO:BP | GO:0051347 | positive regulation of transferase activity | 177 | 258 | 3.80e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 22 | 25 | 3.80e-02 |
| GO:BP | GO:0048878 | chemical homeostasis | 437 | 670 | 3.80e-02 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 22 | 25 | 3.80e-02 |
| GO:BP | GO:0014742 | positive regulation of muscle hypertrophy | 19 | 21 | 3.81e-02 |
| GO:BP | GO:0022038 | corpus callosum development | 19 | 21 | 3.81e-02 |
| GO:BP | GO:0010613 | positive regulation of cardiac muscle hypertrophy | 19 | 21 | 3.81e-02 |
| GO:BP | GO:0044772 | mitotic cell cycle phase transition | 256 | 382 | 3.81e-02 |
| GO:BP | GO:0018107 | peptidyl-threonine phosphorylation | 53 | 69 | 3.87e-02 |
| GO:BP | GO:0009791 | post-embryonic development | 53 | 69 | 3.87e-02 |
| GO:BP | GO:0051650 | establishment of vesicle localization | 122 | 173 | 3.91e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 146 | 210 | 3.91e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 661 | 1031 | 3.97e-02 |
| GO:BP | GO:0002694 | regulation of leukocyte activation | 212 | 313 | 4.00e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 44 | 56 | 4.07e-02 |
| GO:BP | GO:0010038 | response to metal ion | 171 | 249 | 4.09e-02 |
| GO:BP | GO:0002252 | immune effector process | 203 | 299 | 4.09e-02 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 57 | 75 | 4.10e-02 |
| GO:BP | GO:0080134 | regulation of response to stress | 597 | 928 | 4.14e-02 |
| GO:BP | GO:0001706 | endoderm formation | 37 | 46 | 4.17e-02 |
| GO:BP | GO:0097120 | receptor localization to synapse | 37 | 46 | 4.17e-02 |
| GO:BP | GO:0060078 | regulation of postsynaptic membrane potential | 59 | 78 | 4.19e-02 |
| GO:BP | GO:0008037 | cell recognition | 59 | 78 | 4.19e-02 |
| GO:BP | GO:0140238 | presynaptic endocytosis | 46 | 59 | 4.29e-02 |
| GO:BP | GO:0006024 | glycosaminoglycan biosynthetic process | 46 | 59 | 4.29e-02 |
| GO:BP | GO:0009894 | regulation of catabolic process | 536 | 830 | 4.30e-02 |
| GO:BP | GO:0050708 | regulation of protein secretion | 125 | 178 | 4.35e-02 |
| GO:BP | GO:0045576 | mast cell activation | 27 | 32 | 4.36e-02 |
| GO:BP | GO:0030501 | positive regulation of bone mineralization | 27 | 32 | 4.36e-02 |
| GO:BP | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein | 27 | 32 | 4.36e-02 |
| GO:BP | GO:0008219 | cell death | 902 | 1423 | 4.37e-02 |
| GO:BP | GO:0045445 | myoblast differentiation | 65 | 87 | 4.37e-02 |
| GO:BP | GO:0072175 | epithelial tube formation | 85 | 117 | 4.38e-02 |
| GO:BP | GO:0045778 | positive regulation of ossification | 32 | 39 | 4.39e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 123 | 175 | 4.41e-02 |
| GO:BP | GO:0060326 | cell chemotaxis | 108 | 152 | 4.42e-02 |
| GO:BP | GO:0022612 | gland morphogenesis | 69 | 93 | 4.43e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 524 | 811 | 4.43e-02 |
| GO:BP | GO:0070482 | response to oxygen levels | 181 | 265 | 4.43e-02 |
| GO:BP | GO:1905039 | carboxylic acid transmembrane transport | 77 | 105 | 4.43e-02 |
| GO:BP | GO:0070167 | regulation of biomineral tissue development | 48 | 62 | 4.43e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 77 | 105 | 4.43e-02 |
| GO:BP | GO:0071466 | cellular response to xenobiotic stimulus | 77 | 105 | 4.43e-02 |
| GO:BP | GO:0051235 | maintenance of location | 172 | 251 | 4.46e-02 |
| GO:BP | GO:1903078 | positive regulation of protein localization to plasma membrane | 39 | 49 | 4.47e-02 |
| GO:BP | GO:0060420 | regulation of heart growth | 39 | 49 | 4.47e-02 |
| GO:BP | GO:0003170 | heart valve development | 50 | 65 | 4.62e-02 |
| GO:BP | GO:1901654 | response to ketone | 102 | 143 | 4.62e-02 |
| GO:BP | GO:0050867 | positive regulation of cell activation | 141 | 203 | 4.65e-02 |
| GO:BP | GO:0012501 | programmed cell death | 899 | 1419 | 4.71e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 168 | 245 | 4.71e-02 |
| GO:BP | GO:0071675 | regulation of mononuclear cell migration | 52 | 68 | 4.77e-02 |
| GO:BP | GO:0045773 | positive regulation of axon extension | 24 | 28 | 4.79e-02 |
| GO:BP | GO:0001708 | cell fate specification | 41 | 52 | 4.79e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 198 | 292 | 4.79e-02 |
| GO:BP | GO:0045669 | positive regulation of osteoblast differentiation | 41 | 52 | 4.79e-02 |
| GO:BP | GO:0016266 | O-glycan processing | 24 | 28 | 4.79e-02 |
| GO:BP | GO:0071692 | protein localization to extracellular region | 175 | 256 | 4.79e-02 |
| GO:BP | GO:0030837 | negative regulation of actin filament polymerization | 41 | 52 | 4.79e-02 |
| GO:BP | GO:0060421 | positive regulation of heart growth | 24 | 28 | 4.79e-02 |
| GO:BP | GO:0051640 | organelle localization | 337 | 512 | 4.79e-02 |
| GO:BP | GO:0007528 | neuromuscular junction development | 34 | 42 | 4.84e-02 |
| GO:BP | GO:0002696 | positive regulation of leukocyte activation | 137 | 197 | 4.84e-02 |
| GO:BP | GO:0031503 | protein-containing complex localization | 111 | 157 | 4.91e-02 |
| GO:BP | GO:2000369 | regulation of clathrin-dependent endocytosis | 15 | 16 | 4.92e-02 |
| GO:BP | GO:0006470 | protein dephosphorylation | 124 | 177 | 4.92e-02 |
| GO:BP | GO:0032331 | negative regulation of chondrocyte differentiation | 15 | 16 | 4.92e-02 |
| GO:BP | GO:0044281 | small molecule metabolic process | 807 | 1270 | 4.93e-02 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 90 | 125 | 4.97e-02 |
LRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR nESRgenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04971 | Gastric acid secretion | 49 | 51 | 9.58e-07 |
| KEGG | KEGG:04360 | Axon guidance | 125 | 155 | 2.27e-06 |
| KEGG | KEGG:04510 | Focal adhesion | 135 | 169 | 2.27e-06 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 130 | 162 | 2.27e-06 |
| KEGG | KEGG:04014 | Ras signaling pathway | 131 | 164 | 2.58e-06 |
| KEGG | KEGG:04520 | Adherens junction | 72 | 83 | 4.90e-06 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 51 | 56 | 6.73e-06 |
| KEGG | KEGG:04611 | Platelet activation | 75 | 88 | 6.73e-06 |
| KEGG | KEGG:04270 | Vascular smooth muscle contraction | 78 | 92 | 6.73e-06 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 127 | 161 | 6.73e-06 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 133 | 169 | 6.73e-06 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 105 | 129 | 6.73e-06 |
| KEGG | KEGG:04970 | Salivary secretion | 49 | 54 | 1.30e-05 |
| KEGG | KEGG:05200 | Pathways in cancer | 280 | 391 | 1.86e-05 |
| KEGG | KEGG:00000 | KEGG root term | 3399 | 5451 | 2.25e-05 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 115 | 147 | 4.05e-05 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 66 | 78 | 4.31e-05 |
| KEGG | KEGG:05146 | Amoebiasis | 54 | 62 | 4.88e-05 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 57 | 66 | 4.88e-05 |
| KEGG | KEGG:04911 | Insulin secretion | 54 | 62 | 4.88e-05 |
| KEGG | KEGG:04713 | Circadian entrainment | 58 | 68 | 8.64e-05 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 63 | 75 | 9.49e-05 |
| KEGG | KEGG:04730 | Long-term depression | 36 | 39 | 1.01e-04 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 183 | 250 | 1.02e-04 |
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 97 | 124 | 1.66e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 123 | 162 | 1.69e-04 |
| KEGG | KEGG:04972 | Pancreatic secretion | 49 | 57 | 2.30e-04 |
| KEGG | KEGG:04976 | Bile secretion | 37 | 41 | 2.30e-04 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 121 | 160 | 2.47e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 56 | 67 | 3.13e-04 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 168 | 231 | 3.42e-04 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 59 | 72 | 5.88e-04 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 40 | 46 | 6.69e-04 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 101 | 133 | 7.50e-04 |
| KEGG | KEGG:04918 | Thyroid hormone synthesis | 45 | 53 | 7.79e-04 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 83 | 107 | 8.42e-04 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 87 | 113 | 9.09e-04 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 107 | 143 | 1.19e-03 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 35 | 40 | 1.27e-03 |
| KEGG | KEGG:04720 | Long-term potentiation | 43 | 51 | 1.39e-03 |
| KEGG | KEGG:04726 | Serotonergic synapse | 48 | 58 | 1.43e-03 |
| KEGG | KEGG:04530 | Tight junction | 97 | 129 | 1.57e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 80 | 104 | 1.57e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 82 | 107 | 1.59e-03 |
| KEGG | KEGG:04924 | Renin secretion | 42 | 50 | 1.75e-03 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 59 | 74 | 1.82e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 68 | 87 | 1.85e-03 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 70 | 90 | 1.93e-03 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 60 | 76 | 2.50e-03 |
| KEGG | KEGG:04148 | Efferocytosis | 90 | 120 | 2.65e-03 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 64 | 82 | 2.78e-03 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 77 | 101 | 2.79e-03 |
| KEGG | KEGG:04728 | Dopaminergic synapse | 74 | 97 | 3.41e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 76 | 100 | 3.44e-03 |
| KEGG | KEGG:04144 | Endocytosis | 153 | 216 | 3.44e-03 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 60 | 77 | 4.06e-03 |
| KEGG | KEGG:04960 | Aldosterone-regulated sodium reabsorption | 22 | 24 | 4.06e-03 |
| KEGG | KEGG:04725 | Cholinergic synapse | 63 | 82 | 5.79e-03 |
| KEGG | KEGG:04071 | Sphingolipid signaling pathway | 77 | 103 | 6.85e-03 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 81 | 109 | 6.89e-03 |
| KEGG | KEGG:00564 | Glycerophospholipid metabolism | 55 | 71 | 8.01e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 57 | 74 | 8.01e-03 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 78 | 105 | 8.01e-03 |
| KEGG | KEGG:04912 | GnRH signaling pathway | 57 | 74 | 8.01e-03 |
| KEGG | KEGG:05207 | Chemical carcinogenesis - receptor activation | 96 | 132 | 8.01e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 61 | 80 | 8.53e-03 |
| KEGG | KEGG:05032 | Morphine addiction | 43 | 54 | 9.20e-03 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 38 | 47 | 9.97e-03 |
| KEGG | KEGG:04514 | Cell adhesion molecules | 53 | 69 | 1.23e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 55 | 72 | 1.26e-02 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 57 | 75 | 1.26e-02 |
| KEGG | KEGG:04916 | Melanogenesis | 57 | 75 | 1.26e-02 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 93 | 129 | 1.29e-02 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 71 | 96 | 1.36e-02 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 102 | 143 | 1.41e-02 |
| KEGG | KEGG:00280 | Valine, leucine and isoleucine degradation | 34 | 42 | 1.49e-02 |
| KEGG | KEGG:00514 | Other types of O-glycan biosynthesis | 29 | 35 | 1.53e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 62 | 83 | 1.58e-02 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 172 | 252 | 1.67e-02 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 55 | 73 | 1.87e-02 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 79 | 109 | 1.88e-02 |
| KEGG | KEGG:05213 | Endometrial cancer | 42 | 54 | 1.92e-02 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 62 | 84 | 2.26e-02 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 95 | 134 | 2.26e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 60 | 81 | 2.26e-02 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 66 | 90 | 2.26e-02 |
| KEGG | KEGG:00230 | Purine metabolism | 68 | 93 | 2.26e-02 |
| KEGG | KEGG:05131 | Shigellosis | 140 | 204 | 2.48e-02 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 81 | 113 | 2.48e-02 |
| KEGG | KEGG:05216 | Thyroid cancer | 27 | 33 | 2.52e-02 |
| KEGG | KEGG:04913 | Ovarian steroidogenesis | 22 | 26 | 2.52e-02 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 75 | 104 | 2.52e-02 |
| KEGG | KEGG:05416 | Viral myocarditis | 29 | 36 | 2.79e-02 |
| KEGG | KEGG:00062 | Fatty acid elongation | 19 | 22 | 2.81e-02 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 40 | 52 | 2.86e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 76 | 106 | 2.89e-02 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 104 | 149 | 2.90e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 66 | 91 | 3.04e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 21 | 25 | 3.34e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 28 | 35 | 3.54e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 84 | 119 | 3.62e-02 |
| KEGG | KEGG:04211 | Longevity regulating pathway | 55 | 75 | 3.68e-02 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 55 | 75 | 3.68e-02 |
| KEGG | KEGG:00512 | Mucin type O-glycan biosynthesis | 18 | 21 | 3.68e-02 |
| KEGG | KEGG:04922 | Glucagon signaling pathway | 57 | 78 | 3.68e-02 |
| KEGG | KEGG:04923 | Regulation of lipolysis in adipocytes | 32 | 41 | 3.86e-02 |
| KEGG | KEGG:04977 | Vitamin digestion and absorption | 12 | 13 | 4.07e-02 |
| KEGG | KEGG:04723 | Retrograde endocannabinoid signaling | 66 | 92 | 4.07e-02 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 66 | 92 | 4.07e-02 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 62 | 86 | 4.14e-02 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 60 | 83 | 4.14e-02 |
| KEGG | KEGG:04929 | GnRH secretion | 38 | 50 | 4.14e-02 |
| KEGG | KEGG:04650 | Natural killer cell mediated cytotoxicity | 40 | 53 | 4.16e-02 |
| KEGG | KEGG:00310 | Lysine degradation | 42 | 56 | 4.18e-02 |
| KEGG | KEGG:04114 | Oocyte meiosis | 73 | 103 | 4.29e-02 |
| KEGG | KEGG:05215 | Prostate cancer | 59 | 82 | 4.82e-02 |
| KEGG | KEGG:04914 | Progesterone-mediated oocyte maturation | 59 | 82 | 4.82e-02 |
| KEGG | KEGG:04742 | Taste transduction | 17 | 20 | 4.82e-02 |
| KEGG | KEGG:01212 | Fatty acid metabolism | 35 | 46 | 4.88e-02 |
# LR_resgenes_20k_enh <- gost(query = unique(LR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(LR_resgenes_20k_enh,"data/GO_KEGG_analysis/LR_resgenes_20k_enh.RDS")
# LRnom <- gostplot(LR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# LRnom
LRnomtable_20k_enh <- LR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
LRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in LR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0050896 | response to stimulus | 1012 | 5379 | 1.25e-17 |
| GO:BP | GO:0007154 | cell communication | 789 | 3983 | 1.25e-17 |
| GO:BP | GO:0023052 | signaling | 778 | 3918 | 1.25e-17 |
| GO:BP | GO:0048856 | anatomical structure development | 768 | 3867 | 2.10e-17 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 434 | 1924 | 4.48e-17 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 418 | 1844 | 9.43e-17 |
| GO:BP | GO:0032501 | multicellular organismal process | 864 | 4504 | 3.39e-16 |
| GO:BP | GO:0007165 | signal transduction | 718 | 3611 | 4.68e-16 |
| GO:BP | GO:0007275 | multicellular organism development | 641 | 3170 | 2.41e-15 |
| GO:BP | GO:0051716 | cellular response to stimulus | 878 | 4640 | 7.34e-15 |
| GO:BP | GO:0032502 | developmental process | 803 | 4179 | 1.11e-14 |
| GO:BP | GO:0030029 | actin filament-based process | 176 | 640 | 2.32e-13 |
| GO:BP | GO:0072359 | circulatory system development | 220 | 864 | 4.21e-13 |
| GO:BP | GO:0048731 | system development | 553 | 2719 | 4.37e-13 |
| GO:BP | GO:0048519 | negative regulation of biological process | 725 | 3764 | 7.59e-13 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 690 | 3550 | 7.59e-13 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 390 | 1801 | 2.55e-12 |
| GO:BP | GO:0050789 | regulation of biological process | 1301 | 7516 | 3.24e-12 |
| GO:BP | GO:0010646 | regulation of cell communication | 501 | 2444 | 3.51e-12 |
| GO:BP | GO:0007155 | cell adhesion | 231 | 941 | 3.82e-12 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 547 | 2717 | 3.82e-12 |
| GO:BP | GO:0048513 | animal organ development | 424 | 2004 | 4.73e-12 |
| GO:BP | GO:0061061 | muscle structure development | 149 | 536 | 1.04e-11 |
| GO:BP | GO:0023051 | regulation of signaling | 495 | 2438 | 2.67e-11 |
| GO:BP | GO:0065007 | biological regulation | 1326 | 7734 | 3.75e-11 |
| GO:BP | GO:0016477 | cell migration | 240 | 1011 | 4.70e-11 |
| GO:BP | GO:0009966 | regulation of signal transduction | 446 | 2166 | 6.97e-11 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 86 | 258 | 8.53e-11 |
| GO:BP | GO:0009888 | tissue development | 301 | 1348 | 8.79e-11 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 79 | 234 | 3.46e-10 |
| GO:BP | GO:0030154 | cell differentiation | 550 | 2803 | 3.46e-10 |
| GO:BP | GO:0048869 | cellular developmental process | 550 | 2804 | 3.55e-10 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 61 | 162 | 6.44e-10 |
| GO:BP | GO:0048870 | cell motility | 255 | 1120 | 7.91e-10 |
| GO:BP | GO:0044057 | regulation of system process | 111 | 384 | 1.08e-09 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 148 | 566 | 1.56e-09 |
| GO:BP | GO:0050793 | regulation of developmental process | 357 | 1697 | 1.58e-09 |
| GO:BP | GO:0048518 | positive regulation of biological process | 788 | 4301 | 2.69e-09 |
| GO:BP | GO:0050794 | regulation of cellular process | 1227 | 7153 | 3.11e-09 |
| GO:BP | GO:0003013 | circulatory system process | 118 | 426 | 4.29e-09 |
| GO:BP | GO:0042692 | muscle cell differentiation | 96 | 323 | 4.89e-09 |
| GO:BP | GO:0008015 | blood circulation | 103 | 357 | 6.19e-09 |
| GO:BP | GO:0003012 | muscle system process | 96 | 325 | 6.85e-09 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 133 | 508 | 1.45e-08 |
| GO:BP | GO:0040011 | locomotion | 190 | 805 | 2.19e-08 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 173 | 717 | 2.53e-08 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 725 | 3954 | 2.89e-08 |
| GO:BP | GO:0060537 | muscle tissue development | 97 | 339 | 3.42e-08 |
| GO:BP | GO:0001568 | blood vessel development | 135 | 525 | 3.51e-08 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 195 | 837 | 3.57e-08 |
| GO:BP | GO:2000145 | regulation of cell motility | 169 | 700 | 3.62e-08 |
| GO:BP | GO:0001944 | vasculature development | 140 | 552 | 4.20e-08 |
| GO:BP | GO:0003008 | system process | 250 | 1139 | 4.52e-08 |
| GO:BP | GO:0060047 | heart contraction | 64 | 194 | 8.25e-08 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 218 | 972 | 9.89e-08 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 258 | 1193 | 9.89e-08 |
| GO:BP | GO:0040012 | regulation of locomotion | 171 | 720 | 9.89e-08 |
| GO:BP | GO:0030334 | regulation of cell migration | 161 | 668 | 1.01e-07 |
| GO:BP | GO:0003015 | heart process | 66 | 204 | 1.02e-07 |
| GO:BP | GO:0009987 | cellular process | 1718 | 10686 | 1.43e-07 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 381 | 1904 | 1.64e-07 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 377 | 1883 | 1.90e-07 |
| GO:BP | GO:0035239 | tube morphogenesis | 154 | 638 | 2.01e-07 |
| GO:BP | GO:0023057 | negative regulation of signaling | 228 | 1036 | 2.02e-07 |
| GO:BP | GO:0090257 | regulation of muscle system process | 59 | 177 | 2.08e-07 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 117 | 450 | 2.21e-07 |
| GO:BP | GO:0014706 | striated muscle tissue development | 67 | 213 | 2.52e-07 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 227 | 1035 | 2.86e-07 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 256 | 1197 | 2.95e-07 |
| GO:BP | GO:0008150 | biological_process | 1789 | 11244 | 2.95e-07 |
| GO:BP | GO:0035295 | tube development | 181 | 787 | 3.49e-07 |
| GO:BP | GO:0006941 | striated muscle contraction | 51 | 146 | 3.97e-07 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 233 | 1073 | 3.97e-07 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 226 | 1034 | 3.97e-07 |
| GO:BP | GO:0055001 | muscle cell development | 55 | 163 | 3.97e-07 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 149 | 622 | 5.42e-07 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 94 | 344 | 5.59e-07 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 275 | 1314 | 5.84e-07 |
| GO:BP | GO:0030048 | actin filament-based movement | 41 | 107 | 5.84e-07 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 43 | 116 | 7.97e-07 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 202 | 913 | 9.93e-07 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 84 | 300 | 1.03e-06 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 36 | 90 | 1.26e-06 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 30 | 68 | 1.40e-06 |
| GO:BP | GO:0008016 | regulation of heart contraction | 54 | 165 | 1.61e-06 |
| GO:BP | GO:0070252 | actin-mediated cell contraction | 35 | 87 | 1.62e-06 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 62 | 201 | 1.79e-06 |
| GO:BP | GO:0090130 | tissue migration | 72 | 247 | 1.82e-06 |
| GO:BP | GO:0010631 | epithelial cell migration | 71 | 243 | 2.01e-06 |
| GO:BP | GO:0090132 | epithelium migration | 71 | 243 | 2.01e-06 |
| GO:BP | GO:0065008 | regulation of biological quality | 371 | 1893 | 2.51e-06 |
| GO:BP | GO:0032879 | regulation of localization | 293 | 1439 | 2.57e-06 |
| GO:BP | GO:1903522 | regulation of blood circulation | 60 | 194 | 2.57e-06 |
| GO:BP | GO:0043500 | muscle adaptation | 35 | 89 | 2.96e-06 |
| GO:BP | GO:0035556 | intracellular signal transduction | 380 | 1951 | 3.24e-06 |
| GO:BP | GO:0007507 | heart development | 122 | 499 | 3.38e-06 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 54 | 169 | 3.55e-06 |
| GO:BP | GO:0043542 | endothelial cell migration | 55 | 174 | 4.00e-06 |
| GO:BP | GO:0048468 | cell development | 368 | 1886 | 4.48e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 267 | 1299 | 4.64e-06 |
| GO:BP | GO:0031032 | actomyosin structure organization | 57 | 184 | 4.89e-06 |
| GO:BP | GO:0051049 | regulation of transport | 231 | 1098 | 5.92e-06 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 146 | 633 | 7.57e-06 |
| GO:BP | GO:0009605 | response to external stimulus | 310 | 1559 | 9.93e-06 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 159 | 706 | 1.01e-05 |
| GO:BP | GO:0001525 | angiogenesis | 97 | 381 | 1.05e-05 |
| GO:BP | GO:0032409 | regulation of transporter activity | 48 | 148 | 1.09e-05 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 361 | 1862 | 1.17e-05 |
| GO:BP | GO:0055006 | cardiac cell development | 31 | 78 | 1.17e-05 |
| GO:BP | GO:0086001 | cardiac muscle cell action potential | 27 | 63 | 1.18e-05 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 56 | 185 | 1.39e-05 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 35 | 95 | 1.68e-05 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 29 | 72 | 2.03e-05 |
| GO:BP | GO:0010959 | regulation of metal ion transport | 67 | 239 | 2.22e-05 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 217 | 1040 | 2.67e-05 |
| GO:BP | GO:0034330 | cell junction organization | 127 | 545 | 2.67e-05 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 37 | 105 | 2.70e-05 |
| GO:BP | GO:0009611 | response to wounding | 95 | 382 | 4.06e-05 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 152 | 685 | 4.46e-05 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 222 | 1077 | 4.88e-05 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 78 | 298 | 4.92e-05 |
| GO:BP | GO:0007010 | cytoskeleton organization | 234 | 1146 | 4.98e-05 |
| GO:BP | GO:0042221 | response to chemical | 430 | 2304 | 5.06e-05 |
| GO:BP | GO:0098657 | import into cell | 140 | 622 | 5.25e-05 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 55 | 188 | 5.37e-05 |
| GO:BP | GO:0150116 | regulation of cell-substrate junction organization | 25 | 60 | 5.67e-05 |
| GO:BP | GO:0086003 | cardiac muscle cell contraction | 26 | 64 | 6.13e-05 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 149 | 673 | 6.19e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 70 | 261 | 6.57e-05 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 137 | 609 | 6.82e-05 |
| GO:BP | GO:0097553 | calcium ion transmembrane import into cytosol | 40 | 122 | 7.12e-05 |
| GO:BP | GO:0030198 | extracellular matrix organization | 62 | 223 | 7.19e-05 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 74 | 282 | 7.77e-05 |
| GO:BP | GO:0043062 | extracellular structure organization | 62 | 224 | 8.30e-05 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 62 | 224 | 8.30e-05 |
| GO:BP | GO:0061337 | cardiac conduction | 31 | 85 | 8.66e-05 |
| GO:BP | GO:0014902 | myotube differentiation | 31 | 85 | 8.66e-05 |
| GO:BP | GO:0008283 | cell population proliferation | 260 | 1306 | 8.68e-05 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 107 | 452 | 8.70e-05 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 42 | 132 | 8.87e-05 |
| GO:BP | GO:0002040 | sprouting angiogenesis | 34 | 98 | 9.96e-05 |
| GO:BP | GO:0006936 | muscle contraction | 68 | 255 | 1.06e-04 |
| GO:BP | GO:0051283 | negative regulation of sequestering of calcium ion | 32 | 90 | 1.07e-04 |
| GO:BP | GO:1904062 | regulation of monoatomic cation transmembrane transport | 54 | 188 | 1.10e-04 |
| GO:BP | GO:0009725 | response to hormone | 136 | 610 | 1.12e-04 |
| GO:BP | GO:0007015 | actin filament organization | 88 | 357 | 1.27e-04 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 107 | 456 | 1.28e-04 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 197 | 951 | 1.28e-04 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 32 | 91 | 1.35e-04 |
| GO:BP | GO:0043149 | stress fiber assembly | 32 | 91 | 1.35e-04 |
| GO:BP | GO:0007517 | muscle organ development | 70 | 267 | 1.37e-04 |
| GO:BP | GO:0042391 | regulation of membrane potential | 73 | 282 | 1.38e-04 |
| GO:BP | GO:0022898 | regulation of transmembrane transporter activity | 43 | 139 | 1.41e-04 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 102 | 431 | 1.41e-04 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 66 | 248 | 1.49e-04 |
| GO:BP | GO:1900024 | regulation of substrate adhesion-dependent cell spreading | 22 | 52 | 1.54e-04 |
| GO:BP | GO:0043534 | blood vessel endothelial cell migration | 32 | 92 | 1.67e-04 |
| GO:BP | GO:0051282 | regulation of sequestering of calcium ion | 32 | 92 | 1.67e-04 |
| GO:BP | GO:0034765 | regulation of monoatomic ion transmembrane transport | 58 | 210 | 1.67e-04 |
| GO:BP | GO:0016310 | phosphorylation | 230 | 1145 | 1.71e-04 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 31 | 88 | 1.73e-04 |
| GO:BP | GO:0071310 | cellular response to organic substance | 256 | 1297 | 1.80e-04 |
| GO:BP | GO:0043270 | positive regulation of monoatomic ion transport | 40 | 127 | 1.80e-04 |
| GO:BP | GO:0010594 | regulation of endothelial cell migration | 42 | 136 | 1.80e-04 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 131 | 591 | 2.11e-04 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 58 | 212 | 2.19e-04 |
| GO:BP | GO:0051209 | release of sequestered calcium ion into cytosol | 31 | 89 | 2.19e-04 |
| GO:BP | GO:0051899 | membrane depolarization | 23 | 57 | 2.26e-04 |
| GO:BP | GO:0006942 | regulation of striated muscle contraction | 29 | 81 | 2.35e-04 |
| GO:BP | GO:0048041 | focal adhesion assembly | 28 | 77 | 2.40e-04 |
| GO:BP | GO:0006816 | calcium ion transport | 68 | 262 | 2.45e-04 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 64 | 243 | 2.75e-04 |
| GO:BP | GO:0032412 | regulation of monoatomic ion transmembrane transporter activity | 41 | 134 | 2.88e-04 |
| GO:BP | GO:0086065 | cell communication involved in cardiac conduction | 22 | 54 | 2.92e-04 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 59 | 219 | 2.92e-04 |
| GO:BP | GO:0002028 | regulation of sodium ion transport | 23 | 58 | 3.06e-04 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 331 | 1751 | 3.13e-04 |
| GO:BP | GO:0070588 | calcium ion transmembrane transport | 57 | 210 | 3.22e-04 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 32 | 95 | 3.23e-04 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 58 | 215 | 3.25e-04 |
| GO:BP | GO:0000902 | cell morphogenesis | 152 | 713 | 3.30e-04 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 112 | 495 | 3.67e-04 |
| GO:BP | GO:1901652 | response to peptide | 88 | 368 | 3.75e-04 |
| GO:BP | GO:0002027 | regulation of heart rate | 29 | 83 | 3.75e-04 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 102 | 442 | 3.80e-04 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 118 | 528 | 3.80e-04 |
| GO:BP | GO:0090109 | regulation of cell-substrate junction assembly | 22 | 55 | 3.86e-04 |
| GO:BP | GO:0051893 | regulation of focal adhesion assembly | 22 | 55 | 3.86e-04 |
| GO:BP | GO:0051235 | maintenance of location | 65 | 251 | 3.87e-04 |
| GO:BP | GO:0051208 | sequestering of calcium ion | 32 | 96 | 3.90e-04 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 109 | 480 | 3.90e-04 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 93 | 395 | 3.92e-04 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 39 | 127 | 3.94e-04 |
| GO:BP | GO:0006897 | endocytosis | 111 | 492 | 4.32e-04 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 218 | 1093 | 4.32e-04 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 17 | 37 | 4.41e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 61 | 233 | 4.85e-04 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 95 | 408 | 4.92e-04 |
| GO:BP | GO:1901698 | response to nitrogen compound | 155 | 736 | 4.92e-04 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 75 | 304 | 5.04e-04 |
| GO:BP | GO:0010812 | negative regulation of cell-substrate adhesion | 18 | 41 | 5.16e-04 |
| GO:BP | GO:0086010 | membrane depolarization during action potential | 13 | 24 | 5.16e-04 |
| GO:BP | GO:0046486 | glycerolipid metabolic process | 71 | 284 | 5.24e-04 |
| GO:BP | GO:0001508 | action potential | 33 | 102 | 5.41e-04 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 99 | 431 | 5.69e-04 |
| GO:BP | GO:0032231 | regulation of actin filament bundle assembly | 29 | 85 | 5.69e-04 |
| GO:BP | GO:0061448 | connective tissue development | 55 | 205 | 5.78e-04 |
| GO:BP | GO:0051492 | regulation of stress fiber assembly | 27 | 77 | 6.23e-04 |
| GO:BP | GO:1903053 | regulation of extracellular matrix organization | 20 | 49 | 6.23e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 96 | 416 | 6.23e-04 |
| GO:BP | GO:0010644 | cell communication by electrical coupling | 15 | 31 | 6.29e-04 |
| GO:BP | GO:0070296 | sarcoplasmic reticulum calcium ion transport | 15 | 31 | 6.29e-04 |
| GO:BP | GO:0051924 | regulation of calcium ion transport | 44 | 153 | 6.33e-04 |
| GO:BP | GO:0006470 | protein dephosphorylation | 49 | 177 | 6.61e-04 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 99 | 433 | 6.68e-04 |
| GO:BP | GO:0070848 | response to growth factor | 120 | 547 | 6.85e-04 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 250 | 1289 | 6.88e-04 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 308 | 1633 | 6.95e-04 |
| GO:BP | GO:0014808 | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 14 | 28 | 7.29e-04 |
| GO:BP | GO:1903514 | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 14 | 28 | 7.29e-04 |
| GO:BP | GO:0010033 | response to organic substance | 325 | 1736 | 7.30e-04 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 57 | 217 | 7.46e-04 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 115 | 521 | 7.47e-04 |
| GO:BP | GO:0010762 | regulation of fibroblast migration | 16 | 35 | 7.65e-04 |
| GO:BP | GO:0051050 | positive regulation of transport | 124 | 571 | 7.86e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 76 | 314 | 8.03e-04 |
| GO:BP | GO:0007399 | nervous system development | 331 | 1775 | 8.22e-04 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 130 | 605 | 8.35e-04 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 29 | 87 | 8.44e-04 |
| GO:BP | GO:0110020 | regulation of actomyosin structure organization | 29 | 87 | 8.44e-04 |
| GO:BP | GO:0006810 | transport | 528 | 2984 | 8.99e-04 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 37 | 123 | 9.22e-04 |
| GO:BP | GO:0001935 | endothelial cell proliferation | 35 | 114 | 9.31e-04 |
| GO:BP | GO:0030001 | metal ion transport | 115 | 524 | 9.31e-04 |
| GO:BP | GO:0016043 | cellular component organization | 815 | 4802 | 1.00e-03 |
| GO:BP | GO:0040007 | growth | 146 | 697 | 1.00e-03 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 73 | 301 | 1.03e-03 |
| GO:BP | GO:0051928 | positive regulation of calcium ion transport | 25 | 71 | 1.04e-03 |
| GO:BP | GO:2001257 | regulation of cation channel activity | 24 | 67 | 1.08e-03 |
| GO:BP | GO:0010595 | positive regulation of endothelial cell migration | 29 | 89 | 1.31e-03 |
| GO:BP | GO:1903055 | positive regulation of extracellular matrix organization | 13 | 26 | 1.32e-03 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 13 | 26 | 1.32e-03 |
| GO:BP | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 13 | 26 | 1.32e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 104 | 469 | 1.40e-03 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 164 | 804 | 1.40e-03 |
| GO:BP | GO:1904064 | positive regulation of cation transmembrane transport | 27 | 81 | 1.49e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 164 | 805 | 1.49e-03 |
| GO:BP | GO:0006650 | glycerophospholipid metabolic process | 58 | 228 | 1.55e-03 |
| GO:BP | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway | 9 | 14 | 1.59e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 38 | 131 | 1.64e-03 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 110 | 504 | 1.66e-03 |
| GO:BP | GO:0010649 | regulation of cell communication by electrical coupling | 10 | 17 | 1.71e-03 |
| GO:BP | GO:1902105 | regulation of leukocyte differentiation | 51 | 194 | 1.73e-03 |
| GO:BP | GO:0006468 | protein phosphorylation | 190 | 958 | 1.83e-03 |
| GO:BP | GO:0042060 | wound healing | 70 | 291 | 1.84e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 38 | 132 | 1.92e-03 |
| GO:BP | GO:0043010 | camera-type eye development | 58 | 230 | 1.95e-03 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 105 | 479 | 1.99e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 171 | 850 | 1.99e-03 |
| GO:BP | GO:0002521 | leukocyte differentiation | 85 | 371 | 2.00e-03 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 36 | 123 | 2.00e-03 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 69 | 287 | 2.06e-03 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 46 | 171 | 2.10e-03 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 282 | 1504 | 2.18e-03 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 159 | 783 | 2.18e-03 |
| GO:BP | GO:0006950 | response to stress | 452 | 2540 | 2.26e-03 |
| GO:BP | GO:0006812 | monoatomic cation transport | 129 | 614 | 2.28e-03 |
| GO:BP | GO:0001954 | positive regulation of cell-matrix adhesion | 17 | 42 | 2.40e-03 |
| GO:BP | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 12 | 24 | 2.40e-03 |
| GO:BP | GO:0002761 | regulation of myeloid leukocyte differentiation | 26 | 79 | 2.41e-03 |
| GO:BP | GO:0016311 | dephosphorylation | 58 | 232 | 2.41e-03 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 124 | 587 | 2.41e-03 |
| GO:BP | GO:0022008 | neurogenesis | 239 | 1251 | 2.43e-03 |
| GO:BP | GO:0001654 | eye development | 64 | 263 | 2.46e-03 |
| GO:BP | GO:0001501 | skeletal system development | 80 | 347 | 2.48e-03 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 28 | 88 | 2.49e-03 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 30 | 97 | 2.51e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 68 | 284 | 2.51e-03 |
| GO:BP | GO:0006915 | apoptotic process | 260 | 1377 | 2.55e-03 |
| GO:BP | GO:0045655 | regulation of monocyte differentiation | 8 | 12 | 2.66e-03 |
| GO:BP | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading | 8 | 12 | 2.66e-03 |
| GO:BP | GO:0043535 | regulation of blood vessel endothelial cell migration | 24 | 71 | 2.67e-03 |
| GO:BP | GO:0086012 | membrane depolarization during cardiac muscle cell action potential | 11 | 21 | 2.67e-03 |
| GO:BP | GO:0150063 | visual system development | 64 | 264 | 2.68e-03 |
| GO:BP | GO:0048592 | eye morphogenesis | 32 | 107 | 2.95e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 35 | 121 | 2.98e-03 |
| GO:BP | GO:1905709 | negative regulation of membrane permeability | 9 | 15 | 2.98e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 177 | 893 | 3.06e-03 |
| GO:BP | GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 21 | 59 | 3.09e-03 |
| GO:BP | GO:0051216 | cartilage development | 40 | 145 | 3.10e-03 |
| GO:BP | GO:0006937 | regulation of muscle contraction | 36 | 126 | 3.11e-03 |
| GO:BP | GO:0006629 | lipid metabolic process | 182 | 923 | 3.21e-03 |
| GO:BP | GO:0048880 | sensory system development | 64 | 266 | 3.28e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 119 | 564 | 3.28e-03 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 34 | 117 | 3.28e-03 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 211 | 1093 | 3.29e-03 |
| GO:BP | GO:0060284 | regulation of cell development | 120 | 570 | 3.35e-03 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 53 | 210 | 3.38e-03 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 35 | 122 | 3.43e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 123 | 588 | 3.64e-03 |
| GO:BP | GO:0048771 | tissue remodeling | 33 | 113 | 3.64e-03 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 15 | 36 | 3.80e-03 |
| GO:BP | GO:0140253 | cell-cell fusion | 15 | 36 | 3.80e-03 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 15 | 36 | 3.80e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 21 | 60 | 3.85e-03 |
| GO:BP | GO:0007229 | integrin-mediated signaling pathway | 27 | 86 | 3.85e-03 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 29 | 95 | 3.85e-03 |
| GO:BP | GO:0051179 | localization | 639 | 3731 | 4.07e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 41 | 152 | 4.11e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 129 | 624 | 4.12e-03 |
| GO:BP | GO:0051234 | establishment of localization | 561 | 3240 | 4.12e-03 |
| GO:BP | GO:0086002 | cardiac muscle cell action potential involved in contraction | 17 | 44 | 4.12e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 70 | 300 | 4.12e-03 |
| GO:BP | GO:0034767 | positive regulation of monoatomic ion transmembrane transport | 28 | 91 | 4.20e-03 |
| GO:BP | GO:0007520 | myoblast fusion | 13 | 29 | 4.22e-03 |
| GO:BP | GO:2000649 | regulation of sodium ion transmembrane transporter activity | 13 | 29 | 4.22e-03 |
| GO:BP | GO:0150117 | positive regulation of cell-substrate junction organization | 13 | 29 | 4.22e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 59 | 243 | 4.25e-03 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 159 | 796 | 4.26e-03 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 231 | 1218 | 4.41e-03 |
| GO:BP | GO:0048593 | camera-type eye morphogenesis | 27 | 87 | 4.57e-03 |
| GO:BP | GO:0002376 | immune system process | 263 | 1410 | 4.67e-03 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 49 | 193 | 4.76e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 21 | 61 | 4.76e-03 |
| GO:BP | GO:0070482 | response to oxygen levels | 63 | 265 | 4.78e-03 |
| GO:BP | GO:0042592 | homeostatic process | 217 | 1137 | 4.78e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 24 | 74 | 4.80e-03 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 30 | 101 | 4.80e-03 |
| GO:BP | GO:1901184 | regulation of ERBB signaling pathway | 20 | 57 | 4.95e-03 |
| GO:BP | GO:0023056 | positive regulation of signaling | 231 | 1221 | 4.99e-03 |
| GO:BP | GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 8 | 13 | 5.08e-03 |
| GO:BP | GO:0008360 | regulation of cell shape | 31 | 106 | 5.08e-03 |
| GO:BP | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 12 | 26 | 5.14e-03 |
| GO:BP | GO:0012501 | programmed cell death | 264 | 1419 | 5.20e-03 |
| GO:BP | GO:0008610 | lipid biosynthetic process | 111 | 527 | 5.24e-03 |
| GO:BP | GO:0045765 | regulation of angiogenesis | 49 | 194 | 5.25e-03 |
| GO:BP | GO:0043536 | positive regulation of blood vessel endothelial cell migration | 17 | 45 | 5.25e-03 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 376 | 2100 | 5.37e-03 |
| GO:BP | GO:0030030 | cell projection organization | 224 | 1182 | 5.54e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 86 | 390 | 5.64e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 90 | 412 | 5.70e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 24 | 75 | 5.80e-03 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 56 | 231 | 5.97e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 61 | 257 | 5.97e-03 |
| GO:BP | GO:0008219 | cell death | 264 | 1423 | 6.07e-03 |
| GO:BP | GO:1901653 | cellular response to peptide | 64 | 273 | 6.11e-03 |
| GO:BP | GO:0030224 | monocyte differentiation | 11 | 23 | 6.15e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 11 | 23 | 6.15e-03 |
| GO:BP | GO:0006644 | phospholipid metabolic process | 67 | 289 | 6.15e-03 |
| GO:BP | GO:0002026 | regulation of the force of heart contraction | 11 | 23 | 6.15e-03 |
| GO:BP | GO:0009790 | embryo development | 162 | 821 | 6.25e-03 |
| GO:BP | GO:1901019 | regulation of calcium ion transmembrane transporter activity | 18 | 50 | 6.67e-03 |
| GO:BP | GO:0051651 | maintenance of location in cell | 44 | 171 | 6.68e-03 |
| GO:BP | GO:0045668 | negative regulation of osteoblast differentiation | 15 | 38 | 6.69e-03 |
| GO:BP | GO:0006949 | syncytium formation | 15 | 38 | 6.69e-03 |
| GO:BP | GO:0035265 | organ growth | 35 | 127 | 6.82e-03 |
| GO:BP | GO:1903169 | regulation of calcium ion transmembrane transport | 31 | 108 | 6.83e-03 |
| GO:BP | GO:0014894 | response to denervation involved in regulation of muscle adaptation | 6 | 8 | 6.83e-03 |
| GO:BP | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation | 6 | 8 | 6.83e-03 |
| GO:BP | GO:0006811 | monoatomic ion transport | 144 | 719 | 6.85e-03 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 218 | 1152 | 6.92e-03 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 459 | 2622 | 7.03e-03 |
| GO:BP | GO:0032411 | positive regulation of transporter activity | 21 | 63 | 7.08e-03 |
| GO:BP | GO:0001558 | regulation of cell growth | 73 | 323 | 7.21e-03 |
| GO:BP | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process | 10 | 20 | 7.22e-03 |
| GO:BP | GO:1901021 | positive regulation of calcium ion transmembrane transporter activity | 12 | 27 | 7.25e-03 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 115 | 555 | 7.26e-03 |
| GO:BP | GO:0038127 | ERBB signaling pathway | 30 | 104 | 7.53e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 135 | 670 | 7.93e-03 |
| GO:BP | GO:0090559 | regulation of membrane permeability | 19 | 55 | 7.98e-03 |
| GO:BP | GO:1901342 | regulation of vasculature development | 49 | 198 | 7.98e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 39 | 148 | 8.26e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 44 | 173 | 8.32e-03 |
| GO:BP | GO:0019637 | organophosphate metabolic process | 152 | 769 | 8.41e-03 |
| GO:BP | GO:0040008 | regulation of growth | 98 | 462 | 8.42e-03 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 17 | 47 | 8.62e-03 |
| GO:BP | GO:0030010 | establishment of cell polarity | 34 | 124 | 8.68e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 23 | 73 | 9.07e-03 |
| GO:BP | GO:0048661 | positive regulation of smooth muscle cell proliferation | 20 | 60 | 9.37e-03 |
| GO:BP | GO:0001936 | regulation of endothelial cell proliferation | 28 | 96 | 9.37e-03 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 32 | 115 | 9.45e-03 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 32 | 115 | 9.45e-03 |
| GO:BP | GO:0098771 | inorganic ion homeostasis | 77 | 348 | 9.45e-03 |
| GO:BP | GO:1990849 | vacuolar localization | 19 | 56 | 9.96e-03 |
| GO:BP | GO:0032418 | lysosome localization | 19 | 56 | 9.96e-03 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 34 | 125 | 9.96e-03 |
| GO:BP | GO:0034764 | positive regulation of transmembrane transport | 35 | 130 | 1.02e-02 |
| GO:BP | GO:1903670 | regulation of sprouting angiogenesis | 12 | 28 | 1.03e-02 |
| GO:BP | GO:0055074 | calcium ion homeostasis | 52 | 216 | 1.04e-02 |
| GO:BP | GO:1904427 | positive regulation of calcium ion transmembrane transport | 18 | 52 | 1.05e-02 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 216 | 1150 | 1.05e-02 |
| GO:BP | GO:0055117 | regulation of cardiac muscle contraction | 21 | 65 | 1.06e-02 |
| GO:BP | GO:0001666 | response to hypoxia | 55 | 232 | 1.07e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 82 | 377 | 1.07e-02 |
| GO:BP | GO:0045834 | positive regulation of lipid metabolic process | 25 | 83 | 1.07e-02 |
| GO:BP | GO:0032787 | monocarboxylic acid metabolic process | 89 | 416 | 1.10e-02 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 829 | 4988 | 1.13e-02 |
| GO:BP | GO:0044255 | cellular lipid metabolic process | 138 | 694 | 1.13e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 60 | 259 | 1.13e-02 |
| GO:BP | GO:0003254 | regulation of membrane depolarization | 14 | 36 | 1.13e-02 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 56 | 238 | 1.14e-02 |
| GO:BP | GO:0045165 | cell fate commitment | 39 | 151 | 1.18e-02 |
| GO:BP | GO:0003205 | cardiac chamber development | 39 | 151 | 1.18e-02 |
| GO:BP | GO:0048589 | developmental growth | 104 | 501 | 1.18e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 204 | 1082 | 1.20e-02 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 31 | 112 | 1.21e-02 |
| GO:BP | GO:1903589 | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis | 4 | 4 | 1.22e-02 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 32 | 117 | 1.24e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 34 | 127 | 1.29e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 11 | 25 | 1.29e-02 |
| GO:BP | GO:0006658 | phosphatidylserine metabolic process | 9 | 18 | 1.29e-02 |
| GO:BP | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis | 9 | 18 | 1.29e-02 |
| GO:BP | GO:0060402 | calcium ion transport into cytosol | 9 | 18 | 1.29e-02 |
| GO:BP | GO:0043304 | regulation of mast cell degranulation | 9 | 18 | 1.29e-02 |
| GO:BP | GO:0010743 | regulation of macrophage derived foam cell differentiation | 9 | 18 | 1.29e-02 |
| GO:BP | GO:0006814 | sodium ion transport | 36 | 137 | 1.30e-02 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 195 | 1031 | 1.31e-02 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 347 | 1951 | 1.34e-02 |
| GO:BP | GO:0032233 | positive regulation of actin filament bundle assembly | 17 | 49 | 1.35e-02 |
| GO:BP | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 24 | 80 | 1.37e-02 |
| GO:BP | GO:0086005 | ventricular cardiac muscle cell action potential | 12 | 29 | 1.39e-02 |
| GO:BP | GO:0006096 | glycolytic process | 22 | 71 | 1.39e-02 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 344 | 1934 | 1.39e-02 |
| GO:BP | GO:0030832 | regulation of actin filament length | 32 | 118 | 1.40e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 77 | 354 | 1.45e-02 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 63 | 278 | 1.45e-02 |
| GO:BP | GO:0006909 | phagocytosis | 36 | 138 | 1.46e-02 |
| GO:BP | GO:0032414 | positive regulation of ion transmembrane transporter activity | 19 | 58 | 1.47e-02 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 65 | 289 | 1.47e-02 |
| GO:BP | GO:0016049 | cell growth | 82 | 382 | 1.48e-02 |
| GO:BP | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity | 6 | 9 | 1.48e-02 |
| GO:BP | GO:0014745 | negative regulation of muscle adaptation | 6 | 9 | 1.48e-02 |
| GO:BP | GO:0043306 | positive regulation of mast cell degranulation | 6 | 9 | 1.48e-02 |
| GO:BP | GO:0014870 | response to muscle inactivity | 6 | 9 | 1.48e-02 |
| GO:BP | GO:0019222 | regulation of metabolic process | 767 | 4603 | 1.52e-02 |
| GO:BP | GO:0007266 | Rho protein signal transduction | 30 | 109 | 1.52e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 50 | 210 | 1.54e-02 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 288 | 1595 | 1.55e-02 |
| GO:BP | GO:0071871 | response to epinephrine | 7 | 12 | 1.56e-02 |
| GO:BP | GO:0034329 | cell junction assembly | 71 | 323 | 1.64e-02 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 22 | 72 | 1.65e-02 |
| GO:BP | GO:0010761 | fibroblast migration | 17 | 50 | 1.67e-02 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 17 | 50 | 1.67e-02 |
| GO:BP | GO:0001775 | cell activation | 125 | 627 | 1.67e-02 |
| GO:BP | GO:0009179 | purine ribonucleoside diphosphate metabolic process | 25 | 86 | 1.68e-02 |
| GO:BP | GO:0009135 | purine nucleoside diphosphate metabolic process | 25 | 86 | 1.68e-02 |
| GO:BP | GO:0007173 | epidermal growth factor receptor signaling pathway | 25 | 86 | 1.68e-02 |
| GO:BP | GO:1905952 | regulation of lipid localization | 30 | 110 | 1.74e-02 |
| GO:BP | GO:0046902 | regulation of mitochondrial membrane permeability | 16 | 46 | 1.75e-02 |
| GO:BP | GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 11 | 26 | 1.75e-02 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 81 | 379 | 1.75e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 16 | 46 | 1.75e-02 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 35 | 135 | 1.82e-02 |
| GO:BP | GO:0031529 | ruffle organization | 15 | 42 | 1.82e-02 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 80 | 374 | 1.82e-02 |
| GO:BP | GO:0086009 | membrane repolarization | 15 | 42 | 1.82e-02 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 65 | 292 | 1.83e-02 |
| GO:BP | GO:0001974 | blood vessel remodeling | 12 | 30 | 1.85e-02 |
| GO:BP | GO:0098900 | regulation of action potential | 14 | 38 | 1.87e-02 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 147 | 757 | 1.87e-02 |
| GO:BP | GO:0010662 | regulation of striated muscle cell apoptotic process | 13 | 34 | 1.88e-02 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 9 | 19 | 1.90e-02 |
| GO:BP | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 9 | 19 | 1.90e-02 |
| GO:BP | GO:0006874 | intracellular calcium ion homeostasis | 48 | 202 | 1.91e-02 |
| GO:BP | GO:0045017 | glycerolipid biosynthetic process | 48 | 202 | 1.91e-02 |
| GO:BP | GO:0046032 | ADP catabolic process | 22 | 73 | 1.91e-02 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 30 | 111 | 1.95e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 156 | 811 | 1.98e-02 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 134 | 683 | 2.02e-02 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 198 | 1060 | 2.02e-02 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 64 | 288 | 2.03e-02 |
| GO:BP | GO:0007423 | sensory organ development | 82 | 387 | 2.04e-02 |
| GO:BP | GO:0046031 | ADP metabolic process | 23 | 78 | 2.04e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 21 | 69 | 2.11e-02 |
| GO:BP | GO:0014909 | smooth muscle cell migration | 19 | 60 | 2.11e-02 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 28 | 102 | 2.15e-02 |
| GO:BP | GO:0034763 | negative regulation of transmembrane transport | 24 | 83 | 2.15e-02 |
| GO:BP | GO:0003416 | endochondral bone growth | 10 | 23 | 2.19e-02 |
| GO:BP | GO:0010765 | positive regulation of sodium ion transport | 10 | 23 | 2.19e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 87 | 416 | 2.19e-02 |
| GO:BP | GO:0002573 | myeloid leukocyte differentiation | 38 | 152 | 2.24e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 113 | 564 | 2.25e-02 |
| GO:BP | GO:0051496 | positive regulation of stress fiber assembly | 15 | 43 | 2.27e-02 |
| GO:BP | GO:0032272 | negative regulation of protein polymerization | 20 | 65 | 2.31e-02 |
| GO:BP | GO:0035023 | regulation of Rho protein signal transduction | 20 | 65 | 2.31e-02 |
| GO:BP | GO:0048699 | generation of neurons | 200 | 1076 | 2.36e-02 |
| GO:BP | GO:0062012 | regulation of small molecule metabolic process | 53 | 231 | 2.42e-02 |
| GO:BP | GO:0045657 | positive regulation of monocyte differentiation | 5 | 7 | 2.49e-02 |
| GO:BP | GO:0002064 | epithelial cell development | 37 | 148 | 2.54e-02 |
| GO:BP | GO:0031399 | regulation of protein modification process | 172 | 911 | 2.54e-02 |
| GO:BP | GO:0007584 | response to nutrient | 30 | 113 | 2.54e-02 |
| GO:BP | GO:1905475 | regulation of protein localization to membrane | 36 | 143 | 2.54e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 35 | 138 | 2.56e-02 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 181 | 965 | 2.59e-02 |
| GO:BP | GO:0035795 | negative regulation of mitochondrial membrane permeability | 7 | 13 | 2.61e-02 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 122 | 619 | 2.65e-02 |
| GO:BP | GO:0009137 | purine nucleoside diphosphate catabolic process | 22 | 75 | 2.65e-02 |
| GO:BP | GO:0019364 | pyridine nucleotide catabolic process | 22 | 75 | 2.65e-02 |
| GO:BP | GO:0009181 | purine ribonucleoside diphosphate catabolic process | 22 | 75 | 2.65e-02 |
| GO:BP | GO:0006082 | organic acid metabolic process | 123 | 625 | 2.68e-02 |
| GO:BP | GO:0071872 | cellular response to epinephrine stimulus | 6 | 10 | 2.76e-02 |
| GO:BP | GO:0032530 | regulation of microvillus organization | 6 | 10 | 2.76e-02 |
| GO:BP | GO:0033275 | actin-myosin filament sliding | 6 | 10 | 2.76e-02 |
| GO:BP | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 9 | 20 | 2.76e-02 |
| GO:BP | GO:1903671 | negative regulation of sprouting angiogenesis | 6 | 10 | 2.76e-02 |
| GO:BP | GO:0031099 | regeneration | 36 | 144 | 2.81e-02 |
| GO:BP | GO:0070613 | regulation of protein processing | 15 | 44 | 2.81e-02 |
| GO:BP | GO:0050678 | regulation of epithelial cell proliferation | 56 | 249 | 2.81e-02 |
| GO:BP | GO:0002042 | cell migration involved in sprouting angiogenesis | 15 | 44 | 2.81e-02 |
| GO:BP | GO:0010876 | lipid localization | 65 | 298 | 2.82e-02 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 65 | 298 | 2.82e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 32 | 124 | 2.84e-02 |
| GO:BP | GO:0043409 | negative regulation of MAPK cascade | 32 | 124 | 2.84e-02 |
| GO:BP | GO:0007519 | skeletal muscle tissue development | 31 | 119 | 2.84e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 24 | 85 | 2.86e-02 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 39 | 160 | 3.00e-02 |
| GO:BP | GO:0045923 | positive regulation of fatty acid metabolic process | 10 | 24 | 3.01e-02 |
| GO:BP | GO:0098868 | bone growth | 10 | 24 | 3.01e-02 |
| GO:BP | GO:0002763 | positive regulation of myeloid leukocyte differentiation | 13 | 36 | 3.06e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 13 | 36 | 3.06e-02 |
| GO:BP | GO:2001259 | positive regulation of cation channel activity | 13 | 36 | 3.06e-02 |
| GO:BP | GO:0006869 | lipid transport | 58 | 261 | 3.06e-02 |
| GO:BP | GO:0060429 | epithelium development | 151 | 792 | 3.09e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 52 | 229 | 3.15e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 29 | 110 | 3.17e-02 |
| GO:BP | GO:0071805 | potassium ion transmembrane transport | 31 | 120 | 3.20e-02 |
| GO:BP | GO:1904705 | regulation of vascular associated smooth muscle cell proliferation | 16 | 49 | 3.21e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 61 | 278 | 3.23e-02 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 119 | 606 | 3.24e-02 |
| GO:BP | GO:0019752 | carboxylic acid metabolic process | 119 | 606 | 3.24e-02 |
| GO:BP | GO:0048844 | artery morphogenesis | 18 | 58 | 3.27e-02 |
| GO:BP | GO:0010955 | negative regulation of protein processing | 8 | 17 | 3.34e-02 |
| GO:BP | GO:0030206 | chondroitin sulfate biosynthetic process | 8 | 17 | 3.34e-02 |
| GO:BP | GO:1903318 | negative regulation of protein maturation | 8 | 17 | 3.34e-02 |
| GO:BP | GO:0034383 | low-density lipoprotein particle clearance | 8 | 17 | 3.34e-02 |
| GO:BP | GO:0006090 | pyruvate metabolic process | 25 | 91 | 3.38e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 83 | 401 | 3.41e-02 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 125 | 642 | 3.41e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 89 | 435 | 3.42e-02 |
| GO:BP | GO:0009185 | ribonucleoside diphosphate metabolic process | 26 | 96 | 3.44e-02 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 181 | 973 | 3.47e-02 |
| GO:BP | GO:0097191 | extrinsic apoptotic signaling pathway | 41 | 172 | 3.47e-02 |
| GO:BP | GO:0051258 | protein polymerization | 51 | 225 | 3.48e-02 |
| GO:BP | GO:0009132 | nucleoside diphosphate metabolic process | 27 | 101 | 3.48e-02 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 34 | 136 | 3.48e-02 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 669 | 4015 | 3.51e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 17 | 54 | 3.53e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 30 | 116 | 3.54e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 43 | 183 | 3.63e-02 |
| GO:BP | GO:0031638 | zymogen activation | 14 | 41 | 3.63e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 172 | 921 | 3.69e-02 |
| GO:BP | GO:0045216 | cell-cell junction organization | 37 | 152 | 3.72e-02 |
| GO:BP | GO:0019915 | lipid storage | 20 | 68 | 3.72e-02 |
| GO:BP | GO:0055002 | striated muscle cell development | 20 | 68 | 3.72e-02 |
| GO:BP | GO:0043436 | oxoacid metabolic process | 121 | 621 | 3.78e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 13 | 37 | 3.81e-02 |
| GO:BP | GO:1903115 | regulation of actin filament-based movement | 13 | 37 | 3.81e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 16 | 50 | 3.82e-02 |
| GO:BP | GO:0015918 | sterol transport | 25 | 92 | 3.82e-02 |
| GO:BP | GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 16 | 50 | 3.82e-02 |
| GO:BP | GO:0035914 | skeletal muscle cell differentiation | 16 | 50 | 3.82e-02 |
| GO:BP | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 3.83e-02 |
| GO:BP | GO:1904261 | positive regulation of basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 3.83e-02 |
| GO:BP | GO:2001197 | basement membrane assembly involved in embryonic body morphogenesis | 4 | 5 | 3.83e-02 |
| GO:BP | GO:2000669 | negative regulation of dendritic cell apoptotic process | 4 | 5 | 3.83e-02 |
| GO:BP | GO:1904978 | regulation of endosome organization | 4 | 5 | 3.83e-02 |
| GO:BP | GO:0021960 | anterior commissure morphogenesis | 4 | 5 | 3.83e-02 |
| GO:BP | GO:0046898 | response to cycloheximide | 4 | 5 | 3.83e-02 |
| GO:BP | GO:1902267 | regulation of polyamine transmembrane transport | 4 | 5 | 3.83e-02 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 94 | 466 | 3.85e-02 |
| GO:BP | GO:0006790 | sulfur compound metabolic process | 52 | 232 | 3.88e-02 |
| GO:BP | GO:0010927 | cellular component assembly involved in morphogenesis | 28 | 107 | 3.89e-02 |
| GO:BP | GO:0032232 | negative regulation of actin filament bundle assembly | 10 | 25 | 3.90e-02 |
| GO:BP | GO:1901203 | positive regulation of extracellular matrix assembly | 7 | 14 | 3.90e-02 |
| GO:BP | GO:0060142 | regulation of syncytium formation by plasma membrane fusion | 7 | 14 | 3.90e-02 |
| GO:BP | GO:1904738 | vascular associated smooth muscle cell migration | 10 | 25 | 3.90e-02 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 46 | 200 | 3.90e-02 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 402 | 2333 | 3.95e-02 |
| GO:BP | GO:0072526 | pyridine-containing compound catabolic process | 22 | 78 | 3.96e-02 |
| GO:BP | GO:0009191 | ribonucleoside diphosphate catabolic process | 22 | 78 | 3.96e-02 |
| GO:BP | GO:0055017 | cardiac muscle tissue growth | 19 | 64 | 4.01e-02 |
| GO:BP | GO:1904036 | negative regulation of epithelial cell apoptotic process | 15 | 46 | 4.05e-02 |
| GO:BP | GO:0030182 | neuron differentiation | 187 | 1014 | 4.07e-02 |
| GO:BP | GO:0010657 | muscle cell apoptotic process | 17 | 55 | 4.12e-02 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 86 | 422 | 4.17e-02 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 378 | 2186 | 4.24e-02 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 87 | 428 | 4.25e-02 |
| GO:BP | GO:0060538 | skeletal muscle organ development | 32 | 128 | 4.29e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 124 | 642 | 4.34e-02 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 53 | 239 | 4.36e-02 |
| GO:BP | GO:0022408 | negative regulation of cell-cell adhesion | 29 | 113 | 4.36e-02 |
| GO:BP | GO:1905954 | positive regulation of lipid localization | 21 | 74 | 4.42e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 83 | 406 | 4.42e-02 |
| GO:BP | GO:0014854 | response to inactivity | 6 | 11 | 4.46e-02 |
| GO:BP | GO:0014733 | regulation of skeletal muscle adaptation | 6 | 11 | 4.46e-02 |
| GO:BP | GO:1901739 | regulation of myoblast fusion | 6 | 11 | 4.46e-02 |
| GO:BP | GO:0010172 | embryonic body morphogenesis | 6 | 11 | 4.46e-02 |
| GO:BP | GO:0021783 | preganglionic parasympathetic fiber development | 6 | 11 | 4.46e-02 |
| GO:BP | GO:1990874 | vascular associated smooth muscle cell proliferation | 16 | 51 | 4.47e-02 |
| GO:BP | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway | 16 | 51 | 4.47e-02 |
| GO:BP | GO:0030278 | regulation of ossification | 22 | 79 | 4.54e-02 |
| GO:BP | GO:0048666 | neuron development | 157 | 838 | 4.56e-02 |
| GO:BP | GO:0010639 | negative regulation of organelle organization | 62 | 289 | 4.56e-02 |
| GO:BP | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 8 | 18 | 4.61e-02 |
| GO:BP | GO:0055093 | response to hyperoxia | 8 | 18 | 4.61e-02 |
| GO:BP | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway | 5 | 8 | 4.66e-02 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 414 | 2415 | 4.66e-02 |
| GO:BP | GO:0045861 | negative regulation of proteolysis | 32 | 129 | 4.73e-02 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 50 | 224 | 4.76e-02 |
| GO:BP | GO:0046434 | organophosphate catabolic process | 41 | 176 | 4.81e-02 |
| GO:BP | GO:0048639 | positive regulation of developmental growth | 30 | 119 | 4.81e-02 |
| GO:BP | GO:0062013 | positive regulation of small molecule metabolic process | 26 | 99 | 4.83e-02 |
| GO:BP | GO:0045766 | positive regulation of angiogenesis | 29 | 114 | 4.83e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 17 | 56 | 4.83e-02 |
| GO:BP | GO:0002067 | glandular epithelial cell differentiation | 15 | 47 | 4.83e-02 |
| GO:BP | GO:0097006 | regulation of plasma lipoprotein particle levels | 15 | 47 | 4.83e-02 |
| GO:BP | GO:1903317 | regulation of protein maturation | 15 | 47 | 4.83e-02 |
| GO:BP | GO:0001938 | positive regulation of endothelial cell proliferation | 20 | 70 | 4.84e-02 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 107 | 546 | 4.91e-02 |
| GO:BP | GO:0001945 | lymph vessel development | 9 | 22 | 4.91e-02 |
| GO:BP | GO:1900027 | regulation of ruffle assembly | 9 | 22 | 4.91e-02 |
| GO:BP | GO:1903779 | regulation of cardiac conduction | 9 | 22 | 4.91e-02 |
| GO:BP | GO:0030279 | negative regulation of ossification | 9 | 22 | 4.91e-02 |
| GO:BP | GO:0033688 | regulation of osteoblast proliferation | 9 | 22 | 4.91e-02 |
| GO:BP | GO:0051497 | negative regulation of stress fiber assembly | 9 | 22 | 4.91e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 35 | 145 | 4.92e-02 |
| GO:BP | GO:0032373 | positive regulation of sterol transport | 11 | 30 | 4.94e-02 |
| GO:BP | GO:0032376 | positive regulation of cholesterol transport | 11 | 30 | 4.94e-02 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 39 | 166 | 4.96e-02 |
| GO:BP | GO:1904035 | regulation of epithelial cell apoptotic process | 21 | 75 | 4.96e-02 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 21 | 75 | 4.96e-02 |
LRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in LR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:04261 | Adrenergic signaling in cardiomyocytes | 43 | 124 | 2.31e-05 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 32 | 82 | 2.50e-05 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 30 | 77 | 4.24e-05 |
| KEGG | KEGG:03320 | PPAR signaling pathway | 21 | 47 | 1.29e-04 |
| KEGG | KEGG:04510 | Focal adhesion | 48 | 169 | 4.37e-04 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 25 | 67 | 4.37e-04 |
| KEGG | KEGG:04925 | Aldosterone synthesis and secretion | 27 | 75 | 4.37e-04 |
| KEGG | KEGG:04971 | Gastric acid secretion | 20 | 51 | 1.23e-03 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 63 | 252 | 1.35e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 26 | 78 | 1.74e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 62 | 250 | 1.74e-03 |
| KEGG | KEGG:05200 | Pathways in cancer | 88 | 391 | 2.40e-03 |
| KEGG | KEGG:04260 | Cardiac muscle contraction | 22 | 63 | 2.47e-03 |
| KEGG | KEGG:04371 | Apelin signaling pathway | 31 | 104 | 3.08e-03 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 31 | 105 | 3.49e-03 |
| KEGG | KEGG:04512 | ECM-receptor interaction | 22 | 66 | 4.36e-03 |
| KEGG | KEGG:04927 | Cortisol synthesis and secretion | 17 | 46 | 5.32e-03 |
| KEGG | KEGG:04974 | Protein digestion and absorption | 19 | 56 | 8.00e-03 |
| KEGG | KEGG:04973 | Carbohydrate digestion and absorption | 12 | 29 | 1.11e-02 |
| KEGG | KEGG:04911 | Insulin secretion | 20 | 62 | 1.11e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 34 | 129 | 1.28e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 32 | 120 | 1.28e-02 |
| KEGG | KEGG:04931 | Insulin resistance | 26 | 91 | 1.28e-02 |
| KEGG | KEGG:04360 | Axon guidance | 39 | 155 | 1.28e-02 |
| KEGG | KEGG:05215 | Prostate cancer | 24 | 82 | 1.28e-02 |
| KEGG | KEGG:04020 | Calcium signaling pathway | 40 | 161 | 1.33e-02 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 40 | 162 | 1.41e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 40 | 162 | 1.41e-02 |
| KEGG | KEGG:05203 | Viral carcinogenesis | 36 | 142 | 1.42e-02 |
| KEGG | KEGG:04972 | Pancreatic secretion | 18 | 57 | 1.74e-02 |
| KEGG | KEGG:05146 | Amoebiasis | 19 | 62 | 1.82e-02 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 39 | 160 | 1.82e-02 |
| KEGG | KEGG:00000 | KEGG root term | 893 | 5451 | 1.83e-02 |
| KEGG | KEGG:04750 | Inflammatory mediator regulation of TRP channels | 21 | 72 | 2.00e-02 |
| KEGG | KEGG:05222 | Small cell lung cancer | 23 | 82 | 2.15e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 20 | 68 | 2.15e-02 |
| KEGG | KEGG:00330 | Arginine and proline metabolism | 12 | 33 | 2.22e-02 |
| KEGG | KEGG:04740 | Olfactory transduction | 10 | 25 | 2.22e-02 |
| KEGG | KEGG:04520 | Adherens junction | 23 | 83 | 2.29e-02 |
| KEGG | KEGG:04611 | Platelet activation | 24 | 88 | 2.30e-02 |
| KEGG | KEGG:05131 | Shigellosis | 46 | 204 | 3.02e-02 |
| KEGG | KEGG:04330 | Notch signaling pathway | 16 | 52 | 3.02e-02 |
| KEGG | KEGG:04930 | Type II diabetes mellitus | 12 | 35 | 3.33e-02 |
| KEGG | KEGG:04024 | cAMP signaling pathway | 35 | 147 | 3.33e-02 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 23 | 87 | 3.76e-02 |
| KEGG | KEGG:04961 | Endocrine and other factor-regulated calcium reabsorption | 13 | 40 | 3.76e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 27 | 109 | 4.52e-02 |
| KEGG | KEGG:04976 | Bile secretion | 13 | 41 | 4.52e-02 |
| KEGG | KEGG:04934 | Cushing syndrome | 29 | 119 | 4.52e-02 |
| KEGG | KEGG:00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 8 | 20 | 4.54e-02 |
# NR_resgenes_20k <- gost(query = NR_peak_list_20k$NCBI_gene,
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes_20k,"data/GO_KEGG_analysis/NR_resgenes_20k.RDS")
# NRnom <- gostplot(NR_resgenes_20k, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable_20k <- NR_resgenes_20k$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable_20k %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR nESRgenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0065007 | biological regulation | 6753 | 7734 | 7.94e-28 |
| GO:BP | GO:0050789 | regulation of biological process | 6566 | 7516 | 5.66e-27 |
| GO:BP | GO:0032501 | multicellular organismal process | 4014 | 4504 | 1.03e-26 |
| GO:BP | GO:0008150 | biological_process | 9626 | 11244 | 1.58e-26 |
| GO:BP | GO:0007154 | cell communication | 3564 | 3983 | 4.36e-26 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1703 | 1844 | 1.98e-25 |
| GO:BP | GO:0023052 | signaling | 3505 | 3918 | 2.27e-25 |
| GO:BP | GO:0050896 | response to stimulus | 4753 | 5379 | 3.08e-25 |
| GO:BP | GO:0048856 | anatomical structure development | 3460 | 3867 | 3.64e-25 |
| GO:BP | GO:0032502 | developmental process | 3727 | 4179 | 5.82e-25 |
| GO:BP | GO:0050794 | regulation of cellular process | 6245 | 7153 | 9.47e-24 |
| GO:BP | GO:0051716 | cellular response to stimulus | 4115 | 4640 | 2.25e-23 |
| GO:BP | GO:0007275 | multicellular organism development | 2848 | 3170 | 3.18e-22 |
| GO:BP | GO:0007165 | signal transduction | 3228 | 3611 | 3.39e-22 |
| GO:BP | GO:0048731 | system development | 2448 | 2719 | 1.49e-19 |
| GO:BP | GO:0009987 | cellular process | 9149 | 10686 | 1.28e-18 |
| GO:BP | GO:0048869 | cellular developmental process | 2514 | 2804 | 1.41e-17 |
| GO:BP | GO:0030154 | cell differentiation | 2513 | 2803 | 1.45e-17 |
| GO:BP | GO:0048513 | animal organ development | 1818 | 2004 | 3.74e-17 |
| GO:BP | GO:0023051 | regulation of signaling | 2194 | 2438 | 7.97e-17 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 3153 | 3550 | 7.97e-17 |
| GO:BP | GO:0010646 | regulation of cell communication | 2199 | 2444 | 8.62e-17 |
| GO:BP | GO:0048519 | negative regulation of biological process | 3335 | 3764 | 1.61e-16 |
| GO:BP | GO:0048518 | positive regulation of biological process | 3794 | 4301 | 1.80e-16 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 2433 | 2717 | 2.95e-16 |
| GO:BP | GO:0009888 | tissue development | 1238 | 1348 | 1.70e-15 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 3491 | 3954 | 3.66e-15 |
| GO:BP | GO:0022008 | neurogenesis | 1150 | 1251 | 1.32e-14 |
| GO:BP | GO:0050793 | regulation of developmental process | 1541 | 1697 | 1.34e-14 |
| GO:BP | GO:0007267 | cell-cell signaling | 1000 | 1082 | 2.54e-14 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1948 | 2166 | 2.63e-14 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1736 | 1924 | 7.76e-14 |
| GO:BP | GO:0007399 | nervous system development | 1606 | 1775 | 9.10e-14 |
| GO:BP | GO:0048699 | generation of neurons | 993 | 1076 | 9.87e-14 |
| GO:BP | GO:0048468 | cell development | 1702 | 1886 | 1.29e-13 |
| GO:BP | GO:0051179 | localization | 3292 | 3731 | 1.32e-13 |
| GO:BP | GO:0000902 | cell morphogenesis | 670 | 713 | 1.32e-13 |
| GO:BP | GO:0006810 | transport | 2647 | 2984 | 1.02e-12 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1624 | 1801 | 1.46e-12 |
| GO:BP | GO:0030182 | neuron differentiation | 934 | 1014 | 3.10e-12 |
| GO:BP | GO:0016477 | cell migration | 931 | 1011 | 4.05e-12 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 777 | 837 | 4.07e-12 |
| GO:BP | GO:0042221 | response to chemical | 2057 | 2304 | 7.03e-12 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1577 | 1751 | 1.10e-11 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1749 | 1951 | 2.70e-11 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 1092 | 1197 | 2.72e-11 |
| GO:BP | GO:0035295 | tube development | 730 | 787 | 4.16e-11 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 571 | 609 | 6.78e-11 |
| GO:BP | GO:0008283 | cell population proliferation | 1186 | 1306 | 7.04e-11 |
| GO:BP | GO:0048870 | cell motility | 1023 | 1120 | 7.15e-11 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 947 | 1035 | 1.89e-10 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 420 | 442 | 2.02e-10 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 551 | 588 | 2.27e-10 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 2323 | 2622 | 3.04e-10 |
| GO:BP | GO:0051234 | establishment of localization | 2852 | 3240 | 5.16e-10 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 452 | 479 | 9.58e-10 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 625 | 673 | 1.16e-09 |
| GO:BP | GO:0060429 | epithelium development | 730 | 792 | 1.62e-09 |
| GO:BP | GO:0048729 | tissue morphogenesis | 428 | 453 | 1.91e-09 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 2140 | 2415 | 2.60e-09 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 663 | 717 | 2.71e-09 |
| GO:BP | GO:0003008 | system process | 1034 | 1139 | 2.98e-09 |
| GO:BP | GO:0065008 | regulation of biological quality | 1689 | 1893 | 3.54e-09 |
| GO:BP | GO:0120036 | plasma membrane bounded cell projection organization | 1043 | 1150 | 4.34e-09 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 2068 | 2333 | 4.55e-09 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 979 | 1077 | 4.55e-09 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 1186 | 1314 | 4.55e-09 |
| GO:BP | GO:0030029 | actin filament-based process | 594 | 640 | 4.66e-09 |
| GO:BP | GO:0035239 | tube morphogenesis | 592 | 638 | 5.64e-09 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 975 | 1073 | 6.09e-09 |
| GO:BP | GO:0030030 | cell projection organization | 1070 | 1182 | 7.17e-09 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 467 | 498 | 7.17e-09 |
| GO:BP | GO:0016043 | cellular component organization | 4175 | 4802 | 7.83e-09 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 992 | 1093 | 8.03e-09 |
| GO:BP | GO:0071310 | cellular response to organic substance | 1170 | 1297 | 8.23e-09 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 1163 | 1289 | 8.27e-09 |
| GO:BP | GO:0010033 | response to organic substance | 1551 | 1736 | 8.76e-09 |
| GO:BP | GO:0040011 | locomotion | 739 | 805 | 8.86e-09 |
| GO:BP | GO:1901698 | response to nitrogen compound | 678 | 736 | 9.63e-09 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 463 | 494 | 1.01e-08 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 3688 | 4231 | 1.33e-08 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 1349 | 1504 | 1.33e-08 |
| GO:BP | GO:0072359 | circulatory system development | 790 | 864 | 1.68e-08 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 833 | 913 | 1.71e-08 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 586 | 633 | 1.87e-08 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 632 | 685 | 1.91e-08 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 341 | 359 | 2.24e-08 |
| GO:BP | GO:0031175 | neuron projection development | 683 | 743 | 2.25e-08 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 340 | 358 | 2.48e-08 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 526 | 566 | 2.87e-08 |
| GO:BP | GO:0019222 | regulation of metabolic process | 4001 | 4603 | 3.50e-08 |
| GO:BP | GO:0048666 | neuron development | 766 | 838 | 3.52e-08 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 729 | 796 | 3.65e-08 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 448 | 479 | 4.55e-08 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1655 | 1862 | 7.90e-08 |
| GO:BP | GO:0040012 | regulation of locomotion | 661 | 720 | 7.97e-08 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 408 | 435 | 8.88e-08 |
| GO:BP | GO:0007010 | cytoskeleton organization | 1034 | 1146 | 8.88e-08 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 863 | 951 | 1.38e-07 |
| GO:BP | GO:0010468 | regulation of gene expression | 2954 | 3379 | 1.81e-07 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 426 | 456 | 1.89e-07 |
| GO:BP | GO:0006915 | apoptotic process | 1233 | 1377 | 2.39e-07 |
| GO:BP | GO:0098657 | import into cell | 573 | 622 | 2.48e-07 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 3680 | 4233 | 2.72e-07 |
| GO:BP | GO:0023056 | positive regulation of signaling | 1097 | 1221 | 3.09e-07 |
| GO:BP | GO:0007417 | central nervous system development | 636 | 694 | 3.60e-07 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 1094 | 1218 | 3.76e-07 |
| GO:BP | GO:0030334 | regulation of cell migration | 613 | 668 | 3.80e-07 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1930 | 2186 | 4.09e-07 |
| GO:BP | GO:2000145 | regulation of cell motility | 641 | 700 | 4.29e-07 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 558 | 606 | 4.66e-07 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 3042 | 3486 | 5.01e-07 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1645 | 1856 | 5.91e-07 |
| GO:BP | GO:0002009 | morphogenesis of an epithelium | 347 | 369 | 6.03e-07 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 544 | 591 | 8.26e-07 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1631 | 1841 | 9.12e-07 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 3408 | 3918 | 9.12e-07 |
| GO:BP | GO:0007155 | cell adhesion | 851 | 941 | 9.13e-07 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 937 | 1040 | 1.11e-06 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1587 | 1791 | 1.32e-06 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 3489 | 4015 | 1.41e-06 |
| GO:BP | GO:0009725 | response to hormone | 560 | 610 | 1.43e-06 |
| GO:BP | GO:0006468 | protein phosphorylation | 865 | 958 | 1.46e-06 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1724 | 1951 | 1.79e-06 |
| GO:BP | GO:0060322 | head development | 497 | 539 | 1.79e-06 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 982 | 1093 | 1.99e-06 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 3108 | 3569 | 2.09e-06 |
| GO:BP | GO:0007015 | actin filament organization | 335 | 357 | 2.10e-06 |
| GO:BP | GO:0016310 | phosphorylation | 1027 | 1145 | 2.16e-06 |
| GO:BP | GO:0023057 | negative regulation of signaling | 932 | 1036 | 2.41e-06 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 1449 | 1633 | 2.59e-06 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 3129 | 3595 | 2.87e-06 |
| GO:BP | GO:0065009 | regulation of molecular function | 1160 | 1299 | 2.87e-06 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 4311 | 4988 | 3.77e-06 |
| GO:BP | GO:0012501 | programmed cell death | 1263 | 1419 | 4.26e-06 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 929 | 1034 | 4.65e-06 |
| GO:BP | GO:0008219 | cell death | 1266 | 1423 | 5.20e-06 |
| GO:BP | GO:0006897 | endocytosis | 454 | 492 | 5.30e-06 |
| GO:BP | GO:0099536 | synaptic signaling | 446 | 483 | 5.42e-06 |
| GO:BP | GO:0009790 | embryo development | 743 | 821 | 5.46e-06 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 926 | 1031 | 5.55e-06 |
| GO:BP | GO:0051641 | cellular localization | 2297 | 2623 | 5.79e-06 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 468 | 508 | 5.79e-06 |
| GO:BP | GO:0007409 | axonogenesis | 316 | 337 | 6.04e-06 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 186 | 193 | 6.48e-06 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 332 | 355 | 6.50e-06 |
| GO:BP | GO:0061564 | axon development | 347 | 372 | 7.60e-06 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 1407 | 1588 | 9.20e-06 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 161 | 166 | 1.01e-05 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 399 | 431 | 1.12e-05 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 474 | 516 | 1.28e-05 |
| GO:BP | GO:0007420 | brain development | 458 | 498 | 1.39e-05 |
| GO:BP | GO:0036211 | protein modification process | 2010 | 2291 | 1.40e-05 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 955 | 1067 | 1.69e-05 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 1033 | 1157 | 1.73e-05 |
| GO:BP | GO:0060284 | regulation of cell development | 521 | 570 | 1.88e-05 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 1064 | 1193 | 1.88e-05 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 400 | 433 | 2.07e-05 |
| GO:BP | GO:0001944 | vasculature development | 505 | 552 | 2.09e-05 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 1845 | 2100 | 2.09e-05 |
| GO:BP | GO:0099537 | trans-synaptic signaling | 430 | 467 | 2.16e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 1028 | 1152 | 2.29e-05 |
| GO:BP | GO:0001568 | blood vessel development | 481 | 525 | 2.42e-05 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 948 | 1060 | 2.54e-05 |
| GO:BP | GO:0007507 | heart development | 458 | 499 | 2.55e-05 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 566 | 622 | 2.82e-05 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 2326 | 2663 | 2.83e-05 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 1410 | 1595 | 2.88e-05 |
| GO:BP | GO:0007268 | chemical synaptic transmission | 426 | 463 | 2.97e-05 |
| GO:BP | GO:0098916 | anterograde trans-synaptic signaling | 426 | 463 | 2.97e-05 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 463 | 505 | 3.07e-05 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 221 | 233 | 3.27e-05 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 871 | 972 | 3.29e-05 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1701 | 1934 | 3.38e-05 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 272 | 290 | 3.94e-05 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 246 | 261 | 3.97e-05 |
| GO:BP | GO:0060562 | epithelial tube morphogenesis | 246 | 261 | 3.97e-05 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 706 | 783 | 4.25e-05 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 414 | 450 | 4.26e-05 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1339 | 1514 | 4.42e-05 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1656 | 1883 | 5.07e-05 |
| GO:BP | GO:0010035 | response to inorganic substance | 350 | 378 | 5.31e-05 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 550 | 605 | 5.31e-05 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 1433 | 1624 | 5.76e-05 |
| GO:BP | GO:0048880 | sensory system development | 250 | 266 | 6.50e-05 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 1200 | 1354 | 6.59e-05 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 1442 | 1635 | 6.79e-05 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1673 | 1904 | 7.09e-05 |
| GO:BP | GO:0033036 | macromolecule localization | 2020 | 2309 | 7.24e-05 |
| GO:BP | GO:0061448 | connective tissue development | 195 | 205 | 7.46e-05 |
| GO:BP | GO:0006811 | monoatomic ion transport | 649 | 719 | 7.81e-05 |
| GO:BP | GO:0150063 | visual system development | 248 | 264 | 7.81e-05 |
| GO:BP | GO:0001501 | skeletal system development | 322 | 347 | 7.81e-05 |
| GO:BP | GO:1901653 | cellular response to peptide | 256 | 273 | 8.23e-05 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 383 | 416 | 8.48e-05 |
| GO:BP | GO:0001654 | eye development | 247 | 263 | 8.61e-05 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 2116 | 2422 | 8.63e-05 |
| GO:BP | GO:0001525 | angiogenesis | 352 | 381 | 8.64e-05 |
| GO:BP | GO:0071702 | organic substance transport | 1516 | 1722 | 8.65e-05 |
| GO:BP | GO:0030900 | forebrain development | 255 | 272 | 8.92e-05 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 672 | 746 | 1.02e-04 |
| GO:BP | GO:0032879 | regulation of localization | 1272 | 1439 | 1.03e-04 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 2105 | 2410 | 1.06e-04 |
| GO:BP | GO:0043066 | negative regulation of apoptotic process | 561 | 619 | 1.07e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 637 | 706 | 1.07e-04 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 218 | 231 | 1.14e-04 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 364 | 395 | 1.14e-04 |
| GO:BP | GO:0040007 | growth | 629 | 697 | 1.15e-04 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 869 | 973 | 1.16e-04 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 862 | 965 | 1.19e-04 |
| GO:BP | GO:0051049 | regulation of transport | 977 | 1098 | 1.30e-04 |
| GO:BP | GO:0099177 | regulation of trans-synaptic signaling | 300 | 323 | 1.31e-04 |
| GO:BP | GO:0043434 | response to peptide hormone | 292 | 314 | 1.31e-04 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 414 | 452 | 1.38e-04 |
| GO:BP | GO:0007389 | pattern specification process | 267 | 286 | 1.38e-04 |
| GO:BP | GO:0021915 | neural tube development | 129 | 133 | 1.39e-04 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 2518 | 2895 | 1.39e-04 |
| GO:BP | GO:0050804 | modulation of chemical synaptic transmission | 299 | 322 | 1.41e-04 |
| GO:BP | GO:0048589 | developmental growth | 457 | 501 | 1.45e-04 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 1094 | 1234 | 1.57e-04 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 375 | 408 | 1.57e-04 |
| GO:BP | GO:0030001 | metal ion transport | 477 | 524 | 1.63e-04 |
| GO:BP | GO:0042592 | homeostatic process | 1010 | 1137 | 1.70e-04 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 504 | 555 | 1.82e-04 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 1091 | 1231 | 1.82e-04 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 580 | 642 | 1.90e-04 |
| GO:BP | GO:0048598 | embryonic morphogenesis | 387 | 422 | 2.00e-04 |
| GO:BP | GO:0010720 | positive regulation of cell development | 287 | 309 | 2.04e-04 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 349 | 379 | 2.06e-04 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 349 | 379 | 2.06e-04 |
| GO:BP | GO:0007423 | sensory organ development | 356 | 387 | 2.16e-04 |
| GO:BP | GO:0009605 | response to external stimulus | 1373 | 1559 | 2.18e-04 |
| GO:BP | GO:1901652 | response to peptide | 339 | 368 | 2.54e-04 |
| GO:BP | GO:0055085 | transmembrane transport | 822 | 921 | 2.61e-04 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 227 | 242 | 2.61e-04 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 87 | 88 | 2.84e-04 |
| GO:BP | GO:0034220 | monoatomic ion transmembrane transport | 531 | 587 | 3.22e-04 |
| GO:BP | GO:0070848 | response to growth factor | 496 | 547 | 3.24e-04 |
| GO:BP | GO:0043010 | camera-type eye development | 216 | 230 | 3.39e-04 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 241 | 258 | 3.43e-04 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 121 | 125 | 3.90e-04 |
| GO:BP | GO:0051897 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 121 | 125 | 3.90e-04 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 479 | 528 | 4.00e-04 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 486 | 536 | 4.00e-04 |
| GO:BP | GO:0048736 | appendage development | 131 | 136 | 4.15e-04 |
| GO:BP | GO:0060173 | limb development | 131 | 136 | 4.15e-04 |
| GO:BP | GO:0051649 | establishment of localization in cell | 1377 | 1566 | 4.27e-04 |
| GO:BP | GO:0003007 | heart morphogenesis | 205 | 218 | 4.30e-04 |
| GO:BP | GO:0006812 | monoatomic cation transport | 554 | 614 | 4.33e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 641 | 714 | 4.63e-04 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 707 | 790 | 4.74e-04 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 2204 | 2533 | 5.30e-04 |
| GO:BP | GO:0035107 | appendage morphogenesis | 107 | 110 | 5.65e-04 |
| GO:BP | GO:0016331 | morphogenesis of embryonic epithelium | 118 | 122 | 5.65e-04 |
| GO:BP | GO:0035108 | limb morphogenesis | 107 | 110 | 5.65e-04 |
| GO:BP | GO:0006351 | DNA-templated transcription | 2184 | 2510 | 5.80e-04 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 243 | 261 | 6.16e-04 |
| GO:BP | GO:0043491 | phosphatidylinositol 3-kinase/protein kinase B signal transduction | 201 | 214 | 6.50e-04 |
| GO:BP | GO:0050877 | nervous system process | 541 | 600 | 6.55e-04 |
| GO:BP | GO:0031399 | regulation of protein modification process | 811 | 911 | 7.04e-04 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 811 | 911 | 7.04e-04 |
| GO:BP | GO:0031032 | actomyosin structure organization | 174 | 184 | 7.06e-04 |
| GO:BP | GO:0098655 | monoatomic cation transmembrane transport | 449 | 495 | 7.47e-04 |
| GO:BP | GO:0032868 | response to insulin | 191 | 203 | 7.47e-04 |
| GO:BP | GO:0010038 | response to metal ion | 232 | 249 | 8.10e-04 |
| GO:BP | GO:0003002 | regionalization | 240 | 258 | 8.13e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 154 | 162 | 8.64e-04 |
| GO:BP | GO:0097485 | neuron projection guidance | 163 | 172 | 8.72e-04 |
| GO:BP | GO:0007411 | axon guidance | 163 | 172 | 8.72e-04 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 677 | 757 | 8.72e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 247 | 266 | 8.85e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 316 | 344 | 9.13e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 103 | 106 | 9.44e-04 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 153 | 161 | 9.53e-04 |
| GO:BP | GO:0051896 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | 171 | 181 | 9.60e-04 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 277 | 300 | 9.89e-04 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 188 | 200 | 1.00e-03 |
| GO:BP | GO:0048732 | gland development | 284 | 308 | 1.05e-03 |
| GO:BP | GO:0034330 | cell junction organization | 492 | 545 | 1.09e-03 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 757 | 850 | 1.13e-03 |
| GO:BP | GO:0019538 | protein metabolic process | 3125 | 3619 | 1.15e-03 |
| GO:BP | GO:0060485 | mesenchyme development | 228 | 245 | 1.16e-03 |
| GO:BP | GO:0098662 | inorganic cation transmembrane transport | 435 | 480 | 1.21e-03 |
| GO:BP | GO:0009611 | response to wounding | 349 | 382 | 1.24e-03 |
| GO:BP | GO:0042330 | taxis | 227 | 244 | 1.26e-03 |
| GO:BP | GO:0006935 | chemotaxis | 227 | 244 | 1.26e-03 |
| GO:BP | GO:0051960 | regulation of nervous system development | 311 | 339 | 1.36e-03 |
| GO:BP | GO:0035567 | non-canonical Wnt signaling pathway | 61 | 61 | 1.38e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 508 | 564 | 1.47e-03 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 425 | 469 | 1.49e-03 |
| GO:BP | GO:0030855 | epithelial cell differentiation | 389 | 428 | 1.57e-03 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 109 | 113 | 1.74e-03 |
| GO:BP | GO:0003018 | vascular process in circulatory system | 182 | 194 | 1.86e-03 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 277 | 301 | 1.91e-03 |
| GO:BP | GO:0098660 | inorganic ion transmembrane transport | 470 | 521 | 1.91e-03 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 127 | 133 | 2.20e-03 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 495 | 550 | 2.23e-03 |
| GO:BP | GO:0048813 | dendrite morphogenesis | 107 | 111 | 2.24e-03 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 355 | 390 | 2.40e-03 |
| GO:BP | GO:0046777 | protein autophosphorylation | 135 | 142 | 2.59e-03 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 716 | 805 | 2.65e-03 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1751 | 2010 | 2.69e-03 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 2617 | 3026 | 2.77e-03 |
| GO:BP | GO:0043410 | positive regulation of MAPK cascade | 265 | 288 | 2.79e-03 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 715 | 804 | 2.79e-03 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 374 | 412 | 2.83e-03 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 152 | 161 | 2.86e-03 |
| GO:BP | GO:0071705 | nitrogen compound transport | 1272 | 1451 | 2.96e-03 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 610 | 683 | 2.97e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 264 | 287 | 3.01e-03 |
| GO:BP | GO:0003013 | circulatory system process | 386 | 426 | 3.27e-03 |
| GO:BP | GO:0048568 | embryonic organ development | 278 | 303 | 3.27e-03 |
| GO:BP | GO:0061061 | muscle structure development | 482 | 536 | 3.29e-03 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 159 | 169 | 3.39e-03 |
| GO:BP | GO:0099003 | vesicle-mediated transport in synapse | 159 | 169 | 3.39e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 574 | 642 | 3.55e-03 |
| GO:BP | GO:0048167 | regulation of synaptic plasticity | 132 | 139 | 3.55e-03 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 299 | 327 | 3.55e-03 |
| GO:BP | GO:0033993 | response to lipid | 514 | 573 | 3.61e-03 |
| GO:BP | GO:0044057 | regulation of system process | 349 | 384 | 3.66e-03 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 1559 | 1787 | 3.71e-03 |
| GO:BP | GO:0007517 | muscle organ development | 246 | 267 | 3.78e-03 |
| GO:BP | GO:0008104 | protein localization | 1741 | 2000 | 3.80e-03 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 2532 | 2928 | 3.83e-03 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 418 | 463 | 3.84e-03 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 418 | 463 | 3.84e-03 |
| GO:BP | GO:0072175 | epithelial tube formation | 112 | 117 | 3.99e-03 |
| GO:BP | GO:0008152 | metabolic process | 6750 | 7921 | 3.99e-03 |
| GO:BP | GO:0001838 | embryonic epithelial tube formation | 102 | 106 | 4.03e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 498 | 555 | 4.17e-03 |
| GO:BP | GO:0031503 | protein-containing complex localization | 148 | 157 | 4.24e-03 |
| GO:BP | GO:0009267 | cellular response to starvation | 139 | 147 | 4.33e-03 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 1637 | 1879 | 4.35e-03 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 189 | 203 | 4.56e-03 |
| GO:BP | GO:0043009 | chordate embryonic development | 456 | 507 | 4.61e-03 |
| GO:BP | GO:0042692 | muscle cell differentiation | 295 | 323 | 4.75e-03 |
| GO:BP | GO:0009894 | regulation of catabolic process | 736 | 830 | 4.78e-03 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 2530 | 2927 | 4.81e-03 |
| GO:BP | GO:0050769 | positive regulation of neurogenesis | 172 | 184 | 4.84e-03 |
| GO:BP | GO:0043412 | macromolecule modification | 2157 | 2489 | 4.94e-03 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 468 | 521 | 5.03e-03 |
| GO:BP | GO:0051216 | cartilage development | 137 | 145 | 5.33e-03 |
| GO:BP | GO:0016358 | dendrite development | 171 | 183 | 5.33e-03 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 203 | 219 | 5.39e-03 |
| GO:BP | GO:0001841 | neural tube formation | 89 | 92 | 5.56e-03 |
| GO:BP | GO:0090596 | sensory organ morphogenesis | 162 | 173 | 5.71e-03 |
| GO:BP | GO:0035148 | tube formation | 118 | 124 | 5.89e-03 |
| GO:BP | GO:0031099 | regeneration | 136 | 144 | 5.90e-03 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 719 | 811 | 5.90e-03 |
| GO:BP | GO:0055001 | muscle cell development | 153 | 163 | 6.04e-03 |
| GO:BP | GO:0051051 | negative regulation of transport | 262 | 286 | 6.27e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 583 | 654 | 6.28e-03 |
| GO:BP | GO:0071704 | organic substance metabolic process | 6459 | 7578 | 6.46e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 224 | 243 | 6.49e-03 |
| GO:BP | GO:0060560 | developmental growth involved in morphogenesis | 177 | 190 | 6.49e-03 |
| GO:BP | GO:0060541 | respiratory system development | 152 | 162 | 6.64e-03 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 216 | 234 | 6.67e-03 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 246 | 268 | 6.82e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 143 | 152 | 6.94e-03 |
| GO:BP | GO:0060326 | cell chemotaxis | 143 | 152 | 6.94e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 489 | 546 | 7.01e-03 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 2477 | 2867 | 7.08e-03 |
| GO:BP | GO:0050773 | regulation of dendrite development | 76 | 78 | 7.16e-03 |
| GO:BP | GO:0046907 | intracellular transport | 1019 | 1160 | 7.18e-03 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 260 | 284 | 7.20e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 125 | 132 | 7.24e-03 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 5593 | 6550 | 7.42e-03 |
| GO:BP | GO:0050673 | epithelial cell proliferation | 274 | 300 | 7.54e-03 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 789 | 893 | 7.59e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 142 | 151 | 7.59e-03 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 393 | 436 | 7.74e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 124 | 131 | 8.04e-03 |
| GO:BP | GO:0050772 | positive regulation of axonogenesis | 63 | 64 | 8.24e-03 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 63 | 64 | 8.24e-03 |
| GO:BP | GO:0044238 | primary metabolic process | 6153 | 7216 | 8.24e-03 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 385 | 427 | 8.32e-03 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 182 | 196 | 8.33e-03 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 105 | 110 | 8.59e-03 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 518 | 580 | 8.66e-03 |
| GO:BP | GO:0034762 | regulation of transmembrane transport | 272 | 298 | 8.66e-03 |
| GO:BP | GO:0009410 | response to xenobiotic stimulus | 250 | 273 | 8.70e-03 |
| GO:BP | GO:0002682 | regulation of immune system process | 767 | 868 | 8.74e-03 |
| GO:BP | GO:0045664 | regulation of neuron differentiation | 123 | 130 | 8.80e-03 |
| GO:BP | GO:0021537 | telencephalon development | 181 | 195 | 9.06e-03 |
| GO:BP | GO:0030097 | hemopoiesis | 556 | 624 | 9.15e-03 |
| GO:BP | GO:0033043 | regulation of organelle organization | 840 | 953 | 9.48e-03 |
| GO:BP | GO:0051961 | negative regulation of nervous system development | 104 | 109 | 9.54e-03 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 196 | 212 | 9.56e-03 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 396 | 440 | 9.72e-03 |
| GO:BP | GO:0001764 | neuron migration | 122 | 129 | 9.75e-03 |
| GO:BP | GO:0061351 | neural precursor cell proliferation | 113 | 119 | 9.75e-03 |
| GO:BP | GO:0035113 | embryonic appendage morphogenesis | 84 | 87 | 9.82e-03 |
| GO:BP | GO:0030326 | embryonic limb morphogenesis | 84 | 87 | 9.82e-03 |
| GO:BP | GO:0014020 | primary neural tube formation | 84 | 87 | 9.82e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 73 | 75 | 1.02e-02 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 130 | 138 | 1.05e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 374 | 415 | 1.07e-02 |
| GO:BP | GO:0043588 | skin development | 163 | 175 | 1.08e-02 |
| GO:BP | GO:0080134 | regulation of response to stress | 818 | 928 | 1.09e-02 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 3736 | 4354 | 1.09e-02 |
| GO:BP | GO:0031346 | positive regulation of cell projection organization | 261 | 286 | 1.13e-02 |
| GO:BP | GO:0001775 | cell activation | 558 | 627 | 1.15e-02 |
| GO:BP | GO:0051098 | regulation of binding | 186 | 201 | 1.15e-02 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 120 | 127 | 1.19e-02 |
| GO:BP | GO:0006950 | response to stress | 2196 | 2540 | 1.20e-02 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 60 | 61 | 1.22e-02 |
| GO:BP | GO:0090132 | epithelium migration | 223 | 243 | 1.24e-02 |
| GO:BP | GO:0010631 | epithelial cell migration | 223 | 243 | 1.24e-02 |
| GO:BP | GO:0051261 | protein depolymerization | 92 | 96 | 1.24e-02 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 82 | 85 | 1.25e-02 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 46 | 46 | 1.27e-02 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 128 | 136 | 1.27e-02 |
| GO:BP | GO:0046661 | male sex differentiation | 101 | 106 | 1.31e-02 |
| GO:BP | GO:0000165 | MAPK cascade | 451 | 504 | 1.31e-02 |
| GO:BP | GO:0007043 | cell-cell junction assembly | 101 | 106 | 1.31e-02 |
| GO:BP | GO:0001763 | morphogenesis of a branching structure | 136 | 145 | 1.33e-02 |
| GO:BP | GO:0042063 | gliogenesis | 222 | 242 | 1.33e-02 |
| GO:BP | GO:0002376 | immune system process | 1231 | 1410 | 1.36e-02 |
| GO:BP | GO:0035725 | sodium ion transmembrane transport | 91 | 95 | 1.38e-02 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 127 | 135 | 1.39e-02 |
| GO:BP | GO:0007498 | mesoderm development | 81 | 84 | 1.39e-02 |
| GO:BP | GO:0060606 | tube closure | 81 | 84 | 1.39e-02 |
| GO:BP | GO:0061138 | morphogenesis of a branching epithelium | 127 | 135 | 1.39e-02 |
| GO:BP | GO:0042060 | wound healing | 265 | 291 | 1.40e-02 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 624 | 704 | 1.41e-02 |
| GO:BP | GO:0034329 | cell junction assembly | 293 | 323 | 1.44e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 109 | 115 | 1.46e-02 |
| GO:BP | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 45 | 45 | 1.46e-02 |
| GO:BP | GO:0071229 | cellular response to acid chemical | 70 | 72 | 1.46e-02 |
| GO:BP | GO:0043269 | regulation of monoatomic ion transport | 257 | 282 | 1.48e-02 |
| GO:BP | GO:0001666 | response to hypoxia | 213 | 232 | 1.49e-02 |
| GO:BP | GO:0031667 | response to nutrient levels | 320 | 354 | 1.52e-02 |
| GO:BP | GO:0001843 | neural tube closure | 80 | 83 | 1.56e-02 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 340 | 377 | 1.59e-02 |
| GO:BP | GO:0007623 | circadian rhythm | 142 | 152 | 1.63e-02 |
| GO:BP | GO:0006996 | organelle organization | 2428 | 2815 | 1.70e-02 |
| GO:BP | GO:0090130 | tissue migration | 226 | 247 | 1.72e-02 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 276 | 304 | 1.76e-02 |
| GO:BP | GO:0042542 | response to hydrogen peroxide | 79 | 82 | 1.76e-02 |
| GO:BP | GO:0048771 | tissue remodeling | 107 | 113 | 1.79e-02 |
| GO:BP | GO:0048754 | branching morphogenesis of an epithelial tube | 107 | 113 | 1.79e-02 |
| GO:BP | GO:0050768 | negative regulation of neurogenesis | 98 | 103 | 1.79e-02 |
| GO:BP | GO:0099504 | synaptic vesicle cycle | 141 | 151 | 1.79e-02 |
| GO:BP | GO:0050900 | leukocyte migration | 180 | 195 | 1.87e-02 |
| GO:BP | GO:0044089 | positive regulation of cellular component biogenesis | 351 | 390 | 1.88e-02 |
| GO:BP | GO:0006816 | calcium ion transport | 239 | 262 | 1.93e-02 |
| GO:BP | GO:0002685 | regulation of leukocyte migration | 115 | 122 | 1.95e-02 |
| GO:BP | GO:1904019 | epithelial cell apoptotic process | 97 | 102 | 2.00e-02 |
| GO:BP | GO:0032147 | activation of protein kinase activity | 56 | 57 | 2.06e-02 |
| GO:BP | GO:0001934 | positive regulation of protein phosphorylation | 356 | 396 | 2.10e-02 |
| GO:BP | GO:0046903 | secretion | 552 | 622 | 2.14e-02 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 87 | 91 | 2.16e-02 |
| GO:BP | GO:0031334 | positive regulation of protein-containing complex assembly | 139 | 149 | 2.16e-02 |
| GO:BP | GO:0072001 | renal system development | 223 | 244 | 2.16e-02 |
| GO:BP | GO:0072073 | kidney epithelium development | 105 | 111 | 2.22e-02 |
| GO:BP | GO:0034101 | erythrocyte homeostasis | 105 | 111 | 2.22e-02 |
| GO:BP | GO:0001101 | response to acid chemical | 96 | 101 | 2.22e-02 |
| GO:BP | GO:0045926 | negative regulation of growth | 170 | 184 | 2.27e-02 |
| GO:BP | GO:0031648 | protein destabilization | 42 | 42 | 2.27e-02 |
| GO:BP | GO:0003229 | ventricular cardiac muscle tissue development | 55 | 56 | 2.35e-02 |
| GO:BP | GO:0104004 | cellular response to environmental stimulus | 229 | 251 | 2.35e-02 |
| GO:BP | GO:0071214 | cellular response to abiotic stimulus | 229 | 251 | 2.35e-02 |
| GO:BP | GO:0030323 | respiratory tube development | 138 | 148 | 2.36e-02 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 236 | 259 | 2.39e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 86 | 90 | 2.40e-02 |
| GO:BP | GO:0010232 | vascular transport | 66 | 68 | 2.40e-02 |
| GO:BP | GO:0150104 | transport across blood-brain barrier | 66 | 68 | 2.40e-02 |
| GO:BP | GO:0030177 | positive regulation of Wnt signaling pathway | 104 | 110 | 2.44e-02 |
| GO:BP | GO:0040008 | regulation of growth | 413 | 462 | 2.47e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 199 | 217 | 2.47e-02 |
| GO:BP | GO:0006909 | phagocytosis | 129 | 138 | 2.54e-02 |
| GO:BP | GO:0048863 | stem cell differentiation | 176 | 191 | 2.58e-02 |
| GO:BP | GO:0061383 | trabecula morphogenesis | 41 | 41 | 2.61e-02 |
| GO:BP | GO:0055008 | cardiac muscle tissue morphogenesis | 54 | 55 | 2.66e-02 |
| GO:BP | GO:0021953 | central nervous system neuron differentiation | 94 | 99 | 2.74e-02 |
| GO:BP | GO:0043062 | extracellular structure organization | 205 | 224 | 2.75e-02 |
| GO:BP | GO:0045229 | external encapsulating structure organization | 205 | 224 | 2.75e-02 |
| GO:BP | GO:0070482 | response to oxygen levels | 241 | 265 | 2.77e-02 |
| GO:BP | GO:0055006 | cardiac cell development | 75 | 78 | 2.78e-02 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 128 | 137 | 2.78e-02 |
| GO:BP | GO:0071772 | response to BMP | 111 | 118 | 2.87e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 111 | 118 | 2.87e-02 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 226 | 248 | 2.90e-02 |
| GO:BP | GO:0030198 | extracellular matrix organization | 204 | 223 | 2.96e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 84 | 88 | 2.98e-02 |
| GO:BP | GO:0098927 | vesicle-mediated transport between endosomal compartments | 40 | 40 | 3.01e-02 |
| GO:BP | GO:0016049 | cell growth | 343 | 382 | 3.01e-02 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 93 | 98 | 3.02e-02 |
| GO:BP | GO:0071230 | cellular response to amino acid stimulus | 64 | 66 | 3.06e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 135 | 145 | 3.06e-02 |
| GO:BP | GO:0014033 | neural crest cell differentiation | 74 | 77 | 3.12e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 260 | 287 | 3.19e-02 |
| GO:BP | GO:0061458 | reproductive system development | 188 | 205 | 3.26e-02 |
| GO:BP | GO:0030048 | actin filament-based movement | 101 | 107 | 3.30e-02 |
| GO:BP | GO:0034446 | substrate adhesion-dependent cell spreading | 83 | 87 | 3.32e-02 |
| GO:BP | GO:0008015 | blood circulation | 321 | 357 | 3.35e-02 |
| GO:BP | GO:0030324 | lung development | 134 | 144 | 3.35e-02 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 536 | 605 | 3.35e-02 |
| GO:BP | GO:0007548 | sex differentiation | 165 | 179 | 3.37e-02 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 252 | 278 | 3.40e-02 |
| GO:BP | GO:0048332 | mesoderm morphogenesis | 52 | 53 | 3.44e-02 |
| GO:BP | GO:0014009 | glial cell proliferation | 39 | 39 | 3.47e-02 |
| GO:BP | GO:0001822 | kidney development | 216 | 237 | 3.53e-02 |
| GO:BP | GO:0014074 | response to purine-containing compound | 100 | 106 | 3.64e-02 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 603 | 683 | 3.74e-02 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 385 | 431 | 3.90e-02 |
| GO:BP | GO:0016239 | positive regulation of macroautophagy | 62 | 64 | 3.93e-02 |
| GO:BP | GO:0045165 | cell fate commitment | 140 | 151 | 3.98e-02 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 3000 | 3495 | 4.02e-02 |
| GO:BP | GO:0060041 | retina development in camera-type eye | 99 | 105 | 4.05e-02 |
| GO:BP | GO:2001222 | regulation of neuron migration | 38 | 38 | 4.05e-02 |
| GO:BP | GO:0048608 | reproductive structure development | 185 | 202 | 4.10e-02 |
| GO:BP | GO:0014902 | myotube differentiation | 81 | 85 | 4.12e-02 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 221 | 243 | 4.12e-02 |
| GO:BP | GO:0033135 | regulation of peptidyl-serine phosphorylation | 81 | 85 | 4.12e-02 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 90 | 95 | 4.13e-02 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 192 | 210 | 4.16e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 192 | 210 | 4.16e-02 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 767 | 874 | 4.16e-02 |
| GO:BP | GO:0046649 | lymphocyte activation | 396 | 444 | 4.34e-02 |
| GO:BP | GO:0001823 | mesonephros development | 71 | 74 | 4.40e-02 |
| GO:BP | GO:0002688 | regulation of leukocyte chemotaxis | 61 | 63 | 4.41e-02 |
| GO:BP | GO:0030218 | erythrocyte differentiation | 98 | 104 | 4.42e-02 |
| GO:BP | GO:0030902 | hindbrain development | 98 | 104 | 4.42e-02 |
| GO:BP | GO:0051048 | negative regulation of secretion | 98 | 104 | 4.42e-02 |
| GO:BP | GO:0001707 | mesoderm formation | 50 | 51 | 4.46e-02 |
| GO:BP | GO:0001704 | formation of primary germ layer | 89 | 94 | 4.57e-02 |
| GO:BP | GO:0007584 | response to nutrient | 106 | 113 | 4.63e-02 |
| GO:BP | GO:0045022 | early endosome to late endosome transport | 37 | 37 | 4.63e-02 |
| GO:BP | GO:0010658 | striated muscle cell apoptotic process | 37 | 37 | 4.63e-02 |
| GO:BP | GO:0007610 | behavior | 375 | 420 | 4.64e-02 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 247 | 273 | 4.72e-02 |
| GO:BP | GO:0060627 | regulation of vesicle-mediated transport | 335 | 374 | 4.75e-02 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 168 | 183 | 4.80e-02 |
| GO:BP | GO:0072163 | mesonephric epithelium development | 70 | 73 | 4.89e-02 |
| GO:BP | GO:0072164 | mesonephric tubule development | 70 | 73 | 4.89e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 60 | 62 | 4.94e-02 |
NRnomtable_20k %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR nESRgenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 4747 | 5451 | 5.17e-12 |
| KEGG | KEGG:05200 | Pathways in cancer | 365 | 391 | 5.04e-06 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 218 | 231 | 1.94e-04 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 129 | 133 | 1.94e-04 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 153 | 162 | 3.97e-03 |
| KEGG | KEGG:04520 | Adherens junction | 81 | 83 | 3.97e-03 |
| KEGG | KEGG:04510 | Focal adhesion | 159 | 169 | 3.97e-03 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 123 | 129 | 3.97e-03 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 136 | 144 | 5.87e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 87 | 90 | 6.07e-03 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 76 | 78 | 6.07e-03 |
| KEGG | KEGG:05217 | Basal cell carcinoma | 48 | 48 | 7.54e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 113 | 119 | 7.54e-03 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 229 | 250 | 1.06e-02 |
| KEGG | KEGG:04148 | Efferocytosis | 113 | 120 | 1.88e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 65 | 67 | 2.04e-02 |
| KEGG | KEGG:04360 | Axon guidance | 144 | 155 | 2.04e-02 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 101 | 107 | 2.04e-02 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 133 | 143 | 2.04e-02 |
| KEGG | KEGG:05165 | Human papillomavirus infection | 229 | 252 | 2.04e-02 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 148 | 160 | 2.04e-02 |
| KEGG | KEGG:04670 | Leukocyte transendothelial migration | 73 | 76 | 2.04e-02 |
| KEGG | KEGG:03013 | Nucleocytoplasmic transport | 91 | 96 | 2.04e-02 |
| KEGG | KEGG:04611 | Platelet activation | 84 | 88 | 2.04e-02 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 150 | 162 | 2.04e-02 |
| KEGG | KEGG:04724 | Glutamatergic synapse | 71 | 74 | 2.27e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 79 | 83 | 2.61e-02 |
| KEGG | KEGG:04530 | Tight junction | 120 | 129 | 2.68e-02 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 120 | 129 | 2.68e-02 |
| KEGG | KEGG:05414 | Dilated cardiomyopathy | 78 | 82 | 2.68e-02 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 95 | 101 | 2.73e-02 |
| KEGG | KEGG:00562 | Inositol phosphate metabolism | 58 | 60 | 2.74e-02 |
| KEGG | KEGG:04540 | Gap junction | 68 | 71 | 2.74e-02 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 76 | 80 | 3.02e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 155 | 169 | 3.14e-02 |
| KEGG | KEGG:04713 | Circadian entrainment | 65 | 68 | 3.62e-02 |
| KEGG | KEGG:05410 | Hypertrophic cardiomyopathy | 73 | 77 | 4.00e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 98 | 105 | 4.00e-02 |
| KEGG | KEGG:05224 | Breast cancer | 105 | 113 | 4.30e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 150 | 164 | 4.30e-02 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 126 | 137 | 4.98e-02 |
| KEGG | KEGG:05032 | Morphine addiction | 52 | 54 | 4.98e-02 |
# NR_resgenes_20k_enh <- gost(query = unique(NR_enh_peaks_20k$NCBI_gene),
# organism = "hsapiens",
# significant = FALSE,
# ordered_query = FALSE,
# domain_scope = "custom",
# measure_underrepresentation = FALSE,
# evcodes = FALSE,
# user_threshold = 0.05,
# correction_method = c("fdr"),
# custom_bg = background_df$ENTREZID,
# sources=c("GO:BP","KEGG"))
# saveRDS(NR_resgenes_20k_enh,"data/GO_KEGG_analysis/NR_resgenes_20k_enh.RDS")
# NRnom <- gostplot(NR_resgenes_20k_enh, capped = FALSE, interactive = TRUE)
# NRnom
NRnomtable_20k_enh <- NR_resgenes_20k_enh$result %>%
dplyr::select(c(source, term_id,
term_name,intersection_size,
term_size, p_value))# %>%
NRnomtable_20k_enh %>%
filter(source=="GO:BP", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(.,caption = "GO:BP terms found in NR neargenes_20k" ) %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| GO:BP | GO:0065007 | biological regulation | 4230 | 7734 | 9.66e-28 |
| GO:BP | GO:0050789 | regulation of biological process | 4120 | 7516 | 1.29e-27 |
| GO:BP | GO:0050794 | regulation of cellular process | 3931 | 7153 | 3.23e-26 |
| GO:BP | GO:0048523 | negative regulation of cellular process | 2068 | 3550 | 5.64e-24 |
| GO:BP | GO:0007165 | signal transduction | 2097 | 3611 | 1.83e-23 |
| GO:BP | GO:0048519 | negative regulation of biological process | 2176 | 3764 | 3.12e-23 |
| GO:BP | GO:0051716 | cellular response to stimulus | 2632 | 4640 | 5.29e-23 |
| GO:BP | GO:0050896 | response to stimulus | 3012 | 5379 | 6.75e-23 |
| GO:BP | GO:0008150 | biological_process | 5864 | 11244 | 8.77e-23 |
| GO:BP | GO:0023052 | signaling | 2243 | 3918 | 5.28e-21 |
| GO:BP | GO:0048518 | positive regulation of biological process | 2442 | 4301 | 7.27e-21 |
| GO:BP | GO:0007154 | cell communication | 2275 | 3983 | 9.78e-21 |
| GO:BP | GO:0019222 | regulation of metabolic process | 2585 | 4603 | 9.97e-19 |
| GO:BP | GO:0009893 | positive regulation of metabolic process | 1539 | 2622 | 4.31e-18 |
| GO:BP | GO:0048522 | positive regulation of cellular process | 2243 | 3954 | 4.41e-18 |
| GO:BP | GO:0048583 | regulation of response to stimulus | 1588 | 2717 | 8.05e-18 |
| GO:BP | GO:0071310 | cellular response to organic substance | 813 | 1297 | 1.07e-17 |
| GO:BP | GO:0009987 | cellular process | 5587 | 10686 | 1.45e-17 |
| GO:BP | GO:0070887 | cellular response to chemical stimulus | 1063 | 1751 | 2.03e-17 |
| GO:BP | GO:0051172 | negative regulation of nitrogen compound metabolic process | 997 | 1633 | 3.36e-17 |
| GO:BP | GO:0010033 | response to organic substance | 1053 | 1736 | 4.29e-17 |
| GO:BP | GO:0060255 | regulation of macromolecule metabolic process | 2378 | 4231 | 8.17e-17 |
| GO:BP | GO:0051254 | positive regulation of RNA metabolic process | 840 | 1354 | 1.08e-16 |
| GO:BP | GO:0009719 | response to endogenous stimulus | 752 | 1197 | 1.19e-16 |
| GO:BP | GO:0009966 | regulation of signal transduction | 1284 | 2166 | 1.42e-16 |
| GO:BP | GO:0080090 | regulation of primary metabolic process | 2263 | 4015 | 1.63e-16 |
| GO:BP | GO:0042221 | response to chemical | 1358 | 2304 | 1.63e-16 |
| GO:BP | GO:0009892 | negative regulation of metabolic process | 1247 | 2100 | 2.22e-16 |
| GO:BP | GO:0051252 | regulation of RNA metabolic process | 1549 | 2663 | 2.59e-16 |
| GO:BP | GO:0010604 | positive regulation of macromolecule metabolic process | 1416 | 2415 | 2.82e-16 |
| GO:BP | GO:0010605 | negative regulation of macromolecule metabolic process | 1165 | 1951 | 3.39e-16 |
| GO:BP | GO:0051173 | positive regulation of nitrogen compound metabolic process | 1292 | 2186 | 3.63e-16 |
| GO:BP | GO:0030029 | actin filament-based process | 431 | 640 | 3.91e-16 |
| GO:BP | GO:0071495 | cellular response to endogenous stimulus | 658 | 1035 | 4.03e-16 |
| GO:BP | GO:0031324 | negative regulation of cellular metabolic process | 1155 | 1934 | 4.21e-16 |
| GO:BP | GO:0051171 | regulation of nitrogen compound metabolic process | 2208 | 3918 | 5.56e-16 |
| GO:BP | GO:0045892 | negative regulation of DNA-templated transcription | 617 | 965 | 8.15e-16 |
| GO:BP | GO:0031323 | regulation of cellular metabolic process | 2370 | 4233 | 1.00e-15 |
| GO:BP | GO:0035556 | intracellular signal transduction | 1162 | 1951 | 1.00e-15 |
| GO:BP | GO:1902679 | negative regulation of RNA biosynthetic process | 621 | 973 | 1.04e-15 |
| GO:BP | GO:0032502 | developmental process | 2340 | 4179 | 1.77e-15 |
| GO:BP | GO:0051253 | negative regulation of RNA metabolic process | 673 | 1067 | 1.89e-15 |
| GO:BP | GO:0010468 | regulation of gene expression | 1921 | 3379 | 2.41e-15 |
| GO:BP | GO:2001141 | regulation of RNA biosynthetic process | 1412 | 2422 | 4.20e-15 |
| GO:BP | GO:0006355 | regulation of DNA-templated transcription | 1405 | 2410 | 5.14e-15 |
| GO:BP | GO:0031325 | positive regulation of cellular metabolic process | 1362 | 2333 | 9.91e-15 |
| GO:BP | GO:0048856 | anatomical structure development | 2172 | 3867 | 9.91e-15 |
| GO:BP | GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 917 | 1514 | 1.50e-14 |
| GO:BP | GO:0010558 | negative regulation of macromolecule biosynthetic process | 957 | 1588 | 1.92e-14 |
| GO:BP | GO:0010646 | regulation of cell communication | 1419 | 2444 | 2.31e-14 |
| GO:BP | GO:1902680 | positive regulation of RNA biosynthetic process | 761 | 1234 | 2.75e-14 |
| GO:BP | GO:0010556 | regulation of macromolecule biosynthetic process | 1969 | 3486 | 3.09e-14 |
| GO:BP | GO:0045893 | positive regulation of DNA-templated transcription | 759 | 1231 | 3.09e-14 |
| GO:BP | GO:0030036 | actin cytoskeleton organization | 381 | 566 | 3.09e-14 |
| GO:BP | GO:0006351 | DNA-templated transcription | 1452 | 2510 | 4.74e-14 |
| GO:BP | GO:1901698 | response to nitrogen compound | 479 | 736 | 4.74e-14 |
| GO:BP | GO:0032774 | RNA biosynthetic process | 1464 | 2533 | 5.13e-14 |
| GO:BP | GO:0031327 | negative regulation of cellular biosynthetic process | 974 | 1624 | 5.40e-14 |
| GO:BP | GO:0023051 | regulation of signaling | 1413 | 2438 | 5.59e-14 |
| GO:BP | GO:0007166 | cell surface receptor signaling pathway | 1070 | 1801 | 6.07e-14 |
| GO:BP | GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 716 | 1157 | 6.93e-14 |
| GO:BP | GO:0009890 | negative regulation of biosynthetic process | 979 | 1635 | 7.85e-14 |
| GO:BP | GO:0009653 | anatomical structure morphogenesis | 1092 | 1844 | 1.00e-13 |
| GO:BP | GO:0009889 | regulation of biosynthetic process | 2021 | 3595 | 1.35e-13 |
| GO:BP | GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1653 | 2895 | 1.37e-13 |
| GO:BP | GO:0031326 | regulation of cellular biosynthetic process | 2007 | 3569 | 1.50e-13 |
| GO:BP | GO:0010243 | response to organonitrogen compound | 447 | 685 | 2.19e-13 |
| GO:BP | GO:0010557 | positive regulation of macromolecule biosynthetic process | 1059 | 1791 | 5.37e-13 |
| GO:BP | GO:0050793 | regulation of developmental process | 1008 | 1697 | 5.37e-13 |
| GO:BP | GO:0048869 | cellular developmental process | 1600 | 2804 | 6.75e-13 |
| GO:BP | GO:0030154 | cell differentiation | 1599 | 2803 | 7.81e-13 |
| GO:BP | GO:0006357 | regulation of transcription by RNA polymerase II | 1055 | 1787 | 1.08e-12 |
| GO:BP | GO:0009891 | positive regulation of biosynthetic process | 1091 | 1856 | 1.78e-12 |
| GO:BP | GO:0045595 | regulation of cell differentiation | 662 | 1073 | 2.23e-12 |
| GO:BP | GO:0031328 | positive regulation of cellular biosynthetic process | 1082 | 1841 | 2.47e-12 |
| GO:BP | GO:1901699 | cellular response to nitrogen compound | 323 | 479 | 3.53e-12 |
| GO:BP | GO:0036211 | protein modification process | 1322 | 2291 | 4.14e-12 |
| GO:BP | GO:1901701 | cellular response to oxygen-containing compound | 505 | 796 | 4.89e-12 |
| GO:BP | GO:0141124 | intracellular signaling cassette | 793 | 1314 | 5.91e-12 |
| GO:BP | GO:0071417 | cellular response to organonitrogen compound | 300 | 442 | 8.21e-12 |
| GO:BP | GO:1901700 | response to oxygen-containing compound | 670 | 1093 | 9.42e-12 |
| GO:BP | GO:1902531 | regulation of intracellular signal transduction | 777 | 1289 | 1.57e-11 |
| GO:BP | GO:0006366 | transcription by RNA polymerase II | 1097 | 1879 | 1.83e-11 |
| GO:BP | GO:0018130 | heterocycle biosynthetic process | 1654 | 2927 | 2.01e-11 |
| GO:BP | GO:1901362 | organic cyclic compound biosynthetic process | 1705 | 3026 | 2.77e-11 |
| GO:BP | GO:0034654 | nucleobase-containing compound biosynthetic process | 1621 | 2867 | 3.05e-11 |
| GO:BP | GO:0019438 | aromatic compound biosynthetic process | 1652 | 2928 | 4.27e-11 |
| GO:BP | GO:0045596 | negative regulation of cell differentiation | 303 | 452 | 6.27e-11 |
| GO:BP | GO:0009725 | response to hormone | 394 | 610 | 8.60e-11 |
| GO:BP | GO:0097435 | supramolecular fiber organization | 407 | 633 | 9.37e-11 |
| GO:BP | GO:0048585 | negative regulation of response to stimulus | 720 | 1193 | 9.39e-11 |
| GO:BP | GO:0032870 | cellular response to hormone stimulus | 291 | 433 | 1.11e-10 |
| GO:BP | GO:0009968 | negative regulation of signal transduction | 597 | 972 | 1.38e-10 |
| GO:BP | GO:0051093 | negative regulation of developmental process | 400 | 622 | 1.38e-10 |
| GO:BP | GO:0045944 | positive regulation of transcription by RNA polymerase II | 542 | 874 | 1.63e-10 |
| GO:BP | GO:0000122 | negative regulation of transcription by RNA polymerase II | 446 | 704 | 1.96e-10 |
| GO:BP | GO:0007167 | enzyme-linked receptor protein signaling pathway | 453 | 717 | 2.37e-10 |
| GO:BP | GO:0051239 | regulation of multicellular organismal process | 1113 | 1924 | 3.01e-10 |
| GO:BP | GO:0007275 | multicellular organism development | 1772 | 3170 | 3.07e-10 |
| GO:BP | GO:0032501 | multicellular organismal process | 2464 | 4504 | 3.29e-10 |
| GO:BP | GO:0007015 | actin filament organization | 244 | 357 | 5.05e-10 |
| GO:BP | GO:0023057 | negative regulation of signaling | 629 | 1036 | 6.35e-10 |
| GO:BP | GO:0043434 | response to peptide hormone | 218 | 314 | 6.60e-10 |
| GO:BP | GO:0048584 | positive regulation of response to stimulus | 884 | 1504 | 8.18e-10 |
| GO:BP | GO:0010648 | negative regulation of cell communication | 627 | 1034 | 9.27e-10 |
| GO:BP | GO:1901652 | response to peptide | 249 | 368 | 1.52e-09 |
| GO:BP | GO:0016477 | cell migration | 612 | 1011 | 2.57e-09 |
| GO:BP | GO:0072359 | circulatory system development | 529 | 864 | 5.47e-09 |
| GO:BP | GO:0007010 | cytoskeleton organization | 684 | 1146 | 6.28e-09 |
| GO:BP | GO:0001944 | vasculature development | 353 | 552 | 7.66e-09 |
| GO:BP | GO:0008152 | metabolic process | 4177 | 7921 | 1.78e-08 |
| GO:BP | GO:0044271 | cellular nitrogen compound biosynthetic process | 1926 | 3495 | 1.88e-08 |
| GO:BP | GO:0009605 | response to external stimulus | 903 | 1559 | 3.62e-08 |
| GO:BP | GO:0032868 | response to insulin | 146 | 203 | 3.94e-08 |
| GO:BP | GO:0030155 | regulation of cell adhesion | 325 | 508 | 4.00e-08 |
| GO:BP | GO:0071375 | cellular response to peptide hormone stimulus | 163 | 231 | 4.09e-08 |
| GO:BP | GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 295 | 456 | 4.54e-08 |
| GO:BP | GO:0006793 | phosphorus metabolic process | 1086 | 1904 | 5.64e-08 |
| GO:BP | GO:0001568 | blood vessel development | 334 | 525 | 5.72e-08 |
| GO:BP | GO:0045597 | positive regulation of cell differentiation | 371 | 591 | 6.96e-08 |
| GO:BP | GO:0009888 | tissue development | 787 | 1348 | 7.67e-08 |
| GO:BP | GO:0198738 | cell-cell signaling by wnt | 238 | 359 | 7.75e-08 |
| GO:BP | GO:0048513 | animal organ development | 1138 | 2004 | 7.75e-08 |
| GO:BP | GO:0048731 | system development | 1515 | 2719 | 8.04e-08 |
| GO:BP | GO:0002376 | immune system process | 820 | 1410 | 8.73e-08 |
| GO:BP | GO:0006796 | phosphate-containing compound metabolic process | 1073 | 1883 | 9.32e-08 |
| GO:BP | GO:0016055 | Wnt signaling pathway | 237 | 358 | 9.96e-08 |
| GO:BP | GO:1901653 | cellular response to peptide | 187 | 273 | 9.97e-08 |
| GO:BP | GO:0044238 | primary metabolic process | 3816 | 7216 | 1.09e-07 |
| GO:BP | GO:0071407 | cellular response to organic cyclic compound | 249 | 379 | 1.11e-07 |
| GO:BP | GO:0030334 | regulation of cell migration | 413 | 668 | 1.20e-07 |
| GO:BP | GO:0065009 | regulation of molecular function | 759 | 1299 | 1.22e-07 |
| GO:BP | GO:0019538 | protein metabolic process | 1982 | 3619 | 1.27e-07 |
| GO:BP | GO:0065008 | regulation of biological quality | 1077 | 1893 | 1.32e-07 |
| GO:BP | GO:0016310 | phosphorylation | 675 | 1145 | 1.45e-07 |
| GO:BP | GO:0032970 | regulation of actin filament-based process | 202 | 300 | 1.95e-07 |
| GO:BP | GO:0043412 | macromolecule modification | 1390 | 2489 | 2.29e-07 |
| GO:BP | GO:0051246 | regulation of protein metabolic process | 916 | 1595 | 2.43e-07 |
| GO:BP | GO:0051179 | localization | 2037 | 3731 | 2.47e-07 |
| GO:BP | GO:0061061 | muscle structure development | 337 | 536 | 2.89e-07 |
| GO:BP | GO:0071704 | organic substance metabolic process | 3992 | 7578 | 3.25e-07 |
| GO:BP | GO:1902532 | negative regulation of intracellular signal transduction | 277 | 431 | 3.43e-07 |
| GO:BP | GO:0006810 | transport | 1647 | 2984 | 3.85e-07 |
| GO:BP | GO:0007155 | cell adhesion | 561 | 941 | 3.97e-07 |
| GO:BP | GO:0008283 | cell population proliferation | 759 | 1306 | 4.22e-07 |
| GO:BP | GO:0043170 | macromolecule metabolic process | 3474 | 6550 | 4.26e-07 |
| GO:BP | GO:0030097 | hemopoiesis | 385 | 624 | 5.69e-07 |
| GO:BP | GO:0048646 | anatomical structure formation involved in morphogenesis | 503 | 837 | 5.69e-07 |
| GO:BP | GO:0051336 | regulation of hydrolase activity | 276 | 431 | 5.89e-07 |
| GO:BP | GO:0035295 | tube development | 475 | 787 | 6.84e-07 |
| GO:BP | GO:0040011 | locomotion | 484 | 805 | 1.01e-06 |
| GO:BP | GO:2000145 | regulation of cell motility | 426 | 700 | 1.01e-06 |
| GO:BP | GO:0051094 | positive regulation of developmental process | 543 | 913 | 1.10e-06 |
| GO:BP | GO:0046907 | intracellular transport | 677 | 1160 | 1.21e-06 |
| GO:BP | GO:0042127 | regulation of cell population proliferation | 632 | 1077 | 1.22e-06 |
| GO:BP | GO:0060070 | canonical Wnt signaling pathway | 165 | 242 | 1.31e-06 |
| GO:BP | GO:0006468 | protein phosphorylation | 567 | 958 | 1.34e-06 |
| GO:BP | GO:0014070 | response to organic cyclic compound | 373 | 606 | 1.36e-06 |
| GO:BP | GO:0040012 | regulation of locomotion | 436 | 720 | 1.55e-06 |
| GO:BP | GO:0009967 | positive regulation of signal transduction | 639 | 1093 | 2.16e-06 |
| GO:BP | GO:0048468 | cell development | 1063 | 1886 | 2.24e-06 |
| GO:BP | GO:0048870 | cell motility | 653 | 1120 | 2.65e-06 |
| GO:BP | GO:0042592 | homeostatic process | 662 | 1137 | 2.81e-06 |
| GO:BP | GO:0022603 | regulation of anatomical structure morphogenesis | 373 | 609 | 2.89e-06 |
| GO:BP | GO:0016070 | RNA metabolic process | 1829 | 3352 | 3.05e-06 |
| GO:BP | GO:0006807 | nitrogen compound metabolic process | 3646 | 6912 | 3.19e-06 |
| GO:BP | GO:0051240 | positive regulation of multicellular organismal process | 609 | 1040 | 3.29e-06 |
| GO:BP | GO:0016567 | protein ubiquitination | 377 | 617 | 3.47e-06 |
| GO:BP | GO:0032869 | cellular response to insulin stimulus | 115 | 161 | 3.66e-06 |
| GO:BP | GO:0006915 | apoptotic process | 790 | 1377 | 3.84e-06 |
| GO:BP | GO:0070647 | protein modification by small protein conjugation or removal | 459 | 766 | 3.92e-06 |
| GO:BP | GO:0048514 | blood vessel morphogenesis | 283 | 450 | 4.25e-06 |
| GO:BP | GO:0006950 | response to stress | 1404 | 2540 | 4.76e-06 |
| GO:BP | GO:0043687 | post-translational protein modification | 483 | 811 | 5.09e-06 |
| GO:BP | GO:0044092 | negative regulation of molecular function | 313 | 504 | 5.16e-06 |
| GO:BP | GO:0012501 | programmed cell death | 811 | 1419 | 5.87e-06 |
| GO:BP | GO:0044237 | cellular metabolic process | 3716 | 7058 | 5.91e-06 |
| GO:BP | GO:0030099 | myeloid cell differentiation | 192 | 292 | 5.94e-06 |
| GO:BP | GO:0051248 | negative regulation of protein metabolic process | 369 | 605 | 6.01e-06 |
| GO:BP | GO:0031399 | regulation of protein modification process | 536 | 911 | 8.98e-06 |
| GO:BP | GO:0002684 | positive regulation of immune system process | 354 | 580 | 9.88e-06 |
| GO:BP | GO:0060828 | regulation of canonical Wnt signaling pathway | 139 | 203 | 1.01e-05 |
| GO:BP | GO:0016043 | cellular component organization | 2569 | 4802 | 1.02e-05 |
| GO:BP | GO:0033993 | response to lipid | 350 | 573 | 1.02e-05 |
| GO:BP | GO:0035239 | tube morphogenesis | 386 | 638 | 1.03e-05 |
| GO:BP | GO:0008219 | cell death | 811 | 1423 | 1.06e-05 |
| GO:BP | GO:0032956 | regulation of actin cytoskeleton organization | 173 | 261 | 1.07e-05 |
| GO:BP | GO:0030111 | regulation of Wnt signaling pathway | 173 | 261 | 1.07e-05 |
| GO:BP | GO:1901564 | organonitrogen compound metabolic process | 2339 | 4354 | 1.09e-05 |
| GO:BP | GO:0009894 | regulation of catabolic process | 490 | 830 | 1.73e-05 |
| GO:BP | GO:0060284 | regulation of cell development | 347 | 570 | 1.78e-05 |
| GO:BP | GO:0032446 | protein modification by small protein conjugation | 416 | 695 | 1.78e-05 |
| GO:BP | GO:0042692 | muscle cell differentiation | 208 | 323 | 1.78e-05 |
| GO:BP | GO:0030335 | positive regulation of cell migration | 249 | 395 | 1.78e-05 |
| GO:BP | GO:0051234 | establishment of localization | 1762 | 3240 | 1.81e-05 |
| GO:BP | GO:0051174 | regulation of phosphorus metabolic process | 476 | 805 | 1.92e-05 |
| GO:BP | GO:0070848 | response to growth factor | 334 | 547 | 1.94e-05 |
| GO:BP | GO:0044249 | cellular biosynthetic process | 2897 | 5453 | 2.03e-05 |
| GO:BP | GO:0007507 | heart development | 307 | 499 | 2.17e-05 |
| GO:BP | GO:1901576 | organic substance biosynthetic process | 2925 | 5509 | 2.20e-05 |
| GO:BP | GO:0019220 | regulation of phosphate metabolic process | 475 | 804 | 2.23e-05 |
| GO:BP | GO:0051493 | regulation of cytoskeleton organization | 258 | 412 | 2.35e-05 |
| GO:BP | GO:0023056 | positive regulation of signaling | 700 | 1221 | 2.41e-05 |
| GO:BP | GO:0030522 | intracellular receptor signaling pathway | 167 | 253 | 2.44e-05 |
| GO:BP | GO:0010629 | negative regulation of gene expression | 467 | 790 | 2.51e-05 |
| GO:BP | GO:0044419 | biological process involved in interspecies interaction between organisms | 544 | 932 | 2.66e-05 |
| GO:BP | GO:0051128 | regulation of cellular component organization | 1040 | 1862 | 2.78e-05 |
| GO:BP | GO:2000026 | regulation of multicellular organismal development | 554 | 951 | 2.91e-05 |
| GO:BP | GO:1902903 | regulation of supramolecular fiber organization | 196 | 304 | 3.18e-05 |
| GO:BP | GO:0031400 | negative regulation of protein modification process | 208 | 325 | 3.21e-05 |
| GO:BP | GO:0043254 | regulation of protein-containing complex assembly | 209 | 327 | 3.46e-05 |
| GO:BP | GO:0010647 | positive regulation of cell communication | 697 | 1218 | 3.54e-05 |
| GO:BP | GO:0009058 | biosynthetic process | 2941 | 5547 | 3.81e-05 |
| GO:BP | GO:0009059 | macromolecule biosynthetic process | 2574 | 4827 | 3.83e-05 |
| GO:BP | GO:0042981 | regulation of apoptotic process | 596 | 1031 | 4.20e-05 |
| GO:BP | GO:0050790 | regulation of catalytic activity | 521 | 893 | 4.89e-05 |
| GO:BP | GO:0043067 | regulation of programmed cell death | 611 | 1060 | 5.07e-05 |
| GO:BP | GO:0071363 | cellular response to growth factor stimulus | 321 | 528 | 5.32e-05 |
| GO:BP | GO:0002682 | regulation of immune system process | 507 | 868 | 5.65e-05 |
| GO:BP | GO:0016192 | vesicle-mediated transport | 660 | 1152 | 5.65e-05 |
| GO:BP | GO:0034097 | response to cytokine | 354 | 588 | 5.67e-05 |
| GO:BP | GO:0080134 | regulation of response to stress | 539 | 928 | 6.55e-05 |
| GO:BP | GO:0009991 | response to extracellular stimulus | 236 | 377 | 6.93e-05 |
| GO:BP | GO:0050776 | regulation of immune response | 292 | 477 | 6.98e-05 |
| GO:BP | GO:0001525 | angiogenesis | 238 | 381 | 7.84e-05 |
| GO:BP | GO:0051146 | striated muscle cell differentiation | 154 | 234 | 8.08e-05 |
| GO:BP | GO:2000147 | positive regulation of cell motility | 253 | 408 | 8.51e-05 |
| GO:BP | GO:0048762 | mesenchymal cell differentiation | 134 | 200 | 8.90e-05 |
| GO:BP | GO:0071345 | cellular response to cytokine stimulus | 318 | 525 | 9.14e-05 |
| GO:BP | GO:0000902 | cell morphogenesis | 421 | 713 | 1.01e-04 |
| GO:BP | GO:0050778 | positive regulation of immune response | 235 | 377 | 1.12e-04 |
| GO:BP | GO:0071396 | cellular response to lipid | 241 | 388 | 1.22e-04 |
| GO:BP | GO:0007264 | small GTPase-mediated signal transduction | 242 | 390 | 1.30e-04 |
| GO:BP | GO:0001667 | ameboidal-type cell migration | 216 | 344 | 1.36e-04 |
| GO:BP | GO:0070936 | protein K48-linked ubiquitination | 57 | 74 | 1.36e-04 |
| GO:BP | GO:0045936 | negative regulation of phosphate metabolic process | 184 | 288 | 1.50e-04 |
| GO:BP | GO:0051247 | positive regulation of protein metabolic process | 527 | 911 | 1.57e-04 |
| GO:BP | GO:0061448 | connective tissue development | 136 | 205 | 1.63e-04 |
| GO:BP | GO:0010467 | gene expression | 2372 | 4449 | 1.64e-04 |
| GO:BP | GO:0040017 | positive regulation of locomotion | 256 | 416 | 1.65e-04 |
| GO:BP | GO:0006897 | endocytosis | 298 | 492 | 1.85e-04 |
| GO:BP | GO:0051345 | positive regulation of hydrolase activity | 171 | 266 | 1.87e-04 |
| GO:BP | GO:0044087 | regulation of cellular component biogenesis | 443 | 757 | 1.94e-04 |
| GO:BP | GO:0033554 | cellular response to stress | 805 | 1433 | 1.96e-04 |
| GO:BP | GO:0044093 | positive regulation of molecular function | 457 | 783 | 1.99e-04 |
| GO:BP | GO:0010563 | negative regulation of phosphorus metabolic process | 184 | 289 | 2.00e-04 |
| GO:BP | GO:0032879 | regulation of localization | 808 | 1439 | 2.03e-04 |
| GO:BP | GO:0006955 | immune response | 502 | 867 | 2.27e-04 |
| GO:BP | GO:0006470 | protein dephosphorylation | 119 | 177 | 2.36e-04 |
| GO:BP | GO:1902533 | positive regulation of intracellular signal transduction | 419 | 714 | 2.36e-04 |
| GO:BP | GO:0016311 | dephosphorylation | 151 | 232 | 2.38e-04 |
| GO:BP | GO:0048872 | homeostasis of number of cells | 145 | 222 | 2.74e-04 |
| GO:BP | GO:0001837 | epithelial to mesenchymal transition | 95 | 137 | 2.87e-04 |
| GO:BP | GO:0032922 | circadian regulation of gene expression | 46 | 58 | 2.88e-04 |
| GO:BP | GO:0031667 | response to nutrient levels | 220 | 354 | 2.89e-04 |
| GO:BP | GO:0051241 | negative regulation of multicellular organismal process | 414 | 706 | 2.91e-04 |
| GO:BP | GO:0008285 | negative regulation of cell population proliferation | 284 | 469 | 3.01e-04 |
| GO:BP | GO:0060485 | mesenchyme development | 158 | 245 | 3.12e-04 |
| GO:BP | GO:0098657 | import into cell | 368 | 622 | 3.13e-04 |
| GO:BP | GO:0071496 | cellular response to external stimulus | 171 | 268 | 3.40e-04 |
| GO:BP | GO:0051641 | cellular localization | 1426 | 2623 | 3.50e-04 |
| GO:BP | GO:0010717 | regulation of epithelial to mesenchymal transition | 63 | 85 | 3.55e-04 |
| GO:BP | GO:0014902 | myotube differentiation | 63 | 85 | 3.55e-04 |
| GO:BP | GO:0034101 | erythrocyte homeostasis | 79 | 111 | 3.58e-04 |
| GO:BP | GO:0007162 | negative regulation of cell adhesion | 123 | 185 | 3.63e-04 |
| GO:BP | GO:0043065 | positive regulation of apoptotic process | 234 | 380 | 3.66e-04 |
| GO:BP | GO:0003012 | muscle system process | 203 | 325 | 3.91e-04 |
| GO:BP | GO:0009896 | positive regulation of catabolic process | 265 | 436 | 3.95e-04 |
| GO:BP | GO:0048871 | multicellular organismal-level homeostasis | 320 | 536 | 4.27e-04 |
| GO:BP | GO:0007520 | myoblast fusion | 26 | 29 | 4.50e-04 |
| GO:BP | GO:0032271 | regulation of protein polymerization | 108 | 160 | 4.50e-04 |
| GO:BP | GO:0031032 | actomyosin structure organization | 122 | 184 | 4.70e-04 |
| GO:BP | GO:0010631 | epithelial cell migration | 156 | 243 | 4.88e-04 |
| GO:BP | GO:0090132 | epithelium migration | 156 | 243 | 4.88e-04 |
| GO:BP | GO:0045444 | fat cell differentiation | 119 | 179 | 4.92e-04 |
| GO:BP | GO:0003170 | heart valve development | 50 | 65 | 5.13e-04 |
| GO:BP | GO:0002253 | activation of immune response | 182 | 289 | 5.35e-04 |
| GO:BP | GO:0022604 | regulation of cell morphogenesis | 127 | 193 | 5.37e-04 |
| GO:BP | GO:0110053 | regulation of actin filament organization | 138 | 212 | 5.37e-04 |
| GO:BP | GO:0051056 | regulation of small GTPase mediated signal transduction | 150 | 233 | 5.61e-04 |
| GO:BP | GO:0030218 | erythrocyte differentiation | 74 | 104 | 6.58e-04 |
| GO:BP | GO:0071840 | cellular component organization or biogenesis | 2638 | 4988 | 6.67e-04 |
| GO:BP | GO:0010628 | positive regulation of gene expression | 433 | 746 | 6.67e-04 |
| GO:BP | GO:0010921 | regulation of phosphatase activity | 36 | 44 | 7.55e-04 |
| GO:BP | GO:0002262 | myeloid cell homeostasis | 93 | 136 | 7.81e-04 |
| GO:BP | GO:0045785 | positive regulation of cell adhesion | 188 | 301 | 7.81e-04 |
| GO:BP | GO:0008360 | regulation of cell shape | 75 | 106 | 7.81e-04 |
| GO:BP | GO:2000628 | regulation of miRNA metabolic process | 54 | 72 | 8.11e-04 |
| GO:BP | GO:0090257 | regulation of muscle system process | 117 | 177 | 8.26e-04 |
| GO:BP | GO:0030323 | respiratory tube development | 100 | 148 | 8.30e-04 |
| GO:BP | GO:0002521 | leukocyte differentiation | 227 | 371 | 8.49e-04 |
| GO:BP | GO:0009607 | response to biotic stimulus | 472 | 820 | 8.65e-04 |
| GO:BP | GO:0008286 | insulin receptor signaling pathway | 70 | 98 | 8.65e-04 |
| GO:BP | GO:0042325 | regulation of phosphorylation | 398 | 683 | 8.70e-04 |
| GO:BP | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway | 178 | 284 | 9.37e-04 |
| GO:BP | GO:0090130 | tissue migration | 157 | 247 | 9.47e-04 |
| GO:BP | GO:0031668 | cellular response to extracellular stimulus | 141 | 219 | 9.47e-04 |
| GO:BP | GO:0010810 | regulation of cell-substrate adhesion | 108 | 162 | 9.48e-04 |
| GO:BP | GO:0003179 | heart valve morphogenesis | 43 | 55 | 9.59e-04 |
| GO:BP | GO:0051129 | negative regulation of cellular component organization | 328 | 555 | 9.74e-04 |
| GO:BP | GO:0046649 | lymphocyte activation | 267 | 444 | 1.00e-03 |
| GO:BP | GO:0043068 | positive regulation of programmed cell death | 236 | 388 | 1.01e-03 |
| GO:BP | GO:0014897 | striated muscle hypertrophy | 55 | 74 | 1.01e-03 |
| GO:BP | GO:0035966 | response to topologically incorrect protein | 89 | 130 | 1.03e-03 |
| GO:BP | GO:0045646 | regulation of erythrocyte differentiation | 29 | 34 | 1.03e-03 |
| GO:BP | GO:0031589 | cell-substrate adhesion | 163 | 258 | 1.05e-03 |
| GO:BP | GO:0010586 | miRNA metabolic process | 63 | 87 | 1.06e-03 |
| GO:BP | GO:0051707 | response to other organism | 457 | 794 | 1.13e-03 |
| GO:BP | GO:0043207 | response to external biotic stimulus | 457 | 794 | 1.13e-03 |
| GO:BP | GO:0048878 | chemical homeostasis | 390 | 670 | 1.14e-03 |
| GO:BP | GO:0043087 | regulation of GTPase activity | 110 | 166 | 1.15e-03 |
| GO:BP | GO:0051494 | negative regulation of cytoskeleton organization | 87 | 127 | 1.18e-03 |
| GO:BP | GO:1902893 | regulation of miRNA transcription | 46 | 60 | 1.18e-03 |
| GO:BP | GO:0008064 | regulation of actin polymerization or depolymerization | 81 | 117 | 1.21e-03 |
| GO:BP | GO:0030324 | lung development | 97 | 144 | 1.23e-03 |
| GO:BP | GO:0006996 | organelle organization | 1518 | 2815 | 1.23e-03 |
| GO:BP | GO:0036293 | response to decreased oxygen levels | 154 | 243 | 1.33e-03 |
| GO:BP | GO:0055001 | muscle cell development | 108 | 163 | 1.33e-03 |
| GO:BP | GO:0001775 | cell activation | 366 | 627 | 1.41e-03 |
| GO:BP | GO:0090090 | negative regulation of canonical Wnt signaling pathway | 76 | 109 | 1.41e-03 |
| GO:BP | GO:0003300 | cardiac muscle hypertrophy | 54 | 73 | 1.42e-03 |
| GO:BP | GO:0002764 | immune response-regulating signaling pathway | 168 | 268 | 1.43e-03 |
| GO:BP | GO:0052547 | regulation of peptidase activity | 113 | 172 | 1.53e-03 |
| GO:BP | GO:0008154 | actin polymerization or depolymerization | 99 | 148 | 1.53e-03 |
| GO:BP | GO:0071559 | response to transforming growth factor beta | 140 | 219 | 1.56e-03 |
| GO:BP | GO:0051049 | regulation of transport | 618 | 1098 | 1.65e-03 |
| GO:BP | GO:0002757 | immune response-activating signaling pathway | 162 | 258 | 1.69e-03 |
| GO:BP | GO:0032101 | regulation of response to external stimulus | 380 | 654 | 1.70e-03 |
| GO:BP | GO:1901201 | regulation of extracellular matrix assembly | 18 | 19 | 1.74e-03 |
| GO:BP | GO:0014896 | muscle hypertrophy | 55 | 75 | 1.78e-03 |
| GO:BP | GO:0034109 | homotypic cell-cell adhesion | 50 | 67 | 1.80e-03 |
| GO:BP | GO:0030832 | regulation of actin filament length | 81 | 118 | 1.85e-03 |
| GO:BP | GO:0080135 | regulation of cellular response to stress | 263 | 440 | 1.90e-03 |
| GO:BP | GO:1903131 | mononuclear cell differentiation | 173 | 278 | 1.91e-03 |
| GO:BP | GO:0140747 | regulation of ncRNA transcription | 58 | 80 | 1.91e-03 |
| GO:BP | GO:0001932 | regulation of protein phosphorylation | 373 | 642 | 1.96e-03 |
| GO:BP | GO:0090287 | regulation of cellular response to growth factor stimulus | 156 | 248 | 1.97e-03 |
| GO:BP | GO:0071383 | cellular response to steroid hormone stimulus | 105 | 159 | 1.97e-03 |
| GO:BP | GO:0048384 | retinoic acid receptor signaling pathway | 23 | 26 | 2.02e-03 |
| GO:BP | GO:1903706 | regulation of hemopoiesis | 161 | 257 | 2.04e-03 |
| GO:BP | GO:0033036 | macromolecule localization | 1252 | 2309 | 2.17e-03 |
| GO:BP | GO:0141091 | transforming growth factor beta receptor superfamily signaling pathway | 162 | 259 | 2.17e-03 |
| GO:BP | GO:0006325 | chromatin organization | 352 | 604 | 2.21e-03 |
| GO:BP | GO:0071560 | cellular response to transforming growth factor beta stimulus | 137 | 215 | 2.23e-03 |
| GO:BP | GO:0061614 | miRNA transcription | 46 | 61 | 2.23e-03 |
| GO:BP | GO:0031669 | cellular response to nutrient levels | 126 | 196 | 2.40e-03 |
| GO:BP | GO:0035967 | cellular response to topologically incorrect protein | 62 | 87 | 2.40e-03 |
| GO:BP | GO:0009887 | animal organ morphogenesis | 389 | 673 | 2.43e-03 |
| GO:BP | GO:0030048 | actin filament-based movement | 74 | 107 | 2.51e-03 |
| GO:BP | GO:0001570 | vasculogenesis | 49 | 66 | 2.54e-03 |
| GO:BP | GO:0030098 | lymphocyte differentiation | 156 | 249 | 2.55e-03 |
| GO:BP | GO:0035303 | regulation of dephosphorylation | 57 | 79 | 2.63e-03 |
| GO:BP | GO:0000165 | MAPK cascade | 297 | 504 | 2.68e-03 |
| GO:BP | GO:0051235 | maintenance of location | 157 | 251 | 2.70e-03 |
| GO:BP | GO:0009611 | response to wounding | 230 | 382 | 2.74e-03 |
| GO:BP | GO:0006338 | chromatin remodeling | 287 | 486 | 2.84e-03 |
| GO:BP | GO:0043433 | negative regulation of DNA-binding transcription factor activity | 72 | 104 | 2.90e-03 |
| GO:BP | GO:0032535 | regulation of cellular component size | 177 | 287 | 2.99e-03 |
| GO:BP | GO:1903902 | positive regulation of viral life cycle | 17 | 18 | 3.00e-03 |
| GO:BP | GO:0042326 | negative regulation of phosphorylation | 150 | 239 | 3.00e-03 |
| GO:BP | GO:0001666 | response to hypoxia | 146 | 232 | 3.05e-03 |
| GO:BP | GO:0051649 | establishment of localization in cell | 862 | 1566 | 3.07e-03 |
| GO:BP | GO:1990845 | adaptive thermogenesis | 82 | 121 | 3.07e-03 |
| GO:BP | GO:0090066 | regulation of anatomical structure size | 228 | 379 | 3.07e-03 |
| GO:BP | GO:1902905 | positive regulation of supramolecular fiber organization | 92 | 138 | 3.07e-03 |
| GO:BP | GO:0009952 | anterior/posterior pattern specification | 82 | 121 | 3.07e-03 |
| GO:BP | GO:0003007 | heart morphogenesis | 138 | 218 | 3.10e-03 |
| GO:BP | GO:0098609 | cell-cell adhesion | 329 | 564 | 3.23e-03 |
| GO:BP | GO:0120161 | regulation of cold-induced thermogenesis | 76 | 111 | 3.23e-03 |
| GO:BP | GO:0032989 | cellular anatomical entity morphogenesis | 342 | 588 | 3.23e-03 |
| GO:BP | GO:0010720 | positive regulation of cell development | 189 | 309 | 3.30e-03 |
| GO:BP | GO:0031329 | regulation of cellular catabolic process | 324 | 555 | 3.33e-03 |
| GO:BP | GO:0097581 | lamellipodium organization | 53 | 73 | 3.37e-03 |
| GO:BP | GO:0060341 | regulation of cellular localization | 443 | 776 | 3.47e-03 |
| GO:BP | GO:0030178 | negative regulation of Wnt signaling pathway | 90 | 135 | 3.53e-03 |
| GO:BP | GO:0009790 | embryo development | 467 | 821 | 3.55e-03 |
| GO:BP | GO:0045598 | regulation of fat cell differentiation | 65 | 93 | 3.85e-03 |
| GO:BP | GO:1902904 | negative regulation of supramolecular fiber organization | 84 | 125 | 3.86e-03 |
| GO:BP | GO:0070482 | response to oxygen levels | 164 | 265 | 3.93e-03 |
| GO:BP | GO:0000302 | response to reactive oxygen species | 102 | 156 | 4.01e-03 |
| GO:BP | GO:0003176 | aortic valve development | 30 | 37 | 4.01e-03 |
| GO:BP | GO:0060429 | epithelium development | 451 | 792 | 4.01e-03 |
| GO:BP | GO:0043666 | regulation of phosphoprotein phosphatase activity | 28 | 34 | 4.05e-03 |
| GO:BP | GO:0062197 | cellular response to chemical stress | 156 | 251 | 4.16e-03 |
| GO:BP | GO:0003205 | cardiac chamber development | 99 | 151 | 4.25e-03 |
| GO:BP | GO:0022407 | regulation of cell-cell adhesion | 171 | 278 | 4.40e-03 |
| GO:BP | GO:0070727 | cellular macromolecule localization | 1092 | 2010 | 4.40e-03 |
| GO:BP | GO:0006886 | intracellular protein transport | 342 | 590 | 4.41e-03 |
| GO:BP | GO:0018193 | peptidyl-amino acid modification | 323 | 555 | 4.48e-03 |
| GO:BP | GO:0052548 | regulation of endopeptidase activity | 100 | 153 | 4.64e-03 |
| GO:BP | GO:0009056 | catabolic process | 1052 | 1934 | 4.69e-03 |
| GO:BP | GO:0090304 | nucleic acid metabolic process | 2004 | 3777 | 4.75e-03 |
| GO:BP | GO:0031331 | positive regulation of cellular catabolic process | 168 | 273 | 4.76e-03 |
| GO:BP | GO:0043393 | regulation of protein binding | 76 | 112 | 4.76e-03 |
| GO:BP | GO:0106106 | cold-induced thermogenesis | 76 | 112 | 4.76e-03 |
| GO:BP | GO:0042060 | wound healing | 178 | 291 | 4.85e-03 |
| GO:BP | GO:0051090 | regulation of DNA-binding transcription factor activity | 150 | 241 | 4.87e-03 |
| GO:BP | GO:0030833 | regulation of actin filament polymerization | 70 | 102 | 4.98e-03 |
| GO:BP | GO:0005975 | carbohydrate metabolic process | 242 | 407 | 4.98e-03 |
| GO:BP | GO:0030903 | notochord development | 16 | 17 | 5.05e-03 |
| GO:BP | GO:0045321 | leukocyte activation | 309 | 530 | 5.05e-03 |
| GO:BP | GO:0060612 | adipose tissue development | 35 | 45 | 5.05e-03 |
| GO:BP | GO:0060541 | respiratory system development | 105 | 162 | 5.07e-03 |
| GO:BP | GO:0006986 | response to unfolded protein | 80 | 119 | 5.10e-03 |
| GO:BP | GO:0007163 | establishment or maintenance of cell polarity | 117 | 183 | 5.16e-03 |
| GO:BP | GO:2000737 | negative regulation of stem cell differentiation | 21 | 24 | 5.20e-03 |
| GO:BP | GO:0006139 | nucleobase-containing compound metabolic process | 2212 | 4185 | 5.27e-03 |
| GO:BP | GO:0007179 | transforming growth factor beta receptor signaling pathway | 110 | 171 | 5.55e-03 |
| GO:BP | GO:0032103 | positive regulation of response to external stimulus | 207 | 344 | 5.57e-03 |
| GO:BP | GO:0050851 | antigen receptor-mediated signaling pathway | 71 | 104 | 5.61e-03 |
| GO:BP | GO:0036294 | cellular response to decreased oxygen levels | 81 | 121 | 5.68e-03 |
| GO:BP | GO:0010464 | regulation of mesenchymal cell proliferation | 23 | 27 | 5.79e-03 |
| GO:BP | GO:0035886 | vascular associated smooth muscle cell differentiation | 23 | 27 | 5.79e-03 |
| GO:BP | GO:0001933 | negative regulation of protein phosphorylation | 140 | 224 | 5.82e-03 |
| GO:BP | GO:0043124 | negative regulation of canonical NF-kappaB signal transduction | 29 | 36 | 5.94e-03 |
| GO:BP | GO:0000768 | syncytium formation by plasma membrane fusion | 29 | 36 | 5.94e-03 |
| GO:BP | GO:0010463 | mesenchymal cell proliferation | 29 | 36 | 5.94e-03 |
| GO:BP | GO:0140253 | cell-cell fusion | 29 | 36 | 5.94e-03 |
| GO:BP | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 38 | 50 | 6.05e-03 |
| GO:BP | GO:0043085 | positive regulation of catalytic activity | 317 | 546 | 6.06e-03 |
| GO:BP | GO:0000209 | protein polyubiquitination | 141 | 226 | 6.11e-03 |
| GO:BP | GO:0045637 | regulation of myeloid cell differentiation | 89 | 135 | 6.23e-03 |
| GO:BP | GO:0031401 | positive regulation of protein modification process | 319 | 550 | 6.36e-03 |
| GO:BP | GO:0097696 | receptor signaling pathway via STAT | 63 | 91 | 6.68e-03 |
| GO:BP | GO:0008104 | protein localization | 1084 | 2000 | 6.74e-03 |
| GO:BP | GO:0007584 | response to nutrient | 76 | 113 | 6.83e-03 |
| GO:BP | GO:0030032 | lamellipodium assembly | 41 | 55 | 6.97e-03 |
| GO:BP | GO:0048193 | Golgi vesicle transport | 162 | 264 | 6.97e-03 |
| GO:BP | GO:0061572 | actin filament bundle organization | 87 | 132 | 7.27e-03 |
| GO:BP | GO:0043244 | regulation of protein-containing complex disassembly | 70 | 103 | 7.32e-03 |
| GO:BP | GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 106 | 165 | 7.36e-03 |
| GO:BP | GO:0031344 | regulation of cell projection organization | 300 | 516 | 7.59e-03 |
| GO:BP | GO:0055006 | cardiac cell development | 55 | 78 | 7.68e-03 |
| GO:BP | GO:0003013 | circulatory system process | 251 | 426 | 7.76e-03 |
| GO:BP | GO:0040013 | negative regulation of locomotion | 150 | 243 | 7.78e-03 |
| GO:BP | GO:0046483 | heterocycle metabolic process | 2265 | 4295 | 7.81e-03 |
| GO:BP | GO:0031396 | regulation of protein ubiquitination | 103 | 160 | 7.87e-03 |
| GO:BP | GO:1905314 | semi-lunar valve development | 32 | 41 | 7.90e-03 |
| GO:BP | GO:0010952 | positive regulation of peptidase activity | 71 | 105 | 8.22e-03 |
| GO:BP | GO:1903580 | positive regulation of ATP metabolic process | 20 | 23 | 8.34e-03 |
| GO:BP | GO:1902894 | negative regulation of miRNA transcription | 20 | 23 | 8.34e-03 |
| GO:BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 100 | 155 | 8.42e-03 |
| GO:BP | GO:0072659 | protein localization to plasma membrane | 147 | 238 | 8.42e-03 |
| GO:BP | GO:0006949 | syncytium formation | 30 | 38 | 8.45e-03 |
| GO:BP | GO:0071474 | cellular hyperosmotic response | 15 | 16 | 8.50e-03 |
| GO:BP | GO:1901879 | regulation of protein depolymerization | 50 | 70 | 8.52e-03 |
| GO:BP | GO:0150115 | cell-substrate junction organization | 65 | 95 | 8.61e-03 |
| GO:BP | GO:0090288 | negative regulation of cellular response to growth factor stimulus | 53 | 75 | 8.75e-03 |
| GO:BP | GO:0051017 | actin filament bundle assembly | 86 | 131 | 9.19e-03 |
| GO:BP | GO:0034614 | cellular response to reactive oxygen species | 79 | 119 | 9.31e-03 |
| GO:BP | GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 131 | 210 | 9.50e-03 |
| GO:BP | GO:0045216 | cell-cell junction organization | 98 | 152 | 9.72e-03 |
| GO:BP | GO:0007623 | circadian rhythm | 98 | 152 | 9.72e-03 |
| GO:BP | GO:0033002 | muscle cell proliferation | 98 | 152 | 9.72e-03 |
| GO:BP | GO:0071456 | cellular response to hypoxia | 76 | 114 | 9.74e-03 |
| GO:BP | GO:0046822 | regulation of nucleocytoplasmic transport | 66 | 97 | 9.74e-03 |
| GO:BP | GO:0043086 | negative regulation of catalytic activity | 180 | 298 | 9.76e-03 |
| GO:BP | GO:0030182 | neuron differentiation | 565 | 1014 | 9.82e-03 |
| GO:BP | GO:0098542 | defense response to other organism | 347 | 605 | 9.93e-03 |
| GO:BP | GO:0120035 | regulation of plasma membrane bounded cell projection organization | 293 | 505 | 1.01e-02 |
| GO:BP | GO:0044409 | symbiont entry into host | 73 | 109 | 1.01e-02 |
| GO:BP | GO:2000116 | regulation of cysteine-type endopeptidase activity | 80 | 121 | 1.02e-02 |
| GO:BP | GO:0009267 | cellular response to starvation | 95 | 147 | 1.03e-02 |
| GO:BP | GO:0040007 | growth | 396 | 697 | 1.08e-02 |
| GO:BP | GO:0046777 | protein autophosphorylation | 92 | 142 | 1.11e-02 |
| GO:BP | GO:0043242 | negative regulation of protein-containing complex disassembly | 46 | 64 | 1.12e-02 |
| GO:BP | GO:0051258 | protein polymerization | 139 | 225 | 1.14e-02 |
| GO:BP | GO:1901360 | organic cyclic compound metabolic process | 2346 | 4460 | 1.14e-02 |
| GO:BP | GO:0070935 | 3’-UTR-mediated mRNA stabilization | 17 | 19 | 1.15e-02 |
| GO:BP | GO:0120162 | positive regulation of cold-induced thermogenesis | 49 | 69 | 1.15e-02 |
| GO:BP | GO:0001659 | temperature homeostasis | 85 | 130 | 1.15e-02 |
| GO:BP | GO:0060412 | ventricular septum morphogenesis | 31 | 40 | 1.15e-02 |
| GO:BP | GO:0043500 | muscle adaptation | 61 | 89 | 1.15e-02 |
| GO:BP | GO:0022008 | neurogenesis | 689 | 1251 | 1.18e-02 |
| GO:BP | GO:0007249 | canonical NF-kappaB signal transduction | 140 | 227 | 1.18e-02 |
| GO:BP | GO:1901880 | negative regulation of protein depolymerization | 41 | 56 | 1.20e-02 |
| GO:BP | GO:0060537 | muscle tissue development | 202 | 339 | 1.20e-02 |
| GO:BP | GO:0051058 | negative regulation of small GTPase mediated signal transduction | 36 | 48 | 1.22e-02 |
| GO:BP | GO:0043408 | regulation of MAPK cascade | 250 | 427 | 1.23e-02 |
| GO:BP | GO:0030866 | cortical actin cytoskeleton organization | 29 | 37 | 1.24e-02 |
| GO:BP | GO:0051261 | protein depolymerization | 65 | 96 | 1.26e-02 |
| GO:BP | GO:0048568 | embryonic organ development | 182 | 303 | 1.28e-02 |
| GO:BP | GO:0098781 | ncRNA transcription | 79 | 120 | 1.29e-02 |
| GO:BP | GO:0045639 | positive regulation of myeloid cell differentiation | 47 | 66 | 1.32e-02 |
| GO:BP | GO:0042110 | T cell activation | 183 | 305 | 1.33e-02 |
| GO:BP | GO:0010634 | positive regulation of epithelial cell migration | 83 | 127 | 1.33e-02 |
| GO:BP | GO:0042594 | response to starvation | 111 | 176 | 1.34e-02 |
| GO:BP | GO:0010035 | response to inorganic substance | 223 | 378 | 1.34e-02 |
| GO:BP | GO:0046718 | symbiont entry into host cell | 69 | 103 | 1.35e-02 |
| GO:BP | GO:0030865 | cortical cytoskeleton organization | 34 | 45 | 1.35e-02 |
| GO:BP | GO:0003231 | cardiac ventricle development | 76 | 115 | 1.35e-02 |
| GO:BP | GO:0002831 | regulation of response to biotic stimulus | 184 | 307 | 1.36e-02 |
| GO:BP | GO:1900744 | regulation of p38MAPK cascade | 25 | 31 | 1.37e-02 |
| GO:BP | GO:2000146 | negative regulation of cell motility | 134 | 217 | 1.38e-02 |
| GO:BP | GO:0045981 | positive regulation of nucleotide metabolic process | 21 | 25 | 1.38e-02 |
| GO:BP | GO:0075294 | positive regulation by symbiont of entry into host | 11 | 11 | 1.38e-02 |
| GO:BP | GO:2000629 | negative regulation of miRNA metabolic process | 21 | 25 | 1.38e-02 |
| GO:BP | GO:0046598 | positive regulation of viral entry into host cell | 11 | 11 | 1.38e-02 |
| GO:BP | GO:1900544 | positive regulation of purine nucleotide metabolic process | 21 | 25 | 1.38e-02 |
| GO:BP | GO:0048738 | cardiac muscle tissue development | 125 | 201 | 1.38e-02 |
| GO:BP | GO:0060317 | cardiac epithelial to mesenchymal transition | 23 | 28 | 1.39e-02 |
| GO:BP | GO:0003206 | cardiac chamber morphogenesis | 73 | 110 | 1.40e-02 |
| GO:BP | GO:0010562 | positive regulation of phosphorus metabolic process | 269 | 463 | 1.41e-02 |
| GO:BP | GO:0045937 | positive regulation of phosphate metabolic process | 269 | 463 | 1.41e-02 |
| GO:BP | GO:0030336 | negative regulation of cell migration | 130 | 210 | 1.41e-02 |
| GO:BP | GO:0022411 | cellular component disassembly | 250 | 428 | 1.41e-02 |
| GO:BP | GO:0009755 | hormone-mediated signaling pathway | 88 | 136 | 1.43e-02 |
| GO:BP | GO:0007259 | receptor signaling pathway via JAK-STAT | 60 | 88 | 1.47e-02 |
| GO:BP | GO:0007044 | cell-substrate junction assembly | 60 | 88 | 1.47e-02 |
| GO:BP | GO:0006952 | defense response | 512 | 918 | 1.49e-02 |
| GO:BP | GO:2000630 | positive regulation of miRNA metabolic process | 37 | 50 | 1.49e-02 |
| GO:BP | GO:0048511 | rhythmic process | 136 | 221 | 1.49e-02 |
| GO:BP | GO:0071824 | protein-DNA complex organization | 387 | 683 | 1.49e-02 |
| GO:BP | GO:0030041 | actin filament polymerization | 81 | 124 | 1.49e-02 |
| GO:BP | GO:0010975 | regulation of neuron projection development | 210 | 355 | 1.49e-02 |
| GO:BP | GO:0019915 | lipid storage | 48 | 68 | 1.50e-02 |
| GO:BP | GO:0043502 | regulation of muscle adaptation | 48 | 68 | 1.50e-02 |
| GO:BP | GO:0003158 | endothelium development | 67 | 100 | 1.51e-02 |
| GO:BP | GO:0030856 | regulation of epithelial cell differentiation | 67 | 100 | 1.51e-02 |
| GO:BP | GO:0051495 | positive regulation of cytoskeleton organization | 93 | 145 | 1.54e-02 |
| GO:BP | GO:0031347 | regulation of defense response | 261 | 449 | 1.56e-02 |
| GO:BP | GO:0055082 | intracellular chemical homeostasis | 281 | 486 | 1.57e-02 |
| GO:BP | GO:0008284 | positive regulation of cell population proliferation | 345 | 605 | 1.58e-02 |
| GO:BP | GO:0051145 | smooth muscle cell differentiation | 40 | 55 | 1.59e-02 |
| GO:BP | GO:0016032 | viral process | 195 | 328 | 1.59e-02 |
| GO:BP | GO:0007009 | plasma membrane organization | 71 | 107 | 1.59e-02 |
| GO:BP | GO:0001952 | regulation of cell-matrix adhesion | 61 | 90 | 1.63e-02 |
| GO:BP | GO:0071453 | cellular response to oxygen levels | 86 | 133 | 1.63e-02 |
| GO:BP | GO:0050767 | regulation of neurogenesis | 174 | 290 | 1.65e-02 |
| GO:BP | GO:0071702 | organic substance transport | 933 | 1722 | 1.68e-02 |
| GO:BP | GO:0007159 | leukocyte cell-cell adhesion | 134 | 218 | 1.69e-02 |
| GO:BP | GO:0006725 | cellular aromatic compound metabolic process | 2267 | 4313 | 1.69e-02 |
| GO:BP | GO:0006900 | vesicle budding from membrane | 52 | 75 | 1.74e-02 |
| GO:BP | GO:0085029 | extracellular matrix assembly | 28 | 36 | 1.74e-02 |
| GO:BP | GO:0048660 | regulation of smooth muscle cell proliferation | 65 | 97 | 1.75e-02 |
| GO:BP | GO:0050878 | regulation of body fluid levels | 140 | 229 | 1.78e-02 |
| GO:BP | GO:0006979 | response to oxidative stress | 182 | 305 | 1.80e-02 |
| GO:BP | GO:0001501 | skeletal system development | 205 | 347 | 1.81e-02 |
| GO:BP | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 76 | 116 | 1.81e-02 |
| GO:BP | GO:0009057 | macromolecule catabolic process | 598 | 1083 | 1.82e-02 |
| GO:BP | GO:1902895 | positive regulation of miRNA transcription | 33 | 44 | 1.85e-02 |
| GO:BP | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus | 80 | 123 | 1.85e-02 |
| GO:BP | GO:0038066 | p38MAPK cascade | 33 | 44 | 1.85e-02 |
| GO:BP | GO:0003180 | aortic valve morphogenesis | 26 | 33 | 1.87e-02 |
| GO:BP | GO:0050801 | monoatomic ion homeostasis | 237 | 406 | 1.88e-02 |
| GO:BP | GO:0006402 | mRNA catabolic process | 127 | 206 | 1.89e-02 |
| GO:BP | GO:0010608 | post-transcriptional regulation of gene expression | 264 | 456 | 1.94e-02 |
| GO:BP | GO:0003208 | cardiac ventricle morphogenesis | 44 | 62 | 1.97e-02 |
| GO:BP | GO:0033043 | regulation of organelle organization | 529 | 953 | 1.98e-02 |
| GO:BP | GO:1903828 | negative regulation of protein localization | 101 | 160 | 1.98e-02 |
| GO:BP | GO:0061013 | regulation of mRNA catabolic process | 101 | 160 | 1.98e-02 |
| GO:BP | GO:0043488 | regulation of mRNA stability | 93 | 146 | 2.02e-02 |
| GO:BP | GO:0055080 | monoatomic cation homeostasis | 234 | 401 | 2.05e-02 |
| GO:BP | GO:1904385 | cellular response to angiotensin | 22 | 27 | 2.05e-02 |
| GO:BP | GO:0051098 | regulation of binding | 124 | 201 | 2.05e-02 |
| GO:BP | GO:0043122 | regulation of canonical NF-kappaB signal transduction | 124 | 201 | 2.05e-02 |
| GO:BP | GO:0072538 | T-helper 17 type immune response | 22 | 27 | 2.05e-02 |
| GO:BP | GO:0034655 | nucleobase-containing compound catabolic process | 242 | 416 | 2.13e-02 |
| GO:BP | GO:0097190 | apoptotic signaling pathway | 269 | 466 | 2.16e-02 |
| GO:BP | GO:0051651 | maintenance of location in cell | 107 | 171 | 2.19e-02 |
| GO:BP | GO:0120039 | plasma membrane bounded cell projection morphogenesis | 284 | 494 | 2.22e-02 |
| GO:BP | GO:0048732 | gland development | 183 | 308 | 2.23e-02 |
| GO:BP | GO:0010950 | positive regulation of endopeptidase activity | 64 | 96 | 2.23e-02 |
| GO:BP | GO:0006913 | nucleocytoplasmic transport | 172 | 288 | 2.23e-02 |
| GO:BP | GO:0051169 | nuclear transport | 172 | 288 | 2.23e-02 |
| GO:BP | GO:0031397 | negative regulation of protein ubiquitination | 42 | 59 | 2.25e-02 |
| GO:BP | GO:0035304 | regulation of protein dephosphorylation | 42 | 59 | 2.25e-02 |
| GO:BP | GO:1903708 | positive regulation of hemopoiesis | 75 | 115 | 2.26e-02 |
| GO:BP | GO:1902107 | positive regulation of leukocyte differentiation | 75 | 115 | 2.26e-02 |
| GO:BP | GO:1901203 | positive regulation of extracellular matrix assembly | 13 | 14 | 2.28e-02 |
| GO:BP | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 48 | 69 | 2.28e-02 |
| GO:BP | GO:0048858 | cell projection morphogenesis | 286 | 498 | 2.28e-02 |
| GO:BP | GO:0034260 | negative regulation of GTPase activity | 13 | 14 | 2.28e-02 |
| GO:BP | GO:0048667 | cell morphogenesis involved in neuron differentiation | 252 | 435 | 2.28e-02 |
| GO:BP | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway | 79 | 122 | 2.28e-02 |
| GO:BP | GO:0007267 | cell-cell signaling | 596 | 1082 | 2.35e-02 |
| GO:BP | GO:0034976 | response to endoplasmic reticulum stress | 113 | 182 | 2.35e-02 |
| GO:BP | GO:0044030 | regulation of DNA methylation | 10 | 10 | 2.35e-02 |
| GO:BP | GO:2000479 | regulation of cAMP-dependent protein kinase activity | 10 | 10 | 2.35e-02 |
| GO:BP | GO:0034599 | cellular response to oxidative stress | 123 | 200 | 2.43e-02 |
| GO:BP | GO:0045667 | regulation of osteoblast differentiation | 65 | 98 | 2.44e-02 |
| GO:BP | GO:0051346 | negative regulation of hydrolase activity | 76 | 117 | 2.44e-02 |
| GO:BP | GO:0042113 | B cell activation | 101 | 161 | 2.54e-02 |
| GO:BP | GO:1903320 | regulation of protein modification by small protein conjugation or removal | 124 | 202 | 2.55e-02 |
| GO:BP | GO:0048708 | astrocyte differentiation | 40 | 56 | 2.57e-02 |
| GO:BP | GO:0007517 | muscle organ development | 160 | 267 | 2.57e-02 |
| GO:BP | GO:0030514 | negative regulation of BMP signaling pathway | 32 | 43 | 2.57e-02 |
| GO:BP | GO:0007369 | gastrulation | 89 | 140 | 2.66e-02 |
| GO:BP | GO:0050920 | regulation of chemotaxis | 85 | 133 | 2.67e-02 |
| GO:BP | GO:0048589 | developmental growth | 287 | 501 | 2.67e-02 |
| GO:BP | GO:0002062 | chondrocyte differentiation | 59 | 88 | 2.68e-02 |
| GO:BP | GO:0032386 | regulation of intracellular transport | 135 | 222 | 2.68e-02 |
| GO:BP | GO:0002833 | positive regulation of response to biotic stimulus | 130 | 213 | 2.68e-02 |
| GO:BP | GO:0010632 | regulation of epithelial cell migration | 116 | 188 | 2.73e-02 |
| GO:BP | GO:1903037 | regulation of leukocyte cell-cell adhesion | 121 | 197 | 2.77e-02 |
| GO:BP | GO:0034641 | cellular nitrogen compound metabolic process | 2432 | 4646 | 2.77e-02 |
| GO:BP | GO:0050852 | T cell receptor signaling pathway | 56 | 83 | 2.77e-02 |
| GO:BP | GO:0030162 | regulation of proteolysis | 241 | 416 | 2.77e-02 |
| GO:BP | GO:0008015 | blood circulation | 209 | 357 | 2.77e-02 |
| GO:BP | GO:0043549 | regulation of kinase activity | 209 | 357 | 2.77e-02 |
| GO:BP | GO:0030042 | actin filament depolymerization | 35 | 48 | 2.77e-02 |
| GO:BP | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 35 | 48 | 2.77e-02 |
| GO:BP | GO:0010811 | positive regulation of cell-substrate adhesion | 63 | 95 | 2.79e-02 |
| GO:BP | GO:0071219 | cellular response to molecule of bacterial origin | 74 | 114 | 2.79e-02 |
| GO:BP | GO:0009628 | response to abiotic stimulus | 452 | 811 | 2.80e-02 |
| GO:BP | GO:0003215 | cardiac right ventricle morphogenesis | 15 | 17 | 2.80e-02 |
| GO:BP | GO:0009166 | nucleotide catabolic process | 86 | 135 | 2.81e-02 |
| GO:BP | GO:0007409 | axonogenesis | 198 | 337 | 2.84e-02 |
| GO:BP | GO:0034620 | cellular response to unfolded protein | 53 | 78 | 2.84e-02 |
| GO:BP | GO:0035305 | negative regulation of dephosphorylation | 23 | 29 | 2.86e-02 |
| GO:BP | GO:1990776 | response to angiotensin | 23 | 29 | 2.86e-02 |
| GO:BP | GO:0043542 | endothelial cell migration | 108 | 174 | 2.86e-02 |
| GO:BP | GO:0003279 | cardiac septum development | 67 | 102 | 2.87e-02 |
| GO:BP | GO:0045814 | negative regulation of gene expression, epigenetic | 67 | 102 | 2.87e-02 |
| GO:BP | GO:0048524 | positive regulation of viral process | 38 | 53 | 2.87e-02 |
| GO:BP | GO:0043401 | steroid hormone mediated signaling pathway | 71 | 109 | 2.95e-02 |
| GO:BP | GO:0042176 | regulation of protein catabolic process | 176 | 297 | 2.96e-02 |
| GO:BP | GO:0032880 | regulation of protein localization | 388 | 691 | 2.96e-02 |
| GO:BP | GO:0048710 | regulation of astrocyte differentiation | 17 | 20 | 3.03e-02 |
| GO:BP | GO:0045446 | endothelial cell differentiation | 57 | 85 | 3.03e-02 |
| GO:BP | GO:0001783 | B cell apoptotic process | 17 | 20 | 3.03e-02 |
| GO:BP | GO:0045088 | regulation of innate immune response | 149 | 248 | 3.03e-02 |
| GO:BP | GO:0002053 | positive regulation of mesenchymal cell proliferation | 17 | 20 | 3.03e-02 |
| GO:BP | GO:0019221 | cytokine-mediated signaling pathway | 160 | 268 | 3.03e-02 |
| GO:BP | GO:0046700 | heterocycle catabolic process | 253 | 439 | 3.05e-02 |
| GO:BP | GO:0090077 | foam cell differentiation | 19 | 23 | 3.06e-02 |
| GO:BP | GO:0010742 | macrophage derived foam cell differentiation | 19 | 23 | 3.06e-02 |
| GO:BP | GO:0018209 | peptidyl-serine modification | 105 | 169 | 3.07e-02 |
| GO:BP | GO:0007160 | cell-matrix adhesion | 105 | 169 | 3.07e-02 |
| GO:BP | GO:0009792 | embryo development ending in birth or egg hatching | 297 | 521 | 3.11e-02 |
| GO:BP | GO:0051130 | positive regulation of cellular component organization | 472 | 850 | 3.11e-02 |
| GO:BP | GO:0019725 | cellular homeostasis | 320 | 564 | 3.12e-02 |
| GO:BP | GO:1902305 | regulation of sodium ion transmembrane transport | 28 | 37 | 3.13e-02 |
| GO:BP | GO:0009261 | ribonucleotide catabolic process | 72 | 111 | 3.16e-02 |
| GO:BP | GO:0019058 | viral life cycle | 140 | 232 | 3.18e-02 |
| GO:BP | GO:0031333 | negative regulation of protein-containing complex assembly | 76 | 118 | 3.18e-02 |
| GO:BP | GO:0030100 | regulation of endocytosis | 120 | 196 | 3.19e-02 |
| GO:BP | GO:1901575 | organic substance catabolic process | 845 | 1562 | 3.20e-02 |
| GO:BP | GO:0070527 | platelet aggregation | 36 | 50 | 3.25e-02 |
| GO:BP | GO:0010660 | regulation of muscle cell apoptotic process | 36 | 50 | 3.25e-02 |
| GO:BP | GO:0097193 | intrinsic apoptotic signaling pathway | 152 | 254 | 3.33e-02 |
| GO:BP | GO:0006611 | protein export from nucleus | 39 | 55 | 3.35e-02 |
| GO:BP | GO:0009154 | purine ribonucleotide catabolic process | 69 | 106 | 3.36e-02 |
| GO:BP | GO:0043547 | positive regulation of GTPase activity | 73 | 113 | 3.41e-02 |
| GO:BP | GO:0010256 | endomembrane system organization | 273 | 477 | 3.41e-02 |
| GO:BP | GO:0043009 | chordate embryonic development | 289 | 507 | 3.50e-02 |
| GO:BP | GO:0044403 | biological process involved in symbiotic interaction | 127 | 209 | 3.50e-02 |
| GO:BP | GO:0022409 | positive regulation of cell-cell adhesion | 108 | 175 | 3.57e-02 |
| GO:BP | GO:0048659 | smooth muscle cell proliferation | 66 | 101 | 3.58e-02 |
| GO:BP | GO:0001101 | response to acid chemical | 66 | 101 | 3.58e-02 |
| GO:BP | GO:0019439 | aromatic compound catabolic process | 255 | 444 | 3.64e-02 |
| GO:BP | GO:0031623 | receptor internalization | 59 | 89 | 3.67e-02 |
| GO:BP | GO:0048385 | regulation of retinoic acid receptor signaling pathway | 12 | 13 | 3.67e-02 |
| GO:BP | GO:0060841 | venous blood vessel development | 12 | 13 | 3.67e-02 |
| GO:BP | GO:1903729 | regulation of plasma membrane organization | 12 | 13 | 3.67e-02 |
| GO:BP | GO:0140546 | defense response to symbiont | 315 | 556 | 3.67e-02 |
| GO:BP | GO:0003174 | mitral valve development | 12 | 13 | 3.67e-02 |
| GO:BP | GO:0045600 | positive regulation of fat cell differentiation | 34 | 47 | 3.70e-02 |
| GO:BP | GO:0014743 | regulation of muscle hypertrophy | 34 | 47 | 3.70e-02 |
| GO:BP | GO:0055013 | cardiac muscle cell development | 49 | 72 | 3.71e-02 |
| GO:BP | GO:0071229 | cellular response to acid chemical | 49 | 72 | 3.71e-02 |
| GO:BP | GO:0019318 | hexose metabolic process | 109 | 177 | 3.71e-02 |
| GO:BP | GO:0061564 | axon development | 216 | 372 | 3.72e-02 |
| GO:BP | GO:0032984 | protein-containing complex disassembly | 129 | 213 | 3.75e-02 |
| GO:BP | GO:0014706 | striated muscle tissue development | 129 | 213 | 3.75e-02 |
| GO:BP | GO:0018105 | peptidyl-serine phosphorylation | 100 | 161 | 3.75e-02 |
| GO:BP | GO:0031349 | positive regulation of defense response | 156 | 262 | 3.76e-02 |
| GO:BP | GO:0030857 | negative regulation of epithelial cell differentiation | 24 | 31 | 3.77e-02 |
| GO:BP | GO:0060411 | cardiac septum morphogenesis | 46 | 67 | 3.78e-02 |
| GO:BP | GO:0072089 | stem cell proliferation | 56 | 84 | 3.79e-02 |
| GO:BP | GO:1904063 | negative regulation of cation transmembrane transport | 37 | 52 | 3.79e-02 |
| GO:BP | GO:0048545 | response to steroid hormone | 140 | 233 | 3.80e-02 |
| GO:BP | GO:0072331 | signal transduction by p53 class mediator | 96 | 154 | 3.84e-02 |
| GO:BP | GO:0035108 | limb morphogenesis | 71 | 110 | 3.87e-02 |
| GO:BP | GO:0035107 | appendage morphogenesis | 71 | 110 | 3.87e-02 |
| GO:BP | GO:0042330 | taxis | 146 | 244 | 3.87e-02 |
| GO:BP | GO:0006935 | chemotaxis | 146 | 244 | 3.87e-02 |
| GO:BP | GO:0042327 | positive regulation of phosphorylation | 239 | 415 | 3.92e-02 |
| GO:BP | GO:0030163 | protein catabolic process | 440 | 792 | 3.93e-02 |
| GO:BP | GO:0060397 | growth hormone receptor signaling pathway via JAK-STAT | 9 | 9 | 3.93e-02 |
| GO:BP | GO:0090336 | positive regulation of brown fat cell differentiation | 9 | 9 | 3.93e-02 |
| GO:BP | GO:0030038 | contractile actin filament bundle assembly | 60 | 91 | 3.93e-02 |
| GO:BP | GO:0048845 | venous blood vessel morphogenesis | 9 | 9 | 3.93e-02 |
| GO:BP | GO:0043149 | stress fiber assembly | 60 | 91 | 3.93e-02 |
| GO:BP | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death | 9 | 9 | 3.93e-02 |
| GO:BP | GO:0001765 | membrane raft assembly | 9 | 9 | 3.93e-02 |
| GO:BP | GO:1901292 | nucleoside phosphate catabolic process | 88 | 140 | 3.97e-02 |
| GO:BP | GO:0033673 | negative regulation of kinase activity | 84 | 133 | 4.03e-02 |
| GO:BP | GO:0003171 | atrioventricular valve development | 22 | 28 | 4.03e-02 |
| GO:BP | GO:0098876 | vesicle-mediated transport to the plasma membrane | 84 | 133 | 4.03e-02 |
| GO:BP | GO:0010591 | regulation of lamellipodium assembly | 22 | 28 | 4.03e-02 |
| GO:BP | GO:0032456 | endocytic recycling | 50 | 74 | 4.06e-02 |
| GO:BP | GO:0055007 | cardiac muscle cell differentiation | 68 | 105 | 4.07e-02 |
| GO:BP | GO:1905039 | carboxylic acid transmembrane transport | 68 | 105 | 4.07e-02 |
| GO:BP | GO:0072523 | purine-containing compound catabolic process | 76 | 119 | 4.10e-02 |
| GO:BP | GO:0034332 | adherens junction organization | 32 | 44 | 4.11e-02 |
| GO:BP | GO:0030217 | T cell differentiation | 112 | 183 | 4.16e-02 |
| GO:BP | GO:0071901 | negative regulation of protein serine/threonine kinase activity | 47 | 69 | 4.19e-02 |
| GO:BP | GO:0032273 | positive regulation of protein polymerization | 47 | 69 | 4.19e-02 |
| GO:BP | GO:0044270 | cellular nitrogen compound catabolic process | 250 | 436 | 4.19e-02 |
| GO:BP | GO:0048644 | muscle organ morphogenesis | 44 | 64 | 4.24e-02 |
| GO:BP | GO:0048812 | neuron projection morphogenesis | 273 | 479 | 4.24e-02 |
| GO:BP | GO:0048662 | negative regulation of smooth muscle cell proliferation | 27 | 36 | 4.24e-02 |
| GO:BP | GO:0048699 | generation of neurons | 589 | 1076 | 4.24e-02 |
| GO:BP | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 20 | 25 | 4.24e-02 |
| GO:BP | GO:0072111 | cell proliferation involved in kidney development | 14 | 16 | 4.24e-02 |
| GO:BP | GO:0038095 | Fc-epsilon receptor signaling pathway | 14 | 16 | 4.24e-02 |
| GO:BP | GO:0040029 | epigenetic regulation of gene expression | 103 | 167 | 4.24e-02 |
| GO:BP | GO:0032092 | positive regulation of protein binding | 35 | 49 | 4.24e-02 |
| GO:BP | GO:0043069 | negative regulation of programmed cell death | 360 | 642 | 4.24e-02 |
| GO:BP | GO:0071320 | cellular response to cAMP | 27 | 36 | 4.24e-02 |
| GO:BP | GO:0046323 | glucose import | 38 | 54 | 4.29e-02 |
| GO:BP | GO:0005996 | monosaccharide metabolic process | 118 | 194 | 4.29e-02 |
| GO:BP | GO:0048729 | tissue morphogenesis | 259 | 453 | 4.29e-02 |
| GO:BP | GO:0014910 | regulation of smooth muscle cell migration | 38 | 54 | 4.29e-02 |
| GO:BP | GO:0034766 | negative regulation of monoatomic ion transmembrane transport | 41 | 59 | 4.29e-02 |
| GO:BP | GO:0006195 | purine nucleotide catabolic process | 73 | 114 | 4.34e-02 |
| GO:BP | GO:0006006 | glucose metabolic process | 90 | 144 | 4.36e-02 |
| GO:BP | GO:0035767 | endothelial cell chemotaxis | 18 | 22 | 4.42e-02 |
| GO:BP | GO:0018210 | peptidyl-threonine modification | 51 | 76 | 4.45e-02 |
| GO:BP | GO:1990778 | protein localization to cell periphery | 169 | 287 | 4.53e-02 |
| GO:BP | GO:0045862 | positive regulation of proteolysis | 146 | 245 | 4.54e-02 |
| GO:BP | GO:0019722 | calcium-mediated signaling | 78 | 123 | 4.62e-02 |
| GO:BP | GO:0051701 | biological process involved in interaction with host | 91 | 146 | 4.62e-02 |
| GO:BP | GO:1901873 | regulation of post-translational protein modification | 125 | 207 | 4.63e-02 |
| GO:BP | GO:0055085 | transmembrane transport | 507 | 921 | 4.64e-02 |
| GO:BP | GO:0060048 | cardiac muscle contraction | 74 | 116 | 4.65e-02 |
| GO:BP | GO:0001889 | liver development | 70 | 109 | 4.65e-02 |
| GO:BP | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 55 | 83 | 4.67e-02 |
| GO:BP | GO:2001056 | positive regulation of cysteine-type endopeptidase activity | 55 | 83 | 4.67e-02 |
| GO:BP | GO:0001503 | ossification | 177 | 302 | 4.76e-02 |
| GO:BP | GO:0043933 | protein-containing complex organization | 998 | 1863 | 4.82e-02 |
| GO:BP | GO:0035051 | cardiocyte differentiation | 83 | 132 | 4.82e-02 |
| GO:BP | GO:0060350 | endochondral bone morphogenesis | 33 | 46 | 4.83e-02 |
| GO:BP | GO:0010611 | regulation of cardiac muscle hypertrophy | 33 | 46 | 4.83e-02 |
| GO:BP | GO:0010721 | negative regulation of cell development | 111 | 182 | 4.84e-02 |
| GO:BP | GO:0048705 | skeletal system morphogenesis | 92 | 148 | 4.84e-02 |
| GO:BP | GO:0060415 | muscle tissue morphogenesis | 42 | 61 | 4.86e-02 |
| GO:BP | GO:0072091 | regulation of stem cell proliferation | 42 | 61 | 4.86e-02 |
| GO:BP | GO:0050770 | regulation of axonogenesis | 79 | 125 | 4.88e-02 |
| GO:BP | GO:0030510 | regulation of BMP signaling pathway | 52 | 78 | 4.88e-02 |
| GO:BP | GO:0030518 | intracellular steroid hormone receptor signaling pathway | 63 | 97 | 4.91e-02 |
| GO:BP | GO:0071772 | response to BMP | 75 | 118 | 4.92e-02 |
| GO:BP | GO:0071773 | cellular response to BMP stimulus | 75 | 118 | 4.92e-02 |
| GO:BP | GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 67 | 104 | 4.94e-02 |
| GO:BP | GO:0002520 | immune system development | 88 | 141 | 4.94e-02 |
| GO:BP | GO:0002218 | activation of innate immune response | 102 | 166 | 4.97e-02 |
| GO:BP | GO:0043632 | modification-dependent macromolecule catabolic process | 299 | 529 | 4.98e-02 |
NRnomtable_20k_enh %>%
filter(source=="KEGG", p_value < 0.05) %>%
mutate_at(.vars = 6, .funs = scientific_format()) %>%
kable(., caption = "KEGG terms found in NR enhancer neargenes_20k") %>%
kable_paper("striped", full_width = FALSE) %>%
kable_styling(
full_width = FALSE,
position = "left",
bootstrap_options = c("striped", "hover")
) %>%
scroll_box(width = "100%", height = "400px")| source | term_id | term_name | intersection_size | term_size | p_value |
|---|---|---|---|---|---|
| KEGG | KEGG:00000 | KEGG root term | 2946 | 5451 | 2.10e-09 |
| KEGG | KEGG:04659 | Th17 cell differentiation | 51 | 60 | 4.20e-06 |
| KEGG | KEGG:05200 | Pathways in cancer | 249 | 391 | 9.31e-06 |
| KEGG | KEGG:04510 | Focal adhesion | 114 | 169 | 5.20e-04 |
| KEGG | KEGG:04380 | Osteoclast differentiation | 67 | 92 | 7.50e-04 |
| KEGG | KEGG:04072 | Phospholipase D signaling pathway | 76 | 107 | 7.50e-04 |
| KEGG | KEGG:04931 | Insulin resistance | 66 | 91 | 7.86e-04 |
| KEGG | KEGG:04148 | Efferocytosis | 83 | 120 | 1.15e-03 |
| KEGG | KEGG:04390 | Hippo signaling pathway | 88 | 129 | 1.18e-03 |
| KEGG | KEGG:05135 | Yersinia infection | 75 | 107 | 1.18e-03 |
| KEGG | KEGG:05100 | Bacterial invasion of epithelial cells | 54 | 73 | 1.18e-03 |
| KEGG | KEGG:04630 | JAK-STAT signaling pathway | 60 | 83 | 1.30e-03 |
| KEGG | KEGG:04910 | Insulin signaling pathway | 78 | 113 | 1.32e-03 |
| KEGG | KEGG:05131 | Shigellosis | 131 | 204 | 1.32e-03 |
| KEGG | KEGG:04658 | Th1 and Th2 cell differentiation | 39 | 50 | 1.45e-03 |
| KEGG | KEGG:04550 | Signaling pathways regulating pluripotency of stem cells | 70 | 101 | 2.19e-03 |
| KEGG | KEGG:04917 | Prolactin signaling pathway | 41 | 54 | 2.34e-03 |
| KEGG | KEGG:04520 | Adherens junction | 59 | 83 | 2.34e-03 |
| KEGG | KEGG:05167 | Kaposi sarcoma-associated herpesvirus infection | 89 | 134 | 2.65e-03 |
| KEGG | KEGG:04933 | AGE-RAGE signaling pathway in diabetic complications | 61 | 87 | 2.78e-03 |
| KEGG | KEGG:05205 | Proteoglycans in cancer | 105 | 162 | 2.78e-03 |
| KEGG | KEGG:04310 | Wnt signaling pathway | 88 | 133 | 3.05e-03 |
| KEGG | KEGG:04935 | Growth hormone synthesis, secretion and action | 66 | 96 | 3.46e-03 |
| KEGG | KEGG:05163 | Human cytomegalovirus infection | 103 | 160 | 4.09e-03 |
| KEGG | KEGG:05231 | Choline metabolism in cancer | 56 | 80 | 4.20e-03 |
| KEGG | KEGG:05130 | Pathogenic Escherichia coli infection | 93 | 143 | 4.20e-03 |
| KEGG | KEGG:04350 | TGF-beta signaling pathway | 62 | 90 | 4.20e-03 |
| KEGG | KEGG:04062 | Chemokine signaling pathway | 73 | 109 | 4.75e-03 |
| KEGG | KEGG:04722 | Neurotrophin signaling pathway | 70 | 104 | 4.81e-03 |
| KEGG | KEGG:05225 | Hepatocellular carcinoma | 89 | 137 | 5.21e-03 |
| KEGG | KEGG:05206 | MicroRNAs in cancer | 93 | 144 | 5.21e-03 |
| KEGG | KEGG:04010 | MAPK signaling pathway | 142 | 231 | 5.57e-03 |
| KEGG | KEGG:04066 | HIF-1 signaling pathway | 59 | 86 | 5.57e-03 |
| KEGG | KEGG:04015 | Rap1 signaling pathway | 103 | 162 | 5.63e-03 |
| KEGG | KEGG:04934 | Cushing syndrome | 78 | 119 | 6.70e-03 |
| KEGG | KEGG:04662 | B cell receptor signaling pathway | 38 | 52 | 7.71e-03 |
| KEGG | KEGG:05132 | Salmonella infection | 124 | 201 | 8.78e-03 |
| KEGG | KEGG:04152 | AMPK signaling pathway | 67 | 101 | 8.92e-03 |
| KEGG | KEGG:04625 | C-type lectin receptor signaling pathway | 51 | 74 | 9.41e-03 |
| KEGG | KEGG:04926 | Relaxin signaling pathway | 66 | 100 | 1.13e-02 |
| KEGG | KEGG:05170 | Human immunodeficiency virus 1 infection | 94 | 149 | 1.16e-02 |
| KEGG | KEGG:04360 | Axon guidance | 97 | 155 | 1.28e-02 |
| KEGG | KEGG:04657 | IL-17 signaling pathway | 39 | 55 | 1.28e-02 |
| KEGG | KEGG:04810 | Regulation of actin cytoskeleton | 105 | 169 | 1.28e-02 |
| KEGG | KEGG:05226 | Gastric cancer | 73 | 113 | 1.28e-02 |
| KEGG | KEGG:05166 | Human T-cell leukemia virus 1 infection | 102 | 164 | 1.28e-02 |
| KEGG | KEGG:03083 | Polycomb repressive complex | 48 | 70 | 1.28e-02 |
| KEGG | KEGG:04151 | PI3K-Akt signaling pathway | 150 | 250 | 1.28e-02 |
| KEGG | KEGG:04217 | Necroptosis | 65 | 99 | 1.28e-02 |
| KEGG | KEGG:04664 | Fc epsilon RI signaling pathway | 31 | 42 | 1.29e-02 |
| KEGG | KEGG:05417 | Lipid and atherosclerosis | 90 | 143 | 1.29e-02 |
| KEGG | KEGG:05220 | Chronic myeloid leukemia | 49 | 72 | 1.35e-02 |
| KEGG | KEGG:04660 | T cell receptor signaling pathway | 56 | 84 | 1.37e-02 |
| KEGG | KEGG:04730 | Long-term depression | 29 | 39 | 1.38e-02 |
| KEGG | KEGG:03082 | ATP-dependent chromatin remodeling | 60 | 91 | 1.39e-02 |
| KEGG | KEGG:04340 | Hedgehog signaling pathway | 35 | 49 | 1.47e-02 |
| KEGG | KEGG:04920 | Adipocytokine signaling pathway | 35 | 49 | 1.47e-02 |
| KEGG | KEGG:05210 | Colorectal cancer | 54 | 81 | 1.47e-02 |
| KEGG | KEGG:04392 | Hippo signaling pathway - multiple species | 20 | 25 | 1.47e-02 |
| KEGG | KEGG:04144 | Endocytosis | 130 | 216 | 1.58e-02 |
| KEGG | KEGG:04014 | Ras signaling pathway | 101 | 164 | 1.64e-02 |
| KEGG | KEGG:04921 | Oxytocin signaling pathway | 72 | 113 | 1.81e-02 |
| KEGG | KEGG:05224 | Breast cancer | 72 | 113 | 1.81e-02 |
| KEGG | KEGG:04218 | Cellular senescence | 85 | 136 | 1.81e-02 |
| KEGG | KEGG:04012 | ErbB signaling pathway | 50 | 75 | 1.81e-02 |
| KEGG | KEGG:05202 | Transcriptional misregulation in cancer | 77 | 122 | 1.81e-02 |
| KEGG | KEGG:04150 | mTOR signaling pathway | 81 | 129 | 1.81e-02 |
| KEGG | KEGG:04666 | Fc gamma R-mediated phagocytosis | 50 | 75 | 1.81e-02 |
| KEGG | KEGG:04141 | Protein processing in endoplasmic reticulum | 92 | 149 | 1.96e-02 |
| KEGG | KEGG:05145 | Toxoplasmosis | 48 | 72 | 2.11e-02 |
| KEGG | KEGG:05211 | Renal cell carcinoma | 42 | 62 | 2.30e-02 |
| KEGG | KEGG:04330 | Notch signaling pathway | 36 | 52 | 2.34e-02 |
| KEGG | KEGG:04710 | Circadian rhythm | 22 | 29 | 2.34e-02 |
| KEGG | KEGG:04611 | Platelet activation | 57 | 88 | 2.34e-02 |
| KEGG | KEGG:05418 | Fluid shear stress and atherosclerosis | 69 | 109 | 2.34e-02 |
| KEGG | KEGG:04022 | cGMP-PKG signaling pathway | 80 | 129 | 2.65e-02 |
| KEGG | KEGG:04068 | FoxO signaling pathway | 67 | 106 | 2.67e-02 |
| KEGG | KEGG:04919 | Thyroid hormone signaling pathway | 66 | 105 | 3.35e-02 |
| KEGG | KEGG:04979 | Cholesterol metabolism | 24 | 33 | 3.63e-02 |
| KEGG | KEGG:01521 | EGFR tyrosine kinase inhibitor resistance | 47 | 72 | 3.66e-02 |
| KEGG | KEGG:05412 | Arrhythmogenic right ventricular cardiomyopathy | 44 | 67 | 3.90e-02 |
| KEGG | KEGG:04915 | Estrogen signaling pathway | 57 | 90 | 4.26e-02 |
| KEGG | KEGG:04070 | Phosphatidylinositol signaling system | 53 | 83 | 4.26e-02 |
| KEGG | KEGG:05161 | Hepatitis B | 77 | 126 | 4.51e-02 |
| KEGG | KEGG:04928 | Parathyroid hormone synthesis, secretion and action | 50 | 78 | 4.51e-02 |
| KEGG | KEGG:05212 | Pancreatic cancer | 46 | 71 | 4.51e-02 |
sessionInfo()R version 4.3.1 (2023-06-16 ucrt)
Platform: x86_64-w64-mingw32/x64 (64-bit)
Running under: Windows 10 x64 (build 19045)
Matrix products: default
locale:
[1] LC_COLLATE=English_United States.utf8
[2] LC_CTYPE=English_United States.utf8
[3] LC_MONETARY=English_United States.utf8
[4] LC_NUMERIC=C
[5] LC_TIME=English_United States.utf8
time zone: America/Chicago
tzcode source: internal
attached base packages:
[1] grid stats4 stats graphics grDevices utils datasets
[8] methods base
other attached packages:
[1] biomaRt_2.58.2
[2] ggpubr_0.6.0
[3] BiocParallel_1.36.0
[4] scales_1.3.0
[5] VennDiagram_1.7.3
[6] futile.logger_1.4.3
[7] gridExtra_2.3
[8] ggfortify_0.4.17
[9] edgeR_4.0.16
[10] limma_3.58.1
[11] rtracklayer_1.62.0
[12] org.Hs.eg.db_3.18.0
[13] TxDb.Hsapiens.UCSC.hg38.knownGene_3.18.0
[14] GenomicFeatures_1.54.4
[15] AnnotationDbi_1.64.1
[16] Biobase_2.62.0
[17] GenomicRanges_1.54.1
[18] GenomeInfoDb_1.38.8
[19] IRanges_2.36.0
[20] S4Vectors_0.40.2
[21] BiocGenerics_0.48.1
[22] ChIPseeker_1.38.0
[23] gprofiler2_0.2.3
[24] RColorBrewer_1.1-3
[25] broom_1.0.5
[26] kableExtra_1.4.0
[27] lubridate_1.9.3
[28] forcats_1.0.0
[29] stringr_1.5.1
[30] dplyr_1.1.4
[31] purrr_1.0.2
[32] readr_2.1.5
[33] tidyr_1.3.1
[34] tibble_3.2.1
[35] ggplot2_3.5.1
[36] tidyverse_2.0.0
[37] workflowr_1.7.1
loaded via a namespace (and not attached):
[1] fs_1.6.4
[2] matrixStats_1.3.0
[3] bitops_1.0-7
[4] enrichplot_1.22.0
[5] HDO.db_0.99.1
[6] httr_1.4.7
[7] tools_4.3.1
[8] backports_1.4.1
[9] utf8_1.2.4
[10] R6_2.5.1
[11] lazyeval_0.2.2
[12] withr_3.0.0
[13] prettyunits_1.2.0
[14] cli_3.6.2
[15] formatR_1.14
[16] scatterpie_0.2.2
[17] labeling_0.4.3
[18] sass_0.4.9
[19] Rsamtools_2.18.0
[20] systemfonts_1.0.6
[21] yulab.utils_0.1.4
[22] DOSE_3.28.2
[23] svglite_2.1.3
[24] plotrix_3.8-4
[25] rstudioapi_0.16.0
[26] RSQLite_2.3.6
[27] generics_0.1.3
[28] gridGraphics_0.5-1
[29] TxDb.Hsapiens.UCSC.hg19.knownGene_3.2.2
[30] BiocIO_1.12.0
[31] crosstalk_1.2.1
[32] vroom_1.6.5
[33] gtools_3.9.5
[34] car_3.1-2
[35] GO.db_3.18.0
[36] Matrix_1.6-5
[37] fansi_1.0.6
[38] abind_1.4-5
[39] lifecycle_1.0.4
[40] whisker_0.4.1
[41] yaml_2.3.8
[42] carData_3.0-5
[43] SummarizedExperiment_1.32.0
[44] gplots_3.1.3.1
[45] qvalue_2.34.0
[46] SparseArray_1.2.4
[47] BiocFileCache_2.10.2
[48] blob_1.2.4
[49] promises_1.3.0
[50] crayon_1.5.2
[51] lattice_0.22-6
[52] cowplot_1.1.3
[53] KEGGREST_1.42.0
[54] pillar_1.9.0
[55] knitr_1.46
[56] fgsea_1.28.0
[57] rjson_0.2.21
[58] boot_1.3-30
[59] codetools_0.2-20
[60] fastmatch_1.1-4
[61] glue_1.7.0
[62] getPass_0.2-4
[63] ggfun_0.1.4
[64] data.table_1.15.4
[65] vctrs_0.6.5
[66] png_0.1-8
[67] treeio_1.26.0
[68] gtable_0.3.5
[69] cachem_1.0.8
[70] xfun_0.44
[71] S4Arrays_1.2.1
[72] mime_0.12
[73] tidygraph_1.3.1
[74] statmod_1.5.0
[75] interactiveDisplayBase_1.40.0
[76] nlme_3.1-164
[77] ggtree_3.10.1
[78] bit64_4.0.5
[79] progress_1.2.3
[80] filelock_1.0.3
[81] rprojroot_2.0.4
[82] bslib_0.7.0
[83] KernSmooth_2.23-22
[84] colorspace_2.1-0
[85] DBI_1.2.2
[86] tidyselect_1.2.1
[87] processx_3.8.4
[88] bit_4.0.5
[89] compiler_4.3.1
[90] curl_5.2.1
[91] git2r_0.33.0
[92] xml2_1.3.6
[93] DelayedArray_0.28.0
[94] plotly_4.10.4
[95] shadowtext_0.1.3
[96] caTools_1.18.2
[97] callr_3.7.6
[98] rappdirs_0.3.3
[99] digest_0.6.35
[100] rmarkdown_2.26
[101] XVector_0.42.0
[102] htmltools_0.5.8.1
[103] pkgconfig_2.0.3
[104] MatrixGenerics_1.14.0
[105] highr_0.10
[106] dbplyr_2.5.0
[107] fastmap_1.1.1
[108] rlang_1.1.3
[109] htmlwidgets_1.6.4
[110] shiny_1.8.1.1
[111] farver_2.1.2
[112] jquerylib_0.1.4
[113] jsonlite_1.8.8
[114] GOSemSim_2.28.1
[115] RCurl_1.98-1.14
[116] magrittr_2.0.3
[117] GenomeInfoDbData_1.2.11
[118] ggplotify_0.1.2
[119] patchwork_1.2.0
[120] munsell_0.5.1
[121] Rcpp_1.0.12
[122] ape_5.8
[123] viridis_0.6.5
[124] stringi_1.8.4
[125] ggraph_2.2.1
[126] zlibbioc_1.48.2
[127] MASS_7.3-60.0.1
[128] AnnotationHub_3.10.1
[129] plyr_1.8.9
[130] parallel_4.3.1
[131] ggrepel_0.9.5
[132] Biostrings_2.70.3
[133] graphlayouts_1.1.1
[134] splines_4.3.1
[135] hms_1.1.3
[136] locfit_1.5-9.9
[137] ps_1.7.6
[138] igraph_2.0.3
[139] ggsignif_0.6.4
[140] reshape2_1.4.4
[141] futile.options_1.0.1
[142] BiocVersion_3.18.1
[143] XML_3.99-0.16.1
[144] evaluate_0.23
[145] lambda.r_1.2.4
[146] BiocManager_1.30.23
[147] tzdb_0.4.0
[148] tweenr_2.0.3
[149] httpuv_1.6.15
[150] polyclip_1.10-6
[151] ggforce_0.4.2
[152] xtable_1.8-4
[153] restfulr_0.0.15
[154] tidytree_0.4.6
[155] rstatix_0.7.2
[156] later_1.3.2
[157] viridisLite_0.4.2
[158] aplot_0.2.2
[159] memoise_2.0.1
[160] GenomicAlignments_1.38.2
[161] timechange_0.3.0